
<html lang="en"     class="pb-page"  data-request-id="c114d4ca-6766-4b6d-8b08-b4eb50de7a83"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/acs.jmedchem.6b00544;issue:issue:10.1021/jmcmar.2016.59.issue-13;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Discovery of the Potent and Selective M1 PAM-Agonist N-[(3R,4S)-3-Hydroxytetrahydro-2H-pyran-4-yl]-5-methyl-4-[4-(1,3-thiazol-4-yl)benzyl]pyridine-2-carboxamide (PF-06767832): Evaluation of Efficacy and Cholinergic Side Effects" /></meta><meta name="dc.Creator" content="Jennifer E.  Davoren" /></meta><meta name="dc.Creator" content="Che-Wah  Lee" /></meta><meta name="dc.Creator" content="Michelle  Garnsey" /></meta><meta name="dc.Creator" content="Michael A.  Brodney" /></meta><meta name="dc.Creator" content="Jason  Cordes" /></meta><meta name="dc.Creator" content="Keith  Dlugolenski" /></meta><meta name="dc.Creator" content="Jeremy R.  Edgerton" /></meta><meta name="dc.Creator" content="Anthony R.  Harris" /></meta><meta name="dc.Creator" content="Christopher J.  Helal" /></meta><meta name="dc.Creator" content="Stephen  Jenkinson" /></meta><meta name="dc.Creator" content="Gregory W.  Kauffman" /></meta><meta name="dc.Creator" content="Terrence P.  Kenakin" /></meta><meta name="dc.Creator" content="John T.  Lazzaro" /></meta><meta name="dc.Creator" content="Susan M.  Lotarski" /></meta><meta name="dc.Creator" content="Yuxia  Mao" /></meta><meta name="dc.Creator" content="Deane M.  Nason" /></meta><meta name="dc.Creator" content="Carrie  Northcott" /></meta><meta name="dc.Creator" content="Lisa  Nottebaum" /></meta><meta name="dc.Creator" content="Steven V.  O’Neil" /></meta><meta name="dc.Creator" content="Betty  Pettersen" /></meta><meta name="dc.Creator" content="Michael  Popiolek" /></meta><meta name="dc.Creator" content="Veronica  Reinhart" /></meta><meta name="dc.Creator" content="Romelia  Salomon-Ferrer" /></meta><meta name="dc.Creator" content="Stefanus J.  Steyn" /></meta><meta name="dc.Creator" content="Damien  Webb" /></meta><meta name="dc.Creator" content="Lei  Zhang" /></meta><meta name="dc.Creator" content="Sarah  Grimwood" /></meta><meta name="dc.Description" content="It is hypothesized that selective muscarinic M1 subtype activation could be a strategy to provide cognitive benefits to schizophrenia and Alzheimer’s disease patients while minimizing the cholinerg..." /></meta><meta name="Description" content="It is hypothesized that selective muscarinic M1 subtype activation could be a strategy to provide cognitive benefits to schizophrenia and Alzheimer’s disease patients while minimizing the cholinerg..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="July 1, 2016" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.6b00544" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2016 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.6b00544" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.6b00544" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.6b00544" /></link>
        
    
    

<title>Discovery of the Potent and Selective M1 PAM-Agonist N-[(3R,4S)-3-Hydroxytetrahydro-2H-pyran-4-yl]-5-methyl-4-[4-(1,3-thiazol-4-yl)benzyl]pyridine-2-carboxamide (PF-06767832): Evaluation of Efficacy and Cholinergic Side Effects | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.6b00544" /></meta><meta property="og:title" content="Discovery of the Potent and Selective M1 PAM-Agonist N-[(3R,4S)-3-Hydroxytetrahydro-2H-pyran-4-yl]-5-methyl-4-[4-(1,3-thiazol-4-yl)benzyl]pyridine-2-carboxamide (PF-06767832): Evaluation of Efficacy and Cholinergic Side Effects" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00544/20160708/images/large/jm-2016-005448_0019.jpeg" /></meta><meta property="og:description" content="It is hypothesized that selective muscarinic M1 subtype activation could be a strategy to provide cognitive benefits to schizophrenia and Alzheimer’s disease patients while minimizing the cholinergic side effects observed with nonselective muscarinic orthosteric agonists. Selective activation of M1 with a positive allosteric modulator (PAM) has emerged as a new approach to achieve selective M1 activation. This manuscript describes the development of a series of M1-selective pyridone and pyridine amides and their key pharmacophores. Compound 38 (PF-06767832) is a high quality M1 selective PAM that has well-aligned physicochemical properties, good brain penetration and pharmacokinetic properties. Extensive safety profiling suggested that despite being devoid of mAChR M2/M3 subtype activity, compound 38 still carries gastrointestinal and cardiovascular side effects. These data provide strong evidence that M1 activation contributes to the cholinergic liabilities that were previously attributed to activation of the M2 and M3 receptors." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.6b00544"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.6b00544">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.6b00544&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.6b00544&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.6b00544&amp;href=/doi/10.1021/acs.jmedchem.6b00544" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2016</span><span class="cit-fg-volume">, 59</span><span class="cit-fg-issue">, 13</span><span class="cit-fg-pageRange">, 6313-6328</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/59/13" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.6b00537" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.6b00571" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Discovery of the Potent and Selective M1 PAM-Agonist <i>N</i>-[(3<i>R</i>,4<i>S</i>)-3-Hydroxytetrahydro-2<i>H</i>-pyran-4-yl]-5-methyl-4-[4-(1,3-thiazol-4-yl)benzyl]pyridine-2-carboxamide (PF-06767832): Evaluation of Efficacy and Cholinergic Side Effects</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jennifer+E.++Davoren">Jennifer E. Davoren</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Che-Wah++Lee">Che-Wah Lee</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Michelle++Garnsey">Michelle Garnsey</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Michael+A.++Brodney">Michael A. Brodney</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jason++Cordes">Jason Cordes</a></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Keith++Dlugolenski">Keith Dlugolenski</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jeremy+R.++Edgerton">Jeremy R. Edgerton</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Anthony+R.++Harris">Anthony R. Harris</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Christopher+J.++Helal">Christopher J. Helal</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Stephen++Jenkinson">Stephen Jenkinson</a></span><span class="author-xref-symbol author-aff-symbol"><sup>○</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Gregory+W.++Kauffman">Gregory W. Kauffman</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Terrence+P.++Kenakin">Terrence P. Kenakin</a></span><span class="author-xref-symbol author-aff-symbol"><sup>◇</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=John+T.++Lazzaro">John T. Lazzaro</a></span><span class="author-xref-symbol author-aff-symbol"><sup>#</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Susan+M.++Lotarski">Susan M. Lotarski</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yuxia++Mao">Yuxia Mao</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∇</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Deane+M.++Nason">Deane M. Nason</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Carrie++Northcott">Carrie Northcott</a></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Lisa++Nottebaum">Lisa Nottebaum</a></span><span class="author-xref-symbol author-aff-symbol"><sup>○</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Steven+V.++O%E2%80%99Neil">Steven V. O’Neil</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Betty++Pettersen">Betty Pettersen</a></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Michael++Popiolek">Michael Popiolek</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Veronica++Reinhart">Veronica Reinhart</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Romelia++Salomon-Ferrer">Romelia Salomon-Ferrer</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Stefanus+J.++Steyn">Stefanus J. Steyn</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Damien++Webb">Damien Webb</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Lei++Zhang">Lei Zhang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sarah++Grimwood">Sarah Grimwood</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-text"><sup>†</sup>Neuroscience and Pain Medicinal Chemistry, <sup>‡</sup>Neuroscience and Pain Research Unit, and <sup>§</sup>Pharmacokinetics, Dynamics and Metabolism, Pfizer Worldwide Research and Development, Cambridge, Massachusetts 02139, United States</span></div><div class="aff-info" id="aff2"><span class="aff-text"><sup>∥</sup>Neuroscience and Pain Medicinal Chemistry, <sup>⊥</sup>Drug Safety Research and Development, <sup>#</sup>Primary Pharmacology Group, and <sup>∇</sup>Research Formulations, Pfizer Worldwide Research and Development, Groton, Connecticut 06340, United States</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">○</span> <span class="aff-text">Drug Safety Research and Development, Pfizer Worldwide Research and Development, La Jolla, California 92121, United States</span></div><div class="aff-info" id="aff4"><span class="aff-symbol">◇</span> <span class="aff-text">Department of Pharmacology, University of North Carolina School of Medicine, Chapel Hill, North Carolina 27599, United States</span></div><div class="corresp-info"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#8be1eee5e5e2edeef9a5eea5efeafde4f9eee5cbfbede2f1eef9a5e8e4e6"><span class="__cf_email__" data-cfemail="cfa5aaa1a1a6a9aabde1aae1abaeb9a0bdaaa18fbfa9a6b5aabde1aca0a2">[email protected]</span></a>. Phone: 1-617-395-0655.</div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.6b00544&amp;href=/doi/10.1021%2Facs.jmedchem.6b00544" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2016</span></span><span class="cit-volume">, 59</span><span class="cit-issue">, 13</span><span class="cit-pageRange">, 6313–6328</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">June 8, 2016</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>11 April 2016</li><li><span class="item_label"><b>Published</b> online</span>1 July 2016</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 14 July 2016</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.6b00544" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b00544</a></div><div class="article_header-article-copyright"><strong>Copyright © 2016 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D6313%26pageCount%3D16%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DJennifer%2BE.%2BDavoren%252C%2BChe-Wah%2BLee%252C%2BMichelle%2BGarnsey%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D59%26issueNum%3D13%26contentID%3Dacs.jmedchem.6b00544%26title%3DDiscovery%2Bof%2Bthe%2BPotent%2Band%2BSelective%2BM1%2BPAM-Agonist%2BN-%255B%25283R%252C4S%2529-3-Hydroxytetrahydro-2H-pyran-4-yl%255D-5-methyl-4-%255B4-%25281%252C3-thiazol-4-yl%2529benzyl%255Dpyridine-2-carboxamide%2B%2528PF-06767832%2529%253A%2BEvaluation%2Bof%2BEfficacy%2Band%2BCholinergic%2BSide%2BEffects%26numPages%3D16%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D6328%26publicationDate%3DJuly%2B2016">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.6b00544"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">3207</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">52</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.6b00544" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Discovery of the Potent and Selective M1 PAM-Agonist N-[(3R,4S)-3-Hydroxytetrahydro-2H-pyran-4-yl]-5-methyl-4-[4-(1,3-thiazol-4-yl)benzyl]pyridine-2-carboxamide (PF-06767832): Evaluation of Efficacy and Cholinergic Side Effects&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Jennifer&quot;,&quot;last_name&quot;:&quot;E. Davoren&quot;},{&quot;first_name&quot;:&quot;Che-Wah&quot;,&quot;last_name&quot;:&quot;Lee&quot;},{&quot;first_name&quot;:&quot;Michelle&quot;,&quot;last_name&quot;:&quot;Garnsey&quot;},{&quot;first_name&quot;:&quot;Michael&quot;,&quot;last_name&quot;:&quot;A. Brodney&quot;},{&quot;first_name&quot;:&quot;Jason&quot;,&quot;last_name&quot;:&quot;Cordes&quot;},{&quot;first_name&quot;:&quot;Keith&quot;,&quot;last_name&quot;:&quot;Dlugolenski&quot;},{&quot;first_name&quot;:&quot;Jeremy&quot;,&quot;last_name&quot;:&quot;R. Edgerton&quot;},{&quot;first_name&quot;:&quot;Anthony&quot;,&quot;last_name&quot;:&quot;R. Harris&quot;},{&quot;first_name&quot;:&quot;Christopher&quot;,&quot;last_name&quot;:&quot;J. Helal&quot;},{&quot;first_name&quot;:&quot;Stephen&quot;,&quot;last_name&quot;:&quot;Jenkinson&quot;},{&quot;first_name&quot;:&quot;Gregory&quot;,&quot;last_name&quot;:&quot;W. Kauffman&quot;},{&quot;first_name&quot;:&quot;Terrence&quot;,&quot;last_name&quot;:&quot;P. Kenakin&quot;},{&quot;first_name&quot;:&quot;John&quot;,&quot;last_name&quot;:&quot;T. Lazzaro&quot;},{&quot;first_name&quot;:&quot;Susan&quot;,&quot;last_name&quot;:&quot;M. Lotarski&quot;},{&quot;first_name&quot;:&quot;Yuxia&quot;,&quot;last_name&quot;:&quot;Mao&quot;},{&quot;first_name&quot;:&quot;Deane&quot;,&quot;last_name&quot;:&quot;M. Nason&quot;},{&quot;first_name&quot;:&quot;Carrie&quot;,&quot;last_name&quot;:&quot;Northcott&quot;},{&quot;first_name&quot;:&quot;Lisa&quot;,&quot;last_name&quot;:&quot;Nottebaum&quot;},{&quot;first_name&quot;:&quot;Steven&quot;,&quot;last_name&quot;:&quot;V. O’Neil&quot;},{&quot;first_name&quot;:&quot;Betty&quot;,&quot;last_name&quot;:&quot;Pettersen&quot;},{&quot;first_name&quot;:&quot;Michael&quot;,&quot;last_name&quot;:&quot;Popiolek&quot;},{&quot;first_name&quot;:&quot;Veronica&quot;,&quot;last_name&quot;:&quot;Reinhart&quot;},{&quot;first_name&quot;:&quot;Romelia&quot;,&quot;last_name&quot;:&quot;Salomon-Ferrer&quot;},{&quot;first_name&quot;:&quot;Stefanus&quot;,&quot;last_name&quot;:&quot;J. Steyn&quot;},{&quot;first_name&quot;:&quot;Damien&quot;,&quot;last_name&quot;:&quot;Webb&quot;},{&quot;first_name&quot;:&quot;Lei&quot;,&quot;last_name&quot;:&quot;Zhang&quot;},{&quot;first_name&quot;:&quot;Sarah&quot;,&quot;last_name&quot;:&quot;Grimwood&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2016&quot;,&quot;month&quot;:&quot;07&quot;,&quot;day&quot;:&quot;01&quot;,&quot;issue&quot;:&quot;13&quot;,&quot;volume&quot;:&quot;59&quot;,&quot;pages&quot;:&quot;6313-6328&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.6b00544&quot;},&quot;abstract&quot;:&quot;It is hypothesized that selective muscarinic M1 subtype activation could be a strategy to provide cognitive benefits to schizophrenia and Alzheimer’s disease patients while minimizing the cholinergic side effects observed with nonselective muscarinic orthosteric agonists. Selective activation of M1 with a positive allosteric modulator (PAM) has emerged as a new approach to achieve selective M1 activation. This manuscript describes the development of a series of M1-selective pyridone and pyridine amides and their key pharmacophores. Compound 38 (PF-06767832) is a high quality M1 selective PAM that has well-aligned physicochemical properties, good brain penetration and pharmacokinetic properties. Extensive safety profiling suggested that despite being devoid of mAChR M2/M3 subtype activity, compound 38 still carries gastrointestinal and cardiovascular side effects. These data provide strong evidence that M1 activation contributes to the cholinergic liabilities that were previously attributed to activation of th&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b00544&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b00544" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b00544&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b00544" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b00544&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b00544" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.6b00544&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b00544&amp;href=/doi/10.1021/acs.jmedchem.6b00544" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.6b00544" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.6b00544" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (4 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b00544&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.6b00544%26sid%3Dliteratum%253Aachs%26pmid%3D27275946%26genre%3Darticle%26aulast%3DDavoren%26date%3D2016%26atitle%3DDiscovery%2Bof%2Bthe%2BPotent%2Band%2BSelective%2BM1%2BPAM-Agonist%2BN-%255B%25283R%252C4S%2529-3-Hydroxytetrahydro-2H-pyran-4-yl%255D-5-methyl-4-%255B4-%25281%252C3-thiazol-4-yl%2529benzyl%255Dpyridine-2-carboxamide%2B%2528PF-06767832%2529%253A%2BEvaluation%2Bof%2BEfficacy%2Band%2BCholinergic%2BSide%2BEffects%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D59%26issue%3D13%26spage%3D6313%26epage%3D6328%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291713" title="Polyacrylamide">Polyacrylamide</a>,</li><li><a href="/action/doSearch?ConceptID=292589" title="Agonists">Agonists</a>,</li><li><a href="/action/doSearch?ConceptID=292462" title="Central nervous system">Central nervous system</a>,</li><li><a href="/action/doSearch?ConceptID=291350" title="Assays">Assays</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/59/13" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/jmcmar.2016.59.issue-13/20160714/jmcmar.2016.59.issue-13.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_null" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00544/20160708/images/medium/jm-2016-005448_0019.gif" alt="" id="_i1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00544/20160708/images/large/jm-2016-005448_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00544&amp;id=f_null"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">It is hypothesized that selective muscarinic M<sub>1</sub> subtype activation could be a strategy to provide cognitive benefits to schizophrenia and Alzheimer’s disease patients while minimizing the cholinergic side effects observed with nonselective muscarinic orthosteric agonists. Selective activation of M<sub>1</sub> with a positive allosteric modulator (PAM) has emerged as a new approach to achieve selective M<sub>1</sub> activation. This manuscript describes the development of a series of M<sub>1</sub>-selective pyridone and pyridine amides and their key pharmacophores. Compound <b>38</b> (PF-06767832) is a high quality M<sub>1</sub> selective PAM that has well-aligned physicochemical properties, good brain penetration and pharmacokinetic properties. Extensive safety profiling suggested that despite being devoid of mAChR M<sub>2</sub>/M<sub>3</sub> subtype activity, compound <b>38</b> still carries gastrointestinal and cardiovascular side effects. These data provide strong evidence that M<sub>1</sub> activation contributes to the cholinergic liabilities that were previously attributed to activation of the M<sub>2</sub> and M<sub>3</sub> receptors.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_68552" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_68552" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The muscarinic acetylcholine receptors (mAChRs) are a family of five G-protein-coupled receptors that serve a wide variety of functions within the central and peripheral nervous systems. Decades of positive preclinical and clinical data on the pharmacology of the mAChRs make them attractive targets for addressing the cognitive and psychiatric symptoms associated with schizophrenia and Alzheimer’s disease (AD). Of the five mAChRs, the M<sub>1</sub> subtype is believed to be important for cognition and attention, with potential benefit for the treatment of cognitive and psychiatric symptoms exhibited by those suffering from AD and schizophrenia.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> The search for a fully selective M<sub>1</sub> agonist has been a pharmaceutical quest for many decades.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> Historically, these efforts have met with little success due to the high sequence homology of the orthosteric binding site across all five mAChRs,<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> although a more recent entry by Heptares appears promising.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> In 2009, Merck disclosed another approach toward M<sub>1</sub> activation with their discovery of the highly M<sub>1</sub>-selective positive allosteric modulator (PAM) BQCA (<b>1</b>),<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> and later PQCA (<b>2</b>)<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>). These modulators are believed to bind at an allosteric pocket above the orthosteric site on the extracellular side of the M<sub>1</sub> receptor (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>). This putative binding site shares ≤83% homology<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> with its nearest mAChR subtype neighbors, M<sub>4</sub> and M<sub>5</sub>, which provides a rationale for the M<sub>1</sub> selectivity of these ligands.<a onclick="showRef(event, 'ref3 ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref3 ref8 ref9">(3, 8, 9)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00544/20160708/images/medium/jm-2016-005448_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00544/20160708/images/large/jm-2016-005448_0001.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structural diversity of M<sub>1</sub> PAM chemotypes.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00544/20160708/images/large/jm-2016-005448_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00544&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00544/20160708/images/medium/jm-2016-005448_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00544/20160708/images/large/jm-2016-005448_0002.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Homology model of the active-state M<sub>1</sub> receptor with the orthosteric site (yellow) and the allosteric site (purple). The two sites are separated by a hydrogen bonded typrosine lid<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> located superficial to the agonist.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00544/20160708/images/large/jm-2016-005448_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00544&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">PQCA (<b>2</b>) demonstrated robust efficacy in rodent and non-human primate (NHP) cognition assays<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> and further optimization of <b>2</b> resulted in a multitude of unique, potent chemotypes being disclosed in both the primary literature<a onclick="showRef(event, 'ref6 ref11'); return false;" href="javascript:void(0);" class="ref ref6 ref11">(6, 11)</a> and the Merck patent estate.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> Two such examples include lactam <b>3</b><a onclick="showRef(event, 'cit11d'); return false;" href="javascript:void(0);" class="ref cit11d">(11d)</a> and tricyclic pyrimidone <b>4</b>.<a onclick="showRef(event, 'cit12ae'); return false;" href="javascript:void(0);" class="ref cit12ae">(12ae)</a> Furthermore, Merck recently began a phase II clinical study with the M<sub>1</sub> allosteric modulator MK-7622 (structure not disclosed) to assess its efficacy and safety as an adjunct therapy in patients with Alzheimer’s disease.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> These impressive disclosures have garnered considerable attention<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> from the medicinal chemistry community and have led to the development of a number of additional structurally unique chemotypes. Examples showcasing this diversity include, but are not limited to, indole <b>5</b>,<a onclick="showRef(event, 'cit11d'); return false;" href="javascript:void(0);" class="ref cit11d">(11d)</a> azaindole amide <b>6</b>,<a onclick="showRef(event, 'cit14z'); return false;" href="javascript:void(0);" class="ref cit14z">(14z)</a> 4-alkyloxypyrrolopyrimidinone <b>7</b>,<a onclick="showRef(event, 'cit14w'); return false;" href="javascript:void(0);" class="ref cit14w">(14w)</a> pyrazolepyrimidine <b>8</b>,<a onclick="showRef(event, 'cit14v'); return false;" href="javascript:void(0);" class="ref cit14v">(14v)</a> and 6-phenylpyrimidinone <b>9</b><a onclick="showRef(event, 'cit14y'); return false;" href="javascript:void(0);" class="ref cit14y">(14y)</a> (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>).</div><div class="NLM_p last">Our own efforts in this area have yielded multiple chemically attractive series.<a onclick="showRef(event, 'cit14z ref15'); return false;" href="javascript:void(0);" class="ref cit14z ref15">(14z, 15)</a> Here we describe the SAR, properties, safety, and pharmacology of an optimized series of M<sub>1</sub> PAMs containing a pyridine core. Multiple design iterations targeting improved CNS penetration and potency furnished lead compound <b>38</b> (PF-06767832<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a>), a brain-penetrant M<sub>1</sub> selective PAM with no observed off-target pharmacology across a broad selectivity panel. Compound <b>38</b> demonstrates a robust potentiation of acetylcholine (ACh) activity in in vitro cell-based assays and is active in multiple in vivo models. Compound <b>38</b> was advanced into safety toxicology studies in both rat and dog. While no significant safety findings were observed in rats, clear signs of GI AEs and convulsion were observed in dogs, bringing into question the strategy of targeting selective M<sub>1</sub> activity to avoid cholinergic liabilities.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_10370" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_10370" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The program leading to discovery of compound <b>38</b> began as an effort to identify the minimum pharmacophore required for M<sub>1</sub> modulation. The quinolizinone core of PQCA analogue <b>10</b><a onclick="showRef(event, 'cit11b'); return false;" href="javascript:void(0);" class="ref cit11b">(11b)</a> was truncated<a onclick="showRef(event, 'cit14aa'); return false;" href="javascript:void(0);" class="ref cit14aa">(14aa)</a> and a methyl group was installed at the 6-position to enforce the optimal three-dimensional bent geometry of the benzyl group, as depicted in <a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>. We believe that the benzyl group orientation and an intramolecular hydrogen bond (IMHB) between the amide N–H and pyridone carbonyl are essential components of the M<sub>1</sub> PAM pharmacophore. To further optimize properties toward a more favorable CNS profile,<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> the piperidine in <b>10</b> was replaced with a less basic pyrazole-substituted benzyl group, which we had previously identified in our azaindole amide series.<a onclick="showRef(event, 'cit14z'); return false;" href="javascript:void(0);" class="ref cit14z">(14z)</a> These modifications resulted in pyridone <b>11</b> as an early lead.</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00544/20160708/images/medium/jm-2016-005448_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00544/20160708/images/large/jm-2016-005448_0003.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Evolution of the pyridone M<sub>1</sub> PAM <b>11</b> from PQCA analogue <b>10</b>. The 6-methyl substitution on the pyridone core reinforces the bent three-dimensional geometry predicted by the docked pose in our homology mode to be optimal for binding.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00544/20160708/images/large/jm-2016-005448_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00544&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The initial synthetic approach to analogs in the pyridone series is shown in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a> (route A). Conversion of bromide <b>12</b> to pinacol boronate <b>13</b>, followed by Suzuki coupling with a 4-substituted benzyl halide, afforded compounds of type <b>14</b>. Ester hydrolysis and subsequent amide formation with either (3<i>R</i>,4<i>S</i>)-4-aminotetrahydro-2<i>H</i>-pyran-3-ol (THP) or (1<i>S</i>,2<i>S</i>)-2-aminocyclohexan-1-ol (cyclohexanol) furnished analogues of type <b>16</b>.</div><figure id="sch1" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00544/20160708/images/medium/jm-2016-005448_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00544/20160708/images/large/jm-2016-005448_0010.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Pyridone M<sub>1</sub> PAMs<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00544/20160708/images/large/jm-2016-005448_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00544&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) B<sub>2</sub>pin<sub>2</sub>, Pd(dppf)Cl<sub>2</sub>·CH<sub>2</sub>Cl<sub>2</sub>, KOAc, toluene, 110 °C, 76%; (b) benzyl halide, Pd(PPh<sub>3</sub>)<sub>4</sub>, aq K<sub>2</sub>CO<sub>3</sub>, 110 °C, 85%; (c) NaOH, CH<sub>3</sub>OH, H<sub>2</sub>O, 80 °C, 58%; (d) amino alcohol, HATU, Et<sub>3</sub>N, DMF, rt, 45%; (e) NaOH, CH<sub>3</sub>OH, H<sub>2</sub>O, 92%; (f) amino alcohol, HATU, Et<sub>3</sub>N, DMF, rt, 85%; (g) B<sub>2</sub>pin<sub>2</sub>, Pd<sub>2</sub>(dba)<sub>3</sub>, PCy<sub>3</sub>, KOAc, dioxane, rt, 60%; (h) 2-(4-(bromomethyl)phenyl)-6-methyl-1,3,6,2-dioxazaborocane-4,8-dione, Pd(PPh<sub>3</sub>)<sub>4</sub>, KF (dry solid), CH<sub>3</sub>CN, 80 °C, 90%; (i) aq NaHCO<sub>3</sub>, THF, MeOH, rt, 77%; (j) heteroaryl halide, Pd(PPh<sub>3</sub>)<sub>4</sub>, aq K<sub>2</sub>CO<sub>3</sub>, dioxane, 80 °C; (k) amine or azole, Cu(OAc)<sub>2</sub>, aq NaHCO<sub>3</sub>, pyridine, 60 °C.</p></p></figure><div class="NLM_p">To effectively explore diversity at R<sub>1</sub> using parallel medicinal chemistry (PMC), route B was developed. This alternative synthetic sequence exploits the recent introduction of <i>N</i>-methyliminodiacetic acid (MIDA) boronates as stable surrogates for boronic acids.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> MIDA-protected boronic acids are unreactive under anhydrous cross-coupling conditions but can be easily deprotected and coupled under basic aqueous conditions, thus permitting iterative cross-couplings and greatly streamlining synthetic sequences. Suzuki–Miyaura coupling of intermediate <b>19</b> with 4-MIDA benzyl bromide afforded <b>20</b> as a single product in high yield. Compound <b>20</b> proved to be a versatile template for R<sub>1</sub> SAR expansion using PMC. Hydrolysis of the MIDA boronate in <b>20</b> under mild conditions revealed the latent boronic acid, which was successfully coupled with five- and six-membered heteroaryl halides to give analogs of type <b>16</b>. Additionally, we were able to directly couple five- and six-membered heterocyclic amines by performing an unprecedented Chan–Lam coupling with the MIDA-functionalized intermediate and stoichiometric copper(II) acetate (step k) to afford N-linked products.</div><div class="NLM_p">We were encouraged to find that pyridone <b>11</b> was equally potent to quinolizinone <b>10</b> (M<sub>1</sub> PAM EC<sub>50</sub>, 31 vs 29 nM). The proposed binding mode of <b>11</b> in our M<sub>1</sub> homology model is consistent with our SAR data and with key M<sub>1</sub> residues identified through site-directed mutagenesis work.<a onclick="showRef(event, 'ref5 ref8'); return false;" href="javascript:void(0);" class="ref ref5 ref8">(5, 8)</a> The most notable features of this binding mode are π-stacking of the pyridone core with Trp400 and Tyr179 and the conformation of <b>11</b>, which is stabilized by the 6-methyl substitution that serves two purposes. First, it extends into a hydrophobic pocket, and second, it orients the aryl–heteroaryl linked portion (in this case phenyl–pyrazole) of the molecule to extend into an aromatic-rich pocket between transmembrane (TM) domains 2 and 7 (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>). Lastly, an IMHB locks the amide carbonyl in a conformation where it makes a through water hydrogen bond with GLN177.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a></div><figure id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00544/20160708/images/medium/jm-2016-005448_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00544/20160708/images/large/jm-2016-005448_0004.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Compound <b>11</b> docked in the allosteric site of the M<sub>1</sub> homology model with key interactions highlighted.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00544/20160708/images/large/jm-2016-005448_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00544&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">We explored the SAR of the amide in this pyridone series, but with the exception of a THP amide<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> (example <b>21</b>, <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>), no suitable replacements for the cyclohexanol were identified.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> Although the THP amide provided a considerable improvement in lipophilic efficiency (LipE)<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> relative to the cyclohexanol analog (6.26 vs 5.43), high MDR efflux ratios (ERs)<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> plagued THP amides in this series, preventing their further progression.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. SAR on the Benzyl Group of the Pyridone Series</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00544/20160708/images/medium/jm-2016-005448_0012.gif" alt="" id="fx18" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00544/20160708/images/medium/jm-2016-005448_0013.gif" alt="" id="fx19" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>Table a</sup><p class="last">Compound EC<sub>50</sub> values were measured in a potentiation assay format, with a calcium mobilization readout, on a FLIPR384 fluorometric plate reader (FLIPR) in the presence of an EC<sub>20</sub> concentration of ACh.</p></div><div class="footnote" id="t1fn2"><sup>Table b</sup><p class="last">EC<sub>50</sub> values represent the geometric mean of at least three experiments.</p></div><div class="footnote" id="t1fn3"><sup>Table c</sup><p class="last">LipE calculated as FLIPR pEC<sub>50</sub> – cElogD.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a></p></div><div class="footnote" id="t1fn4"><sup>Table d</sup><p class="last">Ratio of permeability measured as a rate in 10<sup>–6</sup> cm/s in and out (BA/AB) of a Madin–Darby canine kidney (MDCK) epithelial cell line transfected with the MDR1 gene encoding the P-gp efflux transporter.</p></div><div class="footnote" id="t1fn5"><sup>Table e</sup><p class="last">Intrinsic clearance in human liver microsomes (HLM).</p></div><div class="footnote" id="t1fn6"><sup>Table f</sup><p class="last">Permeability in the MDCKII-LE (RRCK)<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> cell line, given as a rate in 10<sup>–6</sup> cm/s.</p></div><div class="footnote" id="t1fn7"><sup>Table g</sup><p class="last">AUC ratio of the drug level in mouse brain to the drug level in plasma.</p></div><div class="footnote" id="t1fn8"><sup>Table h</sup><p class="last">n.d., not determined.</p></div></div><div></div></div><div class="NLM_p">Exploration at the 4-position of the benzyl group (R<sub>1</sub>, <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>) via Suzuki and Chan–Lam libraries (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>) was slightly more fruitful. A number of alkyl, alkoxy, five-membered, and six-membered heteroaromatics were well tolerated in this position (EC<sub>50</sub> < 500 nM). Saturated heterocyles such as <b>25</b> resulted in a substantial loss in potency consistent with our proposed binding mode. However, the majority of these modifications were accompanied by a concomitant increase in MDR ER and/or human liver microsomal (HLM) clearance (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>). No analogues with aligned potency (EC<sub>50</sub> < 100 nM), HLM clearance (<30 mL min<sup>–1</sup> kg<sup>–1</sup>) and MDR ER (<2) were identified (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>). Compounds <b>11</b> and <b>22</b>, which were close to meeting our criteria except for their MDR ER values, were advanced into a mouse neuropharmacokinetic (neuroPK) study to assess their brain penetration. Both compounds exhibited total brain/plasma (<i>B</i>/<i>P</i>) ratios of ≤0.05, indicating a level of brain exposure insufficient to demonstrate the desired pharmacology.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a></div><figure id="fig5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00544/20160708/images/medium/jm-2016-005448_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00544/20160708/images/large/jm-2016-005448_0005.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Analysis of all synthesized pyridones comparing M<sub>1</sub> PAM potency (pEC<sub>50</sub>) to intrinsic clearance (HLM). Compounds are colored by their MDR ER: green, <2; yellow, 2–3; red, >3.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00544/20160708/images/large/jm-2016-005448_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00544&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Given the difficulties encountered in the pyridone series with respect to high MDR ER and consequent low brain penetration, we elected to find an alternative core structure that had a reduced number of hydrogen bond acceptors (HBAs). Toward this end, a concise series of six-membered ring aromatic cores, both with and without an HBA at the 2-position of the ring, were prepared. These analogs were designed to challenge the need for an IMHB to confer activity. Since these modifications increased the lipophilicity of the target molecules, they were also predicted to increase their oxidative clearance.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> To keep ElogD <a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> < 3, these analogs were prepared using the THP amide.</div><div class="NLM_p">Our synthetic approach to the new analogues, as represented by a pyridine core, is shown in <a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a> (full experimental details for additional analogs and intermediates are provided in the <a href="/doi/suppl/10.1021/acs.jmedchem.6b00544/suppl_file/jm6b00544_si_002.pdf" class="ext-link">Supporting Information</a>). The synthesis of compounds of type <b>29</b> commenced with the palladium-mediated borylation of ethyl 4-chloro-5-methylpicolinate <b>26</b> to give intermediate <b>27</b>. Suzuki coupling with <i>p</i>-substituted benzyl halides provided intermediates <b>28a</b>–<b>c</b>. Ester hydrolysis and amide formation completed the synthesis.</div><figure id="sch2" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00544/20160708/images/medium/jm-2016-005448_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00544/20160708/images/large/jm-2016-005448_0011.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Analogues with a Pyridine Core<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00544/20160708/images/large/jm-2016-005448_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00544&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) B<sub>2</sub>pin<sub>2</sub>, Pd(dppf)Cl<sub>2</sub>·CH<sub>2</sub>Cl<sub>2</sub>, KOAc, toluene, 100 °C, 20 h; (b) benzyl halide, Pd(dppf)Cl<sub>2</sub>·CH<sub>2</sub>Cl<sub>2</sub>, K<sub>2</sub>CO<sub>3</sub>, dioxane/H<sub>2</sub>O, 80 °C (50% over two steps). <b>28a</b>: R<sub>1</sub> = N-linked pyrazole. <b>28b</b>: R<sub>1</sub> = 4-oxazole. <b>28c</b>: R<sub>1</sub> = 4-thiazole. (c) NaOH, dioxane, H<sub>2</sub>O, rt, 85%; (d) amino alcohol, HATU, Et<sub>3</sub>N, rt, 90%.</p></p></figure><div class="NLM_p">Replacing the pyridone core with a pyridine bearing the nitrogen at the 2-position<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> (e.g., <b>30</b>) provided the best analogue in this series (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>). Although pyridine <b>30</b> is 5.5-fold less potent than pyridone <b>21</b>, the MDR ER significantly improved (1.4 vs >5.3). Incorporating a fluorine at the 2-position of the corresponding phenyl analogue (<b>31</b>) afforded potency as well as low MDR ER and HLM but at the cost of increased lipophilicity and lower LipE. In compounds <b>32</b> and <b>33</b>, removal of the amide N–H HBA from the core caused a 2- to 3-fold loss in potency, in addition to higher MDR ER values.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a></div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. SAR of the Core: Effect of the IMHB on Potency and P-gp Liability</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00544/20160708/images/medium/jm-2016-005448_0014.gif" alt="" id="fx20" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00544/20160708/images/medium/jm-2016-005448_0015.gif" alt="" id="fx21" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>Table a</sup><p class="last">Compound EC<sub>50</sub> values were measured in a potentiation assay format, with a calcium mobilization readout, on a FLIPR384 fluorometric plate reader in the presence of an EC<sub>20</sub> concentration of ACh.</p></div><div class="footnote" id="t2fn2"><sup>Table b</sup><p class="last">EC<sub>50</sub> values represent the geometric mean of at least three experiments.</p></div><div class="footnote" id="t2fn3"><sup>Table c</sup><p class="last">LipE calculated as FLIPR pEC<sub>50</sub> – cElogD.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a></p></div><div class="footnote" id="t2fn4"><sup>Table d</sup><p class="last">Ratio of permeability, measured as a rate in 10<sup>–6</sup> cm/s in and out (BA/AB) of a Madin–Darby canine kidney (MDCK) epithelial cell line transfected with the MDR1 gene encoding the P-gp efflux transporter.</p></div><div class="footnote" id="t2fn5"><sup>Table e</sup><p class="last">Intrinsic clearance in HLM.</p></div><div class="footnote" id="t2fn6"><sup>Table f</sup><p class="last">Permeability in the MDCKII-LE (RRCK)<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> cell line, given as a rate in 10<sup>–6</sup> cm/s.</p></div><div class="footnote" id="t2fn7"><sup>Table g</sup><p class="last">AUC ratio of the drug level in mouse brain to the drug level in plasma.</p></div><div class="footnote" id="t2fn8"><sup>Table h</sup><p class="last">AUC ratio of the unbound drug level in mouse brain to the unbound drug level in plasma.</p></div><div class="footnote" id="t2fn9"><sup>Table i</sup><p class="last">Dosed subcutaneously as a solution (1 mg/kg) in a vehicle of 5% DMSO/5% Cremophore/90% water.</p></div><div class="footnote" id="t2fn10"><sup>Table j</sup><p class="last">Mouse fraction unbound (<i>F</i><sub>u</sub>) plasma 0.074 and rat <i>F</i><sub>u</sub> brain 0.090.</p></div><div class="footnote" id="t2fn11"><sup>Table k</sup><p class="last">n.d., not determined.</p></div></div><div></div></div><div class="NLM_p">To elucidate the conformational preference of these compounds, a torsional energy scan was performed at 15° intervals along the carbonyl-core bond. Profile plots depict the relative energy profiles of analogues <b>30</b>–<b>34</b> (<a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>). The putative bioactive conformation resides at 0° along each contour. As expected, the energy profile of pyridine <b>30</b> had an energy minimum at 0° due to the stabilization of that conformation by the IMHB between the pyridine nitrogen and the amide hydrogen. The fluorine in compound <b>31</b> is an effective HBA that still favors the bioactive conformation. Removal of the HBA in compounds <b>32</b> and <b>33</b> resulted in relative destabilization of the desired geometry, by producing a broad minimum around the bioactive conformation and a second minimum at a trajectory opposite to the bioactive conformation at ±180°. Aniline <b>34</b>, with a HBD in the 2-position, has its energy minimum in a conformation opposite to the bioactive conformation, thus serving as a negative control.</div><figure id="fig6" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00544/20160708/images/medium/jm-2016-005448_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00544/20160708/images/large/jm-2016-005448_0006.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Torsional energy scans for the carbonyl-core bond from compounds listed in <a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>, in 15° intervals using TeraChem 1.5 (DFT, B3LYP/6-31G**) in vacuo. Green shaded area represents the ideal angle whereby the amide carbonyl can make a through water hydrogen bond with Gln177.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00544/20160708/images/large/jm-2016-005448_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00544&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Together, these data suggest that an IMHB is beneficial but not critical for potency, as long as the analogue can adopt the bioactive conformation wherein the amide carbonyl forms a predicted through water hydrogen bond with Gln177. Of these analogues, the pyridine core exemplified by compound <b>30</b> was optimal for aligning potency with low MDR ER. In a mouse neuroPK study <b>30</b> demonstrated modest brain permeability with an unbound brain (<i>C</i><sub>b,u</sub>) to unbound plasma (<i>C</i><sub>p,u</sub>) concentration ratio of 0.2.</div><div class="NLM_p">PMC enabled a rapid expansion of amide and benzyl group SAR on the pyridine core. Again, the cyclohexanol and THP amides were identified as optimal (<a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>).<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> While pyridine analogues <b>30</b> and <b>35</b> had comparable potency (109 vs 92 nM) and MDR ER (1.4 vs 1.5), the higher lipophilicity of cyclohexanol <b>35</b> resulted in a higher HLM turnover, making THP the preferred amide. Removal of the methyl group (R<sub>1</sub> = H) led to a >80-fold loss of activity, confirming its importance. Replacing the N-linked pyrazole with oxazole (<b>37</b>) reduced M<sub>1</sub> activity, but gratifyingly the thiazole (<b>38</b>) exhibited improved EC<sub>50</sub>. Because the LipE of compound <b>38</b> was reduced relative to <b>37</b> (4.89 vs 5.10), we believe the potency increase is likely due to nonspecific hydrophobic interactions.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. SAR on the Benzyl Group of the Pyridine Series</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00544/20160708/images/medium/jm-2016-005448_0016.gif" alt="" id="GRAPHIC-d7e1377-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00544/20160708/images/medium/jm-2016-005448_0017.gif" alt="" id="GRAPHIC-d7e1378-autogenerated" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>Table a</sup><p class="last">Compound EC<sub>50</sub> values were measured in a potentiation assay format, with a calcium mobilization readout, on a FLIPR384 fluorometric plate reader in the presence of an EC<sub>20</sub> concentration of ACh;</p></div><div class="footnote" id="t3fn2"><sup>Table b</sup><p class="last">EC<sub>50</sub> values represent the geometric mean of at least three experiments;</p></div><div class="footnote" id="t3fn3"><sup>Table c</sup><p class="last">LipE calculated as FLIPR pEC<sub>50</sub> – cElogD;<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a></p></div><div class="footnote" id="t3fn4"><sup>Table d</sup><p class="last">Ratio of permeability, measured as a rate in 10<sup>–6</sup> cm/s in and out (BA/AB) of a Madin–Darby canine kidney (MDCK) epithelial cell line transfected with the MDR1 gene encoding the P-gp efflux transporter.</p></div><div class="footnote" id="t3fn5"><sup>Table e</sup><p class="last">Intrinsic clearance in HLM.</p></div><div class="footnote" id="t3fn6"><sup>Table f</sup><p class="last">Permeability in the MDCKII-LE (RRCK)<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> cell line, given as a rate in 10<sup>–6</sup> cm/s.</p></div><div class="footnote" id="t3fn7"><sup>Table g</sup><p class="last">AUC ratio of the drug level in mouse brain to the drug level in plasma.</p></div><div class="footnote" id="t3fn8"><sup>Table h</sup><p class="last">AUC ratio of the unbound drug level in mouse brain to the unbound drug level in plasma.</p></div><div class="footnote" id="t3fn9"><sup>Table i</sup><p class="last">n.d., not determined.</p></div><div class="footnote" id="t3fn10"><sup>Table j</sup><p class="last">Dosed subcutaneously as a solution (1 mg/kg) in a vehicle of 5% DMSO/15% Solutol/80% water.</p></div><div class="footnote" id="t3fn11"><sup>Table k</sup><p class="last">Mouse <i>F</i><sub>u</sub> plasma 0.029 and rat <i>F</i><sub>u</sub> brain 0.040.</p></div></div><div></div></div><div class="NLM_p">On the basis of its favorable potency, compound <b>38</b> was selected for further in vitro and in vivo profiling. Like <b>30</b>, compound <b>38</b> was brain-permeable in mouse, with a <i>C</i><sub>b,u</sub>/<i>C</i><sub>p,u</sub> = 0.34. In rat and dog, <b>38</b> had comparable brain permeability to that observed in mouse (<a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a>), which improved 1.5-fold in non-human primate to a <i>C</i><sub>b,u</sub>/<i>C</i><sub>p,u</sub> = 0.51. In vivo PK studies in both rat and dog demonstrated that <b>38</b> has a long half-life, good oral bioavailability, and low clearance.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Summary of Calculated and Measured Chemical Properties and Rat, Dog, and Non-Human Primate in Vivo PK As Generated for Compound <b>38</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00544/20160708/images/medium/jm-2016-005448_0018.gif" alt="" id="GRAPHIC-d7e1518-autogenerated" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>Table a</sup><p class="last">Multiparameter optimization score.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a></p></div><div class="footnote" id="t4fn2"><sup>Table b</sup><p class="last">AUC ratio of the total drug level in brain (B) to the unbound drug level in plasma (P).</p></div><div class="footnote" id="t4fn3"><sup>Table c</sup><p class="last">AUC ratio of the unbound drug concentration level in brain (<i>C</i><sub>b,u</sub>) to the unbound drug concentration level in plasma (<i>C</i><sub>p,u</sub>).</p></div><div class="footnote" id="t4fn4"><sup>Table d</sup><p class="last">Rat <i>F</i><sub>u</sub> plasma of 0.043.</p></div><div class="footnote" id="t4fn5"><sup>Table e</sup><p class="last">Observed blood clearance in units of mL mg<sup>–1</sup> kg<sup>–1</sup> following a single iv bolus of 1.0 mg/kg, dosed as a solution in 10% NMP/90% of 20% hydroxypropyl-β-cyclodextrin.</p></div><div class="footnote" id="t4fn6"><sup>Table f</sup><p class="last">Dosed as a suspension of 0.5 mg/kg in 0.5% methylcellulose.</p></div><div class="footnote" id="t4fn7"><sup>Table g</sup><p class="last">Dog <i>F</i><sub>u</sub> plasma of 0.081.</p></div><div class="footnote" id="t4fn8"><sup>Table h</sup><p class="last">Observed blood clearance in units of mL mg<sup>–1</sup> kg<sup>–1</sup> following a single iv bolus of 0.1 mg/kg, dosed as a solution in 20% hydroxypropyl-β-cyclodextrin.</p></div><div class="footnote" id="t4fn9"><sup>Table i</sup><p class="last">Dosed as a suspension 0.5 mg/kg in 0.5% methylcellulose.</p></div><div class="footnote" id="t4fn10"><sup>Table j</sup><p class="last">Compound <b>38</b> neuroPK was measured in a cassette study with another compound in <i>N</i> = 1 animal/time point.</p></div><div class="footnote" id="t4fn11"><sup>Table k</sup><p class="last">Monkey <i>F</i><sub>u</sub> plasma of 0.032.</p></div></div><div></div></div><div class="NLM_p">The in vitro pharmacology of <b>38</b> was extensively evaluated. Compound <b>38</b> showed weak agonist activity in an hM<sub>1</sub> overexpressing recombinant cell systems using FLIPR (Ca<sup>2+</sup>) (EC<sub>50</sub> ≥ 3.9 μM, 51%), inositol phosphate (IP<sub>1</sub>), and β-arrestin assays (<a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>A–C,H). Compound <b>38</b> behaved as a partial agonist in FLIPR and β-arrestin assays but appeared to have efficacy approaching that of a full agonist in the IP<sub>1</sub> assay. In these cell systems, <b>38</b> also potentiated an EC<sub>20</sub> of ACh in a positive concentration-dependent manner at concentrations lower than those at which agonism was observed, classifying the pharmacological profile of this compound as a PAM-agonist.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> Since agonist activity is known to be affected by receptor expression levels,<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> we evaluated <b>38</b>’s pharmacology in a native tissue preparation; a rat hippocampal slice electrophysiology assay measuring spontaneous action potentials of CA1 pyramidal neurons<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> was used. Concentration-dependent increases in CA1 spike rates were observed in both PAM and agonist mode, consistent with the PAM-agonist pharmacology seen using recombinant cell lines (<a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>D).</div><figure id="fig7" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00544/20160708/images/medium/jm-2016-005448_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00544/20160708/images/large/jm-2016-005448_0007.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Functional dose–response curves for <b>38</b> in the presence (PAM mode) and absence (agonist mode) of an EC<sub>20</sub> of ACh in (A) M<sub>1</sub> FLIPR (agonist EC<sub>50</sub> ≥ 3.9 μM,<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> PAM EC<sub>50</sub> = 60 nM); (B) M<sub>1</sub> IP<sub>1</sub> (agonist EC<sub>50</sub> ≥ 9.2 μM, PAM EC<sub>50</sub> = 447 nM); (C) β-arrestin (agonist EC<sub>50</sub> = 3.9 μM, PAM EC<sub>50</sub> = 365 nM). (D) Functional concentration–response curves for compound <b>38</b> in the presence (PAM mode) and absence (agonist mode) of an EC<sub>20</sub> carbachol in hippocampal slice assay. Representative M<sub>1</sub> ACh shift data using (E) FLIPR, (F) β-arrestin, and (G) inhibition of [<sup>3</sup>H]NMS binding in the presence of fixed concentrations of agonist: crimson circle: 10 μM; red square: 3 μM; orange up triangle: 1 μM; brown down triangle: 0.3 μM; blue diamonds: 0.1 μM; black circle: 0 μM (H) Binding and functional parameters for <b>38</b> from the functional allosteric model: <sup><i>a</i></sup>intrinsic efficacy of ACh; <sup><i>b</i></sup>intrinsic efficacy of <b>38</b>; <sup><i>c</i></sup>functional cooperativity of <b>38</b> with ACh.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00544/20160708/images/large/jm-2016-005448_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00544&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">To calculate compound <b>38</b>’s functional cooperativity with ACh (αβ) and its intrinsic agonist efficacy (τ<sub>B</sub>) in the system, the data from the ACh shift assay in the absence and presence of various concentrations of <b>38</b> in both the FLIPR (<a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>E) and β-arrestin assays (<a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>F) were fit to the functional allosteric model<a onclick="showRef(event, 'cit14t ref33'); return false;" href="javascript:void(0);" class="ref cit14t ref33">(14t, 33)</a> (<a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>H). In the calcium mobilization assay ACh has a high efficacy (τ<sub>A</sub>) and <b>38</b> shows high cooperativity (αβ = 126) with low intrinsic efficacy to induce direct response (τ<sub>B</sub> = 0.0095τ<sub>A</sub>). For β-arrestin, ACh is of lower efficacy and <b>38</b> has even higher cooperativity (αβ = 316) with a slightly higher efficacy to induce direct response (τ<sub>B</sub> = 0.14). The ratio of αβ in both pathways quantifies the magnitude of the induced bias produced by <b>38</b> on the two responses.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> Comparing these two in vitro assay end points, compound <b>38</b> produces a slight 2.51-fold bias toward β-arrestin over G-protein mediated calcium signaling. The relevance and translation of this possible signal bias toward in vivo efficacy are unknown. In a similar shift experiment, the effects of <b>38</b> on the affinity (<i>K</i><sub>i</sub>) of ACh were evaluated. We observed a 339-fold shift in the ability of ACh to displace [<sup>3</sup>H]NMS binding to M<sub>1</sub>-expressing cells at the top concentration of 10 μM compound <b>38</b> (<a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>G).</div><div class="NLM_p">In a recombinant panel of mAChR M<sub>1</sub>-M<sub>5</sub> assays, <b>38</b> had no appreciable agonist or PAM activity when tested up to a concentration of 10 μM at M<sub>2</sub>–M<sub>5</sub> receptors (>180-fold selectivity) (<a class="ref internalNav" href="#fig8" aria-label="Figure 8">Figure 8</a>A). To confirm these results in a native preparation, we tested <b>38</b> in the guinea pig ileum (GPI) tissue bath preparation where M<sub>2</sub> and M<sub>3</sub> activation is reported to elicit contractions.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> Although selective in the recombinant mAChR panel, we were surprised that direct treatment with <b>38</b> alone elicited what appeared to be a robust partial agonist effect<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> (EC<sub>50</sub> = 351 nM, 77% compared to a maximal carbachol response) (<a class="ref internalNav" href="#fig8" aria-label="Figure 8">Figure 8</a>B). In PAM mode,<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a><b>38</b> had an EC<sub>50</sub> of 82 nM (<a class="ref internalNav" href="#fig8" aria-label="Figure 8">Figure 8</a>C), a value similar to that determined in the FLIPR PAM assay. We confirmed that these contractions in the GPI were driven by mAChR activation by blocking the response in both the agonist and PAM mode of this assay with the nonselective mAChR antagonist atropine (<a class="ref internalNav" href="#fig8" aria-label="Figure 8">Figure 8</a>B and <a class="ref internalNav" href="#fig8" aria-label="Figure 8">Figure 8</a>C).</div><figure id="fig8" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00544/20160708/images/medium/jm-2016-005448_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00544/20160708/images/large/jm-2016-005448_0008.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. (A) Representative M<sub>1</sub>–M<sub>5</sub> PAM functional dose–response curves for compound <b>38</b> in the presence of EC<sub>20</sub> of ACh. M<sub>1,3,5</sub> used a FLIPR assay, while M<sub>2,4</sub> used a cAMP readout. Functional concentration–response curves for <b>38</b> in the absence (B, agonist mode) and presence (C, PAM mode) of an EC<sub>20</sub> donepezil ± the non-selective muscarinic antagonist atropine in the GPI tissue bath assay. Inhibition of [<sup>3</sup>H]NMS binding to M<sub>2</sub> (D) and M<sub>3</sub> (E) expressing cell lines by ACh in the presence of fixed concentrations of compound <b>38</b>: crimson circle: 10 μM; red square: 3 μM; orange up triangle: 1 μM; brown down triangle: 0.3 μM; blue diamonds: 0.1 μM; black circle: 0 μM. (F) Correlation between pEC<sub>50</sub> in the M<sub>1</sub> PAM FLIPR assay and pEC<sub>50</sub> in the PAM mode of the GPI tissue bath assay (color/shape by chemical series: red circle, azaindoles;<a onclick="showRef(event, 'cit14z'); return false;" href="javascript:void(0);" class="ref cit14z">(14z)</a> yellow down-triangle, pyridones; brown up-triangle, pyridines; blue box, literature standards; black diamond, undisclosed).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00544/20160708/images/large/jm-2016-005448_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00544&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">To complement the functional assays we investigated whether <b>38</b> modulates ACh binding at either M<sub>2</sub> or M<sub>3</sub> by running a [<sup>3</sup>H]NMS radioligand binding assay in the presence of fixed concentrations of compound <b>38</b> (<a class="ref internalNav" href="#fig8" aria-label="Figure 8">Figure 8</a>D and <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a>E, respectively). Compound <b>38</b> did not affect ACh binding, confirming that it either does not bind or is functionally silent at M<sub>2</sub> and M<sub>3</sub>. To see if this effect was compound-specific, we tested >20 M<sub>1</sub> PAMs spanning multiple chemical series, as well as literature standards, in the agonist and PAM mode of this assay. In PAM mode we saw a correlation (<i>R</i><sup>2</sup> = 0.48) between the pEC<sub>50</sub> in the FLIPR assay and the pEC<sub>50</sub> in the GPI contractility assay (<a class="ref internalNav" href="#fig8" aria-label="Figure 8">Figure 8</a>F).</div><div class="NLM_p">To rule out off-target effects, <b>38</b> was tested against a broad panel of targets that included GPCRs (32 targets, including human M<sub>1</sub>, M<sub>2</sub> and M<sub>3</sub>), ion channels (12 targets), nuclear receptors (3 targets), amine transporters (5 targets), phosphodiesterases (PDE; 11 targets), and a panel of enzyme and kinase targets (13 targets). Aside from human M<sub>1</sub>, compound <b>38</b> had no measurable activity (>10 μM) at any target with the exception of PDE 2A (IC<sub>50</sub> = 3.09 μM) and PDE 11A4 (IC<sub>50</sub> = 4.94 μM). On the basis of the weight of evidence, we conclude that compound <b>38</b> contributes to smooth muscle contraction in the guinea pig ileum through an M<sub>1</sub> mechanism of action.</div><div class="NLM_p">Having observed substantial potentiation of ACh affinity in vitro, <b>38</b> was advanced into four in vivo studies (<a class="ref internalNav" href="#fig9" aria-label="Figure 9">Figure 9</a>). The measured <i>C</i><sub>b,u</sub> and <i>C</i><sub>p,u</sub> of <b>38</b> from these studies are given in <a class="ref internalNav" href="#tbl5" aria-label="Table 5">Table 5</a>. Compound <b>38</b> robustly increased striatal IP<sub>1</sub> levels in a dose-responsive manner in vivo (<a class="ref internalNav" href="#fig9" aria-label="Figure 9">Figure 9</a>A). Plotting the average fold increase in IP<sub>1</sub> accumulation over a 2 h treatment for each individual animal against its <i>C</i><sub>b,u</sub> provided a partial dose–response curve (<a class="ref internalNav" href="#fig9" aria-label="Figure 9">Figure 9</a>A). The dynamic range of this assay is large: at a maximum dose of 10 mg/kg (<i>C</i><sub>b,u</sub> = 195 nM) we observed a 42-fold (±3.4) increase in IP<sub>1</sub> over baseline, indicating that <b>38</b> has excellent cooperativity in vivo under endogenous levels of ACh. A more modest 2-fold (±0.5) IP<sub>1</sub> elevation was observed at 1 mg/kg (<i>C</i><sub>b,u</sub> = 14.3 nM). <span class="smallcaps smallerCapital">d</span>-Amphetamine-stimulated locomotor activity (aLMA) has previously been shown to be sensitive to M<sub>1</sub> PAMs<a onclick="showRef(event, 'ref5 cit14z'); return false;" href="javascript:void(0);" class="ref ref5 cit14z">(5, 14z)</a> and agonists.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> As shown in <a class="ref internalNav" href="#fig9" aria-label="Figure 9">Figure 9</a>B, <b>38</b> significantly reduced aLMA in mice administered a 1 mg/kg dose (<i>C</i><sub>b,u</sub> = 18.5 nM), when compared to vehicle, aligning with the observation that M<sub>1</sub> PAM activity measured using an in vivo IP<sub>1</sub> assay correlates with aLMA activity.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a></div><figure id="fig9" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00544/20160708/images/medium/jm-2016-005448_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00544/20160708/images/large/jm-2016-005448_0009.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Effects of compound <b>38</b> on (A) mouse striatal IP<sub>1</sub> levels, (B) mouse amphetamine-stimulated locomotor activity (aLMA), (C) rat scopolamine-induced Morris water maze (MWM) activity, and (D) rat amphetamine-induced prepulse inhibition (aPPI). Data shown are from 5, 10, and 15 dB (see <a href="/doi/suppl/10.1021/acs.jmedchem.6b00544/suppl_file/jm6b00544_si_002.pdf" class="ext-link">Supporting Information</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00544/20160708/images/large/jm-2016-005448_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00544&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Summary of Exposure Data from Biology Studies on Compound <b>38</b><a class="ref internalNav" href="#tbl5-fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center">0.1 mg/kg</th><th class="rowsep1 colsep0" colspan="2" align="center">0.32 mg/kg</th><th class="rowsep1 colsep0" colspan="2" align="center">1 mg/kg</th><th class="rowsep1 colsep0" colspan="2" align="center">3.2 mg/kg</th><th class="rowsep1 colsep0" colspan="2" align="center">10 mg/kg</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">assay</th><th class="colsep0 rowsep0" align="center">species</th><th class="colsep0 rowsep0" align="center"><i>C</i><sub>p,u</sub><a class="ref internalNav" href="#t5fn1" aria-label="b">b</a> (nM)</th><th class="colsep0 rowsep0" align="center"><i>C</i><sub>b,u</sub><a class="ref internalNav" href="#t5fn2" aria-label="c">c</a> (nM)</th><th class="colsep0 rowsep0" align="center"><i>C</i><sub>p,u</sub><a class="ref internalNav" href="#t5fn1" aria-label="b">b</a> (nM)</th><th class="colsep0 rowsep0" align="center"><i>C</i><sub>b,u</sub><a class="ref internalNav" href="#t5fn2" aria-label="c">c</a> (nM)</th><th class="colsep0 rowsep0" align="center"><i>C</i><sub>p,u</sub><a class="ref internalNav" href="#t5fn1" aria-label="b">b</a> (nM)</th><th class="colsep0 rowsep0" align="center"><i>C</i><sub>b,u</sub><a class="ref internalNav" href="#t5fn2" aria-label="c">c</a> (nM)</th><th class="colsep0 rowsep0" align="center"><i>C</i><sub>p,u</sub><a class="ref internalNav" href="#t5fn1" aria-label="b">b</a> (nM)</th><th class="colsep0 rowsep0" align="center"><i>C</i><sub>b,u</sub><a class="ref internalNav" href="#t5fn2" aria-label="c">c</a> (nM)</th><th class="colsep0 rowsep0" align="center"><i>C</i><sub>p,u</sub><a class="ref internalNav" href="#t5fn1" aria-label="b">b</a> (nM)</th><th class="colsep0 rowsep0" align="center"><i>C</i><sub>b,u</sub><a class="ref internalNav" href="#t5fn2" aria-label="c">c</a> (nM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">IP<sub>1</sub><a class="ref internalNav" href="#t5fn3" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">mouse</td><td class="colsep0 rowsep0" align="left">n.d.</td><td class="colsep0 rowsep0" align="left">n.d.</td><td class="colsep0 rowsep0" align="left">n.d.</td><td class="colsep0 rowsep0" align="left">n.d.</td><td class="colsep0 rowsep0" align="left">42.1*<a class="ref internalNav" href="#t5fn7" aria-label="h">h</a></td><td class="colsep0 rowsep0" align="left">14.3*</td><td class="colsep0 rowsep0" align="left">176<a class="ref internalNav" href="#t5fn7" aria-label="h">h</a></td><td class="colsep0 rowsep0" align="left">52.8</td><td class="colsep0 rowsep0" align="left">574<a class="ref internalNav" href="#t5fn7" aria-label="h">h</a></td><td class="colsep0 rowsep0" align="left">195</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">aLMA<a class="ref internalNav" href="#t5fn4" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="left">mouse</td><td class="colsep0 rowsep0" align="left">n.d.</td><td class="colsep0 rowsep0" align="left">n.d.</td><td class="colsep0 rowsep0" align="left">23.4</td><td class="colsep0 rowsep0" align="left">6.38</td><td class="colsep0 rowsep0" align="left">76.1*</td><td class="colsep0 rowsep0" align="left">18.5*</td><td class="colsep0 rowsep0" align="left">255</td><td class="colsep0 rowsep0" align="left">85.2</td><td class="colsep0 rowsep0" align="left">n.d.</td><td class="colsep0 rowsep0" align="left">n.d.</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MWM<a class="ref internalNav" href="#t5fn5" aria-label="f">f</a></td><td class="colsep0 rowsep0" align="left">rat</td><td class="colsep0 rowsep0" align="left">0.9</td><td class="colsep0 rowsep0" align="left">0.31<a class="ref internalNav" href="#t5fn8" aria-label="i">i</a></td><td class="colsep0 rowsep0" align="left">3.7*</td><td class="colsep0 rowsep0" align="left">1.3*<a class="ref internalNav" href="#t5fn8" aria-label="i">i</a></td><td class="colsep0 rowsep0" align="left">19.6</td><td class="colsep0 rowsep0" align="left">6.7<a class="ref internalNav" href="#t5fn8" aria-label="i">i</a></td><td class="colsep0 rowsep0" align="left">n.d.</td><td class="colsep0 rowsep0" align="left">n.d.</td><td class="colsep0 rowsep0" align="left">n.d.</td><td class="colsep0 rowsep0" align="left">n.d.</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">aPPI<a class="ref internalNav" href="#t5fn6" aria-label="g">g</a></td><td class="colsep0 rowsep0" align="left">rat</td><td class="colsep0 rowsep0" align="left">n.d.</td><td class="colsep0 rowsep0" align="left">n.d.</td><td class="colsep0 rowsep0" align="left">11.9</td><td class="colsep0 rowsep0" align="left">4.3</td><td class="colsep0 rowsep0" align="left">45.6*</td><td class="colsep0 rowsep0" align="left">17.4*</td><td class="colsep0 rowsep0" align="left">123</td><td class="colsep0 rowsep0" align="left">44.4</td><td class="colsep0 rowsep0" align="left">n.d.</td><td class="colsep0 rowsep0" align="left">n.d.</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl5-fn1"><div class="footnote" id="tbl5-fn1"><sup>a</sup><p class="last">Minimally effective dose (MED) from each experiment is is indicated by an asterisk (∗).</p></div><div class="footnote" id="t5fn1"><sup>b</sup><p class="last">Concentration of unbound compound in plasma. n.d.: not determined.</p></div><div class="footnote" id="t5fn2"><sup>c</sup><p class="last">Concentration of unbound compound in brain. n.d.: not determined.</p></div><div class="footnote" id="t5fn3"><sup>d</sup><p class="last">Compound concentrations measured in striatal tissue using average exposure from all animals in each dose group (<i>N</i> = 5/dose) at <i>T</i> = 2 h. Compound was administered subcutaneously (sc) as a solution in 5/15/80 DMSO/Solutol/water.</p></div><div class="footnote" id="t5fn4"><sup>e</sup><p class="last">Compound concentrations measured in plasma and brain from a satellite study (<i>N</i> = 2/dose) at <i>T</i> = 1 h using the same dosing solution (solution in 5/15/80 DMSO/Solutol/water) and route of administration (sc) as the aLMA study.</p></div><div class="footnote" id="t5fn5"><sup>f</sup><p class="last">Compound concentrations measured in plasma at <i>T</i> = 1 h from a satellite study is the average exposure (<i>N</i> = 2/dose) using the same dosing solution (suspension in 0.5% methylcellulose in water) and route of administration (oral, po) from the MWM study.</p></div><div class="footnote" id="t5fn6"><sup>g</sup><p class="last">PK measured in plasma and brain is the average of randomly selected (<i>N</i> = 2/dose) animals at the end of the PPI study (<i>T</i> = 1.67 h). Animals were dosed sc with a suspension in 0.5% methylcellulose in water.</p></div><div class="footnote" id="t5fn7"><sup>h</sup><p class="last">Plasma <i>C</i><sub>p,u</sub> exposures were estimated from the exposure in striatal brain tissue using the previously measured AUC <i>C</i><sub>b,u</sub>/<i>C</i><sub>p,u</sub> of 0.34.</p></div><div class="footnote" id="t5fn8"><sup>i</sup><p class="last"><i>C</i><sub>b,u</sub> was estimated from <i>C</i><sub>p,u</sub> using the AUC-derived <i>C</i><sub>b,u</sub>/<i>C</i><sub>p,u</sub> of 0.34.</p></div></div></div><div class="NLM_p">To demonstrate its effects in a cognition assay, <b>38</b> was tested in the rat Morris water maze (MWM) assay to assess its ability to reverse spatial learning and memory deficits induced by scopolamine (<a class="ref internalNav" href="#fig9" aria-label="Figure 9">Figure 9</a>C). Scopolamine was used because anticholinergic treatment has detrimental effects on cognitive functioning in subjects with schizophrenia.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> Significant reversal of scopolamine was observed at doses as low as 0.32 mg/kg (<i>C</i><sub>b,u</sub> = 1.3 nM).</div><div class="NLM_p">Since it had been suggested that M<sub>1</sub> activation could potentially provide antipsychotic effects,<a onclick="showRef(event, 'cit1c'); return false;" href="javascript:void(0);" class="ref cit1c">(1c)</a> we next tested <b>38</b> in rat amphetamine-disrupted prepulse inhibition (aPPI) (<a class="ref internalNav" href="#fig9" aria-label="Figure 9">Figure 9</a>D). PPI deficits have also been observed in patients living with schizophrenia.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> At doses that had no effect on startle reflex or PPI alone, <b>38</b> significantly attenuated the amphetamine-induced deficit in PPI at 1 mg/kg (<i>C</i><sub>b,u</sub> = 17.4 nM) in the collapsed data set.<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> To our knowledge this is the first report of an M<sub>1</sub> PAM being tested in this assay.</div><div class="NLM_p">The safety profile of <b>38</b> was evaluated in a 2-week study in rats (<a class="ref internalNav" href="#tbl6" aria-label="Table 6">Table 6</a>) and a single-dose study in dogs (<a class="ref internalNav" href="#tbl7" aria-label="Table 7">Table 7</a>). In the rat study, all doses tested [3, 10, 30 (males)/15 (females) mg/kg] were well tolerated. Treatment-related findings were limited to slight increases in food intake and body weight gain. There were no histopathological findings at any tested dose.<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> Compared with rat, similar exposures in dogs were poorly tolerated, as evidenced by adverse cholinergic signs. In dogs, dose-dependent cholinergic signs consisted of soft/watery stools, emesis, and salivation at ≥3 mg/kg and ataxia, side-to-side head movements, and generalized convulsions at 45 mg/kg.</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. Summary of Findings from a 2-Week Rat Exploratory Toxicology Study with <b>38</b></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center">treatment exposure</th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">dose<a class="ref internalNav" href="#t6fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" rowspan="2" align="center" valign="middle">sex<a class="ref internalNav" href="#t6fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center"><i>C</i><sub>max</sub> <i>C</i><sub>p,u</sub></th><th class="colsep0 rowsep0" align="center">AUC<sub>(0–24h)</sub> <i>C</i><sub>p,u</sub></th><th class="colsep0 rowsep0" rowspan="2" align="center" valign="middle">TI range</th><th class="colsep0 rowsep0" rowspan="2" align="center" valign="middle">treatment findings</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">mg/kg</th><th class="colsep0 rowsep0" align="center">nM</th><th class="colsep0 rowsep0" align="center">nM·h</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left">M/F</td><td class="colsep0 rowsep0" align="left">195</td><td class="colsep0 rowsep0" align="left">1856</td><td class="colsep0 rowsep0" align="left">3–53</td><td class="colsep0 rowsep0" align="left">none</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">10</td><td class="colsep0 rowsep0" align="left">M/F</td><td class="colsep0 rowsep0" align="left">562</td><td class="colsep0 rowsep0" align="left">5739</td><td class="colsep0 rowsep0" align="left">7–152</td><td class="colsep0 rowsep0" align="left">↑ food intake and body weight gain in males</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">15</td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">708</td><td class="colsep0 rowsep0" align="left">9768</td><td class="colsep0 rowsep0" align="left">9–191</td><td class="colsep0 rowsep0" align="left">↑ food intake</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">30</td><td class="colsep0 rowsep0" align="left">M</td><td class="colsep0 rowsep0" align="left">1221</td><td class="colsep0 rowsep0" align="left">13211</td><td class="colsep0 rowsep0" align="left">16–330</td><td class="colsep0 rowsep0" align="left">↑ food intake and body weight gain</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6fn1"><div class="footnote" id="t6fn1"><sup>a</sup><p class="last">Compound <b>38</b> was dosed orally in a 0.5% methylcellulose formulation.</p></div><div class="footnote" id="t6fn2"><sup>b</sup><p class="last"><i>N</i> = (4/sex)/dose.</p></div></div></div><div class="NLM_table-wrap" id="tbl7"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 7. Summary of Clinical Signs and Exposures Following Oral Administration of <b>38</b> from a Single-Dose Escalation Study</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center">treatment exposure</th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">dose<a class="ref internalNav" href="#t7fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" rowspan="2" align="center">sex<a class="ref internalNav" href="#t7fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center"><i>C</i><sub>max</sub> <i>C</i><sub>p,u</sub></th><th class="colsep0 rowsep0" align="center">AUC<sub>(0–24h)</sub> <i>C</i><sub>p,u</sub></th><th class="colsep0 rowsep0" rowspan="2" align="center">TI range</th><th class="colsep0 rowsep0" rowspan="2" align="center">treatment findings</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">mg/kg</th><th class="colsep0 rowsep0" align="center">nM</th><th class="colsep0 rowsep0" align="center">nM·h</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">0.3<a class="ref internalNav" href="#t7fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">M</td><td class="colsep0 rowsep0" align="left">41<a class="ref internalNav" href="#t7fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">n.d.</td><td class="colsep0 rowsep0" align="left">0.5–11</td><td class="colsep0 rowsep0" align="left">loose stool (1/4 dogs)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">1<a class="ref internalNav" href="#t7fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">M</td><td class="colsep0 rowsep0" align="left">169<a class="ref internalNav" href="#t7fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">n.d.</td><td class="colsep0 rowsep0" align="left">2–46</td><td class="colsep0 rowsep0" align="left">no clinical findings</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">3<a class="ref internalNav" href="#t7fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">M</td><td class="colsep0 rowsep0" align="left">568</td><td class="colsep0 rowsep0" align="left">5242</td><td class="colsep0 rowsep0" align="left">7–152</td><td class="colsep0 rowsep0" align="left">loose/mucoid stool (4/4 dogs), emesis (1/4), and salivation (1/4)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">5</td><td class="colsep0 rowsep0" align="left">M/F</td><td class="colsep0 rowsep0" align="left">659</td><td class="colsep0 rowsep0" align="left">5861</td><td class="colsep0 rowsep0" align="left">9–178</td><td class="colsep0 rowsep0" align="left">soft/watery feces, emesis, salivation</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">15</td><td class="colsep0 rowsep0" align="left">M/F</td><td class="colsep0 rowsep0" align="left">1050</td><td class="colsep0 rowsep0" align="left">7765</td><td class="colsep0 rowsep0" align="left">14–284</td><td class="colsep0 rowsep0" align="left">mucoid feces, emesis, and salivation</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">45</td><td class="colsep0 rowsep0" align="left">M/F</td><td class="colsep0 rowsep0" align="left">n.d.</td><td class="colsep0 rowsep0" align="left">n.d.</td><td class="colsep0 rowsep0" align="left">n.d.</td><td class="colsep0 rowsep0" align="left">soft/mucoid/watery feces, salivation, emesis, ataxia, side-to-side head movements, and convulsions, 45 min postdose (952 and 1099 nM)<a class="ref internalNav" href="#t7fn5" aria-label="e">e</a></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t7fn1"><div class="footnote" id="t7fn1"><sup>a</sup><p class="last">Compound <b>38</b> was dosed orally as a spray-dried dispersion (SDD)<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> (10% drug loading with hydroxypropyl methylcellulose acetate succinate, medium grade (HPMCAS-M)). The SDD suspension formulation was prepared with mortar and pestle in 0.5 wt % methocellulose/0.5 wt % HPMCAS in 20 mM Tris buffer, pH 7.4.</p></div><div class="footnote" id="t7fn2"><sup>b</sup><p class="last"><i>N</i> = (1/sex)/dose.</p></div><div class="footnote" id="t7fn3"><sup>c</sup><p class="last">From the CV study (<i>N</i> = 4).</p></div><div class="footnote" id="t7fn4"><sup>d</sup><p class="last">Extrapolated from 4 h postdose in-life plasma samples.</p></div><div class="footnote" id="t7fn5"><sup>e</sup><p class="last">Rising plasma exposures had not yet reached <i>C</i><sub>max</sub>.</p></div></div></div><div class="NLM_p">Although M<sub>1</sub> activation is generally not thought to be associated with GI adverse effects, these results are consistent with the in vitro guinea pig ileum data, as well as recent preclinical toxicology data on BQCA (<b>1</b>), PQCA (<b>2</b>), and a related analogue.<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> The M<sub>1</sub> mechanism is, however, associated with convulsion,<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> which was observed in both dogs at 45 mg/kg, corresponding to unbound plasma <i>C</i><sub>max</sub> values of 952 and 1099 nM (<i>C</i><sub>p,u</sub>). Using the neuroPK study in dog (<i>C</i><sub>b,u</sub>/<i>C</i><sub>p,u</sub> = 0.3, <a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a>) together with the observed plasma <i>C</i><sub>max</sub> values, we can estimate the dog <i>C</i><sub>b,u</sub> at the time of convulsion. These estimated brain levels (286 and 330 nM) are at or below this compound’s in vitro agonist EC<sub>50</sub>. Hence, at these exposure levels it is unlikely that compound <b>38</b>’s agonist activity is responsible for the observed convulsions. The no-observed-adverse-effect level (NOAEL) of this preclinical study was 5 mg/kg, as the exposures at 15 mg/kg overlapped with those associated with convulsion.</div><div class="NLM_p">To put the safety data into context, the <i>C</i><sub>p,u</sub> exposures from the safety studies are compared to the <i>C</i><sub>p,u</sub> exposures from the preclinical animal models to calculate a therapeutic index (TI) range. Marking the lower end of the preclinical rodent efficacy range was the MWM assay (<i>C</i><sub>p,u</sub> at the lowest effective dose was 3.7 nM), while aLMA marked the upper end (<i>C</i><sub>p,u</sub> at the lowest effective dose was 76.1 nM). Compound <b>38</b>’s TI between efficacy and the onset of cholinergic signs in dog (<i>C</i><sub>p,u</sub> = 568 nM) was between 7.5- and 152-fold, depending on the preclinical efficacy assay. More significantly, due to convulsions, this nonclinical safety data would cap initial clinical studies at <sup>1</sup>/<sub>10</sub> the <i>C</i><sub>max</sub> value at the NOAEL (<i>C</i><sub>p,u</sub> = 659 nM).<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> The TI between efficacy and the <sup>1</sup>/<sub>10</sub> NOAEL (<i>C</i><sub>p,u</sub> = 65.9 nM) was between 0.87- and 17.8-fold, depending on which preclinical assay was considered.</div><div class="NLM_p last">To more fully evaluate the effects of <b>38</b> on the CV system, a three-dose (0.3, 1, and 3 mg/kg) crossover telemetry study in dogs was performed (detailed CV findings are presented in the <a href="/doi/suppl/10.1021/acs.jmedchem.6b00544/suppl_file/jm6b00544_si_002.pdf" class="ext-link">Supporting Information</a>). At 0.3 mg/kg, no change in CV end points was observed. At 1 mg/kg, <b>38</b> produced increases in maximum systolic left ventricular pressure (+8 mmHg), and at 3 mg/kg statistically significant increases in blood pressure (+7 to +10 mmHg), max systolic left ventricular pressure, left ventricular + d<i>P</i>/d<i>t</i> max (an index of cardiac contractility), activity, and heart rate (+25 bpm) were observed, as well as decreases in RR, QT, and QTc intervals up to 9 h postdose.</div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i13">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_51156" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_51156" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">We have identified a series of pyridones and pyridines as a new class of M<sub>1</sub> PAMs. Robust PMC-enabled synthetic routes using MIDA-boronate chemistry enabled extensive study of the SAR in the 4-position of the benzyl ring and identified oxazole and thiazole rings as optimal substituents in this position. On the basis of our M<sub>1</sub> homology model, we believe that both series bind to the allosteric site of the M<sub>1</sub> receptor in a similar fashion to each other. Although both series have favorable physicochemical properties and potency, the most potent pyridones were not CNS penetrant, whereas exemplified compounds <b>30</b> and <b>38</b> in the pyridine series exhibited moderate brain exposure in rodent. Upon the basis of results in an NHP brain availability study, the more potent pyridine, <b>38</b>, would be expected to have a human brain availability <i>C</i><sub>b,u</sub>/<i>C</i><sub>p,u</sub> of ≥0.5.</div><div class="NLM_p">Compound <b>38</b> showed robust cooperativity with ACh at M<sub>1</sub> in both our calcium mobilization and β-arrestin assays. More importantly, compound <b>38</b> retained its allosteric cooperativity with ACh in vivo where we saw a robust potentiation response in striatum (>40-fold) when measuring IP<sub>1</sub> accumulation in a wild-type mouse under endogenous levels of ACh. In addition to its favorable pharmacology, <b>38</b> was shown to have good oral bioavailability, low clearance, and robust in vivo activity in aLMA, PPI, and MWM at low free-brain (<i>C</i><sub>b,u</sub>) concentrations.</div><div class="NLM_p">Compound <b>38</b> has no significant off-target pharmacology, including M<sub>2</sub> and M<sub>3</sub> activity, making it an ideal compound for testing the effects of selective M<sub>1</sub> activation on the GI and CV systems. In the GPI tissue bath assay we observed a robust response in both the presence (PAM mode) and absence (agonist mode) of donepezil which was recapitulated with additional chemically distinct M<sub>1</sub>-selective PAMs. This response was blocked by the muscarinic antagonist atropine which is consistent with an M<sub>1</sub>-mediated effect.</div><div class="NLM_p last">Studies in rat and dog to evaluate safety and cholinergic AEs in vivo were performed on <b>38</b>. While we had no findings in a chronic dose 2-week rat study at exposures as high as 1 μM (<i>C</i><sub>p,u</sub>), at similar exposures dog proved to be a more sensitive species. At exposures of >568 nM (<i>C</i><sub>p,u</sub>) we observed classic cholinergic signs traditionally attributed to M<sub>2</sub> and M<sub>3</sub>, such as increased heart rate, blood pressure, loose stool, and emesis. Though these cholinergic signs were present, compound <b>38</b> does appear to have a TI relative to our preclinical efficacy range. It was, however, convulsion that significantly diminishes <b>38</b>’s TI. Further, similar GI, CV, and convulsion findings were also observed with additional structurally distinct M<sub>1</sub> PAMs, suggesting that these AEs are not compound or chemotype specific. Further efforts targeting the M<sub>1</sub> receptor should acknowledge these risks to ensure that compounds going into the clinic have a sufficient safety window.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i14">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_16262" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_16262" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">All procedures performed on animals in this study were in accordance with established guidelines and regulations and were reviewed and approved by the Pfizer Institutional Animal Care and Use Committee. Pfizer animal care facilities that supported this work are fully accredited by AAALAC International.</div><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Chemistry General Information</h3><div class="NLM_p last">All solvents and reagents were obtained from commercial sources and were used as received. All reactions were monitored by TLC (TLC plates F254, Merck) or UPLC–MS analysis (Waters Acquity, ESCI±, APCI±). Melting points were obtained with a Thomas-Hoover melting point apparatus and are uncorrected. <sup>1</sup>H NMR and <sup>13</sup>C NMR spectra were obtained using deuterated solvent on a Varian 400 MHz instrument. All <sup>1</sup>H NMR shifts are reported in δ units (ppm) relative to the signals for chloroform (7.27 ppm) and MeOH (3.31 ppm). All <sup>13</sup>C shifts are reported in δ units (ppm) relative to the signals for chloroform (77.0 ppm) and MeOH (49.1 ppm) with <sup>1</sup>H-decoupled observation. All coupling constants (<i>J</i> values) are reported in hertz (Hz). NMR abbreviations are as follows: br, broadened; s, singlet; d, doublet; t, triplet; q, quartet; p, pentet; m, multiplet; dd, doublet of doublets; ddd, doublet of doublet of doublets. Optical rotations were determined with a Jasco P-2000 polarimeter. Column chromatography was carried out on silica gel 60 (32–60 mesh, 60 Å) or on prepacked Biotage or ISCO columns. HPLC purity analysis of the final test compounds was carried out using one of four methods. Method A: UPLC/UV. WuXi AppTec, Shanghai, China. Column: Agilent Xtimate C18, 5 mm × 30 mm, 3 μm; UV purity detected at 220 nm; mobile phase A = 0.2% TFA in H<sub>2</sub>O; mobile phase B = 0.1% TFA in CH<sub>3</sub>CN. gradient, 1% B to 100% B in 5.0 min. Flow rate: 1.2 mL/min. Method B: UPLC/UV WuXi AppTec, Shanghai, China. Column: Agilent Xtimate C18, 5 mm × 30 mm, 3 μm; UV purity detected at 220 nm; mobile phase A = 0.1% TFA in H<sub>2</sub>O; mobile phase B = 0.1% TFA in CH<sub>3</sub>CN. gradient, 1% B to 5% B in 1.0 min, 5%B to 100% B in 5.0 min, hold at 100% B for 2.0 min. Flow rate: 1.2 mL/min. Method C: column, UPLC/UV. WuXi AppTec, Shanghai, China. Column: Chiralpak AD-3, 150 mm × 4.6 mm, 5 μm, UV purity detected at 220 nm; mobile phase, 60% EtOH (0.05% DEA) in CO<sub>2</sub>. Flow rate: 1.2 mL/min. Method D: column, Waters Atlantis C18 4.6 mm × 50 mm, 5 μm; UV purity detected at 215 nm; mobile phase A, 0.05% TFA in H<sub>2</sub>O (v/v); mobile phase B, 0.05% TFA in CH<sub>3</sub>CN (v/v); gradient 95.0% H<sub>2</sub>O/5.0% CH<sub>3</sub>CN linear to 5.0% H<sub>2</sub>O/95.0% CH<sub>3</sub>CN in 4.0 min, hold at 5.0% H<sub>2</sub>O/95.0% CH<sub>3</sub>CN to 5.0 min. Flow rate: 2 mL/min. All final compounds were determined to have a purity of >95% by one of the aforementioned methods unless stated otherwise.</div></div><div id="sec4_2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> Experimental Procedures. Ethyl 4-Chloro-5-methylpyridine-2-carboxylate (<b>26</b>)</h3><div class="NLM_p last">A mixture of 2,4-dichloro-5-methylpyridine (33 g, 0.20 mol), Pd(dppf)Cl<sub>2</sub>·CH<sub>2</sub>Cl<sub>2</sub> (7.45 g, 10.2 mmol), and triethylamine (61.8 g, 611 mmol) in ethanol (500 mL) was stirred under carbon monoxide (30 psi) at 60 °C for 4 h. The reaction mixture was filtered and concentrated in vacuo; silica gel chromatography (gradient, 10% to 50% EtOAc in petroleum ether) provided <b>26</b> as a yellow oil. Yield: 25.0 g, 0.125 mol, 62%. LC–MS <i>m</i>/<i>z</i> 200.0 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.56 (s, 1H), 8.11 (s, 1H), 4.48 (q, <i>J</i> = 7.1 Hz, 2H), 2.44 (s, 3H), 1.44 (t, <i>J</i> = 7.1 Hz, 3H).</div></div><div id="sec4_2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> Ethyl 5-Methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine-2-carboxylate (<b>27</b>)</h3><div class="NLM_p last">A mixture of chloride <b>26</b> (16 g, 80 mmol), 4,4,4′,4′,5,5,5′,5′-octamethyl-2,2′-bi-1,3,2-dioxaborolane (30.5 g, 120 mmol), Pd(dppf)Cl<sub>2</sub>·CH<sub>2</sub>Cl<sub>2</sub> (5.86 g, 8.01 mmol), and potassium acetate (28.3 g, 288 mmol) in toluene (1.2 L) was stirred at 130 °C for 20 h. The reaction mixture was cooled to rt, then filtered through diatomaceous earth. The filtrate was concentrated in vacuo; silica gel chromatography (gradient, 10% to 50% EtOAc in petroleum ether) provided a yellow solid (20 g), which was diluted with petroleum ether (50 mL) and stirred at rt for 20 min. The solid was collected via filtration to afford <b>27</b> (8.8 g) as a white solid. The corresponding filtrate was concentrated in vacuo, and the residue was repurified by silica gel chromatography (gradient, 0% to 30% EtOAc in petroleum ether); the isolated material (4.5 g) was washed with petroleum ether (5 mL) to yield additional <b>27</b> (3.5 g) as a white solid. Combined yield: 12.3 g, 42.2 mmol, 53%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.57 (s, 1H), 8.39 (s, 1H), 4.48 (q, <i>J</i> = 7.2 Hz, 2H), 2.57 (s, 3H), 1.45 (t, <i>J</i> = 7.2 Hz, 3H), 1.37 (s, 12H).</div></div><div id="sec4_2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> General Suzuki Procedure A</h3><div class="NLM_p last">A mixture of 27 (0.310 mmol), benzyl halide (0.258 mmol), Pd(dppf)Cl<sub>2</sub>·CH<sub>2</sub>Cl<sub>2</sub> (0.026 mmol), and K<sub>2</sub>CO<sub>3</sub> (0.516 mmol) in 1,4-dioxane (2 mL) and water (0.2 mL) was stirred at 100 °C for 18 h. The reaction mixture was filtered through diatomaceous earth, and the filtrate was concentrated in vacuo.</div></div><div id="sec4_2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> General Hydrolysis/Amidation Procedure B</h3><div class="NLM_p last">A mixture of an ethyl ester of type <b>28</b> (1.0 equiv) and sodium hydroxide (4.0 equiv) in 1:1 MeOH/water (0.1 M) was stirred at 80 °C for 2 h. The reaction mixture was then diluted with water, concentrated in vacuo to remove MeOH, and acidified to a pH of 3–4 with conc HCl. After extraction three times with a mixture of 20:1 DCM/MeOH, the combined organic layers were dried over sodium sulfate, filtered, and concentrated in vacuo to provide the carboxylic acid as a yellow solid. The residue was combined with DMF, amino alcohol (2.5–3.0 equiv), and Et<sub>3</sub>N (4.0 equiv), then treated with HATU (4.1 equiv). The reaction mixture was stirred at rt overnight, whereupon it was diluted with saturated aqueous sodium bicarbonate solution and water (1:1) and extracted 2–4 times with EtOAc. The combined organic extracts were washed twice with water, and once with saturated aqueous sodium chloride solution, dried over magnesium sulfate, filtered, and concentrated in vacuo.</div></div><div id="sec4_2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> 4-(4-(1<i>H</i>-Pyrazol-1-yl)benzyl)-<i>N</i>-((3<i>R</i>,4<i>S</i>)-3-hydroxytetrahydro-2<i>H</i>-pyran-4-yl)-5-methylpicolinamide (<b>30</b>)</h3><div class="NLM_p last">Ethyl 4-(4-(1<i>H</i>-pyrazol-1-yl)benzyl)-5-methylpicolinate (<b>28a</b>) was synthesized from <b>27</b> according to general Suzuki procedure A using 1-(4-(bromomethyl)phenyl)-1<i>H</i>-pyrazole as the benzyl halide. Silica gel chromatography (gradient, 10% to 50% EtOAc in petroleum ether) afforded this intermediate as an off-white gum. Yield: 800 mg, 2.5 mmol, 73%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.53 (s, 1H), 7.89–7.93 (m, 2H), 7.71–7.73 (m, 1H), 7.64 (br d, <i>J</i> = 8.5 Hz, 2H), 7.20 (br d, <i>J</i> = 8.4 Hz, 2H), 6.47 (dd, <i>J</i> = 2.3, 1.9 Hz, 1H), 4.47 (q, <i>J</i> = 7.2 Hz, 2H), 4.07 (s, 2H), 2.32 (s, 3H), 1.44 (t, <i>J</i> = 7.1 Hz, 3H). Intermediate <b>28a</b> was subjected to the general hydrolysis/amidation procedure with amino alcohol (3<i>R</i>,4<i>S</i>)-4-aminotetrahydro-2<i>H</i>-pyran-3-ol. Silica gel chromatography (gradient, 5% to 10% MeOH in DCM), followed by crystallization from a concentrated solution of EtOAc and heptane, provided <b>30</b> as a white solid. Yield: 2.00 g, 5.10 mmol, 75%. LC–MS <i>m</i>/<i>z</i> 393.1 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.42 (s, 1H), 8.19 (dd, <i>J</i> = 2.5, 0.5 Hz, 1H), 7.86 (s, 1H), 7.70–7.71 (m, 1H), 7.69 (br d, <i>J</i> = 8.7 Hz, 2H), 7.30 (br d, <i>J</i> = 8.7 Hz, 2H), 6.51 (dd, <i>J</i> = 2.4, 1.9 Hz, 1H), 4.15 (s, 2H), 3.87–3.99 (m, 3H), 3.64 (ddd, <i>J</i> = 9.7, 9.6, 4.9 Hz, 1H), 3.47 (ddd, <i>J</i> = 11.9, 11.9, 2.2 Hz, 1H), 3.19 (dd, <i>J</i> = 11.1, 9.8 Hz, 1H), 2.37 (s, 3H), 1.98–2.05 (m, 1H), 1.64–1.76 (m, 1H). <sup>13</sup>C NMR (100 MHz, CD<sub>3</sub>OD) δ 167.5, 151.4, 151.1, 149.7, 142.4, 140.4, 138.5, 137.5, 131.5, 129.3, 124.1, 121.1, 109.0, 72.9, 70.5, 68.0, 54.8, 39.3, 32.9, 16.9; Elemental analysis calcd for C<sub>22</sub>H<sub>24</sub>N<sub>4</sub>O<sub>3</sub>: C, 67.33; H, 6.16; N, 14.28. Found: C, 67.27; H, 6.12; N, 14.33. [α]<sub>D</sub><sup>20</sup> −7.6° (<i>c</i> 1.25, CHCl<sub>3</sub>).</div></div><div id="sec4_2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> 4-(4-(1<i>H</i>-Pyrazol-1-yl)benzyl)-<i>N</i>-((1<i>R</i>,2<i>R</i>)-2-hydroxycyclohexyl)-5-methylpicolinamide (<b>35</b>)</h3><div class="NLM_p last">Compound <b>35</b> was synthesized according to general hydrolysis/amidation procedure B from ethyl 4-(4-(1<i>H</i>-pyrazol-1-yl)benzyl)-5-methylpicolinate (<b>28a</b>) using amino alcohol (1<i>S</i>,2<i>S</i>)-2-aminocyclohexan-1-ol. Silica gel chromatography (gradient, 0% to 4% MeOH in DCM) yielded <b>35</b> as a white solid. Yield: 145 mg, 0.371 mmol, 90%. LC–MS <i>m</i>/<i>z</i> 391.1 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.41 (s, 1H), 8.19 (d, <i>J</i> = 2.5 Hz, 1H), 7.86 (s, 1H), 7.70 (d, <i>J</i> = 1.6 Hz, 1H), 7.68 (d, <i>J</i> = 8.5 Hz, 2H), 7.30 (d, <i>J</i> = 8.3 Hz, 2H), 6.51 (dd, <i>J</i> = 2.4, 1.9 Hz, 1H), 4.15 (s, 2H), 3.69–3.79 (m, 1H), 3.47–3.57 (m, 1H), 2.36 (s, 3H), 1.98–2.08 (m, 2H), 1.68–1.81 (m, 2H), 1.31–1.45 (m, 4H).</div></div><div id="sec4_2_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> <i>N</i>-((3<i>R</i>,4<i>S</i>)-3-Hydroxytetrahydro-2<i>H</i>-pyran-4-yl)-5-methyl-4-(4-(oxazol-4-yl)benzyl)picolinamide (<b>37</b>)</h3><div class="NLM_p last">Intermediate ethyl 5-methyl-4-(4-(oxazol-4-yl)benzyl)picolinate (<b>28b</b>) was synthesized according to general Suzuki procedure A using 4-(4-(chloromethyl)phenyl)oxazole as the benzyl halide. LC–MS <i>m</i>/<i>z</i> 322.9 [M + H]<sup>+</sup>. Crude <b>28b</b> was subjected to the general hydrolysis outlined in procedure B to give 5-methyl-4-(4-(oxazol-4-yl)benzyl)picolinic acid. Yield: 62 mg, 0.21 mmol, 81% over 2 steps. LC–MS <i>m</i>/<i>z</i> 294.9 [M + H]<sup>+</sup>. EDCI (56.5 mg, 0.295 mmol), 1<i>H</i>-benzotriazol-1-ol (42.7 mg, 0.316 mmol), and Et<sub>3</sub>N (64.0 mg, 0.632 mmol) were added to a solution of the picolinic acid (62 mg, 0.21 mmol) in a mixture of DCM (5 mL) and DMF (3 mL). The mixture was stirred for 4 h at 25 °C, whereupon (3<i>R</i>,4<i>S</i>)-4-aminotetrahydro-2<i>H</i>-pyran-3-ol (29.6 mg, 0.253 mmol) was added and stirring continued for 18 h at 25 °C. Additional EDCI (56.5 mg, 0.295 mmol), 1<i>H</i>-benzotriazol-1-ol (42.7 mg, 0.316 mmol), and triethylamine (64.0 mg, 0.632 mmol) were introduced, and the reaction mixture was stirred for another 30 min; additional (3<i>R</i>,4<i>S</i>)-4-aminotetrahydro-2<i>H</i>-pyran-3-ol (29.6 mg, 0.253 mmol) was then added, and stirring was carried out for another 18 h at 25 °C. The reaction mixture was diluted with DCM (20 mL), washed sequentially with saturated aqueous citric acid solution (20 mL) and aqueous sodium hydroxide solution (1 M, 20 mL), and concentrated in vacuo. The residue was subjected to preparative thin layer chromatography on silica gel (eluent, 33% petroleum ether in EtOAc), followed by reversed phase HPLC purification (column, Phenomenex Gemini C18, 5 μm; mobile phase A, water containing 0.225% formic acid; mobile phase B, acetonitrile containing 0.225% formic acid; gradient, 23% to 43% B). The product was obtained as a white solid. Yield: 20 mg, 51 μmol, 24%. LC–MS <i>m</i>/<i>z</i> 394.1 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.32 (s, 1H), 8.12 (br d, <i>J</i> = 6 Hz, 1H), 8.00 (s, 1H), 7.92–7.96 (m, 2H), 7.68 (d, <i>J</i> = 8.2 Hz, 2H), 7.17 (d, <i>J</i> = 8.2 Hz, 2H), 4.33–4.46 (br m, 1H), 4.09 (dd, <i>J</i> = 12, 5 Hz, 1H), 4.06 (s, 2H), 3.90–4.04 (m, 2H), 3.59–3.68 (m, 1H), 3.43–3.52 (m, 1H), 3.23 (dd, <i>J</i> = 10.9, 10.2 Hz, 1H), 2.32 (s, 3H), 2.00–2.08 (m, 1H), 1.74–1.87 (m, 1H).</div></div><div id="sec4_2_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> <i>N</i>-((3<i>R</i>,4<i>S</i>)-3-Hydroxytetrahydro-2<i>H</i>-pyran-4-yl)-5-methyl-4-(4-(thiazol-4-yl)benzyl)picolinamide (<b>38</b>)</h3><div class="NLM_p">Ethyl 5-methyl-4-(4-(thiazol-4-yl)benzyl)picolinate (<b>28c</b>) was synthesized according to general Suzuki procedure A using 4-(4-(bromomethyl)phenyl)thiazole as the benzyl halide. The residue was purified by silica gel chromatography (gradient, 20% to 80% EtOAc in heptane) to give the ester intermediate as a white solid. Yield: 872 mg, 2.58 mmol, 52%. LC–MS <i>m</i>/<i>z</i> 339.0 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.86 (d, <i>J</i> = 2.0 Hz, 1H), 8.50–8.52 (m, 1H), 7.92 (s, 1H), 7.86 (br d, <i>J</i> = 7.8 Hz, 2H), 7.50 (d, <i>J</i> = 2.0 Hz, 1H), 7.17 (br d, <i>J</i> = 7.8 Hz, 2H), 4.45 (q, <i>J</i> = 7.1 Hz, 2H), 4.06 (s, 2H), 2.31 (s, 3H), 1.42 (t, <i>J</i> = 7.1 Hz, 3H). The ester intermediate was subjected to the general hydrolysis/amidation procedure B using amino alcohol (3<i>R</i>,4<i>S</i>)-4-aminotetrahydro-2<i>H</i>-pyran-3-ol. The crude product obtained after EtOAc extraction was taken up as a slurry in hot EtOAc (15 mL), which was then allowed to stir and cool to rt over 2 h. The crystals were filtered to afford <b>38</b> as a white solid. Yield: 525 mg, 1.28 mmol, 50%. LC–MS <i>m</i>/<i>z</i> 410.2 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.18 (br d, <i>J</i> = 1 Hz, 1H), 8.51 (d, <i>J</i> = 8.4 Hz, 1H), 8.43 (s, 1H), 8.12 (br d, <i>J</i> = 1 Hz, 1H), 7.94 (d, <i>J</i> = 8.0 Hz, 2H), 7.78 (s, 1H), 7.26 (d, <i>J</i> = 8.0 Hz, 2H), 4.93 (d, <i>J</i> = 5.7 Hz, 1H), 4.12 (s, 2H), 3.71–3.83 (m, 3H), 3.51–3.61 (m, 1H), 3.27–3.36 (m, 1H, assumed; partially obscured by solvent peak), 3.01 (dd, <i>J</i> = 10.5, 10.5 Hz, 1H), 2.33 (s, 3H), 1.77–1.85 (m, 1H), 1.55–1.68 (m, 1H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 166.8, 156.0, 152.9, 149.5, 149.4, 147.3, 137.7, 136.0, 132.9, 129.2, 126.9, 123.4, 112.5, 72.2, 71.4, 66.4, 54.1, 38.9, 31.0, 16.7. Elemental analysis calcd for empirical formula C<sub>22</sub>H<sub>23</sub>N<sub>3</sub>O<sub>3</sub>S: C, 64.53; H, 5.66; N, 10.26. Found: C, 64.52; H, 5.58; N, 10.16. [α]<sub>D</sub><sup>20</sup> −9.4° (<i>c</i> 1.05, CHCl<sub>3</sub>).</div><div class="NLM_p last">Compound <b>38</b> (PF-06767832) is commercially available from Sigma-Aldrich (catalog no. PZ0323).</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i24"><a href="/doi/suppl/10.1021/acs.jmedchem.6b00544">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_10804" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_10804" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.6b00544" class="ext-link">10.1021/acs.jmedchem.6b00544</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.6b00544/suppl_file/jm6b00544_si_001.csv" class="ext-link">CSV</a>)</p></li><li><p class="inline">Full synthetic procedures and characterization for all analogues whose procedures are not included in the main manuscript; experimental details and additional material including statistics and data analyses for our biology assays (<a href="/doi/suppl/10.1021/acs.jmedchem.6b00544/suppl_file/jm6b00544_si_002.pdf" class="ext-link">PDF</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b00544/suppl_file/jm6b00544_si_001.csv">jm6b00544_si_001.csv (0.93 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b00544/suppl_file/jm6b00544_si_002.pdf">jm6b00544_si_002.pdf (2.79 MB)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.6b00544" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_38533" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_38533" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jennifer E. Davoren</span> - <span class="hlFld-Affiliation affiliation">†Neuroscience and Pain Medicinal Chemistry, ‡Neuroscience and Pain Research
Unit, and §Pharmacokinetics, Dynamics and Metabolism, Pfizer Worldwide Research and Development, Cambridge, Massachusetts 02139, United States</span>; 
    <span class="hlFld-Affiliation affiliation">∥Neuroscience and Pain Medicinal Chemistry, ⊥Drug Safety Research and Development, #Primary Pharmacology Group, and ∇Research Formulations, Pfizer Worldwide Research and Development, Groton, Connecticut 06340, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Drug
Safety Research and Development, Pfizer
Worldwide Research and Development, La Jolla, California 92121, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Pharmacology, University of North Carolina
School of Medicine, Chapel Hill, North Carolina 27599, United States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#28424d4646414e4d5a064d064c495e475a4d4668584e41524d5a064b4745"><span class="__cf_email__" data-cfemail="bdd7d8d3d3d4dbd8cf93d893d9dccbd2cfd8d3fdcddbd4c7d8cf93ded2d0">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Che-Wah Lee</span> - <span class="hlFld-Affiliation affiliation">†Neuroscience and Pain Medicinal Chemistry, ‡Neuroscience and Pain Research
Unit, and §Pharmacokinetics, Dynamics and Metabolism, Pfizer Worldwide Research and Development, Cambridge, Massachusetts 02139, United States</span>; 
    <span class="hlFld-Affiliation affiliation">∥Neuroscience and Pain Medicinal Chemistry, ⊥Drug Safety Research and Development, #Primary Pharmacology Group, and ∇Research Formulations, Pfizer Worldwide Research and Development, Groton, Connecticut 06340, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Drug
Safety Research and Development, Pfizer
Worldwide Research and Development, La Jolla, California 92121, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Pharmacology, University of North Carolina
School of Medicine, Chapel Hill, North Carolina 27599, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michelle Garnsey</span> - <span class="hlFld-Affiliation affiliation">†Neuroscience and Pain Medicinal Chemistry, ‡Neuroscience and Pain Research
Unit, and §Pharmacokinetics, Dynamics and Metabolism, Pfizer Worldwide Research and Development, Cambridge, Massachusetts 02139, United States</span>; 
    <span class="hlFld-Affiliation affiliation">∥Neuroscience and Pain Medicinal Chemistry, ⊥Drug Safety Research and Development, #Primary Pharmacology Group, and ∇Research Formulations, Pfizer Worldwide Research and Development, Groton, Connecticut 06340, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Drug
Safety Research and Development, Pfizer
Worldwide Research and Development, La Jolla, California 92121, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Pharmacology, University of North Carolina
School of Medicine, Chapel Hill, North Carolina 27599, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michael A. Brodney</span> - <span class="hlFld-Affiliation affiliation">†Neuroscience and Pain Medicinal Chemistry, ‡Neuroscience and Pain Research
Unit, and §Pharmacokinetics, Dynamics and Metabolism, Pfizer Worldwide Research and Development, Cambridge, Massachusetts 02139, United States</span>; 
    <span class="hlFld-Affiliation affiliation">∥Neuroscience and Pain Medicinal Chemistry, ⊥Drug Safety Research and Development, #Primary Pharmacology Group, and ∇Research Formulations, Pfizer Worldwide Research and Development, Groton, Connecticut 06340, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Drug
Safety Research and Development, Pfizer
Worldwide Research and Development, La Jolla, California 92121, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Pharmacology, University of North Carolina
School of Medicine, Chapel Hill, North Carolina 27599, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jason Cordes</span> - <span class="hlFld-Affiliation affiliation">†Neuroscience and Pain Medicinal Chemistry, ‡Neuroscience and Pain Research
Unit, and §Pharmacokinetics, Dynamics and Metabolism, Pfizer Worldwide Research and Development, Cambridge, Massachusetts 02139, United States</span>; 
    <span class="hlFld-Affiliation affiliation">∥Neuroscience and Pain Medicinal Chemistry, ⊥Drug Safety Research and Development, #Primary Pharmacology Group, and ∇Research Formulations, Pfizer Worldwide Research and Development, Groton, Connecticut 06340, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Drug
Safety Research and Development, Pfizer
Worldwide Research and Development, La Jolla, California 92121, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Pharmacology, University of North Carolina
School of Medicine, Chapel Hill, North Carolina 27599, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Keith Dlugolenski</span> - <span class="hlFld-Affiliation affiliation">†Neuroscience and Pain Medicinal Chemistry, ‡Neuroscience and Pain Research
Unit, and §Pharmacokinetics, Dynamics and Metabolism, Pfizer Worldwide Research and Development, Cambridge, Massachusetts 02139, United States</span>; 
    <span class="hlFld-Affiliation affiliation">∥Neuroscience and Pain Medicinal Chemistry, ⊥Drug Safety Research and Development, #Primary Pharmacology Group, and ∇Research Formulations, Pfizer Worldwide Research and Development, Groton, Connecticut 06340, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Drug
Safety Research and Development, Pfizer
Worldwide Research and Development, La Jolla, California 92121, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Pharmacology, University of North Carolina
School of Medicine, Chapel Hill, North Carolina 27599, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jeremy R. Edgerton</span> - <span class="hlFld-Affiliation affiliation">†Neuroscience and Pain Medicinal Chemistry, ‡Neuroscience and Pain Research
Unit, and §Pharmacokinetics, Dynamics and Metabolism, Pfizer Worldwide Research and Development, Cambridge, Massachusetts 02139, United States</span>; 
    <span class="hlFld-Affiliation affiliation">∥Neuroscience and Pain Medicinal Chemistry, ⊥Drug Safety Research and Development, #Primary Pharmacology Group, and ∇Research Formulations, Pfizer Worldwide Research and Development, Groton, Connecticut 06340, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Drug
Safety Research and Development, Pfizer
Worldwide Research and Development, La Jolla, California 92121, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Pharmacology, University of North Carolina
School of Medicine, Chapel Hill, North Carolina 27599, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Anthony R. Harris</span> - <span class="hlFld-Affiliation affiliation">†Neuroscience and Pain Medicinal Chemistry, ‡Neuroscience and Pain Research
Unit, and §Pharmacokinetics, Dynamics and Metabolism, Pfizer Worldwide Research and Development, Cambridge, Massachusetts 02139, United States</span>; 
    <span class="hlFld-Affiliation affiliation">∥Neuroscience and Pain Medicinal Chemistry, ⊥Drug Safety Research and Development, #Primary Pharmacology Group, and ∇Research Formulations, Pfizer Worldwide Research and Development, Groton, Connecticut 06340, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Drug
Safety Research and Development, Pfizer
Worldwide Research and Development, La Jolla, California 92121, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Pharmacology, University of North Carolina
School of Medicine, Chapel Hill, North Carolina 27599, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christopher J. Helal</span> - <span class="hlFld-Affiliation affiliation">†Neuroscience and Pain Medicinal Chemistry, ‡Neuroscience and Pain Research
Unit, and §Pharmacokinetics, Dynamics and Metabolism, Pfizer Worldwide Research and Development, Cambridge, Massachusetts 02139, United States</span>; 
    <span class="hlFld-Affiliation affiliation">∥Neuroscience and Pain Medicinal Chemistry, ⊥Drug Safety Research and Development, #Primary Pharmacology Group, and ∇Research Formulations, Pfizer Worldwide Research and Development, Groton, Connecticut 06340, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Drug
Safety Research and Development, Pfizer
Worldwide Research and Development, La Jolla, California 92121, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Pharmacology, University of North Carolina
School of Medicine, Chapel Hill, North Carolina 27599, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Stephen Jenkinson</span> - <span class="hlFld-Affiliation affiliation">Drug
Safety Research and Development, Pfizer
Worldwide Research and Development, La Jolla, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gregory W. Kauffman</span> - <span class="hlFld-Affiliation affiliation">†Neuroscience and Pain Medicinal Chemistry, ‡Neuroscience and Pain Research
Unit, and §Pharmacokinetics, Dynamics and Metabolism, Pfizer Worldwide Research and Development, Cambridge, Massachusetts 02139, United States</span>; 
    <span class="hlFld-Affiliation affiliation">∥Neuroscience and Pain Medicinal Chemistry, ⊥Drug Safety Research and Development, #Primary Pharmacology Group, and ∇Research Formulations, Pfizer Worldwide Research and Development, Groton, Connecticut 06340, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Drug
Safety Research and Development, Pfizer
Worldwide Research and Development, La Jolla, California 92121, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Pharmacology, University of North Carolina
School of Medicine, Chapel Hill, North Carolina 27599, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Terrence P. Kenakin</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmacology, University of North Carolina
School of Medicine, Chapel Hill, North Carolina 27599, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">John T. Lazzaro</span> - <span class="hlFld-Affiliation affiliation">†Neuroscience and Pain Medicinal Chemistry, ‡Neuroscience and Pain Research
Unit, and §Pharmacokinetics, Dynamics and Metabolism, Pfizer Worldwide Research and Development, Cambridge, Massachusetts 02139, United States</span>; 
    <span class="hlFld-Affiliation affiliation">∥Neuroscience and Pain Medicinal Chemistry, ⊥Drug Safety Research and Development, #Primary Pharmacology Group, and ∇Research Formulations, Pfizer Worldwide Research and Development, Groton, Connecticut 06340, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Drug
Safety Research and Development, Pfizer
Worldwide Research and Development, La Jolla, California 92121, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Pharmacology, University of North Carolina
School of Medicine, Chapel Hill, North Carolina 27599, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Susan M. Lotarski</span> - <span class="hlFld-Affiliation affiliation">†Neuroscience and Pain Medicinal Chemistry, ‡Neuroscience and Pain Research
Unit, and §Pharmacokinetics, Dynamics and Metabolism, Pfizer Worldwide Research and Development, Cambridge, Massachusetts 02139, United States</span>; 
    <span class="hlFld-Affiliation affiliation">∥Neuroscience and Pain Medicinal Chemistry, ⊥Drug Safety Research and Development, #Primary Pharmacology Group, and ∇Research Formulations, Pfizer Worldwide Research and Development, Groton, Connecticut 06340, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Drug
Safety Research and Development, Pfizer
Worldwide Research and Development, La Jolla, California 92121, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Pharmacology, University of North Carolina
School of Medicine, Chapel Hill, North Carolina 27599, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yuxia Mao</span> - <span class="hlFld-Affiliation affiliation">†Neuroscience and Pain Medicinal Chemistry, ‡Neuroscience and Pain Research
Unit, and §Pharmacokinetics, Dynamics and Metabolism, Pfizer Worldwide Research and Development, Cambridge, Massachusetts 02139, United States</span>; 
    <span class="hlFld-Affiliation affiliation">∥Neuroscience and Pain Medicinal Chemistry, ⊥Drug Safety Research and Development, #Primary Pharmacology Group, and ∇Research Formulations, Pfizer Worldwide Research and Development, Groton, Connecticut 06340, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Drug
Safety Research and Development, Pfizer
Worldwide Research and Development, La Jolla, California 92121, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Pharmacology, University of North Carolina
School of Medicine, Chapel Hill, North Carolina 27599, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Deane M. Nason</span> - <span class="hlFld-Affiliation affiliation">†Neuroscience and Pain Medicinal Chemistry, ‡Neuroscience and Pain Research
Unit, and §Pharmacokinetics, Dynamics and Metabolism, Pfizer Worldwide Research and Development, Cambridge, Massachusetts 02139, United States</span>; 
    <span class="hlFld-Affiliation affiliation">∥Neuroscience and Pain Medicinal Chemistry, ⊥Drug Safety Research and Development, #Primary Pharmacology Group, and ∇Research Formulations, Pfizer Worldwide Research and Development, Groton, Connecticut 06340, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Drug
Safety Research and Development, Pfizer
Worldwide Research and Development, La Jolla, California 92121, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Pharmacology, University of North Carolina
School of Medicine, Chapel Hill, North Carolina 27599, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Carrie Northcott</span> - <span class="hlFld-Affiliation affiliation">†Neuroscience and Pain Medicinal Chemistry, ‡Neuroscience and Pain Research
Unit, and §Pharmacokinetics, Dynamics and Metabolism, Pfizer Worldwide Research and Development, Cambridge, Massachusetts 02139, United States</span>; 
    <span class="hlFld-Affiliation affiliation">∥Neuroscience and Pain Medicinal Chemistry, ⊥Drug Safety Research and Development, #Primary Pharmacology Group, and ∇Research Formulations, Pfizer Worldwide Research and Development, Groton, Connecticut 06340, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Drug
Safety Research and Development, Pfizer
Worldwide Research and Development, La Jolla, California 92121, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Pharmacology, University of North Carolina
School of Medicine, Chapel Hill, North Carolina 27599, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lisa Nottebaum</span> - <span class="hlFld-Affiliation affiliation">Drug
Safety Research and Development, Pfizer
Worldwide Research and Development, La Jolla, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Steven V. O’Neil</span> - <span class="hlFld-Affiliation affiliation">†Neuroscience and Pain Medicinal Chemistry, ‡Neuroscience and Pain Research
Unit, and §Pharmacokinetics, Dynamics and Metabolism, Pfizer Worldwide Research and Development, Cambridge, Massachusetts 02139, United States</span>; 
    <span class="hlFld-Affiliation affiliation">∥Neuroscience and Pain Medicinal Chemistry, ⊥Drug Safety Research and Development, #Primary Pharmacology Group, and ∇Research Formulations, Pfizer Worldwide Research and Development, Groton, Connecticut 06340, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Drug
Safety Research and Development, Pfizer
Worldwide Research and Development, La Jolla, California 92121, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Pharmacology, University of North Carolina
School of Medicine, Chapel Hill, North Carolina 27599, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Betty Pettersen</span> - <span class="hlFld-Affiliation affiliation">†Neuroscience and Pain Medicinal Chemistry, ‡Neuroscience and Pain Research
Unit, and §Pharmacokinetics, Dynamics and Metabolism, Pfizer Worldwide Research and Development, Cambridge, Massachusetts 02139, United States</span>; 
    <span class="hlFld-Affiliation affiliation">∥Neuroscience and Pain Medicinal Chemistry, ⊥Drug Safety Research and Development, #Primary Pharmacology Group, and ∇Research Formulations, Pfizer Worldwide Research and Development, Groton, Connecticut 06340, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Drug
Safety Research and Development, Pfizer
Worldwide Research and Development, La Jolla, California 92121, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Pharmacology, University of North Carolina
School of Medicine, Chapel Hill, North Carolina 27599, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michael Popiolek</span> - <span class="hlFld-Affiliation affiliation">†Neuroscience and Pain Medicinal Chemistry, ‡Neuroscience and Pain Research
Unit, and §Pharmacokinetics, Dynamics and Metabolism, Pfizer Worldwide Research and Development, Cambridge, Massachusetts 02139, United States</span>; 
    <span class="hlFld-Affiliation affiliation">∥Neuroscience and Pain Medicinal Chemistry, ⊥Drug Safety Research and Development, #Primary Pharmacology Group, and ∇Research Formulations, Pfizer Worldwide Research and Development, Groton, Connecticut 06340, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Drug
Safety Research and Development, Pfizer
Worldwide Research and Development, La Jolla, California 92121, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Pharmacology, University of North Carolina
School of Medicine, Chapel Hill, North Carolina 27599, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Veronica Reinhart</span> - <span class="hlFld-Affiliation affiliation">†Neuroscience and Pain Medicinal Chemistry, ‡Neuroscience and Pain Research
Unit, and §Pharmacokinetics, Dynamics and Metabolism, Pfizer Worldwide Research and Development, Cambridge, Massachusetts 02139, United States</span>; 
    <span class="hlFld-Affiliation affiliation">∥Neuroscience and Pain Medicinal Chemistry, ⊥Drug Safety Research and Development, #Primary Pharmacology Group, and ∇Research Formulations, Pfizer Worldwide Research and Development, Groton, Connecticut 06340, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Drug
Safety Research and Development, Pfizer
Worldwide Research and Development, La Jolla, California 92121, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Pharmacology, University of North Carolina
School of Medicine, Chapel Hill, North Carolina 27599, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Romelia Salomon-Ferrer</span> - <span class="hlFld-Affiliation affiliation">†Neuroscience and Pain Medicinal Chemistry, ‡Neuroscience and Pain Research
Unit, and §Pharmacokinetics, Dynamics and Metabolism, Pfizer Worldwide Research and Development, Cambridge, Massachusetts 02139, United States</span>; 
    <span class="hlFld-Affiliation affiliation">∥Neuroscience and Pain Medicinal Chemistry, ⊥Drug Safety Research and Development, #Primary Pharmacology Group, and ∇Research Formulations, Pfizer Worldwide Research and Development, Groton, Connecticut 06340, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Drug
Safety Research and Development, Pfizer
Worldwide Research and Development, La Jolla, California 92121, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Pharmacology, University of North Carolina
School of Medicine, Chapel Hill, North Carolina 27599, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Stefanus J. Steyn</span> - <span class="hlFld-Affiliation affiliation">†Neuroscience and Pain Medicinal Chemistry, ‡Neuroscience and Pain Research
Unit, and §Pharmacokinetics, Dynamics and Metabolism, Pfizer Worldwide Research and Development, Cambridge, Massachusetts 02139, United States</span>; 
    <span class="hlFld-Affiliation affiliation">∥Neuroscience and Pain Medicinal Chemistry, ⊥Drug Safety Research and Development, #Primary Pharmacology Group, and ∇Research Formulations, Pfizer Worldwide Research and Development, Groton, Connecticut 06340, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Drug
Safety Research and Development, Pfizer
Worldwide Research and Development, La Jolla, California 92121, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Pharmacology, University of North Carolina
School of Medicine, Chapel Hill, North Carolina 27599, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Damien Webb</span> - <span class="hlFld-Affiliation affiliation">†Neuroscience and Pain Medicinal Chemistry, ‡Neuroscience and Pain Research
Unit, and §Pharmacokinetics, Dynamics and Metabolism, Pfizer Worldwide Research and Development, Cambridge, Massachusetts 02139, United States</span>; 
    <span class="hlFld-Affiliation affiliation">∥Neuroscience and Pain Medicinal Chemistry, ⊥Drug Safety Research and Development, #Primary Pharmacology Group, and ∇Research Formulations, Pfizer Worldwide Research and Development, Groton, Connecticut 06340, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Drug
Safety Research and Development, Pfizer
Worldwide Research and Development, La Jolla, California 92121, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Pharmacology, University of North Carolina
School of Medicine, Chapel Hill, North Carolina 27599, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lei Zhang</span> - <span class="hlFld-Affiliation affiliation">†Neuroscience and Pain Medicinal Chemistry, ‡Neuroscience and Pain Research
Unit, and §Pharmacokinetics, Dynamics and Metabolism, Pfizer Worldwide Research and Development, Cambridge, Massachusetts 02139, United States</span>; 
    <span class="hlFld-Affiliation affiliation">∥Neuroscience and Pain Medicinal Chemistry, ⊥Drug Safety Research and Development, #Primary Pharmacology Group, and ∇Research Formulations, Pfizer Worldwide Research and Development, Groton, Connecticut 06340, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Drug
Safety Research and Development, Pfizer
Worldwide Research and Development, La Jolla, California 92121, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Pharmacology, University of North Carolina
School of Medicine, Chapel Hill, North Carolina 27599, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sarah Grimwood</span> - <span class="hlFld-Affiliation affiliation">†Neuroscience and Pain Medicinal Chemistry, ‡Neuroscience and Pain Research
Unit, and §Pharmacokinetics, Dynamics and Metabolism, Pfizer Worldwide Research and Development, Cambridge, Massachusetts 02139, United States</span>; 
    <span class="hlFld-Affiliation affiliation">∥Neuroscience and Pain Medicinal Chemistry, ⊥Drug Safety Research and Development, #Primary Pharmacology Group, and ∇Research Formulations, Pfizer Worldwide Research and Development, Groton, Connecticut 06340, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Drug
Safety Research and Development, Pfizer
Worldwide Research and Development, La Jolla, California 92121, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Pharmacology, University of North Carolina
School of Medicine, Chapel Hill, North Carolina 27599, United States</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d7e3991-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i25">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_48216" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_48216" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We acknowledge Lois Chenard and our Wuxi team for technical assistance in running libraries, Deborah Smith and Nicole Matluck for assistance in running binding assays, Brian Samas for X-ray data, Feng Shao and Bruce Rogers for helpful discussions, Rebecca O’Connor and HD Biosciences for screening assistance, Joy Yang and Xinjun Hou for modeling help, and Neal Sach for reaction optimization assistance.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i26" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i26"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i27" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i27"> Abbreviations Used</h2><tr><td class="NLM_term">B<sub>2</sub>pin<sub>2</sub></td><td class="NLM_def"><p class="first last">bis(pinacolato)diboron</p></td></tr><tr><td class="NLM_term">dppf</td><td class="NLM_def"><p class="first last">1,1′-bis(diphenylphosphino)ferrocene</p></td></tr><tr><td class="NLM_term">HATU</td><td class="NLM_def"><p class="first last"><i>O</i>-(7-azabenzotriazol-1-yl)-1-[bis(dimethylamino)methylene]-1<i>H</i>-1,2,3-triazolo[4,5-<i>b</i>]pyridinium 3-oxide hexafluorophosphate</p></td></tr><tr><td class="NLM_term">Pd<sub>2</sub>(dba)<sub>3</sub></td><td class="NLM_def"><p class="first last">tris(dibenzylideneacetone)dipalladium(0)</p></td></tr><tr><td class="NLM_term">HOBt</td><td class="NLM_def"><p class="first last">benzotriazol-1-ol</p></td></tr><tr><td class="NLM_term">EDCI</td><td class="NLM_def"><p class="first last">1-[3-(dimethylamino)propyl]-3-ethylcarbodiimide hydrochloride</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i28">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_30037" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_30037" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 48 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Shirey, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brady, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bridges, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jadhav, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menon, U. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christian, E. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doherty, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quirk, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snyder, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lah, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levey, A. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicolle, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindsley, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conn, P. J.</span><span> </span><span class="NLM_article-title">A selective allosteric potentiator of the M1 muscarinic acetylcholine receptor increases activity of medial prefrontal cortical neurons and restores impairments in reversal learning</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">14271</span><span class="NLM_x">–</span> <span class="NLM_lpage">14286</span><span class="refDoi"> DOI: 10.1523/JNEUROSCI.3930-09.2009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=10.1523%2FJNEUROSCI.3930-09.2009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=19906975" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsVGrsrjL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2009&pages=14271-14286&author=J.+K.+Shireyauthor=A.+E.+Bradyauthor=P.+J.+Jonesauthor=A.+A.+Davisauthor=T.+M.+Bridgesauthor=J.+P.+Kennedyauthor=S.+B.+Jadhavauthor=U.+N.+Menonauthor=Z.+Xiangauthor=M.+L.+Watsonauthor=E.+P.+Christianauthor=J.+J.+Dohertyauthor=M.+C.+Quirkauthor=D.+H.+Snyderauthor=J.+J.+Lahauthor=A.+I.+Leveyauthor=M.+M.+Nicolleauthor=C.+W.+Lindsleyauthor=P.+J.+Conn&title=A+selective+allosteric+potentiator+of+the+M1+muscarinic+acetylcholine+receptor+increases+activity+of+medial+prefrontal+cortical+neurons+and+restores+impairments+in+reversal+learning&doi=10.1523%2FJNEUROSCI.3930-09.2009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1aR"><div class="casContent"><span class="casTitleNuber">1a</span><div class="casTitle"><span class="NLM_cas:atitle">A selective allosteric potentiator of the M1 muscarinic acetylcholine receptor increases activity of medial prefrontal cortical neurons and restores impairments in reversal learning</span></div><div class="casAuthors">Shirey, Jana K.; Brady, Ashley E.; Jones, Paulianda J.; Davis, Albert A.; Bridges, Thomas M.; Kennedy, J. Phillip; Jadhav, Satyawan B.; Menon, Usha N.; Xiang, Zixiu; Watson, Mona L.; Christian, Edward P.; Doherty, James J.; Quirk, Michael C.; Snyder, Dean H.; Lah, James J.; Levey, Allan I.; Nicolle, Michelle M.; Lindsley, Craig W.; Conn, P. Jeffrey</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">45</span>),
    <span class="NLM_cas:pages">14271-14286</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">M1 muscarinic acetylcholine receptors (mAChRs) may represent a viable target for treatment of disorders involving impaired cognitive function.  However, a major limitation to testing this hypothesis has been a lack of highly selective ligands for individual mAChR subtypes.  We now report the rigorous mol. characterization of a novel compd., benzylquinolone carboxylic acid (BQCA), which acts as a potent, highly selective pos. allosteric modulator (PAM) of the rat M1 receptor.  This compd. does not directly activate the receptor, but acts at an allosteric site to increase functional responses to orthosteric agonists.  Radioligand binding studies revealed that BQCA increases M1 receptor affinity for acetylcholine.  We found that activation of the M1 receptor by BQCA induces a robust inward current and increases spontaneous EPSCs in medial prefrontal cortex (mPFC) pyramidal cells, effects which are absent in acute slices from M1 receptor knock-out mice.  Furthermore, to det. the effect of BQCA on intact and functioning brain circuits, multiple single-unit recordings were obtained from the mPFC of rats that showed BQCA increases firing of mPFC pyramidal cells in vivo.  BQCA also restored discrimination reversal learning in a transgenic mouse model of Alzheimer's disease and was found to regulate non-amyloidogenic APP processing in vitro, suggesting that M1 receptor PAMs have the potential to provide both symptomatic and disease modifying effects in Alzheimer's disease patients.  Together, these studies provide compelling evidence that M1 receptor activation induces a dramatic excitation of PFC neurons and suggest that selectively activating the M1 mAChR subtype may ameliorate impairments in cognitive function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPy39j1-erZLVg90H21EOLACvtfcHk0ljOS3j-teb32w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsVGrsrjL&md5=f9b017887d46ba34b925f747cea7ce3b</span></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.3930-09.2009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.3930-09.2009%26sid%3Dliteratum%253Aachs%26aulast%3DShirey%26aufirst%3DJ.%2BK.%26aulast%3DBrady%26aufirst%3DA.%2BE.%26aulast%3DJones%26aufirst%3DP.%2BJ.%26aulast%3DDavis%26aufirst%3DA.%2BA.%26aulast%3DBridges%26aufirst%3DT.%2BM.%26aulast%3DKennedy%26aufirst%3DJ.%2BP.%26aulast%3DJadhav%26aufirst%3DS.%2BB.%26aulast%3DMenon%26aufirst%3DU.%2BN.%26aulast%3DXiang%26aufirst%3DZ.%26aulast%3DWatson%26aufirst%3DM.%2BL.%26aulast%3DChristian%26aufirst%3DE.%2BP.%26aulast%3DDoherty%26aufirst%3DJ.%2BJ.%26aulast%3DQuirk%26aufirst%3DM.%2BC.%26aulast%3DSnyder%26aufirst%3DD.%2BH.%26aulast%3DLah%26aufirst%3DJ.%2BJ.%26aulast%3DLevey%26aufirst%3DA.%2BI.%26aulast%3DNicolle%26aufirst%3DM.%2BM.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26aulast%3DConn%26aufirst%3DP.%2BJ.%26atitle%3DA%2520selective%2520allosteric%2520potentiator%2520of%2520the%2520M1%2520muscarinic%2520acetylcholine%2520receptor%2520increases%2520activity%2520of%2520medial%2520prefrontal%2520cortical%2520neurons%2520and%2520restores%2520impairments%2520in%2520reversal%2520learning%26jtitle%3DJ.%2520Neurosci.%26date%3D2009%26volume%3D29%26spage%3D14271%26epage%3D14286%26doi%3D10.1523%2FJNEUROSCI.3930-09.2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit1b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Felder, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bymaster, F. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeLapp, N.</span><span> </span><span class="NLM_article-title">Therapeutic opportunities for muscarinic receptors in the central nervous system</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">4333</span><span class="NLM_x">–</span> <span class="NLM_lpage">4353</span><span class="refDoi"> DOI: 10.1021/jm990607u</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm990607u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=1%3ACAS%3A528%3ADC%252BD3cXotVGjurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=4333-4353&author=C.+C.+Felderauthor=F.+P.+Bymasterauthor=J.+Wardauthor=N.+DeLapp&title=Therapeutic+opportunities+for+muscarinic+receptors+in+the+central+nervous+system&doi=10.1021%2Fjm990607u"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1bR"><div class="casContent"><span class="casTitleNuber">1b</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic opportunities for muscarinic receptors in the central nervous system</span></div><div class="casAuthors">Felder, Christian C.; Bymaster, Frank P.; Ward, John; DeLapp, Neil</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">4333-4353</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review with 270 refs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqG8rbnUQnx97Vg90H21EOLACvtfcHk0ljOS3j-teb32w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXotVGjurs%253D&md5=5958ba24baebc0ebec67cccfd66b6286</span></div><a href="/servlet/linkout?suffix=cit1b&amp;dbid=16384&amp;doi=10.1021%2Fjm990607u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm990607u%26sid%3Dliteratum%253Aachs%26aulast%3DFelder%26aufirst%3DC.%2BC.%26aulast%3DBymaster%26aufirst%3DF.%2BP.%26aulast%3DWard%26aufirst%3DJ.%26aulast%3DDeLapp%26aufirst%3DN.%26atitle%3DTherapeutic%2520opportunities%2520for%2520muscarinic%2520receptors%2520in%2520the%2520central%2520nervous%2520system%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D4333%26epage%3D4353%26doi%3D10.1021%2Fjm990607u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit1c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Ghoshal, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rook, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dickerson, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roop, G. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morrison, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jalan-Sakrikar, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamsal, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noetzel, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poslusney, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melancon, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stauffer, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daniels, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niswender, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindsley, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conn, P. J.</span><span> </span><span class="NLM_article-title">Potentiation of M1 muscarinic receptor reverses plasticity deficits and negative and cognitive symptoms in a schizophrenia mouse model</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">598</span><span class="NLM_x">–</span> <span class="NLM_lpage">610</span><span class="refDoi"> DOI: 10.1038/npp.2015.189</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=10.1038%2Fnpp.2015.189" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2016&pages=598-610&author=A.+Ghoshalauthor=J.+M.+Rookauthor=J.+W.+Dickersonauthor=G.+N.+Roopauthor=R.+D.+Morrisonauthor=N.+Jalan-Sakrikarauthor=A.+Lamsalauthor=M.+J.+Noetzelauthor=M.+S.+Poslusneyauthor=M.+R.+Woodauthor=B.+J.+Melanconauthor=S.+R.+Staufferauthor=Z.+Xiangauthor=J.+S.+Danielsauthor=C.+M.+Niswenderauthor=C.+K.+Jonesauthor=C.+W.+Lindsleyauthor=P.+J.+Conn&title=Potentiation+of+M1+muscarinic+receptor+reverses+plasticity+deficits+and+negative+and+cognitive+symptoms+in+a+schizophrenia+mouse+model&doi=10.1038%2Fnpp.2015.189"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1c&amp;dbid=16384&amp;doi=10.1038%2Fnpp.2015.189&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnpp.2015.189%26sid%3Dliteratum%253Aachs%26aulast%3DGhoshal%26aufirst%3DA.%26aulast%3DRook%26aufirst%3DJ.%2BM.%26aulast%3DDickerson%26aufirst%3DJ.%2BW.%26aulast%3DRoop%26aufirst%3DG.%2BN.%26aulast%3DMorrison%26aufirst%3DR.%2BD.%26aulast%3DJalan-Sakrikar%26aufirst%3DN.%26aulast%3DLamsal%26aufirst%3DA.%26aulast%3DNoetzel%26aufirst%3DM.%2BJ.%26aulast%3DPoslusney%26aufirst%3DM.%2BS.%26aulast%3DWood%26aufirst%3DM.%2BR.%26aulast%3DMelancon%26aufirst%3DB.%2BJ.%26aulast%3DStauffer%26aufirst%3DS.%2BR.%26aulast%3DXiang%26aufirst%3DZ.%26aulast%3DDaniels%26aufirst%3DJ.%2BS.%26aulast%3DNiswender%26aufirst%3DC.%2BM.%26aulast%3DJones%26aufirst%3DC.%2BK.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26aulast%3DConn%26aufirst%3DP.%2BJ.%26atitle%3DPotentiation%2520of%2520M1%2520muscarinic%2520receptor%2520reverses%2520plasticity%2520deficits%2520and%2520negative%2520and%2520cognitive%2520symptoms%2520in%2520a%2520schizophrenia%2520mouse%2520model%26jtitle%3DNeuropsychopharmacology%26date%3D2016%26volume%3D41%26spage%3D598%26epage%3D610%26doi%3D10.1038%2Fnpp.2015.189" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit1d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Foster, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conn, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rook, J. M.</span><span> </span><span class="NLM_article-title">Activation of M1 and M4 muscarinic receptors as potential treatments for Alzheimer’s disease and schizophrenia</span> <span class="citation_source-journal">Neuropsychiatr. Dis. Treat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">183</span><span class="NLM_x">–</span> <span class="NLM_lpage">191</span><span class="refDoi"> DOI: 10.2147/NDT.S55104</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=10.2147%2FNDT.S55104" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1d&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=24511233" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs12lsLvL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2014&pages=183-191&author=D.+J.+Fosterauthor=D.+L.+Choiauthor=P.+J.+Connauthor=J.+M.+Rook&title=Activation+of+M1+and+M4+muscarinic+receptors+as+potential+treatments+for+Alzheimer%E2%80%99s+disease+and+schizophrenia&doi=10.2147%2FNDT.S55104"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1dR"><div class="casContent"><span class="casTitleNuber">1d</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of M1 and M4 muscarinic receptors as potential treatments for Alzheimer's disease and schizophrenia</span></div><div class="casAuthors">Foster, Daniel J.; Choi, Derrick L.; Conn, P. Jeffrey; Rook, Jerri M.</div><div class="citationInfo"><span class="NLM_cas:title">Neuropsychiatric Disease and Treatment</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">183-191, 9</span>CODEN:
                <span class="NLM_cas:coden">NDTEAZ</span>;
        ISSN:<span class="NLM_cas:issn">1178-2021</span>.
    
            (<span class="NLM_cas:orgname">Dove Medical Press Ltd.</span>)
        </div><div class="casAbstract">A review.  Alzheimer's disease (AD) and schizophrenia (SZ) are neurol. disorders with overlapping symptomatol., including both cognitive deficits and behavioral disturbances.  Current clin. treatments for both disorders have limited efficacy accompanied by dose-limiting side effects, and ultimately fail to adequately address the broad range of symptoms obsd.  Novel therapeutic options for AD and SZ are needed to better manage the spectrum of symptoms with reduced adverse-effect liability.  Substantial evidence suggests that activation of muscarinic acetylcholine receptors (mAChRs) has the potential to treat both cognitive and psychosis-related symptoms assocd. with numerous central nervous system (CNS) disorders.  However, use of nonselective modulators of mAChRs is hampered by dose-limiting peripheral side effects that limit their clin. utility.  In order to maintain the clin. efficacy without the adverse-effect liability, efforts have been focused on the discovery of compds. that selectively modulate the centrally located M1 and M4 mAChR subtypes.  Previous drug discovery attempts have been thwarted by the highly conserved nature of the acetylcholine site across mAChR subtypes.  However, current efforts by our lab. and others have now focused on modulators that bind to allosteric sites on mAChRs, allowing these compds. to display unprecedented subtype selectivity.  Over the past couple of decades, the discovery of small mols. capable of selectively targeting the M1 or M4 mAChR subtypes has allowed researchers to elucidate the roles of these receptors in regulating cognitive and behavioral disturbances in preclin. animal models.  Here, we provide an overview of these promising preclin. and clin. studies, which suggest that M1- and M4-selective modulators represent viable novel targets with the potential to successfully address a broad range of symptoms obsd. in patients with AD and SZ.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1huQLY2kYMrVg90H21EOLACvtfcHk0lhr4NnxVG-VRQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs12lsLvL&md5=cb4b539ecd830e56559b11ad18358622</span></div><a href="/servlet/linkout?suffix=cit1d&amp;dbid=16384&amp;doi=10.2147%2FNDT.S55104&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2147%252FNDT.S55104%26sid%3Dliteratum%253Aachs%26aulast%3DFoster%26aufirst%3DD.%2BJ.%26aulast%3DChoi%26aufirst%3DD.%2BL.%26aulast%3DConn%26aufirst%3DP.%2BJ.%26aulast%3DRook%26aufirst%3DJ.%2BM.%26atitle%3DActivation%2520of%2520M1%2520and%2520M4%2520muscarinic%2520receptors%2520as%2520potential%2520treatments%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%2520and%2520schizophrenia%26jtitle%3DNeuropsychiatr.%2520Dis.%2520Treat.%26date%3D2014%26volume%3D10%26spage%3D183%26epage%3D191%26doi%3D10.2147%2FNDT.S55104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Korczyn, A. D.</span><span> </span><span class="NLM_article-title">Muscarinic M(1) agonists in the treatment of Alzheimer’s disease</span> <span class="citation_source-journal">Expert Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">2259</span><span class="NLM_x">–</span> <span class="NLM_lpage">2267</span><span class="refDoi"> DOI: 10.1517/13543784.9.10.2259</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=10.1517%2F13543784.9.10.2259" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2000&pages=2259-2267&author=A.+D.+Korczyn&title=Muscarinic+M%281%29+agonists+in+the+treatment+of+Alzheimer%E2%80%99s+disease&doi=10.1517%2F13543784.9.10.2259"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1517%2F13543784.9.10.2259&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543784.9.10.2259%26sid%3Dliteratum%253Aachs%26aulast%3DKorczyn%26aufirst%3DA.%2BD.%26atitle%3DMuscarinic%2520M%25281%2529%2520agonists%2520in%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2000%26volume%3D9%26spage%3D2259%26epage%3D2267%26doi%3D10.1517%2F13543784.9.10.2259" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Kruse, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ring, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manglik, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eitel, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hubner, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pardon, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valant, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sexton, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christopoulos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Felder, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gmeiner, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steyaert, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weis, W. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wess, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobilka, B. K.</span><span> </span><span class="NLM_article-title">Activation and allosteric modulation of a muscarinic acetylcholine receptor</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">504</span><span class="NLM_x">, </span> <span class="NLM_fpage">101</span><span class="NLM_x">–</span> <span class="NLM_lpage">106</span><span class="refDoi"> DOI: 10.1038/nature12735</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=10.1038%2Fnature12735" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=24256733" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvVyisLjP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=504&publication_year=2013&pages=101-106&author=A.+C.+Kruseauthor=A.+M.+Ringauthor=A.+Manglikauthor=J.+Huauthor=K.+Huauthor=K.+Eitelauthor=H.+Hubnerauthor=E.+Pardonauthor=C.+Valantauthor=P.+M.+Sextonauthor=A.+Christopoulosauthor=C.+C.+Felderauthor=P.+Gmeinerauthor=J.+Steyaertauthor=W.+I.+Weisauthor=K.+C.+Garciaauthor=J.+Wessauthor=B.+K.+Kobilka&title=Activation+and+allosteric+modulation+of+a+muscarinic+acetylcholine+receptor&doi=10.1038%2Fnature12735"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Activation and allosteric modulation of a muscarinic acetylcholine receptor</span></div><div class="casAuthors">Kruse, Andrew C.; Ring, Aaron M.; Manglik, Aashish; Hu, Jianxin; Hu, Kelly; Eitel, Katrin; Huebner, Harald; Pardon, Els; Valant, Celine; Sexton, Patrick M.; Christopoulos, Arthur; Felder, Christian C.; Gmeiner, Peter; Steyaert, Jan; Weis, William I.; Garcia, K. Christopher; Wess, Juergen; Kobilka, Brian K.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">504</span>
        (<span class="NLM_cas:issue">7478</span>),
    <span class="NLM_cas:pages">101-106</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Despite recent advances in crystallog. and the availability of G-protein-coupled receptor (GPCR) structures, little is known about the mechanism of their activation process, as only the β2 adrenergic receptor (β2AR) and rhodopsin have been crystd. in fully active conformations.  Here we report the structure of an agonist-bound, active state of the human M2 muscarinic acetylcholine receptor stabilized by a G-protein mimetic camelid antibody fragment isolated by conformational selection using yeast surface display.  In addn. to the expected changes in the intracellular surface, the structure reveals larger conformational changes in the extracellular region and orthosteric binding site than obsd. in the active states of the β2AR and rhodopsin.  We also report the structure of the M2 receptor simultaneously bound to the orthosteric agonist iperoxo and the pos. allosteric modulator LY2119620.  This structure reveals that LY2119620 recognizes a largely pre-formed binding site in the extracellular vestibule of the iperoxo-bound receptor, inducing a slight contraction of this outer binding pocket.  These structures offer important insights into the activation mechanism and allosteric modulation of muscarinic receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpOuUgQSB7Dd7Vg90H21EOLACvtfcHk0lhr4NnxVG-VRQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvVyisLjP&md5=ecddab0ab467321ac243b86bb82b71f8</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1038%2Fnature12735&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature12735%26sid%3Dliteratum%253Aachs%26aulast%3DKruse%26aufirst%3DA.%2BC.%26aulast%3DRing%26aufirst%3DA.%2BM.%26aulast%3DManglik%26aufirst%3DA.%26aulast%3DHu%26aufirst%3DJ.%26aulast%3DHu%26aufirst%3DK.%26aulast%3DEitel%26aufirst%3DK.%26aulast%3DHubner%26aufirst%3DH.%26aulast%3DPardon%26aufirst%3DE.%26aulast%3DValant%26aufirst%3DC.%26aulast%3DSexton%26aufirst%3DP.%2BM.%26aulast%3DChristopoulos%26aufirst%3DA.%26aulast%3DFelder%26aufirst%3DC.%2BC.%26aulast%3DGmeiner%26aufirst%3DP.%26aulast%3DSteyaert%26aufirst%3DJ.%26aulast%3DWeis%26aufirst%3DW.%2BI.%26aulast%3DGarcia%26aufirst%3DK.%2BC.%26aulast%3DWess%26aufirst%3DJ.%26aulast%3DKobilka%26aufirst%3DB.%2BK.%26atitle%3DActivation%2520and%2520allosteric%2520modulation%2520of%2520a%2520muscarinic%2520acetylcholine%2520receptor%26jtitle%3DNature%26date%3D2013%26volume%3D504%26spage%3D101%26epage%3D106%26doi%3D10.1038%2Fnature12735" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><a href="http://www.heptares.com/news/261/74/Heptares-Announces-Positive-Results-from-Phase-1b-Clinical-Trial-with-HTL9936-a-First-In-Class-Selective-Muscarinic-M1-Receptor-Agonist-for-Improving-Cognition-in-Dementia-and-Schizophrenia.html" class="extLink">http://www.heptares.com/news/261/74/Heptares-Announces-Positive-Results-from-Phase-1b-Clinical-Trial-with-HTL9936-a-First-In-Class-Selective-Muscarinic-M1-Receptor-Agonist-for-Improving-Cognition-in-Dementia-and-Schizophrenia.html</a> (accessed February 12,<span class="NLM_x"> </span><span class="NLM_year">2016</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=http%3A%2F%2Fwww.heptares.com%2Fnews%2F261%2F74%2FHeptares-Announces-Positive-Results-from-Phase-1b-Clinical-Trial-with-HTL9936-a-First-In-Class-Selective-Muscarinic-M1-Receptor-Agonist-for-Improving-Cognition-in-Dementia-and-Schizophrenia.html+%28accessed+February+12%2C+2016%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Ma, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seager, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wittmann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bickel, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burno, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graufelds, V. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pearson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCampbell, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaspar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shughrue, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Danziger, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Regan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flick, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pascarella, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doran, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kreatsoulas, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Veng, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindsley, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shipe, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuduk, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sur, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kinney, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seabrook, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ray, W. J.</span><span> </span><span class="NLM_article-title">Selective activation of the M<sub>1</sub> muscarinic acetylcholine receptor achieved by allosteric potentiation</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">106</span><span class="NLM_x">, </span> <span class="NLM_fpage">15950</span><span class="NLM_x">–</span> <span class="NLM_lpage">15955</span><span class="refDoi"> DOI: 10.1073/pnas.0900903106</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=10.1073%2Fpnas.0900903106" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=19717450" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFOqt7nL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2009&pages=15950-15955&author=L.+Maauthor=M.+A.+Seagerauthor=M.+Wittmannauthor=M.+Jacobsonauthor=D.+Bickelauthor=M.+Burnoauthor=K.+Jonesauthor=V.+K.+Graufeldsauthor=G.+Xuauthor=M.+Pearsonauthor=A.+McCampbellauthor=R.+Gasparauthor=P.+Shughrueauthor=A.+Danzigerauthor=C.+Reganauthor=R.+Flickauthor=D.+Pascarellaauthor=S.+Garsonauthor=S.+Doranauthor=C.+Kreatsoulasauthor=L.+Vengauthor=C.+W.+Lindsleyauthor=W.+Shipeauthor=S.+Kudukauthor=C.+Surauthor=G.+Kinneyauthor=G.+R.+Seabrookauthor=W.+J.+Ray&title=Selective+activation+of+the+M1+muscarinic+acetylcholine+receptor+achieved+by+allosteric+potentiation&doi=10.1073%2Fpnas.0900903106"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Selective activation of the M1 muscarinic acetylcholine receptor achieved by allosteric potentiation</span></div><div class="casAuthors">Ma, Lei; Seager, Matthew; Wittmann, Marion; Jacobson, Marlene; Bickel, Denise; Burno, Maryann; Jones, Keith; Graufelds, Valerie Kuzmick; Xu, Guangping; Pearson, Michelle; McCampbell, Alexander; Gaspar, Renee; Shughrue, Paul; Danziger, Andrew; Regan, Christopher; Flick, Rose; Pascarella, Danette; Garson, Susan; Doran, Scott; Kreatsoulas, Constantine; Veng, Lone; Lindsley, Craig W.; Shipe, William; Kuduk, Scott; Sur, Cyrille; Kinney, Gene; Seabrook, Guy R.; Ray, William J.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">106</span>
        (<span class="NLM_cas:issue">37</span>),
    <span class="NLM_cas:pages">15950-15955, S15950/1-S15950/9</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The forebrain cholinergic system promotes higher brain function in part by signaling through the M, muscarinic acetylcholine receptor (mAChR).  During Alzheimer's disease (AD), these cholinergic neurons degenerate, therefore selectively activating M1 receptors could improve cognitive function in these patients while avoiding unwanted peripheral responses assocd. with non-selective muscarinic agonists.  We describe here benzyl quinolone carboxylic acid (BQCA), a highly selective allosteric potentiator of the M1 mAChR.  BQCA reduces the concn. of ACh required to activate M1 up to 129-fold with an inflection point value of 845 nM.  No potentiation, agonism, or antagonism activity on other mAChRs is obsd. up to 100 ArM.  Furthermore studies in M1-/- mice demonstrates that BQCA requires M1 to promote inositol phosphate turnover in primary neurons and to increase c-fos and arc RNA expression and ERK phosphorylation in the brain.  Radioligand-binding assays, mol. modeling, and site-directed mutagenesis expts. indicate that BQCA acts at an allosteric site involving residues Y179 and W400.  BQCA reverses scopolamine-induced memory deficits in contextual fear conditioning, increases blood flow to the cerebral cortex, and increases wakefulness while reducing delta sleep.  In contrast to M1 allosteric agonists, which do not improve memory in scopolamine-challenged mice in contextual fear conditioning, BQCA induces 13-arrestin recruitment to M1, suggesting a role for this signal transduction mechanism in the cholinergic modulation of memory.  In summary, BQCA exploits an allosteric potentiation mechanism to provide selectivity for the M1 receptor and represents a promising therapeutic strategy for cognitive disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp0SGRL-coGErVg90H21EOLACvtfcHk0li1fNW4nNRjtw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFOqt7nL&md5=4470732fd762f761a18d2bc96220dcb1</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0900903106&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0900903106%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DL.%26aulast%3DSeager%26aufirst%3DM.%2BA.%26aulast%3DWittmann%26aufirst%3DM.%26aulast%3DJacobson%26aufirst%3DM.%26aulast%3DBickel%26aufirst%3DD.%26aulast%3DBurno%26aufirst%3DM.%26aulast%3DJones%26aufirst%3DK.%26aulast%3DGraufelds%26aufirst%3DV.%2BK.%26aulast%3DXu%26aufirst%3DG.%26aulast%3DPearson%26aufirst%3DM.%26aulast%3DMcCampbell%26aufirst%3DA.%26aulast%3DGaspar%26aufirst%3DR.%26aulast%3DShughrue%26aufirst%3DP.%26aulast%3DDanziger%26aufirst%3DA.%26aulast%3DRegan%26aufirst%3DC.%26aulast%3DFlick%26aufirst%3DR.%26aulast%3DPascarella%26aufirst%3DD.%26aulast%3DGarson%26aufirst%3DS.%26aulast%3DDoran%26aufirst%3DS.%26aulast%3DKreatsoulas%26aufirst%3DC.%26aulast%3DVeng%26aufirst%3DL.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26aulast%3DShipe%26aufirst%3DW.%26aulast%3DKuduk%26aufirst%3DS.%26aulast%3DSur%26aufirst%3DC.%26aulast%3DKinney%26aufirst%3DG.%26aulast%3DSeabrook%26aufirst%3DG.%2BR.%26aulast%3DRay%26aufirst%3DW.%2BJ.%26atitle%3DSelective%2520activation%2520of%2520the%2520M1%2520muscarinic%2520acetylcholine%2520receptor%2520achieved%2520by%2520allosteric%2520potentiation%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2009%26volume%3D106%26spage%3D15950%26epage%3D15955%26doi%3D10.1073%2Fpnas.0900903106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Kuduk, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Marco, C. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pitts, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greshock, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wittmann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seager, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koeplinger, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartman, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bilodeau, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ray, W. J.</span><span> </span><span class="NLM_article-title">Discovery of a selective allosteric M1 receptor modulator with suitable development properties based on a quinolizidinone carboxylic acid scaffold</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">4773</span><span class="NLM_x">–</span> <span class="NLM_lpage">4780</span><span class="refDoi"> DOI: 10.1021/jm200400m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm200400m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=1%3ACAS%3A528%3ADC%252BC3MXnslKisbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=4773-4780&author=S.+D.+Kudukauthor=R.+K.+Changauthor=C.+N.+Di+Marcoauthor=D.+R.+Pittsauthor=T.+J.+Greshockauthor=L.+Maauthor=M.+Wittmannauthor=M.+A.+Seagerauthor=K.+A.+Koeplingerauthor=C.+D.+Thompsonauthor=G.+D.+Hartmanauthor=M.+T.+Bilodeauauthor=W.+J.+Ray&title=Discovery+of+a+selective+allosteric+M1+receptor+modulator+with+suitable+development+properties+based+on+a+quinolizidinone+carboxylic+acid+scaffold&doi=10.1021%2Fjm200400m"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a Selective Allosteric M1 Receptor Modulator with Suitable Development Properties Based on a Quinolizidinone Carboxylic Acid Scaffold</span></div><div class="casAuthors">Kuduk, Scott D.; Chang, Ronald K.; Di Marco, Christina N.; Pitts, Daniel R.; Greshock, Thomas J.; Ma, Lei; Wittmann, Marion; Seager, Matthew A.; Koeplinger, Kenneth A.; Thompson, Charles D.; Hartman, George D.; Bilodeau, Mark T.; Ray, William J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">4773-4780</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">One approach to ameliorate the cognitive decline in Alzheimer's disease (AD) has been to restore neuronal signaling from the basal forebrain cholinergic system via the activation of the M1 muscarinic receptor.  A no. of nonselective M1 muscarinic agonists have previously shown pos. effects on cognitive behaviors in AD patients, but were limited due to cholinergic adverse events thought to be mediated by the activation of the M2 to M5 subtypes.  One strategy to confer selectivity for M1 is the identification of pos. allosteric modulators, which would target an allosteric site on the M1 receptor rather than the highly conserved orthosteric acetylcholine binding site.  Quinoline carboxylic acids have been previously identified as highly selective M1 pos. allosteric modulators with good pharmacokinetic and in vivo properties.  Herein is described the optimization of a novel quinolizidinone carboxylic acid scaffold with 4-cyanopiperidines being a key discovery in terms of enhanced activity.  In particular, modulator 4i (I) gave high plasma free fractions, enhanced central nervous system (CNS) exposure, was efficacious in a rodent in vivo model of cognition, and afforded good physicochem. properties suitable for further preclin. evaluation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqyxzdyAvHaZrVg90H21EOLACvtfcHk0li1fNW4nNRjtw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXnslKisbc%253D&md5=4e7dcc7278bc0af2e2430f3a4e8b7242</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1021%2Fjm200400m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200400m%26sid%3Dliteratum%253Aachs%26aulast%3DKuduk%26aufirst%3DS.%2BD.%26aulast%3DChang%26aufirst%3DR.%2BK.%26aulast%3DDi%2BMarco%26aufirst%3DC.%2BN.%26aulast%3DPitts%26aufirst%3DD.%2BR.%26aulast%3DGreshock%26aufirst%3DT.%2BJ.%26aulast%3DMa%26aufirst%3DL.%26aulast%3DWittmann%26aufirst%3DM.%26aulast%3DSeager%26aufirst%3DM.%2BA.%26aulast%3DKoeplinger%26aufirst%3DK.%2BA.%26aulast%3DThompson%26aufirst%3DC.%2BD.%26aulast%3DHartman%26aufirst%3DG.%2BD.%26aulast%3DBilodeau%26aufirst%3DM.%2BT.%26aulast%3DRay%26aufirst%3DW.%2BJ.%26atitle%3DDiscovery%2520of%2520a%2520selective%2520allosteric%2520M1%2520receptor%2520modulator%2520with%2520suitable%2520development%2520properties%2520based%2520on%2520a%2520quinolizidinone%2520carboxylic%2520acid%2520scaffold%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D4773%26epage%3D4780%26doi%3D10.1021%2Fjm200400m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="note"><p class="first last">The % homology (identity/similarity) at the allosteric binding site with M1: M2 (62/74%), M3 (64/78%), M4 (64/81%), M5 (78/83%).</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Abdul-Ridha, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lane, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mistry, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sexton, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scammells, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christopoulos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Canals, M.</span><span> </span><span class="NLM_article-title">Mechanistic insights into allosteric structure-function relationships at the M<sub>1</sub> muscarinic acetylcholine receptor</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">289</span><span class="NLM_x">, </span> <span class="NLM_fpage">33701</span><span class="NLM_x">–</span> <span class="NLM_lpage">33711</span><span class="refDoi"> DOI: 10.1074/jbc.M114.604967</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=10.1074%2Fjbc.M114.604967" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=25326383" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvF2rsbjI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=289&publication_year=2014&pages=33701-33711&author=A.+Abdul-Ridhaauthor=J.+R.+Laneauthor=S.+N.+Mistryauthor=L.+Lopezauthor=P.+M.+Sextonauthor=P.+J.+Scammellsauthor=A.+Christopoulosauthor=M.+Canals&title=Mechanistic+insights+into+allosteric+structure-function+relationships+at+the+M1+muscarinic+acetylcholine+receptor&doi=10.1074%2Fjbc.M114.604967"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanistic Insights into Allosteric Structure-Function Relationships at the M1 Muscarinic Acetylcholine Receptor</span></div><div class="casAuthors">Abdul-Ridha, Alaa; Lane, J. Robert; Mistry, Shailesh N.; Lopez, Laura; Sexton, Patrick M.; Scammells, Peter J.; Christopoulos, Arthur; Canals, Meritxell</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">289</span>
        (<span class="NLM_cas:issue">48</span>),
    <span class="NLM_cas:pages">33701-33711</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Benzylquinolone carboxylic acid (BQCA) is the first highly selective pos. allosteric modulator (PAM) for the M1 muscarinic acetylcholine receptor (mAChR), but it possesses low affinity for the allosteric site on the receptor.  More recent drug discovery efforts identified 3-((1S,2S)-2-hydroxycyclohexyl)-6-((6-(1-methyl-1H-pyrazol-4-yl)pyridin-3-yl)methyl)benzo[h]quinazolin-4(3H)-one (referred to herein as benzoquinazolinone 12) as a more potent M1 mAChR PAM with a structural ancestry originating from BQCA and related compds.  In the current study, we optimized the synthesis of and fully characterized the pharmacol. of benzoquinazolinone 12, finding that its improved potency derived from a 50-fold increase in allosteric site affinity as compared with BQCA, while retaining a similar level of pos. cooperativity with acetylcholine.  We then utilized site-directed mutagenesis and mol. modeling to validate the allosteric binding pocket we previously described for BQCA as a shared site for benzoquinazolinone 12 and provide a mol. basis for its improved activity at the M1 mAChR.  This includes a key role for hydrophobic and polar interactions with residues Tyr-179, in the second extracellular loop (ECL2) and Trp-4007.35 in transmembrane domain (TM) 7.  Collectively, this study highlights how the properties of affinity and cooperativity can be differentially modified on a common structural scaffold and identifies mol. features that can be exploited to tailor the development of M1 mAChR-targeting PAMs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpknjxCgLZYXLVg90H21EOLACvtfcHk0li1fNW4nNRjtw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvF2rsbjI&md5=c85ea5d192d466a495ebd58545dd4dc4</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M114.604967&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M114.604967%26sid%3Dliteratum%253Aachs%26aulast%3DAbdul-Ridha%26aufirst%3DA.%26aulast%3DLane%26aufirst%3DJ.%2BR.%26aulast%3DMistry%26aufirst%3DS.%2BN.%26aulast%3DLopez%26aufirst%3DL.%26aulast%3DSexton%26aufirst%3DP.%2BM.%26aulast%3DScammells%26aufirst%3DP.%2BJ.%26aulast%3DChristopoulos%26aufirst%3DA.%26aulast%3DCanals%26aufirst%3DM.%26atitle%3DMechanistic%2520insights%2520into%2520allosteric%2520structure-function%2520relationships%2520at%2520the%2520M1%2520muscarinic%2520acetylcholine%2520receptor%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2014%26volume%3D289%26spage%3D33701%26epage%3D33711%26doi%3D10.1074%2Fjbc.M114.604967" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="note"><p class="first last">Values were calculated taking all residues within 7 Å of the PAM binding site of aligned homology models for M1, M3, M4, M5 prepared based on M2 (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4MQT">4MQT</a>). Identity and similarity values were calculated using “seqidentity” function from the Bio3D package in R.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Vardigan, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cannon, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Puri, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dancho, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koser, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wittmann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuduk, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renger, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uslaner, J. M.</span><span> </span><span class="NLM_article-title">Improved cognition without adverse effects: novel M1 muscarinic potentiator compares favorably to donepezil and xanomeline in rhesus monkey</span> <span class="citation_source-journal">Psychopharmacology (Berl)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">232</span><span class="NLM_x">, </span> <span class="NLM_fpage">1859</span><span class="NLM_x">–</span> <span class="NLM_lpage">1866</span><span class="refDoi"> DOI: 10.1007/s00213-014-3813-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=10.1007%2Fs00213-014-3813-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=25491927" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=1%3ACAS%3A280%3ADC%252BC2MzmslGltw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=232&publication_year=2015&pages=1859-1866&author=J.+D.+Vardiganauthor=C.+E.+Cannonauthor=V.+Puriauthor=M.+Danchoauthor=A.+Koserauthor=M.+Wittmannauthor=S.+D.+Kudukauthor=J.+J.+Rengerauthor=J.+M.+Uslaner&title=Improved+cognition+without+adverse+effects%3A+novel+M1+muscarinic+potentiator+compares+favorably+to+donepezil+and+xanomeline+in+rhesus+monkey&doi=10.1007%2Fs00213-014-3813-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10aR"><div class="casContent"><span class="casTitleNuber">10a</span><div class="casTitle"><span class="NLM_cas:atitle">Improved cognition without adverse effects: novel M1 muscarinic potentiator compares favorably to donepezil and xanomeline in rhesus monkey</span></div><div class="casAuthors">Vardigan Joshua D; Cannon Christopher E; Puri Vanita; Dancho Mandy; Koser AmyJo; Wittmann Marion; Kuduk Scott D; Renger John J; Uslaner Jason M</div><div class="citationInfo"><span class="NLM_cas:title">Psychopharmacology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">232</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1859-66</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">RATIONALE:  The standards of care for Alzheimer's disease, acetylcholinesterase inhibitors such as donepezil (Aricept®), are dose-limited due to adverse side-effects.  These adverse events lead to significant patient non-compliance, constraining the dose and magnitude of efficacy that can be achieved.  Non-selective muscarinic receptor orthosteric agonists such as Xanomeline have been shown to be effective in treating symptoms as well, but were also poorly tolerated.  Therefore, there is an unmet medical need for a symptomatic treatment that improves symptoms and is better tolerated.  METHODS:  We compared donepezil, xanomeline, and the novel selective muscarinic 1 receptor positive allosteric modulator PQCA in combination with donepezil in the object retrieval detour (ORD) cognition test in rhesus macaque.  Gastrointestinal (GI) side effects (salivation and feces output) were then assessed with all compounds to determine therapeutic window.  RESULTS:  All three compounds significantly reduced a scopolamine-induced deficit in ORD.  Consistent with what is observed clinically in patients, both donepezil and xanomeline produced significant GI effects in rhesus at doses equal to or less than a fivefold margin from the minimum effective dose that improves cognition.  In stark contrast, PQCA produced no GI side effects when tested at the same dose range.  CONCLUSIONS:  These data suggest M1 positive allosteric modulators have the potential to improve cognition in Alzheimer's disease with a greater therapeutic margin than the current standard of care, addressing an important unmet medical need.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSs79JpLH9cdoJKJbLTgsvCfW6udTcc2eYPPIWG3PppB7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2MzmslGltw%253D%253D&md5=fe42c4d69929cfddab924411a136c1d1</span></div><a href="/servlet/linkout?suffix=cit10a&amp;dbid=16384&amp;doi=10.1007%2Fs00213-014-3813-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00213-014-3813-x%26sid%3Dliteratum%253Aachs%26aulast%3DVardigan%26aufirst%3DJ.%2BD.%26aulast%3DCannon%26aufirst%3DC.%2BE.%26aulast%3DPuri%26aufirst%3DV.%26aulast%3DDancho%26aufirst%3DM.%26aulast%3DKoser%26aufirst%3DA.%26aulast%3DWittmann%26aufirst%3DM.%26aulast%3DKuduk%26aufirst%3DS.%2BD.%26aulast%3DRenger%26aufirst%3DJ.%2BJ.%26aulast%3DUslaner%26aufirst%3DJ.%2BM.%26atitle%3DImproved%2520cognition%2520without%2520adverse%2520effects%253A%2520novel%2520M1%2520muscarinic%2520potentiator%2520compares%2520favorably%2520to%2520donepezil%2520and%2520xanomeline%2520in%2520rhesus%2520monkey%26jtitle%3DPsychopharmacology%2520%2528Berl%2529%26date%3D2015%26volume%3D232%26spage%3D1859%26epage%3D1866%26doi%3D10.1007%2Fs00213-014-3813-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit10b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Uslaner, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eddins, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Puri, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cannon, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sutcliffe, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chew, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pearson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vivian, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ray, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuduk, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wittmann, M.</span><span> </span><span class="NLM_article-title">The muscarinic M1 receptor positive allosteric modulator PQCA improves cognitive measures in rat, cynomolgus macaque, and rhesus macaque</span> <span class="citation_source-journal">Psychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">225</span><span class="NLM_x">, </span> <span class="NLM_fpage">21</span><span class="NLM_x">–</span> <span class="NLM_lpage">30</span><span class="refDoi"> DOI: 10.1007/s00213-012-2788-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=10.1007%2Fs00213-012-2788-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=22825578" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVOgtrzP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=225&publication_year=2013&pages=21-30&author=J.+M.+Uslanerauthor=D.+Eddinsauthor=V.+Puriauthor=C.+E.+Cannonauthor=J.+Sutcliffeauthor=C.+S.+Chewauthor=M.+Pearsonauthor=J.+A.+Vivianauthor=R.+K.+Changauthor=W.+J.+Rayauthor=S.+D.+Kudukauthor=M.+Wittmann&title=The+muscarinic+M1+receptor+positive+allosteric+modulator+PQCA+improves+cognitive+measures+in+rat%2C+cynomolgus+macaque%2C+and+rhesus+macaque&doi=10.1007%2Fs00213-012-2788-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10bR"><div class="casContent"><span class="casTitleNuber">10b</span><div class="casTitle"><span class="NLM_cas:atitle">The muscarinic M1 receptor positive allosteric modulator PQCA improves cognitive measures in rat, cynomolgus macaque, and rhesus macaque</span></div><div class="casAuthors">Uslaner, Jason M.; Eddins, Donnie; Puri, Vanita; Cannon, Christopher E.; Sutcliffe, Jane; Chew, Chan Sing; Pearson, Michelle; Vivian, Jeffrey A.; Chang, Ronald K.; Ray, William J.; Kuduk, Scott D.; Wittmann, Marion</div><div class="citationInfo"><span class="NLM_cas:title">Psychopharmacology (Heidelberg, Germany)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">225</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">21-30</span>CODEN:
                <span class="NLM_cas:coden">PSCHDL</span>;
        ISSN:<span class="NLM_cas:issn">0033-3158</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Rationale: The current stds. of care for Alzheimer's disease, acetylcholinesterase inhibitors, have limited efficacy due to a host of mechanism-related side effects arising from indiscriminate activation of muscarinic and nicotinic receptors.  The M1 muscarinic receptor is predominantly expressed in the brain in regions involved in cognition, and therefore selective activation of the M1 receptor would be expected to boost cognitive performance with reduced risk of peripheral side effects.  Objectives: Here we investigated whether the selective M1 muscarinic receptor pos. allosteric modulator, PQCA, improves cognitive performance and cerebral blood flow.  Results: PQCA attenuated a scopolamine-induced deficit in novel object recognition in rat, self-ordered spatial search in cynomolgus macaque, and the object retrieval detour task in rhesus macaque.  Beneficial effects in each of these assays and species were obsd. at similar plasma drug concns.  Furthermore, at similar drug concns. that were effective in the behavioral studies, PQCA increased blood flow in the frontal cortex of mice, providing a translational biomarker that could be used to guide dose selection for clin. studies.  Conclusions: These findings provide a framework for appropriately testing an M1 selective compd. in patients with Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrURcvS521RF7Vg90H21EOLACvtfcHk0lgzcfITi0jPMA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVOgtrzP&md5=860d634a782a26e6b67207f3305585ff</span></div><a href="/servlet/linkout?suffix=cit10b&amp;dbid=16384&amp;doi=10.1007%2Fs00213-012-2788-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00213-012-2788-8%26sid%3Dliteratum%253Aachs%26aulast%3DUslaner%26aufirst%3DJ.%2BM.%26aulast%3DEddins%26aufirst%3DD.%26aulast%3DPuri%26aufirst%3DV.%26aulast%3DCannon%26aufirst%3DC.%2BE.%26aulast%3DSutcliffe%26aufirst%3DJ.%26aulast%3DChew%26aufirst%3DC.%2BS.%26aulast%3DPearson%26aufirst%3DM.%26aulast%3DVivian%26aufirst%3DJ.%2BA.%26aulast%3DChang%26aufirst%3DR.%2BK.%26aulast%3DRay%26aufirst%3DW.%2BJ.%26aulast%3DKuduk%26aufirst%3DS.%2BD.%26aulast%3DWittmann%26aufirst%3DM.%26atitle%3DThe%2520muscarinic%2520M1%2520receptor%2520positive%2520allosteric%2520modulator%2520PQCA%2520improves%2520cognitive%2520measures%2520in%2520rat%252C%2520cynomolgus%2520macaque%252C%2520and%2520rhesus%2520macaque%26jtitle%3DPsychopharmacology%26date%3D2013%26volume%3D225%26spage%3D21%26epage%3D30%26doi%3D10.1007%2Fs00213-012-2788-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit10c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Lange, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cannon, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drott, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuduk, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uslaner, J. M.</span><span> </span><span class="NLM_article-title">The M1 muscarinic positive allosteric modulator PQCA improves performance on translatable tests of memory and attention in rhesus monkeys</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">355</span><span class="NLM_x">, </span> <span class="NLM_fpage">442</span><span class="NLM_x">–</span> <span class="NLM_lpage">450</span><span class="refDoi"> DOI: 10.1124/jpet.115.226712</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=10.1124%2Fjpet.115.226712" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=26446308" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhslaks7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=355&publication_year=2015&pages=442-450&author=H.+S.+Langeauthor=C.+E.+Cannonauthor=J.+T.+Drottauthor=S.+D.+Kudukauthor=J.+M.+Uslaner&title=The+M1+muscarinic+positive+allosteric+modulator+PQCA+improves+performance+on+translatable+tests+of+memory+and+attention+in+rhesus+monkeys&doi=10.1124%2Fjpet.115.226712"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10cR"><div class="casContent"><span class="casTitleNuber">10c</span><div class="casTitle"><span class="NLM_cas:atitle">The M1 muscarinic positive allosteric modulator PQCA improves performance on translatable tests of memory and attention in rhesus monkeys</span></div><div class="casAuthors">Lange, Henry S.; Cannon, Christopher E.; Drott, Jason T.; Kuduk, Scott D.; Uslaner, Jason M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">355</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">442-450</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Improved treatment of Alzheimer disease (AD) is a significant unmet medical need that is becoming even more crit. given the rise in the no. of patients and the substantial economic burden.  The current stds. of care, acetylcholinesterase inhibitors (AChEIs), are hindered by gastrointestinal side effects owing to their nonselective activation of muscarinic and nicotinic receptors.  Recently, the highly selective M1 pos. allosteric modulator PQCA (1-(4-cyano-4-(pyridine-2-yl)piperidin-1-yl)methyl-4-oxo-4 H-quinolizine-3-carboxylic acid) has been demonstrated to improve cognition in a variety of rodent and nonhuman primate cognition models without producing significant gastrointestinal side effects.  Here we describe the effect of PQCA and the AChEI donepezil on two clin. relevant and highly translatable touchscreen cognition tasks in nonhuman primates: paired-assocs. learning (PAL) and the continuous-performance task (CPT).  Blockade of muscarinic signaling by scopolamine produced significant impairments in both PAL and CPT.  PQCA and donepezil attenuated the scopolamine deficits in both tasks, and the action of these two compds. was similar in magnitude.  In addn., the combination of subeffective doses of PQCA and donepezil enhanced PAL performance.  These results further suggest that M1-pos. allosteric modulators, either as monotherapy or as an add-on to current stds. of care, have potential to reduce the cognitive deficits assocd. with AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrOAPD1PIwsgbVg90H21EOLACvtfcHk0lgzcfITi0jPMA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhslaks7w%253D&md5=19b01aa71aeeff840c3a4d48e3f918ea</span></div><a href="/servlet/linkout?suffix=cit10c&amp;dbid=16384&amp;doi=10.1124%2Fjpet.115.226712&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.115.226712%26sid%3Dliteratum%253Aachs%26aulast%3DLange%26aufirst%3DH.%2BS.%26aulast%3DCannon%26aufirst%3DC.%2BE.%26aulast%3DDrott%26aufirst%3DJ.%2BT.%26aulast%3DKuduk%26aufirst%3DS.%2BD.%26aulast%3DUslaner%26aufirst%3DJ.%2BM.%26atitle%3DThe%2520M1%2520muscarinic%2520positive%2520allosteric%2520modulator%2520PQCA%2520improves%2520performance%2520on%2520translatable%2520tests%2520of%2520memory%2520and%2520attention%2520in%2520rhesus%2520monkeys%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2015%26volume%3D355%26spage%3D442%26epage%3D450%26doi%3D10.1124%2Fjpet.115.226712" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Kuduk, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beshore, D. C.</span><span> </span><span class="NLM_article-title">SAR studies on carboxylic acid series M(1) selective positive allosteric modulators (PAMs)</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">1738</span><span class="NLM_x">–</span> <span class="NLM_lpage">1754</span><span class="refDoi"> DOI: 10.2174/1568026614666140826120224</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=10.2174%2F1568026614666140826120224" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=25176125" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhslGqurrL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2014&pages=1738-1754&author=S.+D.+Kudukauthor=D.+C.+Beshore&title=SAR+studies+on+carboxylic+acid+series+M%281%29+selective+positive+allosteric+modulators+%28PAMs%29&doi=10.2174%2F1568026614666140826120224"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11aR"><div class="casContent"><span class="casTitleNuber">11a</span><div class="casTitle"><span class="NLM_cas:atitle">SAR Studies on Carboxylic Acid Series M1 Selective Positive Allosteric Modulators (PAMs)</span></div><div class="casAuthors">Kuduk, Scott D.; Beshore, Douglas C.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">1738-1754</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  There is mounting evidence from preclin. and early proof-of-concept studies suggesting that selective modulation of the M1 muscarinic receptor is efficacious in cognitive models of Alzheimer's disease (AD).  A no. of nonselective M1 muscarinic agonists have previously shown pos. effects on cognitive function in AD patients, but were limited due to cholinergic adverse events thought to be mediated by pan activation of the M2 to M5 sub-types.  Thus, there is a need to identify selective activators of the M1 receptor to evaluate their potential in cognitive disorders.  One strategy to confer selectivity for M1 is the identification of allosteric agonists or pos. allosteric modulators, which would target an allosteric site on the M1 receptor rather than the highly conserved orthosteric acetylcholine binding site.  BQCA has been identified as a highly selective carboxylic acid M1 PAM and this review focuses on an extensive lead optimization campaign undertaken on this compd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYVW5CI2NUBrVg90H21EOLACvtfcHk0liO3GlhVQiSkQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhslGqurrL&md5=2cc31d1a5534ee7861e89751c0b87625</span></div><a href="/servlet/linkout?suffix=cit11a&amp;dbid=16384&amp;doi=10.2174%2F1568026614666140826120224&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026614666140826120224%26sid%3Dliteratum%253Aachs%26aulast%3DKuduk%26aufirst%3DS.%2BD.%26aulast%3DBeshore%26aufirst%3DD.%2BC.%26atitle%3DSAR%2520studies%2520on%2520carboxylic%2520acid%2520series%2520M%25281%2529%2520selective%2520positive%2520allosteric%2520modulators%2520%2528PAMs%2529%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2014%26volume%3D14%26spage%3D1738%26epage%3D1754%26doi%3D10.2174%2F1568026614666140826120224" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit11b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Kuduk, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greshock, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ray, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wittmann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seager, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koeplinger, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartman, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bilodeau, M. T.</span><span> </span><span class="NLM_article-title">Identification of amides as carboxylic Acid surrogates for quinolizidinone-based M1 positive allosteric modulators</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">1070</span><span class="NLM_x">–</span> <span class="NLM_lpage">1074</span><span class="refDoi"> DOI: 10.1021/ml300280g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml300280g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref11/cit11b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsFSgs7rE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=1070-1074&author=S.+D.+Kudukauthor=R.+K.+Changauthor=T.+J.+Greshockauthor=W.+J.+Rayauthor=L.+Maauthor=M.+Wittmannauthor=M.+A.+Seagerauthor=K.+A.+Koeplingerauthor=C.+D.+Thompsonauthor=G.+D.+Hartmanauthor=M.+T.+Bilodeau&title=Identification+of+amides+as+carboxylic+Acid+surrogates+for+quinolizidinone-based+M1+positive+allosteric+modulators&doi=10.1021%2Fml300280g"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11bR"><div class="casContent"><span class="casTitleNuber">11b</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of Amides as Carboxylic Acid Surrogates for Quinolizidinone-Based M1 Positive Allosteric Modulators</span></div><div class="casAuthors">Kuduk, Scott D.; Chang, Ronald K.; Greshock, Thomas J.; Ray, William J.; Ma, Lei; Wittmann, Marion; Seager, Matthew A.; Koeplinger, Kenneth A.; Thompson, Charles D.; Hartman, George D.; Bilodeau, Mark T.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1070-1074</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Selective activation of the M1 muscarinic receptor via pos. allosteric modulation represents an approach to treat the cognitive decline in patients with Alzheimer's disease.  A series of amides were examd. as a replacement for the carboxylic acid moiety in a class of quinolizidinone carboxylic acid M1 muscarinic receptor pos. allosteric modulators, and leading pyran 4o (I) and cyclohexane 5c were found to possess good potency and in vivo efficacy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp0ldxuQ6OgkLVg90H21EOLACvtfcHk0liO3GlhVQiSkQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsFSgs7rE&md5=d9f053e33ab39596a05d18a9821077b3</span></div><a href="/servlet/linkout?suffix=cit11b&amp;dbid=16384&amp;doi=10.1021%2Fml300280g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml300280g%26sid%3Dliteratum%253Aachs%26aulast%3DKuduk%26aufirst%3DS.%2BD.%26aulast%3DChang%26aufirst%3DR.%2BK.%26aulast%3DGreshock%26aufirst%3DT.%2BJ.%26aulast%3DRay%26aufirst%3DW.%2BJ.%26aulast%3DMa%26aufirst%3DL.%26aulast%3DWittmann%26aufirst%3DM.%26aulast%3DSeager%26aufirst%3DM.%2BA.%26aulast%3DKoeplinger%26aufirst%3DK.%2BA.%26aulast%3DThompson%26aufirst%3DC.%2BD.%26aulast%3DHartman%26aufirst%3DG.%2BD.%26aulast%3DBilodeau%26aufirst%3DM.%2BT.%26atitle%3DIdentification%2520of%2520amides%2520as%2520carboxylic%2520Acid%2520surrogates%2520for%2520quinolizidinone-based%2520M1%2520positive%2520allosteric%2520modulators%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D3%26spage%3D1070%26epage%3D1074%26doi%3D10.1021%2Fml300280g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit11c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Kuduk, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Marco, C. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saffold, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ray, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wittmann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koeplinger, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartman, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bilodeau, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beshore, D. C.</span><span> </span><span class="NLM_article-title">Identification of a methoxynaphthalene scaffold as a core replacement in quinolizidinone amide M(1) positive allosteric modulators</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">1417</span><span class="NLM_x">–</span> <span class="NLM_lpage">1420</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2014.01.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=10.1016%2Fj.bmcl.2014.01.012" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=1417-1420&author=S.+D.+Kudukauthor=C.+N.+Di+Marcoauthor=J.+R.+Saffoldauthor=W.+J.+Rayauthor=L.+Maauthor=M.+Wittmannauthor=K.+A.+Koeplingerauthor=C.+D.+Thompsonauthor=G.+D.+Hartmanauthor=M.+T.+Bilodeauauthor=D.+C.+Beshore&title=Identification+of+a+methoxynaphthalene+scaffold+as+a+core+replacement+in+quinolizidinone+amide+M%281%29+positive+allosteric+modulators&doi=10.1016%2Fj.bmcl.2014.01.012"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11c&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2014.01.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2014.01.012%26sid%3Dliteratum%253Aachs%26aulast%3DKuduk%26aufirst%3DS.%2BD.%26aulast%3DDi%2BMarco%26aufirst%3DC.%2BN.%26aulast%3DSaffold%26aufirst%3DJ.%2BR.%26aulast%3DRay%26aufirst%3DW.%2BJ.%26aulast%3DMa%26aufirst%3DL.%26aulast%3DWittmann%26aufirst%3DM.%26aulast%3DKoeplinger%26aufirst%3DK.%2BA.%26aulast%3DThompson%26aufirst%3DC.%2BD.%26aulast%3DHartman%26aufirst%3DG.%2BD.%26aulast%3DBilodeau%26aufirst%3DM.%2BT.%26aulast%3DBeshore%26aufirst%3DD.%2BC.%26atitle%3DIdentification%2520of%2520a%2520methoxynaphthalene%2520scaffold%2520as%2520a%2520core%2520replacement%2520in%2520quinolizidinone%2520amide%2520M%25281%2529%2520positive%2520allosteric%2520modulators%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D24%26spage%3D1417%26epage%3D1420%26doi%3D10.1016%2Fj.bmcl.2014.01.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit11d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Yang, Z. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wittmann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ray, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seager, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koeplinger, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartman, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bilodeau, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuduk, S. D.</span><span> </span><span class="NLM_article-title">Discovery of naphthyl-fused 5-membered lactams as a new class of m1 positive allosteric modulators</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">604</span><span class="NLM_x">–</span> <span class="NLM_lpage">608</span><span class="refDoi"> DOI: 10.1021/ml500055h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml500055h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref11/cit11d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=1%3ACAS%3A528%3ADC%252BC2cXivVaqs7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=604-608&author=Z.+Q.+Yangauthor=Y.+Shuauthor=L.+Maauthor=M.+Wittmannauthor=W.+J.+Rayauthor=M.+A.+Seagerauthor=K.+A.+Koeplingerauthor=C.+D.+Thompsonauthor=G.+D.+Hartmanauthor=M.+T.+Bilodeauauthor=S.+D.+Kuduk&title=Discovery+of+naphthyl-fused+5-membered+lactams+as+a+new+class+of+m1+positive+allosteric+modulators&doi=10.1021%2Fml500055h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11dR"><div class="casContent"><span class="casTitleNuber">11d</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Naphthyl-Fused 5-Membered Lactams as a New Class of M1 Positive Allosteric Modulators</span></div><div class="casAuthors">Yang, Zhi-Qiang; Shu, Youheng; Ma, Lei; Wittmann, Marion; Ray, William J.; Seager, Matthew A.; Koeplinger, Kenneth A.; Thompson, Charles D.; Hartman, George D.; Bilodeau, Mark T.; Kuduk, Scott D.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">604-608</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Selective activation of the M1 muscarinic receptor via pos. allosteric modulation represents an original approach to treat the cognitive decline in patients with Alzheimer's disease.  A series of naphthyl-fused 5-membered lactams were identified as a new class of M1 pos. allosteric modulators and were found to possess good potency and in vivo efficacy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrp0-UygW2fhrVg90H21EOLACvtfcHk0lhB59LFf8dj3w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXivVaqs7o%253D&md5=a3858be25de507f8fee6003bb50edb67</span></div><a href="/servlet/linkout?suffix=cit11d&amp;dbid=16384&amp;doi=10.1021%2Fml500055h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml500055h%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DZ.%2BQ.%26aulast%3DShu%26aufirst%3DY.%26aulast%3DMa%26aufirst%3DL.%26aulast%3DWittmann%26aufirst%3DM.%26aulast%3DRay%26aufirst%3DW.%2BJ.%26aulast%3DSeager%26aufirst%3DM.%2BA.%26aulast%3DKoeplinger%26aufirst%3DK.%2BA.%26aulast%3DThompson%26aufirst%3DC.%2BD.%26aulast%3DHartman%26aufirst%3DG.%2BD.%26aulast%3DBilodeau%26aufirst%3DM.%2BT.%26aulast%3DKuduk%26aufirst%3DS.%2BD.%26atitle%3DDiscovery%2520of%2520naphthyl-fused%25205-membered%2520lactams%2520as%2520a%2520new%2520class%2520of%2520m1%2520positive%2520allosteric%2520modulators%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D5%26spage%3D604%26epage%3D608%26doi%3D10.1021%2Fml500055h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit11e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Kuduk, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Marco, C. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ray, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wittmann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seager, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koeplinger, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartman, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bilodeau, M. T.</span><span> </span><span class="NLM_article-title">Quinolizidinone carboxylic acids as CNS penetrant, selective m1 allosteric muscarinic receptor modulators</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">263</span><span class="NLM_x">–</span> <span class="NLM_lpage">267</span><span class="refDoi"> DOI: 10.1021/ml100095k</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml100095k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref11/cit11e&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=1%3ACAS%3A528%3ADC%252BC3cXmvFKlsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=263-267&author=S.+D.+Kudukauthor=R.+K.+Changauthor=C.+N.+Di+Marcoauthor=W.+J.+Rayauthor=L.+Maauthor=M.+Wittmannauthor=M.+A.+Seagerauthor=K.+A.+Koeplingerauthor=C.+D.+Thompsonauthor=G.+D.+Hartmanauthor=M.+T.+Bilodeau&title=Quinolizidinone+carboxylic+acids+as+CNS+penetrant%2C+selective+m1+allosteric+muscarinic+receptor+modulators&doi=10.1021%2Fml100095k"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11eR"><div class="casContent"><span class="casTitleNuber">11e</span><div class="casTitle"><span class="NLM_cas:atitle">Quinolizidinone Carboxylic Acids as CNS Penetrant, Selective M1 Allosteric Muscarinic Receptor Modulators</span></div><div class="casAuthors">Kuduk, Scott D.; Chang, Ronald K.; Di Marco, Christina N.; Ray, William J.; Ma, Lei; Wittmann, Marion; Seager, Matthew A.; Koeplinger, Kenneth A.; Thompson, Charles D.; Hartman, George D.; Bilodeau, Mark T.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">263-267</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Pos. allosteric modulation of the M1 muscarinic receptor represents an approach to treat the cognitive decline in patients with Alzheimer's disease.  Replacement of a quinolone ring system in a quinolone carboxylic acid series of M1 modulators with a quinolizidinone bearing a basic amine linkage led to a series of compds. with higher free fraction, enhanced CNS exposure, and improved efficacy in rodent in vivo models of cognition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrSw8FeLsW52bVg90H21EOLACvtfcHk0lhB59LFf8dj3w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXmvFKlsro%253D&md5=d07d556638f4c5380fd2c4578b344b58</span></div><a href="/servlet/linkout?suffix=cit11e&amp;dbid=16384&amp;doi=10.1021%2Fml100095k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml100095k%26sid%3Dliteratum%253Aachs%26aulast%3DKuduk%26aufirst%3DS.%2BD.%26aulast%3DChang%26aufirst%3DR.%2BK.%26aulast%3DDi%2BMarco%26aufirst%3DC.%2BN.%26aulast%3DRay%26aufirst%3DW.%2BJ.%26aulast%3DMa%26aufirst%3DL.%26aulast%3DWittmann%26aufirst%3DM.%26aulast%3DSeager%26aufirst%3DM.%2BA.%26aulast%3DKoeplinger%26aufirst%3DK.%2BA.%26aulast%3DThompson%26aufirst%3DC.%2BD.%26aulast%3DHartman%26aufirst%3DG.%2BD.%26aulast%3DBilodeau%26aufirst%3DM.%2BT.%26atitle%3DQuinolizidinone%2520carboxylic%2520acids%2520as%2520CNS%2520penetrant%252C%2520selective%2520m1%2520allosteric%2520muscarinic%2520receptor%2520modulators%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D1%26spage%3D263%26epage%3D267%26doi%3D10.1021%2Fml100095k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit11f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Kuduk, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Marco, C. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cofre, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pitts, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ray, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wittmann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Veng, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seager, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koeplinger, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartman, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bilodeau, M. T.</span><span> </span><span class="NLM_article-title">N-heterocyclic derived M1 positive allosteric modulators</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">1334</span><span class="NLM_x">–</span> <span class="NLM_lpage">1337</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2010.01.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11f&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=10.1016%2Fj.bmcl.2010.01.013" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=1334-1337&author=S.+D.+Kudukauthor=C.+N.+Di+Marcoauthor=V.+Cofreauthor=D.+R.+Pittsauthor=W.+J.+Rayauthor=L.+Maauthor=M.+Wittmannauthor=L.+Vengauthor=M.+A.+Seagerauthor=K.+Koeplingerauthor=C.+D.+Thompsonauthor=G.+D.+Hartmanauthor=M.+T.+Bilodeau&title=N-heterocyclic+derived+M1+positive+allosteric+modulators&doi=10.1016%2Fj.bmcl.2010.01.013"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11f&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2010.01.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2010.01.013%26sid%3Dliteratum%253Aachs%26aulast%3DKuduk%26aufirst%3DS.%2BD.%26aulast%3DDi%2BMarco%26aufirst%3DC.%2BN.%26aulast%3DCofre%26aufirst%3DV.%26aulast%3DPitts%26aufirst%3DD.%2BR.%26aulast%3DRay%26aufirst%3DW.%2BJ.%26aulast%3DMa%26aufirst%3DL.%26aulast%3DWittmann%26aufirst%3DM.%26aulast%3DVeng%26aufirst%3DL.%26aulast%3DSeager%26aufirst%3DM.%2BA.%26aulast%3DKoeplinger%26aufirst%3DK.%26aulast%3DThompson%26aufirst%3DC.%2BD.%26aulast%3DHartman%26aufirst%3DG.%2BD.%26aulast%3DBilodeau%26aufirst%3DM.%2BT.%26atitle%3DN-heterocyclic%2520derived%2520M1%2520positive%2520allosteric%2520modulators%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D1334%26epage%3D1337%26doi%3D10.1016%2Fj.bmcl.2010.01.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit11g"><span><span class="NLM_label">(g) </span><span class="NLM_contrib-group">Kuduk, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Marco, C. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ray, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wittmann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seager, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koeplinger, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartman, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bilodeau, M. T.</span><span> </span><span class="NLM_article-title">Quinolizidinone carboxylic acid selective M1 allosteric modulators: SAR in the piperidine series</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">1710</span><span class="NLM_x">–</span> <span class="NLM_lpage">1715</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2011.01.094</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11g&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=10.1016%2Fj.bmcl.2011.01.094" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=1710-1715&author=S.+D.+Kudukauthor=R.+K.+Changauthor=C.+N.+Di+Marcoauthor=W.+J.+Rayauthor=L.+Maauthor=M.+Wittmannauthor=M.+A.+Seagerauthor=K.+A.+Koeplingerauthor=C.+D.+Thompsonauthor=G.+D.+Hartmanauthor=M.+T.+Bilodeau&title=Quinolizidinone+carboxylic+acid+selective+M1+allosteric+modulators%3A+SAR+in+the+piperidine+series&doi=10.1016%2Fj.bmcl.2011.01.094"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11g&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2011.01.094&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2011.01.094%26sid%3Dliteratum%253Aachs%26aulast%3DKuduk%26aufirst%3DS.%2BD.%26aulast%3DChang%26aufirst%3DR.%2BK.%26aulast%3DDi%2BMarco%26aufirst%3DC.%2BN.%26aulast%3DRay%26aufirst%3DW.%2BJ.%26aulast%3DMa%26aufirst%3DL.%26aulast%3DWittmann%26aufirst%3DM.%26aulast%3DSeager%26aufirst%3DM.%2BA.%26aulast%3DKoeplinger%26aufirst%3DK.%2BA.%26aulast%3DThompson%26aufirst%3DC.%2BD.%26aulast%3DHartman%26aufirst%3DG.%2BD.%26aulast%3DBilodeau%26aufirst%3DM.%2BT.%26atitle%3DQuinolizidinone%2520carboxylic%2520acid%2520selective%2520M1%2520allosteric%2520modulators%253A%2520SAR%2520in%2520the%2520piperidine%2520series%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D1710%26epage%3D1715%26doi%3D10.1016%2Fj.bmcl.2011.01.094" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit11h"><span><span class="NLM_label">(h) </span><span class="NLM_contrib-group">Kuduk, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Marco, C. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cofre, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ray, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wittmann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seager, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koeplinger, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartman, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bilodeau, M. T.</span><span> </span><span class="NLM_article-title">Fused heterocyclic M1 positive allosteric modulators</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">2769</span><span class="NLM_x">–</span> <span class="NLM_lpage">2772</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2010.10.028</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11h&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=10.1016%2Fj.bmcl.2010.10.028" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=2769-2772&author=S.+D.+Kudukauthor=C.+N.+Di+Marcoauthor=V.+Cofreauthor=W.+J.+Rayauthor=L.+Maauthor=M.+Wittmannauthor=M.+A.+Seagerauthor=K.+A.+Koeplingerauthor=C.+D.+Thompsonauthor=G.+D.+Hartmanauthor=M.+T.+Bilodeau&title=Fused+heterocyclic+M1+positive+allosteric+modulators&doi=10.1016%2Fj.bmcl.2010.10.028"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11h&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2010.10.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2010.10.028%26sid%3Dliteratum%253Aachs%26aulast%3DKuduk%26aufirst%3DS.%2BD.%26aulast%3DDi%2BMarco%26aufirst%3DC.%2BN.%26aulast%3DCofre%26aufirst%3DV.%26aulast%3DRay%26aufirst%3DW.%2BJ.%26aulast%3DMa%26aufirst%3DL.%26aulast%3DWittmann%26aufirst%3DM.%26aulast%3DSeager%26aufirst%3DM.%2BA.%26aulast%3DKoeplinger%26aufirst%3DK.%2BA.%26aulast%3DThompson%26aufirst%3DC.%2BD.%26aulast%3DHartman%26aufirst%3DG.%2BD.%26aulast%3DBilodeau%26aufirst%3DM.%2BT.%26atitle%3DFused%2520heterocyclic%2520M1%2520positive%2520allosteric%2520modulators%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D2769%26epage%3D2772%26doi%3D10.1016%2Fj.bmcl.2010.10.028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Kuduk, S. D.; Dimarco, C. N.; Yang, Z.-Q.</span><span> </span><span class="NLM_article-title">N-linked quinolineamide M1 receptor positive allosteric modulators</span>. WO 2012158474, May 11,<span class="NLM_x"> </span><span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=S.+D.+Kuduk&author=C.+N.+Dimarco&author=Z.-Q.+Yang&title=N-linked+quinolineamide+M1+receptor+positive+allosteric+modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DKuduk%26aufirst%3DS.%2BD.%26atitle%3DN-linked%2520quinolineamide%2520M1%2520receptor%2520positive%2520allosteric%2520modulators%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit12b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Kuduk, S. D.; Di Marco, C. N.; Greshock, T. J.</span><span> </span><span class="NLM_article-title">N-methyl-tetrahydroquinoline M1 receptor positive allosteric modulators</span>. WO 2012158473, May 11,<span class="NLM_x"> </span><span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=S.+D.+Kuduk&author=C.+N.+Di+Marco&author=T.+J.+Greshock&title=N-methyl-tetrahydroquinoline+M1+receptor+positive+allosteric+modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DKuduk%26aufirst%3DS.%2BD.%26atitle%3DN-methyl-tetrahydroquinoline%2520M1%2520receptor%2520positive%2520allosteric%2520modulators%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit12c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Kuduk, S. D.; Chang, R. K.; Greshock, T. J.</span><span> </span><span class="NLM_article-title">Dihydrobenzoquinazolinone M1 receptor positive allosteric modulators</span>. WO 2012047702, September 29,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=S.+D.+Kuduk&author=R.+K.+Chang&author=T.+J.+Greshock&title=Dihydrobenzoquinazolinone+M1+receptor+positive+allosteric+modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DKuduk%26aufirst%3DS.%2BD.%26atitle%3DDihydrobenzoquinazolinone%2520M1%2520receptor%2520positive%2520allosteric%2520modulators%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit12d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Kuduk, S. D.; Beshore, D. C.; Yang, Z.-Q.; Shu, Y.; Pitts, D.</span><span> </span><span class="NLM_article-title">Preparation of benzoisoindolylmethyllactam derivatives and analogs for use as M1 receptor positive allosteric modulators</span>. WO 2012158475, May 11,<span class="NLM_x"> </span><span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=S.+D.+Kuduk&author=D.+C.+Beshore&author=Z.-Q.+Yang&author=Y.+Shu&author=D.+Pitts&title=Preparation+of+benzoisoindolylmethyllactam+derivatives+and+analogs+for+use+as+M1+receptor+positive+allosteric+modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DKuduk%26aufirst%3DS.%2BD.%26atitle%3DPreparation%2520of%2520benzoisoindolylmethyllactam%2520derivatives%2520and%2520analogs%2520for%2520use%2520as%2520M1%2520receptor%2520positive%2520allosteric%2520modulators%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit12e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Kuduk, S. D.; Beshore, D. C.; Yang, Z.; Shu, Y.</span><span> </span><span class="NLM_article-title">Fused isoindolone M1 receptor positive allosteric modulators and their preparation and use for the treatment of M1-mediated diseases</span>. WO 2012003147, June 27,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=S.+D.+Kuduk&author=D.+C.+Beshore&author=Z.+Yang&author=Y.+Shu&title=Fused+isoindolone+M1+receptor+positive+allosteric+modulators+and+their+preparation+and+use+for+the+treatment+of+M1-mediated+diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12e&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DKuduk%26aufirst%3DS.%2BD.%26atitle%3DFused%2520isoindolone%2520M1%2520receptor%2520positive%2520allosteric%2520modulators%2520and%2520their%2520preparation%2520and%2520use%2520for%2520the%2520treatment%2520of%2520M1-mediated%2520diseases%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit12f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Kuduk, S. D.; Skudlarek, J. W.</span><span> </span><span class="NLM_article-title">Preparation of heterocyclic fused phenanthrolinones as M1 receptor positive allosteric modulators for the treatment of diseases mediated by the M1 receptor</span>. WO 2011159553, June 10,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=S.+D.+Kuduk&author=J.+W.+Skudlarek&title=Preparation+of+heterocyclic+fused+phenanthrolinones+as+M1+receptor+positive+allosteric+modulators+for+the+treatment+of+diseases+mediated+by+the+M1+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12f&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DKuduk%26aufirst%3DS.%2BD.%26atitle%3DPreparation%2520of%2520heterocyclic%2520fused%2520phenanthrolinones%2520as%2520M1%2520receptor%2520positive%2520allosteric%2520modulators%2520for%2520the%2520treatment%2520of%2520diseases%2520mediated%2520by%2520the%2520M1%2520receptor%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit12g"><span><span class="NLM_label">(g) </span><span class="NLM_contrib-group">Kuduk, S. D.; Schlegel, K.-A.; Yang, Z.-Q.</span><span> </span><span class="NLM_article-title">Quinoline-amide derivatives as M1 receptor positive allosteric modulators and their preparation, pharmaceutical compositions and use in the treatment of diseases</span>. WO 2011084368, December 13,<span class="NLM_x"> </span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=S.+D.+Kuduk&author=K.-A.+Schlegel&author=Z.-Q.+Yang&title=Quinoline-amide+derivatives+as+M1+receptor+positive+allosteric+modulators+and+their+preparation%2C+pharmaceutical+compositions+and+use+in+the+treatment+of+diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12g&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DKuduk%26aufirst%3DS.%2BD.%26atitle%3DQuinoline-amide%2520derivatives%2520as%2520M1%2520receptor%2520positive%2520allosteric%2520modulators%2520and%2520their%2520preparation%252C%2520pharmaceutical%2520compositions%2520and%2520use%2520in%2520the%2520treatment%2520of%2520diseases%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit12h"><span><span class="NLM_label">(h) </span><span class="NLM_contrib-group">Kuduk, S. D.; Gilbert, K. F.</span><span> </span><span class="NLM_article-title">Preparation of tetrahydroquinolinylamide derivatives for use as M1 receptor positive allosteric modulators</span>. WO 2011159554, June 10,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=S.+D.+Kuduk&author=K.+F.+Gilbert&title=Preparation+of+tetrahydroquinolinylamide+derivatives+for+use+as+M1+receptor+positive+allosteric+modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12h&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DKuduk%26aufirst%3DS.%2BD.%26atitle%3DPreparation%2520of%2520tetrahydroquinolinylamide%2520derivatives%2520for%2520use%2520as%2520M1%2520receptor%2520positive%2520allosteric%2520modulators%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit12i"><span><span class="NLM_label">(i) </span><span class="NLM_contrib-group">Kuduk, S. D.; Chang, R. K.; Greshock, T. J.</span><span> </span><span class="NLM_article-title">Benzoquinazolinone derivatives as M1 receptor positive allosteric modulators and their preparation, pharmaceutical compositions and use in the treatment of diseases</span>. WO 2011025851, August 26,<span class="NLM_x"> </span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=S.+D.+Kuduk&author=R.+K.+Chang&author=T.+J.+Greshock&title=Benzoquinazolinone+derivatives+as+M1+receptor+positive+allosteric+modulators+and+their+preparation%2C+pharmaceutical+compositions+and+use+in+the+treatment+of+diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12i&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DKuduk%26aufirst%3DS.%2BD.%26atitle%3DBenzoquinazolinone%2520derivatives%2520as%2520M1%2520receptor%2520positive%2520allosteric%2520modulators%2520and%2520their%2520preparation%252C%2520pharmaceutical%2520compositions%2520and%2520use%2520in%2520the%2520treatment%2520of%2520diseases%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit12j"><span><span class="NLM_label">(j) </span><span class="NLM_contrib-group">Kuduk, S. D.; Chang, R. K.; Greshock, T. J.</span><span> </span><span class="NLM_article-title">Quinolizine-3-carboxamide derivatives as M1 receptor positive allosteric modulators and their preparation and for the treatment of diseases</span>. WO 2011062853, November 15,<span class="NLM_x"> </span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=S.+D.+Kuduk&author=R.+K.+Chang&author=T.+J.+Greshock&title=Quinolizine-3-carboxamide+derivatives+as+M1+receptor+positive+allosteric+modulators+and+their+preparation+and+for+the+treatment+of+diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12j&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DKuduk%26aufirst%3DS.%2BD.%26atitle%3DQuinolizine-3-carboxamide%2520derivatives%2520as%2520M1%2520receptor%2520positive%2520allosteric%2520modulators%2520and%2520their%2520preparation%2520and%2520for%2520the%2520treatment%2520of%2520diseases%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit12k"><span><span class="NLM_label">(k) </span><span class="NLM_contrib-group">Kuduk, S. D.; Chang, R. K.; Greshock, T. J.</span><span> </span><span class="NLM_article-title">Pyridoquinazolinone as M1 receptor positive allosteric modulators and their preparation, pharmaceutical compositions and use in the treatment of diseases</span>. WO 2011075371, December 9,<span class="NLM_x"> </span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=S.+D.+Kuduk&author=R.+K.+Chang&author=T.+J.+Greshock&title=Pyridoquinazolinone+as+M1+receptor+positive+allosteric+modulators+and+their+preparation%2C+pharmaceutical+compositions+and+use+in+the+treatment+of+diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12k&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DKuduk%26aufirst%3DS.%2BD.%26atitle%3DPyridoquinazolinone%2520as%2520M1%2520receptor%2520positive%2520allosteric%2520modulators%2520and%2520their%2520preparation%252C%2520pharmaceutical%2520compositions%2520and%2520use%2520in%2520the%2520treatment%2520of%2520diseases%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit12l"><span><span class="NLM_label">(l) </span><span class="NLM_contrib-group">Kuduk, S. D.; Beshore, D. C.; Dimarco, C. N.; Greshock, T. J.</span><span> </span><span class="NLM_article-title">Aminobenzoquinazolinone M1 receptor positive allosteric modulators</span>. WO 2011084371, December 13,<span class="NLM_x"> </span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=S.+D.+Kuduk&author=D.+C.+Beshore&author=C.+N.+Dimarco&author=T.+J.+Greshock&title=Aminobenzoquinazolinone+M1+receptor+positive+allosteric+modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12l&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DKuduk%26aufirst%3DS.%2BD.%26atitle%3DAminobenzoquinazolinone%2520M1%2520receptor%2520positive%2520allosteric%2520modulators%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit12m"><span><span class="NLM_label">(m) </span><span class="NLM_contrib-group">Beshore, D. C.; Kuduk, S. D.; Dipardo, R. M.</span><span> </span><span class="NLM_article-title">Pyrazoloquinolinone derivatives as M1 receptor positive allosteric modulators and their preparation and use for the treatment of M1 receptor-mediated diseases</span>. WO 2011049731, October 1,<span class="NLM_x"> </span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=D.+C.+Beshore&author=S.+D.+Kuduk&author=R.+M.+Dipardo&title=Pyrazoloquinolinone+derivatives+as+M1+receptor+positive+allosteric+modulators+and+their+preparation+and+use+for+the+treatment+of+M1+receptor-mediated+diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12m&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBeshore%26aufirst%3DD.%2BC.%26atitle%3DPyrazoloquinolinone%2520derivatives%2520as%2520M1%2520receptor%2520positive%2520allosteric%2520modulators%2520and%2520their%2520preparation%2520and%2520use%2520for%2520the%2520treatment%2520of%2520M1%2520receptor-mediated%2520diseases%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit12n"><span><span class="NLM_label">(n) </span><span class="NLM_contrib-group">Beshore, D. C.; Kuduk, S. D.</span><span> </span><span class="NLM_article-title">Heterocyclic-fused pyrazolo[4,3-c]pyridin-3-one M1 receptor positive allosteric modulators</span>. WO 2011041143, September 20,<span class="NLM_x"> </span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=D.+C.+Beshore&author=S.+D.+Kuduk&title=Heterocyclic-fused+pyrazolo%5B4%2C3-c%5Dpyridin-3-one+M1+receptor+positive+allosteric+modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12n&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBeshore%26aufirst%3DD.%2BC.%26atitle%3DHeterocyclic-fused%2520pyrazolo%255B4%252C3-c%255Dpyridin-3-one%2520M1%2520receptor%2520positive%2520allosteric%2520modulators%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit12o"><span><span class="NLM_label">(o) </span><span class="NLM_contrib-group">Beshore, D. C.; Kuduk, S. D.</span><span> </span><span class="NLM_article-title">Heterocyclic quinolizine derived M1 receptor positive allosteric modulators</span>. WO 2011137049, April 25,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=D.+C.+Beshore&author=S.+D.+Kuduk&title=Heterocyclic+quinolizine+derived+M1+receptor+positive+allosteric+modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12o&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBeshore%26aufirst%3DD.%2BC.%26atitle%3DHeterocyclic%2520quinolizine%2520derived%2520M1%2520receptor%2520positive%2520allosteric%2520modulators%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit12p"><span><span class="NLM_label">(p) </span><span class="NLM_contrib-group">Beshore, D. C.; Dimarco, C. N.; Kuduk, S. D.</span><span> </span><span class="NLM_article-title">Naphthalene carboxamide muscarinic M1 receptor positive allosteric modulators</span>. WO 2011149801, May 23,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=D.+C.+Beshore&author=C.+N.+Dimarco&author=S.+D.+Kuduk&title=Naphthalene+carboxamide+muscarinic+M1+receptor+positive+allosteric+modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12p&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBeshore%26aufirst%3DD.%2BC.%26atitle%3DNaphthalene%2520carboxamide%2520muscarinic%2520M1%2520receptor%2520positive%2520allosteric%2520modulators%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit12q"><span><span class="NLM_label">(q) </span><span class="NLM_contrib-group">Kuduk, S. D.; Di Marco, C. N.</span><span> </span><span class="NLM_article-title">Preparation of 1-benzyl-4-oxo-1,4-dihydroquinoline-3-carboxylates as M1 receptor positive allosteric modulators</span>. WO 2009094279, July 31,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=S.+D.+Kuduk&author=C.+N.+Di+Marco&title=Preparation+of+1-benzyl-4-oxo-1%2C4-dihydroquinoline-3-carboxylates+as+M1+receptor+positive+allosteric+modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12q&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DKuduk%26aufirst%3DS.%2BD.%26atitle%3DPreparation%2520of%25201-benzyl-4-oxo-1%252C4-dihydroquinoline-3-carboxylates%2520as%2520M1%2520receptor%2520positive%2520allosteric%2520modulators%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit12r"><span><span class="NLM_label">(r) </span><span class="NLM_contrib-group">Kuduk, S. D.; Di Marco, C. N.</span><span> </span><span class="NLM_article-title">Preparation of quinolizidinone M1 receptor positive allosteric modulators</span>. WO 2010042347, September 29,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=S.+D.+Kuduk&author=C.+N.+Di+Marco&title=Preparation+of+quinolizidinone+M1+receptor+positive+allosteric+modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12r&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DKuduk%26aufirst%3DS.%2BD.%26atitle%3DPreparation%2520of%2520quinolizidinone%2520M1%2520receptor%2520positive%2520allosteric%2520modulators%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit12s"><span><span class="NLM_label">(s) </span><span class="NLM_contrib-group">Kuduk, S. D.; Di Marco, C. N.</span><span> </span><span class="NLM_article-title">Preparation of fused heterocyclic M1 receptor positive allosteric modulators</span>. WO 2010047990, October 13,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=S.+D.+Kuduk&author=C.+N.+Di+Marco&title=Preparation+of+fused+heterocyclic+M1+receptor+positive+allosteric+modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12s&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DKuduk%26aufirst%3DS.%2BD.%26atitle%3DPreparation%2520of%2520fused%2520heterocyclic%2520M1%2520receptor%2520positive%2520allosteric%2520modulators%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit12t"><span><span class="NLM_label">(t) </span><span class="NLM_contrib-group">Beshore, D. C.; Kuduk, S. D.</span><span> </span><span class="NLM_article-title">Pyrazolo[4,3-c]cinnolin-3-one derivatives as M1 receptor positive allosteric modulators and their preparation, pharmaceutical compositions and use in the treatment of diseases</span>. WO 2010096338, February 12,<span class="NLM_x"> </span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=D.+C.+Beshore&author=S.+D.+Kuduk&title=Pyrazolo%5B4%2C3-c%5Dcinnolin-3-one+derivatives+as+M1+receptor+positive+allosteric+modulators+and+their+preparation%2C+pharmaceutical+compositions+and+use+in+the+treatment+of+diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12t&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBeshore%26aufirst%3DD.%2BC.%26atitle%3DPyrazolo%255B4%252C3-c%255Dcinnolin-3-one%2520derivatives%2520as%2520M1%2520receptor%2520positive%2520allosteric%2520modulators%2520and%2520their%2520preparation%252C%2520pharmaceutical%2520compositions%2520and%2520use%2520in%2520the%2520treatment%2520of%2520diseases%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit12u"><span><span class="NLM_label">(u) </span><span class="NLM_contrib-group">Beshore, D. C.; Kuduk, S. D.</span><span> </span><span class="NLM_article-title">Preparation of fused pyrazolopyridazines as muscarinic M1 receptor positive allosteric modulators</span>. WO 2010123716, April 13,<span class="NLM_x"> </span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=D.+C.+Beshore&author=S.+D.+Kuduk&title=Preparation+of+fused+pyrazolopyridazines+as+muscarinic+M1+receptor+positive+allosteric+modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12u&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBeshore%26aufirst%3DD.%2BC.%26atitle%3DPreparation%2520of%2520fused%2520pyrazolopyridazines%2520as%2520muscarinic%2520M1%2520receptor%2520positive%2520allosteric%2520modulators%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit12v"><span><span class="NLM_label">(v) </span><span class="NLM_contrib-group">Kuduk, S. D.; Di Marco, C. N.; Shipe, W. D.</span><span> </span><span class="NLM_article-title">Preparation of oxodihydroquinoline derivatives for use as M1 receptor positive allosteric modulators</span>. WO 2009134668, April 23,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=S.+D.+Kuduk&author=C.+N.+Di+Marco&author=W.+D.+Shipe&title=Preparation+of+oxodihydroquinoline+derivatives+for+use+as+M1+receptor+positive+allosteric+modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12v&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DKuduk%26aufirst%3DS.%2BD.%26atitle%3DPreparation%2520of%2520oxodihydroquinoline%2520derivatives%2520for%2520use%2520as%2520M1%2520receptor%2520positive%2520allosteric%2520modulators%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit12w"><span><span class="NLM_label">(w) </span><span class="NLM_contrib-group">Kuduk, S. D.; Chang, R. K.; Di Marco, C. N.</span><span> </span><span class="NLM_article-title">Quinolizidinone M1 receptor positive allosteric modulators</span>. WO 2009102574, February 3,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=S.+D.+Kuduk&author=R.+K.+Chang&author=C.+N.+Di+Marco&title=Quinolizidinone+M1+receptor+positive+allosteric+modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12w&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DKuduk%26aufirst%3DS.%2BD.%26atitle%3DQuinolizidinone%2520M1%2520receptor%2520positive%2520allosteric%2520modulators%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit12x"><span><span class="NLM_label">(x) </span><span class="NLM_contrib-group">Kuduk, S. D.; Chang, R. K.; Di Marco, C. N.</span><span> </span><span class="NLM_article-title">Preparation of quinolizidinone M1 receptor positive allosteric modulators</span>. WO 2009117283, March 11,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=S.+D.+Kuduk&author=R.+K.+Chang&author=C.+N.+Di+Marco&title=Preparation+of+quinolizidinone+M1+receptor+positive+allosteric+modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12x&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DKuduk%26aufirst%3DS.%2BD.%26atitle%3DPreparation%2520of%2520quinolizidinone%2520M1%2520receptor%2520positive%2520allosteric%2520modulators%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit12y"><span><span class="NLM_label">(y) </span><span class="NLM_contrib-group">Kuduk, S. D.; Chang, R. K.</span><span> </span><span class="NLM_article-title">Synthesis of quinolizidinone M1 receptor positive allosteric modulators</span>. WO 2009051715, October 15,<span class="NLM_x"> </span><span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=S.+D.+Kuduk&author=R.+K.+Chang&title=Synthesis+of+quinolizidinone+M1+receptor+positive+allosteric+modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12y&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DKuduk%26aufirst%3DS.%2BD.%26atitle%3DSynthesis%2520of%2520quinolizidinone%2520M1%2520receptor%2520positive%2520allosteric%2520modulators%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit12z"><span><span class="NLM_label">(z) </span><span class="NLM_contrib-group">Kuduk, S. D.; Chang, R. K.</span><span> </span><span class="NLM_article-title">Preparation of heterocyclylmethyl oxoquinolizinecarboxylates as muscarinic M1 receptor positive allosteric modulators</span>. WO 2009094279, January 15,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=S.+D.+Kuduk&author=R.+K.+Chang&title=Preparation+of+heterocyclylmethyl+oxoquinolizinecarboxylates+as+muscarinic+M1+receptor+positive+allosteric+modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12z&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DKuduk%26aufirst%3DS.%2BD.%26atitle%3DPreparation%2520of%2520heterocyclylmethyl%2520oxoquinolizinecarboxylates%2520as%2520muscarinic%2520M1%2520receptor%2520positive%2520allosteric%2520modulators%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit12aa"><span><span class="NLM_label">(aa) </span><span class="NLM_contrib-group">Beshore, D. C.; Dipardo, R. M.; Kuduk, S. D.</span><span> </span><span class="NLM_article-title">Preparation of fused pyridone M1 receptor positive allosteric modulators</span>. WO 2009102588, February 4,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=D.+C.+Beshore&author=R.+M.+Dipardo&author=S.+D.+Kuduk&title=Preparation+of+fused+pyridone+M1+receptor+positive+allosteric+modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12aa&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBeshore%26aufirst%3DD.%2BC.%26atitle%3DPreparation%2520of%2520fused%2520pyridone%2520M1%2520receptor%2520positive%2520allosteric%2520modulators%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit12ab"><span><span class="NLM_label">(ab) </span><span class="NLM_contrib-group">Lindsley, C.; Shipe, W. D.; Yang, F.; Bunda, J. L.</span><span> </span><span class="NLM_article-title">Preparation of benzyl-substituted quinolone M1 receptor positive allosteric modulators</span>. WO 2008002621, June 27,<span class="NLM_x"> </span><span class="NLM_year">2007</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&author=C.+Lindsley&author=W.+D.+Shipe&author=F.+Yang&author=J.+L.+Bunda&title=Preparation+of+benzyl-substituted+quinolone+M1+receptor+positive+allosteric+modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12ab&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DLindsley%26aufirst%3DC.%26atitle%3DPreparation%2520of%2520benzyl-substituted%2520quinolone%2520M1%2520receptor%2520positive%2520allosteric%2520modulators%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit12ac"><span><span class="NLM_label">(ac) </span><span class="NLM_contrib-group">Shipe, W. D.; Lindsley, C.; Hallett, D.</span><span> </span><span class="NLM_article-title">Quinolone derivatives, processes for preparing them, pharmaceutical compositions containing them, and their use as M1 receptor positive allosteric modulators</span>. WO 2007067489, December 4,<span class="NLM_x"> </span><span class="NLM_year">2006</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&author=W.+D.+Shipe&author=C.+Lindsley&author=D.+Hallett&title=Quinolone+derivatives%2C+processes+for+preparing+them%2C+pharmaceutical+compositions+containing+them%2C+and+their+use+as+M1+receptor+positive+allosteric+modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12ac&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DShipe%26aufirst%3DW.%2BD.%26atitle%3DQuinolone%2520derivatives%252C%2520processes%2520for%2520preparing%2520them%252C%2520pharmaceutical%2520compositions%2520containing%2520them%252C%2520and%2520their%2520use%2520as%2520M1%2520receptor%2520positive%2520allosteric%2520modulators%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit12ad"><span><span class="NLM_label">(ad) </span><span class="NLM_contrib-group">Shipe, W. D.; Lindsley, C.; Hallett, D.</span><span> </span><span class="NLM_article-title">Preparation of quinolone M1 receptor positive allosteric modulators</span>. WO 2007100366, December 4,<span class="NLM_x"> </span><span class="NLM_year">2006</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&author=W.+D.+Shipe&author=C.+Lindsley&author=D.+Hallett&title=Preparation+of+quinolone+M1+receptor+positive+allosteric+modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12ad&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DShipe%26aufirst%3DW.%2BD.%26atitle%3DPreparation%2520of%2520quinolone%2520M1%2520receptor%2520positive%2520allosteric%2520modulators%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit12ae"><span><span class="NLM_label">(ae) </span><span class="NLM_contrib-group">Kuduk, S. D.; Beshore, D. C.; Di Marco, C. N.; Greshock, T. J.</span><span> </span><span class="NLM_article-title">Benzoquinazolinone derivatives as M1 receptor positive allosteric modulators and their preparation, pharmaceutical compositions and use in the treatment of diseases</span>. WO 2010059773, May 27,<span class="NLM_x"> </span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=S.+D.+Kuduk&author=D.+C.+Beshore&author=C.+N.+Di+Marco&author=T.+J.+Greshock&title=Benzoquinazolinone+derivatives+as+M1+receptor+positive+allosteric+modulators+and+their+preparation%2C+pharmaceutical+compositions+and+use+in+the+treatment+of+diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12ae&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DKuduk%26aufirst%3DS.%2BD.%26atitle%3DBenzoquinazolinone%2520derivatives%2520as%2520M1%2520receptor%2520positive%2520allosteric%2520modulators%2520and%2520their%2520preparation%252C%2520pharmaceutical%2520compositions%2520and%2520use%2520in%2520the%2520treatment%2520of%2520diseases%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="note"><p class="first last">During the review process of this manuscript the Merck clinical trial (ClinicalTrials.gov Identifier:NCT01852110) was terminated for reasons not disclosed at this time.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Yamada, M.; Suzuki, S.; Sugimoto, T.; Nakamura, M.; Sakamoto, H.; Kamata, M.</span><span> </span><span class="NLM_article-title">Isoindolin-1-one derivatives as cholinergic muscarinic M1 receptor positive allosteric modulators and their preparation and use for the treatment of diseases</span>. WO 2015163485 April 22,<span class="NLM_x"> </span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=M.+Yamada&author=S.+Suzuki&author=T.+Sugimoto&author=M.+Nakamura&author=H.+Sakamoto&author=M.+Kamata&title=Isoindolin-1-one+derivatives+as+cholinergic+muscarinic+M1+receptor+positive+allosteric+modulators+and+their+preparation+and+use+for+the+treatment+of+diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DYamada%26aufirst%3DM.%26atitle%3DIsoindolin-1-one%2520derivatives%2520as%2520cholinergic%2520muscarinic%2520M1%2520receptor%2520positive%2520allosteric%2520modulators%2520and%2520their%2520preparation%2520and%2520use%2520for%2520the%2520treatment%2520of%2520diseases%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit14b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Payne, A.; Castro Pineiro, J. L.; Birch, L. M.; Khan, A.; Braunton, A. J.; Kitulagoda, J. E.; Soejima, M.</span><span> </span><span class="NLM_article-title">Preparation of 4-azaindole derivatives as muscarinic M1 receptor modulators for treatment of cognitive deficits</span>. US 20150094328, September 30,<span class="NLM_x"> </span><span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=A.+Payne&author=J.+L.+Castro+Pineiro&author=L.+M.+Birch&author=A.+Khan&author=A.+J.+Braunton&author=J.+E.+Kitulagoda&author=M.+Soejima&title=Preparation+of+4-azaindole+derivatives+as+muscarinic+M1+receptor+modulators+for+treatment+of+cognitive+deficits"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DPayne%26aufirst%3DA.%26atitle%3DPreparation%2520of%25204-azaindole%2520derivatives%2520as%2520muscarinic%2520M1%2520receptor%2520modulators%2520for%2520treatment%2520of%2520cognitive%2520deficits%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit14c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Ogino, M.; Kimura, E.; Suzuki, S.; Ashizawa, T.; Imaeda, T.; Fujimori, I.; Arai, R.</span><span> </span><span class="NLM_article-title">Preparation of nitrogen-containing heterocyclic compound as muscarinic M1 receptor positive allosteric modulators for treatment of nervous system disease</span>. WO 2015190564, June 11,<span class="NLM_x"> </span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=M.+Ogino&author=E.+Kimura&author=S.+Suzuki&author=T.+Ashizawa&author=T.+Imaeda&author=I.+Fujimori&author=R.+Arai&title=Preparation+of+nitrogen-containing+heterocyclic+compound+as+muscarinic+M1+receptor+positive+allosteric+modulators+for+treatment+of+nervous+system+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DOgino%26aufirst%3DM.%26atitle%3DPreparation%2520of%2520nitrogen-containing%2520heterocyclic%2520compound%2520as%2520muscarinic%2520M1%2520receptor%2520positive%2520allosteric%2520modulators%2520for%2520treatment%2520of%2520nervous%2520system%2520disease%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit14d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Lindsley, C. W.; Conn, P. J.; Stauffer, S. R.; Panarese, J. D.</span><span> </span><span class="NLM_article-title">Preparation of benzyldihydrobenzooxazinecarboxamide derivatives for use as positive allosteric modulators of muscarinic acetylcholine receptor M1</span>. WO 2015080904, November 18,<span class="NLM_x"> </span><span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=C.+W.+Lindsley&author=P.+J.+Conn&author=S.+R.+Stauffer&author=J.+D.+Panarese&title=Preparation+of+benzyldihydrobenzooxazinecarboxamide+derivatives+for+use+as+positive+allosteric+modulators+of+muscarinic+acetylcholine+receptor+M1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26atitle%3DPreparation%2520of%2520benzyldihydrobenzooxazinecarboxamide%2520derivatives%2520for%2520use%2520as%2520positive%2520allosteric%2520modulators%2520of%2520muscarinic%2520acetylcholine%2520receptor%2520M1%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit14e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Groebke Zbinden, K.; Pinard, E.; Ryckmans, T.</span><span> </span><span class="NLM_article-title">Preparation of fluoro-naphthyl derivatives as muscarinic M1 receptor positive allosteric modulators</span>. WO 2015110370, January 19,<span class="NLM_x"> </span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=K.+Groebke+Zbinden&author=E.+Pinard&author=T.+Ryckmans&title=Preparation+of+fluoro-naphthyl+derivatives+as+muscarinic+M1+receptor+positive+allosteric+modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14e&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DGroebke%2BZbinden%26aufirst%3DK.%26atitle%3DPreparation%2520of%2520fluoro-naphthyl%2520derivatives%2520as%2520muscarinic%2520M1%2520receptor%2520positive%2520allosteric%2520modulators%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit14f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Ballard, T. M.; Groebke Zbinden, K.; Pinard, E.; Ryckmans, T.; Schaffhauser, H.</span><span> </span><span class="NLM_article-title">Preparation of indole and indazole derivatives as muscarinic M1 receptor pos. allosteric modulators</span>. WO 2015044072, September 22,<span class="NLM_x"> </span><span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=T.+M.+Ballard&author=K.+Groebke+Zbinden&author=E.+Pinard&author=T.+Ryckmans&author=H.+Schaffhauser&title=Preparation+of+indole+and+indazole+derivatives+as+muscarinic+M1+receptor+pos.+allosteric+modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14f&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBallard%26aufirst%3DT.%2BM.%26atitle%3DPreparation%2520of%2520indole%2520and%2520indazole%2520derivatives%2520as%2520muscarinic%2520M1%2520receptor%2520pos.%2520allosteric%2520modulators%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit14g"><span><span class="NLM_label">(g) </span><span class="NLM_contrib-group">Ballard, T. M.; Flohr, A.; Groebke Zbinden, K.; Pinard, E.; Ryckmans, T.; Schaffhauser, H.</span><span> </span><span class="NLM_article-title">Preparation of pyrrolopyridine and pyrazolopyridine derivatives as muscarinic M1 receptor modulators</span>. WO 2015028483, August 8,<span class="NLM_x"> </span><span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=T.+M.+Ballard&author=A.+Flohr&author=K.+Groebke+Zbinden&author=E.+Pinard&author=T.+Ryckmans&author=H.+Schaffhauser&title=Preparation+of+pyrrolopyridine+and+pyrazolopyridine+derivatives+as+muscarinic+M1+receptor+modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14g&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBallard%26aufirst%3DT.%2BM.%26atitle%3DPreparation%2520of%2520pyrrolopyridine%2520and%2520pyrazolopyridine%2520derivatives%2520as%2520muscarinic%2520M1%2520receptor%2520modulators%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit14h"><span><span class="NLM_label">(h) </span><span class="NLM_contrib-group">Sugimoto, T.; Nakamura, M.; Sakamoto, H.; Suzuki, S.; Yamada, M.; Kamata, M.; Kojima, T.; Fujimori, I.; Shimokawa, K.</span><span> </span><span class="NLM_article-title">Preparation of nitrogen-containing heterocyclic compounds as muscarinic M1 receptor positive allosteric modulators</span>. WO 2014077401, November 18,<span class="NLM_x"> </span><span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=T.+Sugimoto&author=M.+Nakamura&author=H.+Sakamoto&author=S.+Suzuki&author=M.+Yamada&author=M.+Kamata&author=T.+Kojima&author=I.+Fujimori&author=K.+Shimokawa&title=Preparation+of+nitrogen-containing+heterocyclic+compounds+as+muscarinic+M1+receptor+positive+allosteric+modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14h&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DSugimoto%26aufirst%3DT.%26atitle%3DPreparation%2520of%2520nitrogen-containing%2520heterocyclic%2520compounds%2520as%2520muscarinic%2520M1%2520receptor%2520positive%2520allosteric%2520modulators%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit14i"><span><span class="NLM_label">(i) </span><span class="NLM_contrib-group">Lindsley, C. W.; Conn, P. J.; Stauffer, S. R.; Panarese, J. D.</span><span> </span><span class="NLM_article-title">Substituted 1-benzylquinoxalin-2(1H)-one analogs as positive allosteric modulators of muscarinic acetylcholine receptor M1</span>. WO 2014179226, April 28,<span class="NLM_x"> </span><span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=C.+W.+Lindsley&author=P.+J.+Conn&author=S.+R.+Stauffer&author=J.+D.+Panarese&title=Substituted+1-benzylquinoxalin-2%281H%29-one+analogs+as+positive+allosteric+modulators+of+muscarinic+acetylcholine+receptor+M1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14i&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26atitle%3DSubstituted%25201-benzylquinoxalin-2%25281H%2529-one%2520analogs%2520as%2520positive%2520allosteric%2520modulators%2520of%2520muscarinic%2520acetylcholine%2520receptor%2520M1%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit14j"><span><span class="NLM_label">(j) </span><span class="NLM_contrib-group">Lindsley, C. W.; Conn, P. J.; Stauffer, S. R.; Panarese, J. D.</span><span> </span><span class="NLM_article-title">Quinazolinone and pyridopyrimidinone derivatives as positive allosteric modulators of muscarinic acetylcholine receptor M1 and their preparation and use for the treatment of neurological and psychiatric disorders</span>. WO 2014179237, April 28,<span class="NLM_x"> </span><span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=C.+W.+Lindsley&author=P.+J.+Conn&author=S.+R.+Stauffer&author=J.+D.+Panarese&title=Quinazolinone+and+pyridopyrimidinone+derivatives+as+positive+allosteric+modulators+of+muscarinic+acetylcholine+receptor+M1+and+their+preparation+and+use+for+the+treatment+of+neurological+and+psychiatric+disorders"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14j&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26atitle%3DQuinazolinone%2520and%2520pyridopyrimidinone%2520derivatives%2520as%2520positive%2520allosteric%2520modulators%2520of%2520muscarinic%2520acetylcholine%2520receptor%2520M1%2520and%2520their%2520preparation%2520and%2520use%2520for%2520the%2520treatment%2520of%2520neurological%2520and%2520psychiatric%2520disorders%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit14k"><span><span class="NLM_label">(k) </span><span class="NLM_contrib-group">Davie, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valant, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sexton, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Capuano, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christopoulos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scammells, P. J.</span><span> </span><span class="NLM_article-title">Synthesis and pharmacological evaluation of analogues of Benzyl Quinolone Carboxylic Acid (BQCA) designed to bind irreversibly to an allosteric site of the M1 muscarinic acetylcholine receptor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">5405</span><span class="NLM_x">–</span> <span class="NLM_lpage">5418</span><span class="refDoi"> DOI: 10.1021/jm500556a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm500556a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=5405-5418&author=B.+J.+Davieauthor=C.+Valantauthor=J.+M.+Whiteauthor=P.+M.+Sextonauthor=B.+Capuanoauthor=A.+Christopoulosauthor=P.+J.+Scammells&title=Synthesis+and+pharmacological+evaluation+of+analogues+of+Benzyl+Quinolone+Carboxylic+Acid+%28BQCA%29+designed+to+bind+irreversibly+to+an+allosteric+site+of+the+M1+muscarinic+acetylcholine+receptor&doi=10.1021%2Fjm500556a"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14k&amp;dbid=16384&amp;doi=10.1021%2Fjm500556a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500556a%26sid%3Dliteratum%253Aachs%26aulast%3DDavie%26aufirst%3DB.%2BJ.%26aulast%3DValant%26aufirst%3DC.%26aulast%3DWhite%26aufirst%3DJ.%2BM.%26aulast%3DSexton%26aufirst%3DP.%2BM.%26aulast%3DCapuano%26aufirst%3DB.%26aulast%3DChristopoulos%26aufirst%3DA.%26aulast%3DScammells%26aufirst%3DP.%2BJ.%26atitle%3DSynthesis%2520and%2520pharmacological%2520evaluation%2520of%2520analogues%2520of%2520Benzyl%2520Quinolone%2520Carboxylic%2520Acid%2520%2528BQCA%2529%2520designed%2520to%2520bind%2520irreversibly%2520to%2520an%2520allosteric%2520site%2520of%2520the%2520M1%2520muscarinic%2520acetylcholine%2520receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D5405%26epage%3D5418%26doi%3D10.1021%2Fjm500556a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit14l"><span><span class="NLM_label">(l) </span><span class="NLM_contrib-group">Swinnen, D.; Montagne, C.; Pomel, V.; Quattropani, A.; Molette, J.; Gerber, P.</span><span> </span><span class="NLM_article-title">Tetraaza-cyclopenta[a]indenyl derivatives as M1 receptor positive allosteric modulators useful in the treatment of diseases mediated by the muscarinic M1 mediator and their preparation</span>. WO 2013091773, November 30,<span class="NLM_x"> </span><span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=D.+Swinnen&author=C.+Montagne&author=V.+Pomel&author=A.+Quattropani&author=J.+Molette&author=P.+Gerber&title=Tetraaza-cyclopenta%5Ba%5Dindenyl+derivatives+as+M1+receptor+positive+allosteric+modulators+useful+in+the+treatment+of+diseases+mediated+by+the+muscarinic+M1+mediator+and+their+preparation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14l&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DSwinnen%26aufirst%3DD.%26atitle%3DTetraaza-cyclopenta%255Ba%255Dindenyl%2520derivatives%2520as%2520M1%2520receptor%2520positive%2520allosteric%2520modulators%2520useful%2520in%2520the%2520treatment%2520of%2520diseases%2520mediated%2520by%2520the%2520muscarinic%2520M1%2520mediator%2520and%2520their%2520preparation%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit14m"><span><span class="NLM_label">(m) </span><span class="NLM_contrib-group">Sakamoto, H.; Sugimoto, T.</span><span> </span><span class="NLM_article-title">Preparation of heterocyclic compounds as cholinergic muscarinic M1 receptor positive allosteric modulators</span>. WO 2013129622, February 28,<span class="NLM_x"> </span><span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=H.+Sakamoto&author=T.+Sugimoto&title=Preparation+of+heterocyclic+compounds+as+cholinergic+muscarinic+M1+receptor+positive+allosteric+modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14m&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DSakamoto%26aufirst%3DH.%26atitle%3DPreparation%2520of%2520heterocyclic%2520compounds%2520as%2520cholinergic%2520muscarinic%2520M1%2520receptor%2520positive%2520allosteric%2520modulators%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit14n"><span><span class="NLM_label">(n) </span><span class="NLM_contrib-group">Lindsley, C. W.; Conn, P. J.; Wood, M. R.; Melancon, B. J.; Poslusney, M. S.; Tarr, J. C.</span><span> </span><span class="NLM_article-title">Substituted pyrazol-benzyl analogues as positive allosteric modulators of mAChR M1 receptors</span>. WO 2013106795, January 12,<span class="NLM_x"> </span><span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=C.+W.+Lindsley&author=P.+J.+Conn&author=M.+R.+Wood&author=B.+J.+Melancon&author=M.+S.+Poslusney&author=J.+C.+Tarr&title=Substituted+pyrazol-benzyl+analogues+as+positive+allosteric+modulators+of+mAChR+M1+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14n&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26atitle%3DSubstituted%2520pyrazol-benzyl%2520analogues%2520as%2520positive%2520allosteric%2520modulators%2520of%2520mAChR%2520M1%2520receptors%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit14o"><span><span class="NLM_label">(o) </span><span class="NLM_contrib-group">Lindsley, C. W.; Conn, P. J.; Wood, M. R.; Hopkins, C. R.; Melancon, B. J.; Poslusney, M. S.; Engers, D. W.</span><span> </span><span class="NLM_article-title">Substituted 2-(4-heterocyclylbenzyl)isoindolin-1-one analogs as positive allosteric modulators of the muscarinic acetylcholine receptor M1</span>. WO 2013063549, October 28,<span class="NLM_x"> </span><span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=C.+W.+Lindsley&author=P.+J.+Conn&author=M.+R.+Wood&author=C.+R.+Hopkins&author=B.+J.+Melancon&author=M.+S.+Poslusney&author=D.+W.+Engers&title=Substituted+2-%284-heterocyclylbenzyl%29isoindolin-1-one+analogs+as+positive+allosteric+modulators+of+the+muscarinic+acetylcholine+receptor+M1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14o&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26atitle%3DSubstituted%25202-%25284-heterocyclylbenzyl%2529isoindolin-1-one%2520analogs%2520as%2520positive%2520allosteric%2520modulators%2520of%2520the%2520muscarinic%2520acetylcholine%2520receptor%2520M1%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit14p"><span><span class="NLM_label">(p) </span><span class="NLM_contrib-group">Lindsley, C. W.; Conn, P. J.; Wood, M. R.; Hopkins, C. R.; Melancon, B. J.; Poslusney, M. S.</span><span> </span><span class="NLM_article-title">Preparation of substituted benzylspiroindolin-2-one derivatives as positive allosteric modulators of mAChR M1 receptor</span>. WO 2013071201, November 10,<span class="NLM_x"> </span><span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=C.+W.+Lindsley&author=P.+J.+Conn&author=M.+R.+Wood&author=C.+R.+Hopkins&author=B.+J.+Melancon&author=M.+S.+Poslusney&title=Preparation+of+substituted+benzylspiroindolin-2-one+derivatives+as+positive+allosteric+modulators+of+mAChR+M1+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14p&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26atitle%3DPreparation%2520of%2520substituted%2520benzylspiroindolin-2-one%2520derivatives%2520as%2520positive%2520allosteric%2520modulators%2520of%2520mAChR%2520M1%2520receptor%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit14q"><span><span class="NLM_label">(q) </span><span class="NLM_contrib-group">Lindsley, C. W.; Conn, P. J.; Wood, M. R.; Tarr, J. C.; Bridges, T. M.</span><span> </span><span class="NLM_article-title">Indole compounds as positive allosteric modulators of the muscarinic receptor</span>. WO 2011163280, June 21,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=C.+W.+Lindsley&author=P.+J.+Conn&author=M.+R.+Wood&author=J.+C.+Tarr&author=T.+M.+Bridges&title=Indole+compounds+as+positive+allosteric+modulators+of+the+muscarinic+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14q&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26atitle%3DIndole%2520compounds%2520as%2520positive%2520allosteric%2520modulators%2520of%2520the%2520muscarinic%2520receptor%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit14r"><span><span class="NLM_label">(r) </span><span class="NLM_contrib-group">Reid, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bridges, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheffler, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cho, H. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Days, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daniels, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niswender, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weaver, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conn, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindsley, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, M. R.</span><span> </span><span class="NLM_article-title">Discovery and optimization of a novel, selective and brain penetrant M1 positive allosteric modulator (PAM): The development of ML169, an MLPCN probe</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">2697</span><span class="NLM_x">–</span> <span class="NLM_lpage">2701</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2010.12.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14r&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=10.1016%2Fj.bmcl.2010.12.015" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=2697-2701&author=P.+R.+Reidauthor=T.+M.+Bridgesauthor=D.+J.+Shefflerauthor=H.+P.+Choauthor=L.+M.+Lewisauthor=E.+Daysauthor=J.+S.+Danielsauthor=C.+K.+Jonesauthor=C.+M.+Niswenderauthor=C.+D.+Weaverauthor=P.+J.+Connauthor=C.+W.+Lindsleyauthor=M.+R.+Wood&title=Discovery+and+optimization+of+a+novel%2C+selective+and+brain+penetrant+M1+positive+allosteric+modulator+%28PAM%29%3A+The+development+of+ML169%2C+an+MLPCN+probe&doi=10.1016%2Fj.bmcl.2010.12.015"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14r&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2010.12.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2010.12.015%26sid%3Dliteratum%253Aachs%26aulast%3DReid%26aufirst%3DP.%2BR.%26aulast%3DBridges%26aufirst%3DT.%2BM.%26aulast%3DSheffler%26aufirst%3DD.%2BJ.%26aulast%3DCho%26aufirst%3DH.%2BP.%26aulast%3DLewis%26aufirst%3DL.%2BM.%26aulast%3DDays%26aufirst%3DE.%26aulast%3DDaniels%26aufirst%3DJ.%2BS.%26aulast%3DJones%26aufirst%3DC.%2BK.%26aulast%3DNiswender%26aufirst%3DC.%2BM.%26aulast%3DWeaver%26aufirst%3DC.%2BD.%26aulast%3DConn%26aufirst%3DP.%2BJ.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26aulast%3DWood%26aufirst%3DM.%2BR.%26atitle%3DDiscovery%2520and%2520optimization%2520of%2520a%2520novel%252C%2520selective%2520and%2520brain%2520penetrant%2520M1%2520positive%2520allosteric%2520modulator%2520%2528PAM%2529%253A%2520The%2520development%2520of%2520ML169%252C%2520an%2520MLPCN%2520probe%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D2697%26epage%3D2701%26doi%3D10.1016%2Fj.bmcl.2010.12.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit14s"><span><span class="NLM_label">(s) </span><span class="NLM_contrib-group">Tarr, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turlington, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reid, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Utley, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheffler, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cho, H. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pancani, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klein, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bridges, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morrison, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blobaum, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daniels, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niswender, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conn, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindsley, C. W.</span><span> </span><span class="NLM_article-title">Targeting selective activation of M(1) for the treatment of Alzheimer’s disease: further chemical optimization and pharmacological characterization of the M(1) positive allosteric modulator ML169</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">884</span><span class="NLM_x">–</span> <span class="NLM_lpage">895</span><span class="refDoi"> DOI: 10.1021/cn300068s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cn300068s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14s&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVGhs7jI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=884-895&author=J.+C.+Tarrauthor=M.+L.+Turlingtonauthor=P.+R.+Reidauthor=T.+J.+Utleyauthor=D.+J.+Shefflerauthor=H.+P.+Choauthor=R.+Klarauthor=T.+Pancaniauthor=M.+T.+Kleinauthor=T.+M.+Bridgesauthor=R.+D.+Morrisonauthor=A.+L.+Blobaumauthor=Z.+Xiangauthor=J.+S.+Danielsauthor=C.+M.+Niswenderauthor=P.+J.+Connauthor=M.+R.+Woodauthor=C.+W.+Lindsley&title=Targeting+selective+activation+of+M%281%29+for+the+treatment+of+Alzheimer%E2%80%99s+disease%3A+further+chemical+optimization+and+pharmacological+characterization+of+the+M%281%29+positive+allosteric+modulator+ML169&doi=10.1021%2Fcn300068s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14sR"><div class="casContent"><span class="casTitleNuber">14s</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting Selective Activation of M1 for the Treatment of Alzheimer's Disease: Further Chemical Optimization and Pharmacological Characterization of the M1 Positive Allosteric Modulator ML169</span></div><div class="casAuthors">Tarr, James C.; Turlington, Mark L.; Reid, Paul R.; Utley, Thomas J.; Sheffler, Douglas J.; Cho, Hyekyung P.; Klar, Rebecca; Pancani, Tristano; Klein, Michael T.; Bridges, Thomas M.; Morrison, Ryan D.; Blobaum, Anna L.; Xiang, Zixui; Daniels, J. Scott; Niswender, Colleen M.; Conn, P. Jeffrey; Wood, Michael R.; Lindsley, Craig W.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">884-895</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The M1 muscarinic acetylcholine receptor is thought to play an important role in memory and cognition, making it a potential target for the treatment of Alzheimer's disease (AD) and schizophrenia.  Moreover, M1 interacts with BACE1 and regulates its proteasomal degrdn., suggesting selective M1 activation could afford both palliative cognitive benefit as well as disease modification in AD.  A key challenge in targeting the muscarinic acetylcholine receptors is achieving mAChR subtype selectivity.  Our lab has previously reported the M1 selective pos. allosteric modulator ML169.  Herein we describe our efforts to further optimize this lead compd. by prepg. analog libraries and probing novel scaffolds.  We were able to identify several analogs that possessed submicromolar potency, with our best example displaying an EC50 of 310 nM.  The new compds. maintained complete selectivity for the M1 receptor over the other subtypes (M2-M5), displayed improved DMPK profiles, and potentiated the carbachol (CCh)-induced excitation in striatal MSNs.  Selected analogs were able to potentiate CCh-mediated non-amyloidogenic APPα release, further strengthening the concept that M1 PAMs may afford a disease-modifying role in the treatment of AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1gJudWdQ8i7Vg90H21EOLACvtfcHk0lhCeyGkF0CF-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVGhs7jI&md5=dd85b45664febaaa063a2c53d5379c50</span></div><a href="/servlet/linkout?suffix=cit14s&amp;dbid=16384&amp;doi=10.1021%2Fcn300068s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn300068s%26sid%3Dliteratum%253Aachs%26aulast%3DTarr%26aufirst%3DJ.%2BC.%26aulast%3DTurlington%26aufirst%3DM.%2BL.%26aulast%3DReid%26aufirst%3DP.%2BR.%26aulast%3DUtley%26aufirst%3DT.%2BJ.%26aulast%3DSheffler%26aufirst%3DD.%2BJ.%26aulast%3DCho%26aufirst%3DH.%2BP.%26aulast%3DKlar%26aufirst%3DR.%26aulast%3DPancani%26aufirst%3DT.%26aulast%3DKlein%26aufirst%3DM.%2BT.%26aulast%3DBridges%26aufirst%3DT.%2BM.%26aulast%3DMorrison%26aufirst%3DR.%2BD.%26aulast%3DBlobaum%26aufirst%3DA.%2BL.%26aulast%3DXiang%26aufirst%3DZ.%26aulast%3DDaniels%26aufirst%3DJ.%2BS.%26aulast%3DNiswender%26aufirst%3DC.%2BM.%26aulast%3DConn%26aufirst%3DP.%2BJ.%26aulast%3DWood%26aufirst%3DM.%2BR.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26atitle%3DTargeting%2520selective%2520activation%2520of%2520M%25281%2529%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520further%2520chemical%2520optimization%2520and%2520pharmacological%2520characterization%2520of%2520the%2520M%25281%2529%2520positive%2520allosteric%2520modulator%2520ML169%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2012%26volume%3D3%26spage%3D884%26epage%3D895%26doi%3D10.1021%2Fcn300068s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit14t"><span><span class="NLM_label">(t) </span><span class="NLM_contrib-group">Mistry, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valant, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sexton, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Capuano, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christopoulos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scammells, P. J.</span><span> </span><span class="NLM_article-title">Synthesis and pharmacological profiling of analogues of benzyl quinolone carboxylic acid (BQCA) as allosteric modulators of the M1 muscarinic receptor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">5151</span><span class="NLM_x">–</span> <span class="NLM_lpage">5172</span><span class="refDoi"> DOI: 10.1021/jm400540b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400540b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14t&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=1%3ACAS%3A528%3ADC%252BC3sXosVaqtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=5151-5172&author=S.+N.+Mistryauthor=C.+Valantauthor=P.+M.+Sextonauthor=B.+Capuanoauthor=A.+Christopoulosauthor=P.+J.+Scammells&title=Synthesis+and+pharmacological+profiling+of+analogues+of+benzyl+quinolone+carboxylic+acid+%28BQCA%29+as+allosteric+modulators+of+the+M1+muscarinic+receptor&doi=10.1021%2Fjm400540b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14tR"><div class="casContent"><span class="casTitleNuber">14t</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Pharmacological Profiling of Analogues of Benzyl Quinolone Carboxylic Acid (BQCA) as Allosteric Modulators of the M1 Muscarinic Receptor</span></div><div class="casAuthors">Mistry, Shailesh N.; Valant, Celine; Sexton, Patrick M.; Capuano, Ben; Christopoulos, Arthur; Scammells, Peter J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">5151-5172</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Established therapy in Alzheimer's disease involves potentiation of the endogenous orthosteric ligand, acetylcholine, at the M1 muscarinic receptors found in higher concns. in the cortex and hippocampus.  Adverse effects, due to indiscriminate activation of other muscarinic receptor subtypes, are common.  M1 muscarinic pos. allosteric modulators/allosteric agonists such as BQCA [1-(4-methoxybenzyl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid, I] offer an attractive soln., being exquisitely M1-selective over other muscarinic subtypes.  A common difficulty with allosteric ligands is interpreting SAR, based on composite potency values derived in the presence of fixed concn. of agonist.  In reality these values encompass multiple pharmacol. parameters, each potentially and differentially sensitive to structural modification of the ligand.  We report novel BQCA analogs which appear to augment ligand affinity for the receptor (pKB), intrinsic efficacy (τB), and both binding (α) and functional (β) cooperativity with acetylcholine.  Ultimately, development of such enriched SAR surrounding allosteric modulators will provide insight into their mode of action.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoigST7OJR7vbVg90H21EOLACvtfcHk0lgwKvqw6AL0SQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXosVaqtbs%253D&md5=ab134e0b5400aa825916695eaf1203b1</span></div><a href="/servlet/linkout?suffix=cit14t&amp;dbid=16384&amp;doi=10.1021%2Fjm400540b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400540b%26sid%3Dliteratum%253Aachs%26aulast%3DMistry%26aufirst%3DS.%2BN.%26aulast%3DValant%26aufirst%3DC.%26aulast%3DSexton%26aufirst%3DP.%2BM.%26aulast%3DCapuano%26aufirst%3DB.%26aulast%3DChristopoulos%26aufirst%3DA.%26aulast%3DScammells%26aufirst%3DP.%2BJ.%26atitle%3DSynthesis%2520and%2520pharmacological%2520profiling%2520of%2520analogues%2520of%2520benzyl%2520quinolone%2520carboxylic%2520acid%2520%2528BQCA%2529%2520as%2520allosteric%2520modulators%2520of%2520the%2520M1%2520muscarinic%2520receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D5151%26epage%3D5172%26doi%3D10.1021%2Fjm400540b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit14u"><span><span class="NLM_label">(u) </span><span class="NLM_contrib-group">Davie, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sexton, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Capuano, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christopoulos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scammells, P. J.</span><span> </span><span class="NLM_article-title">Development of a photoactivatable allosteric ligand for the M1 muscarinic acetylcholine receptor</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">902</span><span class="NLM_x">–</span> <span class="NLM_lpage">907</span><span class="refDoi"> DOI: 10.1021/cn500173x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cn500173x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14u&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsVyjt7vO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=902-907&author=B.+J.+Davieauthor=P.+M.+Sextonauthor=B.+Capuanoauthor=A.+Christopoulosauthor=P.+J.+Scammells&title=Development+of+a+photoactivatable+allosteric+ligand+for+the+M1+muscarinic+acetylcholine+receptor&doi=10.1021%2Fcn500173x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14uR"><div class="casContent"><span class="casTitleNuber">14u</span><div class="casTitle"><span class="NLM_cas:atitle">Development of a Photoactivatable Allosteric Ligand for the M1 Muscarinic Acetylcholine Receptor</span></div><div class="casAuthors">Davie, Briana J.; Sexton, Patrick M.; Capuano, Ben; Christopoulos, Arthur; Scammells, Peter J.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">902-907</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The field of G protein-coupled receptor drug discovery has benefited greatly from the structural and functional insights afforded by photoactivatable ligands.  One G protein-coupled receptor subfamily for which photoactivatable ligands have been developed is the muscarinic acetylcholine receptor family, though, to date, all such ligands have been designed to target the orthosteric (endogenous ligand) binding site of these receptors.  Herein the authors report the synthesis and pharmacol. investigation of a novel photoaffinity label, MIPS1455 I, designed to bind irreversibly to an allosteric site of the M1 muscarinic acetylcholine receptor; a target of therapeutic interest for the treatment of cognitive deficits.  MIPS1455 may be a valuable mol. tool for further investigating allosteric interactions at this receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUjdEGSeJezLVg90H21EOLACvtfcHk0lgwKvqw6AL0SQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsVyjt7vO&md5=451636b661b7ec22e289573725961fad</span></div><a href="/servlet/linkout?suffix=cit14u&amp;dbid=16384&amp;doi=10.1021%2Fcn500173x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn500173x%26sid%3Dliteratum%253Aachs%26aulast%3DDavie%26aufirst%3DB.%2BJ.%26aulast%3DSexton%26aufirst%3DP.%2BM.%26aulast%3DCapuano%26aufirst%3DB.%26aulast%3DChristopoulos%26aufirst%3DA.%26aulast%3DScammells%26aufirst%3DP.%2BJ.%26atitle%3DDevelopment%2520of%2520a%2520photoactivatable%2520allosteric%2520ligand%2520for%2520the%2520M1%2520muscarinic%2520acetylcholine%2520receptor%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2014%26volume%3D5%26spage%3D902%26epage%3D907%26doi%3D10.1021%2Fcn500173x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit14v"><span><span class="NLM_label">(v) </span><span class="NLM_contrib-group">Quattropani, A.; Kulkarni, S. S.; Murugesan, K.; Banerjee, J.</span><span> </span><span class="NLM_article-title">Preparation of tetraaza-cyclopenta[a]indenyl derivatives as muscarinic M1 mediators</span>. WO 2014198808 Dec 18,<span class="NLM_x"> </span><span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=A.+Quattropani&author=S.+S.+Kulkarni&author=K.+Murugesan&author=J.+Banerjee&title=Preparation+of+tetraaza-cyclopenta%5Ba%5Dindenyl+derivatives+as+muscarinic+M1+mediators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14v&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DQuattropani%26aufirst%3DA.%26atitle%3DPreparation%2520of%2520tetraaza-cyclopenta%255Ba%255Dindenyl%2520derivatives%2520as%2520muscarinic%2520M1%2520mediators%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit14w"><span><span class="NLM_label">(w) </span><span class="NLM_contrib-group">Sugimoto, T.; Shimokawa, K.; Kojima, T.; Sakamoto, H.; Fujimori, I.; Nakamura, M.; Yamada, M.; Murakami, M.; Kamata, M.; Suzuki, S.</span><span> </span><span class="NLM_article-title">Nitrogen-containing heterocyclic compounds and their use for pharmaceuticals and cholinergic muscarinic M1 receptor positive allosteric modulation</span>. WO 2015174534 Nov 19,<span class="NLM_x"> </span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=T.+Sugimoto&author=K.+Shimokawa&author=T.+Kojima&author=H.+Sakamoto&author=I.+Fujimori&author=M.+Nakamura&author=M.+Yamada&author=M.+Murakami&author=M.+Kamata&author=S.+Suzuki&title=Nitrogen-containing+heterocyclic+compounds+and+their+use+for+pharmaceuticals+and+cholinergic+muscarinic+M1+receptor+positive+allosteric+modulation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14w&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DSugimoto%26aufirst%3DT.%26atitle%3DNitrogen-containing%2520heterocyclic%2520compounds%2520and%2520their%2520use%2520for%2520pharmaceuticals%2520and%2520cholinergic%2520muscarinic%2520M1%2520receptor%2520positive%2520allosteric%2520modulation%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit14x"><span><span class="NLM_label">(x) </span><span class="NLM_contrib-group">Davoren, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Neil, S. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brodney, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chenard, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dlugolenski, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edgerton, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garnsey, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grimwood, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kauffman, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaChapelle, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lazzaro, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, C.-W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lotarski, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nason, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Obach, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reinhart, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salomon-Ferrer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steyn, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webb, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span> </span><span class="NLM_article-title">Design and optimization of selective azaindole amide M1 positive allosteric modulators</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">650</span><span class="NLM_x">–</span> <span class="NLM_lpage">655</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2015.11.053</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14x&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=10.1016%2Fj.bmcl.2015.11.053" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14x&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=26631313" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14x&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvFant73L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=650-655&author=J.+E.+Davorenauthor=S.+V.+O%E2%80%99Neilauthor=D.+P.+Andersonauthor=M.+A.+Brodneyauthor=L.+Chenardauthor=K.+Dlugolenskiauthor=J.+R.+Edgertonauthor=M.+Greenauthor=M.+Garnseyauthor=S.+Grimwoodauthor=A.+R.+Harrisauthor=G.+W.+Kauffmanauthor=E.+LaChapelleauthor=J.+T.+Lazzaroauthor=C.-W.+Leeauthor=S.+M.+Lotarskiauthor=D.+M.+Nasonauthor=R.+S.+Obachauthor=V.+Reinhartauthor=R.+Salomon-Ferrerauthor=S.+J.+Steynauthor=D.+Webbauthor=J.+Yanauthor=L.+Zhang&title=Design+and+optimization+of+selective+azaindole+amide+M1+positive+allosteric+modulators&doi=10.1016%2Fj.bmcl.2015.11.053"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14xR"><div class="casContent"><span class="casTitleNuber">14x</span><div class="casTitle"><span class="NLM_cas:atitle">Design and optimization of selective azaindole amide M1 positive allosteric modulators</span></div><div class="casAuthors">Davoren, Jennifer E.; O'Neil, Steven V.; Anderson, Dennis P.; Brodney, Michael A.; Chenard, Lois; Dlugolenski, Keith; Edgerton, Jeremy R.; Green, Michael; Garnsey, Michelle; Grimwood, Sarah; Harris, Anthony R.; Kauffman, Gregory W.; LaChapelle, Erik; Lazzaro, John T.; Lee, Che-Wah; Lotarski, Susan M.; Nason, Deane M.; Obach, R. Scott; Reinhart, Veronica; Salomon-Ferrer, Romelia; Steyn, Stefanus J.; Webb, Damien; Yan, Jiangli; Zhang, Lei</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">650-655</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Selective activation of the M1 receptor via a pos. allosteric modulator (PAM) is a new approach for the treatment of the cognitive impairments assocd. with schizophrenia and Alzheimer's disease.  A novel series of azaindole amides and their key pharmacophore elements are described.  The nitrogen of the azaindole core is a key design element as it forms an intramol. hydrogen bond with the amide N-H thus reinforcing the bioactive conformation predicted by published SAR and the authors' homol. model.  Representative compd. 25 is a potent and selective M1 PAM that has well aligned physicochem. properties, adequate brain penetration and pharmacokinetic (PK) properties, and is active in vivo.  These favorable properties indicate that this series possesses suitable qualities for further development and studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpOEhH8MxkKIrVg90H21EOLACvtfcHk0linh_mRzbcZXQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvFant73L&md5=5c227d1371fe4f0cc3348af8314dd370</span></div><a href="/servlet/linkout?suffix=cit14x&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2015.11.053&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2015.11.053%26sid%3Dliteratum%253Aachs%26aulast%3DDavoren%26aufirst%3DJ.%2BE.%26aulast%3DO%25E2%2580%2599Neil%26aufirst%3DS.%2BV.%26aulast%3DAnderson%26aufirst%3DD.%2BP.%26aulast%3DBrodney%26aufirst%3DM.%2BA.%26aulast%3DChenard%26aufirst%3DL.%26aulast%3DDlugolenski%26aufirst%3DK.%26aulast%3DEdgerton%26aufirst%3DJ.%2BR.%26aulast%3DGreen%26aufirst%3DM.%26aulast%3DGarnsey%26aufirst%3DM.%26aulast%3DGrimwood%26aufirst%3DS.%26aulast%3DHarris%26aufirst%3DA.%2BR.%26aulast%3DKauffman%26aufirst%3DG.%2BW.%26aulast%3DLaChapelle%26aufirst%3DE.%26aulast%3DLazzaro%26aufirst%3DJ.%2BT.%26aulast%3DLee%26aufirst%3DC.-W.%26aulast%3DLotarski%26aufirst%3DS.%2BM.%26aulast%3DNason%26aufirst%3DD.%2BM.%26aulast%3DObach%26aufirst%3DR.%2BS.%26aulast%3DReinhart%26aufirst%3DV.%26aulast%3DSalomon-Ferrer%26aufirst%3DR.%26aulast%3DSteyn%26aufirst%3DS.%2BJ.%26aulast%3DWebb%26aufirst%3DD.%26aulast%3DYan%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DL.%26atitle%3DDesign%2520and%2520optimization%2520of%2520selective%2520azaindole%2520amide%2520M1%2520positive%2520allosteric%2520modulators%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D26%26spage%3D650%26epage%3D655%26doi%3D10.1016%2Fj.bmcl.2015.11.053" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit14y"><span><span class="NLM_label">(y) </span><span class="NLM_contrib-group">Mistry, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jorg, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lim, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vinh, N. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sexton, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Capuano, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christopoulos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lane, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scammells, P. J.</span><span> </span><span class="NLM_article-title">4-Phenylpyridin-2-one derivatives: A novel class of positive allosteric modulator of the M1 muscarinic acetylcholine receptor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">388</span><span class="NLM_x">–</span> <span class="NLM_lpage">409</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01562</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01562" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14y&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvFegu7zP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=388-409&author=S.+N.+Mistryauthor=M.+Jorgauthor=H.+Limauthor=N.+B.+Vinhauthor=P.+M.+Sextonauthor=B.+Capuanoauthor=A.+Christopoulosauthor=J.+R.+Laneauthor=P.+J.+Scammells&title=4-Phenylpyridin-2-one+derivatives%3A+A+novel+class+of+positive+allosteric+modulator+of+the+M1+muscarinic+acetylcholine+receptor&doi=10.1021%2Facs.jmedchem.5b01562"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14yR"><div class="casContent"><span class="casTitleNuber">14y</span><div class="casTitle"><span class="NLM_cas:atitle">4-Phenylpyridin-2-one Derivatives: A Novel Class of Positive Allosteric Modulator of the M1 Muscarinic Acetylcholine Receptor</span></div><div class="casAuthors">Mistry, Shailesh N.; Jorg, Manuela; Lim, Herman; Vinh, Natalie B.; Sexton, Patrick M.; Capuano, Ben; Christopoulos, Arthur; Lane, J. Robert; Scammells, Peter J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">388-409</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Pos. allosteric modulators (PAMs) of the M1 muscarinic acetylcholine receptor (M1 mAChR) are a promising strategy for the treatment of the cognitive deficits assocd. with diseases including Alzheimer's and schizophrenia.  Herein, we report the design, synthesis, and characterization of a novel family of M1 mAChR PAMs.  The most active compds. of the 4-phenylpyridin-2-one series exhibited comparable binding affinity to the ref. compd., 1-(4-methoxybenzyl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid (BQCA), but markedly improved pos. cooperativity with acetylcholine, and retained exquisite selectivity for the M1 mAChR.  Furthermore, the pharmacol. characterization revealed ligands with a diverse range of activities, including modulators that displayed both high intrinsic efficacy and PAM activity, those that showed no detectable agonism but robust PAM activity and ligands that displayed robust allosteric agonism but little modulatory activity.  Compd. I was found to have the best pharmacol. profile.  Thus, the 4-phenylpyridin-2-one scaffold offers an attractive starting point for further lead optimization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMlFmtgndXrbVg90H21EOLACvtfcHk0linh_mRzbcZXQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvFegu7zP&md5=315362c43e2b6c204f038f30c6ade642</span></div><a href="/servlet/linkout?suffix=cit14y&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01562&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01562%26sid%3Dliteratum%253Aachs%26aulast%3DMistry%26aufirst%3DS.%2BN.%26aulast%3DJorg%26aufirst%3DM.%26aulast%3DLim%26aufirst%3DH.%26aulast%3DVinh%26aufirst%3DN.%2BB.%26aulast%3DSexton%26aufirst%3DP.%2BM.%26aulast%3DCapuano%26aufirst%3DB.%26aulast%3DChristopoulos%26aufirst%3DA.%26aulast%3DLane%26aufirst%3DJ.%2BR.%26aulast%3DScammells%26aufirst%3DP.%2BJ.%26atitle%3D4-Phenylpyridin-2-one%2520derivatives%253A%2520A%2520novel%2520class%2520of%2520positive%2520allosteric%2520modulator%2520of%2520the%2520M1%2520muscarinic%2520acetylcholine%2520receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D388%26epage%3D409%26doi%3D10.1021%2Facs.jmedchem.5b01562" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit14z"><span><span class="NLM_label">(z) </span><span class="NLM_contrib-group">Davoren, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Neil, S. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brodney, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chenard, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dlugolenski, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edgerton, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garnsey, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grimwood, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kauffman, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaChapelle, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lazzaro, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lotarski, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nason, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Obach, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reinhart, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salomon-Ferrer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steyn, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webb, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span> </span><span class="NLM_article-title">Design and optimization of selective azaindole amide M1 positive allosteric modulators</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">650</span><span class="NLM_x">–</span> <span class="NLM_lpage">655</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2015.11.053</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14z&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=10.1016%2Fj.bmcl.2015.11.053" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14z&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=26631313" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14z&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvFant73L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=650-655&author=J.+E.+Davorenauthor=S.+V.+O%E2%80%99Neilauthor=D.+P.+Andersonauthor=M.+A.+Brodneyauthor=L.+Chenardauthor=K.+Dlugolenskiauthor=J.+R.+Edgertonauthor=M.+Greenauthor=M.+Garnseyauthor=S.+Grimwoodauthor=A.+R.+Harrisauthor=G.+W.+Kauffmanauthor=E.+LaChapelleauthor=J.+T.+Lazzaroauthor=C.+W.+Leeauthor=S.+M.+Lotarskiauthor=D.+M.+Nasonauthor=R.+S.+Obachauthor=V.+Reinhartauthor=R.+Salomon-Ferrerauthor=S.+J.+Steynauthor=D.+Webbauthor=J.+Yanauthor=L.+Zhang&title=Design+and+optimization+of+selective+azaindole+amide+M1+positive+allosteric+modulators&doi=10.1016%2Fj.bmcl.2015.11.053"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14zR"><div class="casContent"><span class="casTitleNuber">14z</span><div class="casTitle"><span class="NLM_cas:atitle">Design and optimization of selective azaindole amide M1 positive allosteric modulators</span></div><div class="casAuthors">Davoren, Jennifer E.; O'Neil, Steven V.; Anderson, Dennis P.; Brodney, Michael A.; Chenard, Lois; Dlugolenski, Keith; Edgerton, Jeremy R.; Green, Michael; Garnsey, Michelle; Grimwood, Sarah; Harris, Anthony R.; Kauffman, Gregory W.; LaChapelle, Erik; Lazzaro, John T.; Lee, Che-Wah; Lotarski, Susan M.; Nason, Deane M.; Obach, R. Scott; Reinhart, Veronica; Salomon-Ferrer, Romelia; Steyn, Stefanus J.; Webb, Damien; Yan, Jiangli; Zhang, Lei</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">650-655</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Selective activation of the M1 receptor via a pos. allosteric modulator (PAM) is a new approach for the treatment of the cognitive impairments assocd. with schizophrenia and Alzheimer's disease.  A novel series of azaindole amides and their key pharmacophore elements are described.  The nitrogen of the azaindole core is a key design element as it forms an intramol. hydrogen bond with the amide N-H thus reinforcing the bioactive conformation predicted by published SAR and the authors' homol. model.  Representative compd. 25 is a potent and selective M1 PAM that has well aligned physicochem. properties, adequate brain penetration and pharmacokinetic (PK) properties, and is active in vivo.  These favorable properties indicate that this series possesses suitable qualities for further development and studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpOEhH8MxkKIrVg90H21EOLACvtfcHk0linh_mRzbcZXQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvFant73L&md5=5c227d1371fe4f0cc3348af8314dd370</span></div><a href="/servlet/linkout?suffix=cit14z&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2015.11.053&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2015.11.053%26sid%3Dliteratum%253Aachs%26aulast%3DDavoren%26aufirst%3DJ.%2BE.%26aulast%3DO%25E2%2580%2599Neil%26aufirst%3DS.%2BV.%26aulast%3DAnderson%26aufirst%3DD.%2BP.%26aulast%3DBrodney%26aufirst%3DM.%2BA.%26aulast%3DChenard%26aufirst%3DL.%26aulast%3DDlugolenski%26aufirst%3DK.%26aulast%3DEdgerton%26aufirst%3DJ.%2BR.%26aulast%3DGreen%26aufirst%3DM.%26aulast%3DGarnsey%26aufirst%3DM.%26aulast%3DGrimwood%26aufirst%3DS.%26aulast%3DHarris%26aufirst%3DA.%2BR.%26aulast%3DKauffman%26aufirst%3DG.%2BW.%26aulast%3DLaChapelle%26aufirst%3DE.%26aulast%3DLazzaro%26aufirst%3DJ.%2BT.%26aulast%3DLee%26aufirst%3DC.%2BW.%26aulast%3DLotarski%26aufirst%3DS.%2BM.%26aulast%3DNason%26aufirst%3DD.%2BM.%26aulast%3DObach%26aufirst%3DR.%2BS.%26aulast%3DReinhart%26aufirst%3DV.%26aulast%3DSalomon-Ferrer%26aufirst%3DR.%26aulast%3DSteyn%26aufirst%3DS.%2BJ.%26aulast%3DWebb%26aufirst%3DD.%26aulast%3DYan%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DL.%26atitle%3DDesign%2520and%2520optimization%2520of%2520selective%2520azaindole%2520amide%2520M1%2520positive%2520allosteric%2520modulators%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D26%26spage%3D650%26epage%3D655%26doi%3D10.1016%2Fj.bmcl.2015.11.053" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit14aa"><span><span class="NLM_label">(aa) </span><span class="NLM_contrib-group">Mistry, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lim, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jorg, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Capuano, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christopoulos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lane, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scammells, P. J.</span><span> </span><span class="NLM_article-title">Novel Fused Arylpyrimidinone Based Allosteric Modulators of the M Muscarinic Acetylcholine Receptor</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">647</span><span class="NLM_x">–</span> <span class="NLM_lpage">661</span><span class="refDoi"> DOI: 10.1021/acschemneuro.6b00018</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschemneuro.6b00018" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14aa&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=1%3ACAS%3A528%3ADC%252BC28XislaitL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=647-661&author=S.+N.+Mistryauthor=H.+Limauthor=M.+Jorgauthor=B.+Capuanoauthor=A.+Christopoulosauthor=J.+R.+Laneauthor=P.+J.+Scammells&title=Novel+Fused+Arylpyrimidinone+Based+Allosteric+Modulators+of+the+M+Muscarinic+Acetylcholine+Receptor&doi=10.1021%2Facschemneuro.6b00018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14aaR"><div class="casContent"><span class="casTitleNuber">14aa</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Fused Arylpyrimidinone Based Allosteric Modulators of the M1 Muscarinic Acetylcholine Receptor</span></div><div class="casAuthors">Mistry, Shailesh N.; Lim, Herman; Jorg, Manuela; Capuano, Ben; Christopoulos, Arthur; Lane, J. Robert; Scammells, Peter J.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">647-661</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Benzoquinazolinone 1 is a pos. allosteric modulator (PAM) of the M1 muscarinic acetylcholine receptor (mAChR), which is significantly more potent than the prototypical PAM, 1-(4-methoxybenzyl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid (BQCA).  In this study, we explored the structural determinants that underlie the activity of 1 as a PAM of the M1 mAChR.  We paid particular attention to the importance of the tricyclic scaffold of compd. 1, for the activity of the mol.  Complete deletion of the peripheral fused benzene ring caused a significant decrease in affinity and binding cooperativity with acetylcholine (ACh).  This loss of affinity was rescued with the addn. of either one or two Me groups in the 7- and/or 8-position of the quinazolin-4(3H)-one core.  These results demonstrate that the tricyclic benzo[h]quinazolin-4(3H)-one core could be replaced with a quinazolin-4(3H)-one core and maintain functional affinity.  As such, the quinazolin-4(3H)-one core represents a novel scaffold to further explore M1 mAChR PAMs with improved physicochem. properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpah7jlrVCf2rVg90H21EOLACvtfcHk0lj1nvLt6CzHWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XislaitL4%253D&md5=6e2271cd08c284eac5cdb0a553dd7839</span></div><a href="/servlet/linkout?suffix=cit14aa&amp;dbid=16384&amp;doi=10.1021%2Facschemneuro.6b00018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschemneuro.6b00018%26sid%3Dliteratum%253Aachs%26aulast%3DMistry%26aufirst%3DS.%2BN.%26aulast%3DLim%26aufirst%3DH.%26aulast%3DJorg%26aufirst%3DM.%26aulast%3DCapuano%26aufirst%3DB.%26aulast%3DChristopoulos%26aufirst%3DA.%26aulast%3DLane%26aufirst%3DJ.%2BR.%26aulast%3DScammells%26aufirst%3DP.%2BJ.%26atitle%3DNovel%2520Fused%2520Arylpyrimidinone%2520Based%2520Allosteric%2520Modulators%2520of%2520the%2520M%2520Muscarinic%2520Acetylcholine%2520Receptor%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2016%26volume%3D7%26spage%3D647%26epage%3D661%26doi%3D10.1021%2Facschemneuro.6b00018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Brodney, M. A.; Davoren, J. E.; Garnsey, M. R.; Zhang, L.; O’Neil, S. V.</span><span> </span><span class="NLM_article-title">Pyridine derivatives as muscarinic m1 receptor positive allosteric modulators</span>. WO 2016009297, July 2,<span class="NLM_x"> </span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=M.+A.+Brodney&author=J.+E.+Davoren&author=M.+R.+Garnsey&author=L.+Zhang&author=S.+V.+O%E2%80%99Neil&title=Pyridine+derivatives+as+muscarinic+m1+receptor+positive+allosteric+modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBrodney%26aufirst%3DM.%2BA.%26atitle%3DPyridine%2520derivatives%2520as%2520muscarinic%2520m1%2520receptor%2520positive%2520allosteric%2520modulators%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Wager, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hou, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verhoest, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villalobos, A.</span><span> </span><span class="NLM_article-title">Moving beyond rules: the development of a central nervous system multiparameter optimization (CNS MPO) approach to enable alignment of druglike properties</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">435</span><span class="NLM_x">–</span> <span class="NLM_lpage">449</span><span class="refDoi"> DOI: 10.1021/cn100008c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cn100008c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjvVejtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=435-449&author=T.+T.+Wagerauthor=X.+Houauthor=P.+R.+Verhoestauthor=A.+Villalobos&title=Moving+beyond+rules%3A+the+development+of+a+central+nervous+system+multiparameter+optimization+%28CNS+MPO%29+approach+to+enable+alignment+of+druglike+properties&doi=10.1021%2Fcn100008c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Moving beyond Rules: The Development of a Central Nervous System Multiparameter Optimization (CNS MPO) Approach To Enable Alignment of Druglike Properties</span></div><div class="casAuthors">Wager, Travis T.; Hou, Xinjun; Verhoest, Patrick R.; Villalobos, Anabella</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">435-449</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The interplay among commonly used physicochem. properties in drug design was examd. and utilized to create a prospective design tool focused on the alignment of key druglike attributes.  Using a set of six physicochem. parameters ((a) lipophilicity, calcd. partition coeff. (ClogP); (b) calcd. distribution coeff. at pH = 7.4 (ClogD); (c) mol. wt. (MW); (d) topol. polar surface area (TPSA); (e) no. of hydrogen bond donors (HBD); (f) most basic center (pKa)), a druglikeness central nervous system multiparameter optimization (CNS MPO) algorithm was built and applied to a set of marketed CNS drugs (N = 119) and Pfizer CNS candidates (N = 108), as well as to a large diversity set of Pfizer proprietary compds. (N = 11 303).  The novel CNS MPO algorithm showed that 74% of marketed CNS drugs displayed a high CNS MPO score (MPO desirability score ≥ 4, using a scale of 0-6), in comparison to 60% of the Pfizer CNS candidates.  This anal. suggests that this algorithm could potentially be used to identify compds. with a higher probability of successfully testing hypotheses in the clinic.  In addn., a relationship between an increasing CNS MPO score and alignment of key in vitro attributes of drug discovery (favorable permeability, P-glycoprotein (P-gp) efflux, metabolic stability, and safety) was seen in the marketed CNS drug set, the Pfizer candidate set, and the Pfizer proprietary diversity set.  The CNS MPO scoring function offers advantages over hard cutoffs or utilization of single parameters to optimize structure-activity relationships (SAR) by expanding medicinal chem. design space through a holistic assessment approach.  Based on six physicochem. properties commonly used by medicinal chemists, the CNS MPO function may be used prospectively at the design stage to accelerate the identification of compds. with increased probability of success.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqB3Mvkgm_X5bVg90H21EOLACvtfcHk0lj1nvLt6CzHWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjvVejtr8%253D&md5=e94998f65a420be6ee4dec4a987cb983</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fcn100008c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn100008c%26sid%3Dliteratum%253Aachs%26aulast%3DWager%26aufirst%3DT.%2BT.%26aulast%3DHou%26aufirst%3DX.%26aulast%3DVerhoest%26aufirst%3DP.%2BR.%26aulast%3DVillalobos%26aufirst%3DA.%26atitle%3DMoving%2520beyond%2520rules%253A%2520the%2520development%2520of%2520a%2520central%2520nervous%2520system%2520multiparameter%2520optimization%2520%2528CNS%2520MPO%2529%2520approach%2520to%2520enable%2520alignment%2520of%2520druglike%2520properties%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2010%26volume%3D1%26spage%3D435%26epage%3D449%26doi%3D10.1021%2Fcn100008c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grillo, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burke, M. D.</span><span> </span><span class="NLM_article-title">From synthesis to function via iterative assembly of N-methyliminodiacetic acid boronate building blocks</span> <span class="citation_source-journal">Acc. Chem. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">2297</span><span class="NLM_x">–</span> <span class="NLM_lpage">2307</span><span class="refDoi"> DOI: 10.1021/acs.accounts.5b00128</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.accounts.5b00128" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht1SrsLrE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2015&pages=2297-2307&author=J.+Liauthor=A.+S.+Grilloauthor=M.+D.+Burke&title=From+synthesis+to+function+via+iterative+assembly+of+N-methyliminodiacetic+acid+boronate+building+blocks&doi=10.1021%2Facs.accounts.5b00128"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17aR"><div class="casContent"><span class="casTitleNuber">17a</span><div class="casTitle"><span class="NLM_cas:atitle">From Synthesis to Function via Iterative Assembly of N-Methyliminodiacetic Acid Boronate Building Blocks</span></div><div class="casAuthors">Li, Junqi; Grillo, Anthony S.; Burke, Martin D.</div><div class="citationInfo"><span class="NLM_cas:title">Accounts of Chemical Research</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2297-2307</span>CODEN:
                <span class="NLM_cas:coden">ACHRE4</span>;
        ISSN:<span class="NLM_cas:issn">0001-4842</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The study and optimization of small mol. function is often impeded by the time-intensive and specialist-dependent process that is typically used to make such compds.  In contrast, general and automated platforms have been developed for making peptides, oligonucleotides, and increasingly oligosaccharides, where synthesis is simplified to iterative applications of the same reactions.  Inspired by the way natural products are biosynthesized via the iterative assembly of a defined set of building blocks, we developed a platform for small mol. synthesis involving the iterative coupling of haloboronic acids protected as the corresponding N-methyliminodiacetic acid (MIDA) boronates.  Here we summarize our efforts thus far to develop this platform into a generalized and automated approach for small mol. synthesis.  We and others have employed this approach to access many polyene-based compds., including the polyene motifs found in >75% of all polyene natural products.  This platform further allowed us to derivatize amphotericin B, the powerful and resistance-evasive but also highly toxic last line of defense in treating systemic fungal infections, and thereby understand its mechanism of action.  This synthesis-enabled mechanistic understanding has led us to develop less toxic derivs. currently under evaluation as improved antifungal agents.  To access more Csp3-contg. small mols., we gained a stereocontrolled entry into chiral, non-racemic α-boryl aldehydes through the discovery of a chiral deriv. of MIDA.  These α-boryl aldehydes are versatile intermediates for the synthesis of many Csp3 boronate building blocks that are otherwise difficult to access.  In addn., we demonstrated the utility of these types of building blocks in accessing pharmaceutically relevant targets via an iterative Csp3 cross-coupling cycle.  We have further expanded the scope of the platform to include stereochem. complex macrocyclic and polycyclic mols. using a linear-to-cyclized strategy, in which Csp3 boronate building blocks are iteratively assembled into linear precursors that are then cyclized into the cyclic frameworks found in many natural products and natural product-like structures.  Enabled by the serendipitous discovery of a catch-and-release protocol for generally purifying MIDA boronate intermediates, the platform has been automated.  The synthesis of 14 distinct classes of small mols., including pharmaceuticals, materials components, and polycyclic natural products, has been achieved using this new synthesis machine.  It is anticipated that the scope of small mols. accessible by this platform will continue to expand via further developments in building block synthesis, Csp3 cross-coupling methodologies, and cyclization strategies.  Achieving these goals will enable the more generalized synthesis of small mols. and thereby help shift the rate-limiting step in small mol. science from synthesis to function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8wb3eT2AJ_rVg90H21EOLACvtfcHk0lj1nvLt6CzHWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht1SrsLrE&md5=60e27155883bd0128616013ade63cd2b</span></div><a href="/servlet/linkout?suffix=cit17a&amp;dbid=16384&amp;doi=10.1021%2Facs.accounts.5b00128&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.accounts.5b00128%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DGrillo%26aufirst%3DA.%2BS.%26aulast%3DBurke%26aufirst%3DM.%2BD.%26atitle%3DFrom%2520synthesis%2520to%2520function%2520via%2520iterative%2520assembly%2520of%2520N-methyliminodiacetic%2520acid%2520boronate%2520building%2520blocks%26jtitle%3DAcc.%2520Chem.%2520Res.%26date%3D2015%26volume%3D48%26spage%3D2297%26epage%3D2307%26doi%3D10.1021%2Facs.accounts.5b00128" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit17b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Gillis, E. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burke, M. D.</span><span> </span><span class="NLM_article-title">Iterative Cross-Couplng with MIDA Boronates: Towards a General Platform for Small Molecule Synthesis</span> <span class="citation_source-journal">Aldrichim. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">17</span><span class="NLM_x">–</span> <span class="NLM_lpage">27</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=22523433" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=1%3ACAS%3A528%3ADC%252BD1MXpslOkurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2009&pages=17-27&author=E.+P.+Gillisauthor=M.+D.+Burke&title=Iterative+Cross-Couplng+with+MIDA+Boronates%3A+Towards+a+General+Platform+for+Small+Molecule+Synthesis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17bR"><div class="casContent"><span class="casTitleNuber">17b</span><div class="casTitle"><span class="NLM_cas:atitle">Iterative cross-coupling with MIDA boronates: towards a general-strategy for small-molecule synthesis</span></div><div class="casAuthors">Gillis, Eric P.; Burke, Martin D.</div><div class="citationInfo"><span class="NLM_cas:title">Aldrichimica Acta</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">17-27</span>CODEN:
                <span class="NLM_cas:coden">ALACBI</span>;
        ISSN:<span class="NLM_cas:issn">0002-5100</span>.
    
            (<span class="NLM_cas:orgname">Aldrich Chemical Co.</span>)
        </div><div class="casAbstract">A review outlines the targeted development of building blocks representing substructures that appear frequently in natural products and the chem. that will enable their precise union via metal-mediated cross-coupling reactions.  N-methyliminodiacetic acid (MIDI) boronates represent a highly promising platform for this iterative cross coupling approach wherein all the required functional groups preinstalled in the correct oxidn. state and with the desired stereochem. relationships are iteratively united using only stereospecific cross-coupling reactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-q8DWdrHxmrVg90H21EOLACvtfcHk0lhZaBlpZ1kNSQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXpslOkurc%253D&md5=a20a93b406ff44ee15d7fc52d97aa50a</span></div><a href="/servlet/linkout?suffix=cit17b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGillis%26aufirst%3DE.%2BP.%26aulast%3DBurke%26aufirst%3DM.%2BD.%26atitle%3DIterative%2520Cross-Couplng%2520with%2520MIDA%2520Boronates%253A%2520Towards%2520a%2520General%2520Platform%2520for%2520Small%2520Molecule%2520Synthesis%26jtitle%3DAldrichim.%2520Acta%26date%3D2009%26volume%3D42%26spage%3D17%26epage%3D27" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="note"><p class="first last">Water network was modeled by a 20 ns molecular dynamics simulation using Desmond in Maestro 2015-3 with an OPLS3 force field.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span>The exemplified THP ring has been highlighted in multiple Merck patents. For a recent relevant example see the following: <span class="NLM_contrib-group">Kuduk, S. D.; Gilbert, K. F.</span><span> </span><span class="NLM_article-title">Tetrahydroquinoline amide m1 receptor positive allosteric modulators</span>. WO 2011159554,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=S.+D.+Kuduk&author=K.+F.+Gilbert&title=Tetrahydroquinoline+amide+m1+receptor+positive+allosteric+modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DKuduk%26aufirst%3DS.%2BD.%26atitle%3DTetrahydroquinoline%2520amide%2520m1%2520receptor%2520positive%2520allosteric%2520modulators%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="note"><p class="first last">Though the homology model does not explain the steep SAR observed on the amide bond, it is worth noting that in certain molecular dynamics simulations we did observe a through water hydrogen bond between the THP-OH group and Ser412.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Ryckmans, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horne, V. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Correia, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Owen, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tutt, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, T.</span><span> </span><span class="NLM_article-title">Rapid assessment of a novel series of selective CB(2) agonists using parallel synthesis protocols: A Lipophilic Efficiency (LipE) analysis</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">4406</span><span class="NLM_x">–</span> <span class="NLM_lpage">4409</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2009.05.062</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=10.1016%2Fj.bmcl.2009.05.062" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=19500981" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=1%3ACAS%3A528%3ADC%252BD1MXosVGlsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=4406-4409&author=T.+Ryckmansauthor=M.+P.+Edwardsauthor=V.+A.+Horneauthor=A.+M.+Correiaauthor=D.+R.+Owenauthor=L.+R.+Thompsonauthor=I.+Tranauthor=M.+F.+Tuttauthor=T.+Young&title=Rapid+assessment+of+a+novel+series+of+selective+CB%282%29+agonists+using+parallel+synthesis+protocols%3A+A+Lipophilic+Efficiency+%28LipE%29+analysis&doi=10.1016%2Fj.bmcl.2009.05.062"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Rapid assessment of a novel series of selective CB2 agonists using parallel synthesis protocols: A Lipophilic Efficiency (LipE) analysis</span></div><div class="casAuthors">Ryckmans, Thomas; Edwards, Martin P.; Horne, Val A.; Correia, Ana Monica; Owen, Dafydd R.; Thompson, Lisa R.; Tran, Isabelle; Tutt, Michelle F.; Young, Tim</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">4406-4409</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A series of libraries were designed using the 1-(cyclopropylmethyl)-2-alkyl-4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridin-5-ium templates 2a-b, and Sulfonamide derivs. 11a-n proved to be potent agonists of the CB2 receptor.  Anal. of the Lipophilic Efficiency (LipE) of potent compds. provided new insight for the design of potent, metabolically stable CB2 agonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1cihq9YHuO7Vg90H21EOLACvtfcHk0lhZaBlpZ1kNSQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXosVGlsrg%253D&md5=b62d97e5f52a594cfdd510f32d2e566f</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.05.062&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.05.062%26sid%3Dliteratum%253Aachs%26aulast%3DRyckmans%26aufirst%3DT.%26aulast%3DEdwards%26aufirst%3DM.%2BP.%26aulast%3DHorne%26aufirst%3DV.%2BA.%26aulast%3DCorreia%26aufirst%3DA.%2BM.%26aulast%3DOwen%26aufirst%3DD.%2BR.%26aulast%3DThompson%26aufirst%3DL.%2BR.%26aulast%3DTran%26aufirst%3DI.%26aulast%3DTutt%26aufirst%3DM.%2BF.%26aulast%3DYoung%26aufirst%3DT.%26atitle%3DRapid%2520assessment%2520of%2520a%2520novel%2520series%2520of%2520selective%2520CB%25282%2529%2520agonists%2520using%2520parallel%2520synthesis%2520protocols%253A%2520A%2520Lipophilic%2520Efficiency%2520%2528LipE%2529%2520analysis%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D4406%26epage%3D4409%26doi%3D10.1016%2Fj.bmcl.2009.05.062" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Feng, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mills, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davidson, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mireles, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janiszewski, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Troutman, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Morais, S. M.</span><span> </span><span class="NLM_article-title">In vitro P-glycoprotein assays to predict the in vivo interactions of P-glycoprotein with drugs in the central nervous system</span> <span class="citation_source-journal">Drug. Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">268</span><span class="NLM_x">–</span> <span class="NLM_lpage">275</span><span class="refDoi"> DOI: 10.1124/dmd.107.017434</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=10.1124%2Fdmd.107.017434" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=17962372" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1yktbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2008&pages=268-275&author=B.+Fengauthor=J.+B.+Millsauthor=R.+E.+Davidsonauthor=R.+J.+Mirelesauthor=J.+S.+Janiszewskiauthor=M.+D.+Troutmanauthor=S.+M.+de+Morais&title=In+vitro+P-glycoprotein+assays+to+predict+the+in+vivo+interactions+of+P-glycoprotein+with+drugs+in+the+central+nervous+system&doi=10.1124%2Fdmd.107.017434"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro P-glycoprotein assays to predict the in vivo interactions of P-glycoprotein with drugs in the central nervous system</span></div><div class="casAuthors">Feng, Bo; Mills, Jessica B.; Davidson, Ralph E.; Mireles, Rouchelle J.; Janiszewski, John S.; Troutman, Matthew D.; de Morais, Sonia M.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">268-275</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Thirty-one structurally diverse marketed central nervous system (CNS)-active drugs, one active metabolite, and seven non-CNS-active compds. were tested in three P-glycoprotein (P-gp) in vitro assays: transwell assays using MDCK, human MDR1-MDCK, and mouse Mdr1a-MDCK cells, ATPase, and calcein AM inhibition.  Addnl., the permeability for these compds. was measured in two in vitro models: parallel artificial membrane permeation assay and apical-to-basolateral apparent permeability in MDCK.  The exposure of the same set of compds. in brain and plasma was measured in P-gp knockout (KO) and wild-type (WT) mice after s.c. administration.  One drug and its metabolite, risperidone and 9-hydroxyrisperidone, of the 32 CNS compds., and 6 of the 7 non-CNS drugs were detd. to have pos. efflux using ratio of ratios in MDR1-MDCK vs. MDCK transwell assays.  Data from transwell studies correlated well with the brain-to-plasma area under the curve ratios between P-gp KO and WT mice for the 32 CNS compds.  In addn., 3300 Pfizer compds. were tested in MDR1-MDCK and Mdr1a-MDCK transwell assays, with a good correlation (R2 = 0.92) between the efflux ratios in human MDR1-MDCK and mouse Mdr1a-MDCK cells.  Permeability data showed that the majority of the 32 CNS compds. have moderate to high passive permeability.  This work has demonstrated that in vitro transporter assays help in understanding the role of P-gp-mediated efflux activity in detg. the disposition of CNS drugs in vivo, and the transwell assay is a valuable in vitro assay to evaluate human P-gp interaction with compds. for assessing brain penetration of new chem. entities to treat CNS disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsQyRSOySyGLVg90H21EOLACvtfcHk0lhZaBlpZ1kNSQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1yktbc%253D&md5=bbf8b6969bd6d6b3d741b6ef9e7853f3</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1124%2Fdmd.107.017434&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.107.017434%26sid%3Dliteratum%253Aachs%26aulast%3DFeng%26aufirst%3DB.%26aulast%3DMills%26aufirst%3DJ.%2BB.%26aulast%3DDavidson%26aufirst%3DR.%2BE.%26aulast%3DMireles%26aufirst%3DR.%2BJ.%26aulast%3DJaniszewski%26aufirst%3DJ.%2BS.%26aulast%3DTroutman%26aufirst%3DM.%2BD.%26aulast%3Dde%2BMorais%26aufirst%3DS.%2BM.%26atitle%3DIn%2520vitro%2520P-glycoprotein%2520assays%2520to%2520predict%2520the%2520in%2520vivo%2520interactions%2520of%2520P-glycoprotein%2520with%2520drugs%2520in%2520the%2520central%2520nervous%2520system%26jtitle%3DDrug.%2520Metab.%2520Dispos.%26date%3D2008%26volume%3D36%26spage%3D268%26epage%3D275%26doi%3D10.1124%2Fdmd.107.017434" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Reichel, A.</span><span> </span><span class="NLM_article-title">The role of blood-brain barrier studies in the pharmaceutical industry</span> <span class="citation_source-journal">Curr. Drug Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">183</span><span class="NLM_x">–</span> <span class="NLM_lpage">203</span><span class="refDoi"> DOI: 10.2174/138920006775541525</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=10.2174%2F138920006775541525" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=16472107" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1Oms7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2006&pages=183-203&author=A.+Reichel&title=The+role+of+blood-brain+barrier+studies+in+the+pharmaceutical+industry&doi=10.2174%2F138920006775541525"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">The role of blood-brain barrier studies in the pharmaceutical industry</span></div><div class="casAuthors">Reichel, Andreas</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Metabolism</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">183-203</span>CODEN:
                <span class="NLM_cas:coden">CDMUBU</span>;
        ISSN:<span class="NLM_cas:issn">1389-2002</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The blood-brain barrier (BBB) remains one of the greatest challenges for the discovery and development of treatments for CNS disorders, which to this day remains one of the most risky disease areas in terms of clin. success rates.  Although the BBB is currently seen predominantly as a permeability obstacle for CNS drug delivery, it is becoming increasingly clear that the BBB has many more implications for the pharmaceutical industry impacting on CNS pharmacol. and pathol., CNS pharmacokinetics and pharmacodynamics, and adverse CNS effects, to name but a few areas.  The present review does not intend to summarize the activities in the field of BBB research per se, which was accomplished by a no. of excellent recent reviews, but instead to provide an overview of the role of BBB studies from a pharmaceutical industry perspective.  This review will elaborate on the specific needs in terms of BBB-related issues across the different drug discovery and development phases, i.e. target identification and validation, lead generation and optimization, candidate selection and profiling, preclin. development and clin. studies.  The specific approaches taken will be discussed in terms of specific requirements, questions to be asked, feasibility, interpretability, and impact.  It becomes clear that few of the existing BBB models fully meet the requirements of the industrialized drug discovery process, highlighting the need for an array of new or modified tools and approaches that are more effective in helping make decisions which are more specifically tailored to the various stages of the lengthy process from target to the clinic.  In looking at the numerous ongoing activities in the area of BBB research from the drug discovery and development point of view, an attempt was made to place a stronger emphasis on the applicability of particular techniques and approaches, to identify gaps and areas for future activities.  In order to materialize the considerable knowledge gained in recent years, the review is intended to foster an increased awareness of the need to better integrate basic academic research with the specific requirements of the pharmaceutical industry for the search of effective and safe new CNS medicines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWYQEy2IuSnrVg90H21EOLACvtfcHk0lgcJryN_caq3A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1Oms7o%253D&md5=aa9c03f9ea46b2dd74d7b517865dbdea</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.2174%2F138920006775541525&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138920006775541525%26sid%3Dliteratum%253Aachs%26aulast%3DReichel%26aufirst%3DA.%26atitle%3DThe%2520role%2520of%2520blood-brain%2520barrier%2520studies%2520in%2520the%2520pharmaceutical%2520industry%26jtitle%3DCurr.%2520Drug%2520Metab.%26date%3D2006%26volume%3D7%26spage%3D183%26epage%3D203%26doi%3D10.2174%2F138920006775541525" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Lombardo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shalaeva, M. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tupper, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, F.</span><span> </span><span class="NLM_article-title">ElogD(oct): a tool for lipophilicity determination in drug discovery. 2. Basic and neutral compounds</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">2490</span><span class="NLM_x">–</span> <span class="NLM_lpage">2497</span><span class="refDoi"> DOI: 10.1021/jm0100990</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0100990" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=1%3ACAS%3A528%3ADC%252BD3MXksFOmtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2001&pages=2490-2497&author=F.+Lombardoauthor=M.+Y.+Shalaevaauthor=K.+A.+Tupperauthor=F.+Gao&title=ElogD%28oct%29%3A+a+tool+for+lipophilicity+determination+in+drug+discovery.+2.+Basic+and+neutral+compounds&doi=10.1021%2Fjm0100990"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">ElogDoct: A Tool for Lipophilicity Determination in Drug Discovery. 2. Basic and Neutral Compounds</span></div><div class="casAuthors">Lombardo, Franco; Shalaeva, Marina Y.; Tupper, Karl A.; Gao, Feng</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">2490-2497</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We present an RP-HPLC method for the detn. of the octanol-water distribution coeffs. at pH 7.4, as log Doct7.4 values, for neutral and basic drugs, which combines ease of operation with high accuracy.  The method is shown to work for a training set of 90 mols. comprised largely of drugs, and it was also applied to a test set of 10 proprietary compds.  This work expands the applicability of the method presented in our earlier report, for the detn. of logPoct for neutral compds. (J. Med. Chem. 2000, 43, 2922-2928), and it offers the same general features but widens the scope.  Generally, the method (i) is compd. sparing (≤1 mL of a 50-100 μg/mL soln. needed), (ii) is insensitive to concn. and phase ratio effects obsd. in some shake-flask detns., (iii) is amenable to rapid detns. (≤20 min on av.), (iv) is insensitive to impurities, (v) possesses a wide lipophilicity range (>7 log Doct7.4 units), and (vi) offers a good accuracy, (vii) an excellent reproducibility, (viii) and an excellent potential for automation.  To the best of our knowledge, a similar performance, on a set of noncongeneric drugs, has not been previously reported.  We refer to the value generated via this method as ElogDoct.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrynjvQ2-0sibVg90H21EOLACvtfcHk0lgcJryN_caq3A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXksFOmtbc%253D&md5=e390cfeacbb1cab5660909eccfeb7eb2</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fjm0100990&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0100990%26sid%3Dliteratum%253Aachs%26aulast%3DLombardo%26aufirst%3DF.%26aulast%3DShalaeva%26aufirst%3DM.%2BY.%26aulast%3DTupper%26aufirst%3DK.%2BA.%26aulast%3DGao%26aufirst%3DF.%26atitle%3DElogD%2528oct%2529%253A%2520a%2520tool%2520for%2520lipophilicity%2520determination%2520in%2520drug%2520discovery.%25202.%2520Basic%2520and%2520neutral%2520compounds%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2001%26volume%3D44%26spage%3D2490%26epage%3D2497%26doi%3D10.1021%2Fjm0100990" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Di, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whitney-Pickett, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Umland, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gebhard, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Federico, J. J.,  3rd</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davidson, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reyner, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rotter, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varma, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kempshall, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fenner, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">El-Kattan, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liston, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Troutman, M. D.</span><span> </span><span class="NLM_article-title">Development of a new permeability assay using low-efflux MDCKII cells</span> <span class="citation_source-journal">J. Pharm. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">100</span><span class="NLM_x">, </span> <span class="NLM_fpage">4974</span><span class="NLM_x">–</span> <span class="NLM_lpage">4985</span><span class="refDoi"> DOI: 10.1002/jps.22674</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=10.1002%2Fjps.22674" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=21766308" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=1%3ACAS%3A528%3ADC%252BC3MXovFGltb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2011&pages=4974-4985&author=L.+Diauthor=C.+Whitney-Pickettauthor=J.+P.+Umlandauthor=H.+Zhangauthor=X.+Zhangauthor=D.+F.+Gebhardauthor=Y.+Laiauthor=J.+J.+Federicoauthor=R.+E.+Davidsonauthor=R.+Smithauthor=E.+L.+Reynerauthor=C.+Leeauthor=B.+Fengauthor=C.+Rotterauthor=M.+V.+Varmaauthor=S.+Kempshallauthor=K.+Fennerauthor=A.+F.+El-Kattanauthor=T.+E.+Listonauthor=M.+D.+Troutman&title=Development+of+a+new+permeability+assay+using+low-efflux+MDCKII+cells&doi=10.1002%2Fjps.22674"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Development of a new permeability assay using low-efflux MDCKII cells</span></div><div class="casAuthors">Di, Li; Whitney-Pickett, Carrie; Umland, John P.; Zhang, Hui; Zhang, Xun; Gebhard, David F.; Lai, Yurong; Federico, James J.; Davidson, Ralph E.; Smith, Russ; Reyner, Eric L.; Lee, Caroline; Feng, Bo; Rotter, Charles; Varma, Manthena V.; Kempshall, Sarah; Fenner, Katherine; El-kattan, Ayman F.; Liston, Theodore E.; Troutman, Matthew D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">100</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4974-4985</span>CODEN:
                <span class="NLM_cas:coden">JPMSAE</span>;
        ISSN:<span class="NLM_cas:issn">0022-3549</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Permeability is an important property of drug candidates.  The Madin-Darby canine kidney cell line (MDCK) permeability assay is widely used and the primary concern of using MDCK cells is the presence of endogenous transporters of nonhuman origin.  The canine P-glycoprotein (Pgp) can interfere with permeability and transporter studies, leading to less reliable data.  A new cell line, MDCKII-LE (low efflux), has been developed by selecting a subpopulation of low-efflux cells from MDCKII-WT using an iterative fluorescence-activated cell sorting technique with calcein-AM as a Pgp and efflux substrate.  MDCKII-LE cells are a subpopulation of MDCKII cells with over 200-fold lower canine Pgp mRNA level and fivefold lower protein level than MDCKII-WT.  MDCKII-LE cells showed less functional efflux activity than MDCKII-WT based on efflux ratios.  Notably, MDCKII-MDR1 showed about 1.5-fold decreased expression of endogenous canine Pgp, suggesting that using the net flux ratio might not completely cancel out the background endogenous transporter activities.  MDCKII-LE cells offer clear advantages over the MDCKII-WT by providing less efflux transporter background signals and minimizing interference from canine Pgp.  The MDCKII-LE apparent permeability values well differentiates compds. from high to medium/low human intestinal absorption and can be used for Biopharmaceutical Classification System.  The MDCKII-LE permeability assay (4-in-1 cassette dosing) is high throughput with good precision, reproducibility, robustness, and cost-effective. © 2011 Wiley-Liss, Inc. and the American Pharmacists Assocn. J Pharm Sci.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTVtRmYnbF17Vg90H21EOLACvtfcHk0lgcJryN_caq3A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXovFGltb8%253D&md5=97f647fc215ea6d04882351ffc912a1e</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1002%2Fjps.22674&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjps.22674%26sid%3Dliteratum%253Aachs%26aulast%3DDi%26aufirst%3DL.%26aulast%3DWhitney-Pickett%26aufirst%3DC.%26aulast%3DUmland%26aufirst%3DJ.%2BP.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DGebhard%26aufirst%3DD.%2BF.%26aulast%3DLai%26aufirst%3DY.%26aulast%3DFederico%26aufirst%3DJ.%2BJ.%26aulast%3DDavidson%26aufirst%3DR.%2BE.%26aulast%3DSmith%26aufirst%3DR.%26aulast%3DReyner%26aufirst%3DE.%2BL.%26aulast%3DLee%26aufirst%3DC.%26aulast%3DFeng%26aufirst%3DB.%26aulast%3DRotter%26aufirst%3DC.%26aulast%3DVarma%26aufirst%3DM.%2BV.%26aulast%3DKempshall%26aufirst%3DS.%26aulast%3DFenner%26aufirst%3DK.%26aulast%3DEl-Kattan%26aufirst%3DA.%2BF.%26aulast%3DListon%26aufirst%3DT.%2BE.%26aulast%3DTroutman%26aufirst%3DM.%2BD.%26atitle%3DDevelopment%2520of%2520a%2520new%2520permeability%2520assay%2520using%2520low-efflux%2520MDCKII%2520cells%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D2011%26volume%3D100%26spage%3D4974%26epage%3D4985%26doi%3D10.1002%2Fjps.22674" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Johnson, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dress, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, M.</span><span> </span><span class="NLM_article-title">Using the Golden Triangle to optimize clearance and oral absorption</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">5560</span><span class="NLM_x">–</span> <span class="NLM_lpage">5564</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2009.08.045</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=10.1016%2Fj.bmcl.2009.08.045" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=19720530" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFaktbfE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=5560-5564&author=T.+W.+Johnsonauthor=K.+R.+Dressauthor=M.+Edwards&title=Using+the+Golden+Triangle+to+optimize+clearance+and+oral+absorption&doi=10.1016%2Fj.bmcl.2009.08.045"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Using the Golden Triangle to optimize clearance and oral absorption</span></div><div class="casAuthors">Johnson, Ted W.; Dress, Klaus R.; Edwards, Martin</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">5560-5564</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The Golden Triangle is a visualization tool developed from in vitro permeability, in vitro clearance and computational data designed to aid medicinal chemists in achieving metabolically stable, permeable and potent drug candidates.  Classifying compds. as permeable and stable and plotting mol. wt. (MW) vs. octanol:buffer (pH 7.4) distribution coeffs. (log D) or estd. octanol:buffer (pH 7.4) distribution coeffs. (elog D) reveals useful trends.  Anal. of at least 2 orthogonal trends, such as permeability and clearance, can be extremely effective in balancing and optimizing multiple properties.  In addn., mol. wt. and log D impact potency-efficiency calcns., allowing potency, clearance and permeability to be optimized simultaneously.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqjGjEaOp0237Vg90H21EOLACvtfcHk0lhJfuEIYyDKLw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFaktbfE&md5=3cfed1288ec451eb4419f1db753ae4b4</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.08.045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.08.045%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DT.%2BW.%26aulast%3DDress%26aufirst%3DK.%2BR.%26aulast%3DEdwards%26aufirst%3DM.%26atitle%3DUsing%2520the%2520Golden%2520Triangle%2520to%2520optimize%2520clearance%2520and%2520oral%2520absorption%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D5560%26epage%3D5564%26doi%3D10.1016%2Fj.bmcl.2009.08.045" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span>Independent to our own research efforts Takeda published a patent on a set of compounds containing a similarly substituted pyridine ring. See the following: <span class="NLM_contrib-group">Ogino, M.; Kimura, E.; Suzuki, S.; Ashizawa, T.; Imaeda, T.; Fujimori, I.; Arai, R.</span><span> </span><span class="NLM_article-title">Nitrogen-containing heterocyclic compound</span>. WO2015190564,<span class="NLM_x"> </span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=M.+Ogino&author=E.+Kimura&author=S.+Suzuki&author=T.+Ashizawa&author=T.+Imaeda&author=I.+Fujimori&author=R.+Arai&title=Nitrogen-containing+heterocyclic+compound"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DOgino%26aufirst%3DM.%26atitle%3DNitrogen-containing%2520heterocyclic%2520compound%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Johnson, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richardson, P. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bailey, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brooun, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burke, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collins, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cui, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deal, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deng, Y. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dinh, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Engstrom, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffman, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kania, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kath, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lam, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lam, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lingardo, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McTigue, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palmer, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sach, N. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smeal, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stewart, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Timofeevski, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zou, H. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, M. P.</span><span> </span><span class="NLM_article-title">Discovery of (10R)-7-amino-12-fluoro-2,10,16-trimethyl-15-oxo-10,15,16,17-tetrahydro-2H-8,4-(metheno)pyrazolo[4,3-h][2,5,11]-benzoxadiazacyclotetradecine-3-carbonitrile (PF-06463922), a macrocyclic inhibitor of anaplastic lymphoma kinase (ALK) and c-ros oncogene 1 (ROS1) with preclinical brain exposure and broad-spectrum potency against ALK-resistant mutations</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">4720</span><span class="NLM_x">–</span> <span class="NLM_lpage">4744</span><span class="refDoi"> DOI: 10.1021/jm500261q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm500261q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=1%3ACAS%3A528%3ADC%252BC2cXnvVSgtL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=4720-4744&author=T.+W.+Johnsonauthor=P.+F.+Richardsonauthor=S.+Baileyauthor=A.+Broounauthor=B.+J.+Burkeauthor=M.+R.+Collinsauthor=J.+J.+Cuiauthor=J.+G.+Dealauthor=Y.+L.+Dengauthor=D.+Dinhauthor=L.+D.+Engstromauthor=M.+Heauthor=J.+Hoffmanauthor=R.+L.+Hoffmanauthor=Q.+Huangauthor=R.+S.+Kaniaauthor=J.+C.+Kathauthor=H.+Lamauthor=J.+L.+Lamauthor=P.+T.+Leauthor=L.+Lingardoauthor=W.+Liuauthor=M.+McTigueauthor=C.+L.+Palmerauthor=N.+W.+Sachauthor=T.+Smealauthor=G.+L.+Smithauthor=A.+E.+Stewartauthor=S.+Timofeevskiauthor=H.+Zhuauthor=J.+Zhuauthor=H.+Y.+Zouauthor=M.+P.+Edwards&title=Discovery+of+%2810R%29-7-amino-12-fluoro-2%2C10%2C16-trimethyl-15-oxo-10%2C15%2C16%2C17-tetrahydro-2H-8%2C4-%28metheno%29pyrazolo%5B4%2C3-h%5D%5B2%2C5%2C11%5D-benzoxadiazacyclotetradecine-3-carbonitrile+%28PF-06463922%29%2C+a+macrocyclic+inhibitor+of+anaplastic+lymphoma+kinase+%28ALK%29+and+c-ros+oncogene+1+%28ROS1%29+with+preclinical+brain+exposure+and+broad-spectrum+potency+against+ALK-resistant+mutations&doi=10.1021%2Fjm500261q"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of (10R)-7-Amino-12-fluoro-2,10,16-trimethyl-15-oxo-10,15,16,17-tetrahydro-2H-8,4-(metheno)pyrazolo[4,3-h][2,5,11]-benzoxadiazacyclotetradecine-3-carbonitrile (PF-06463922), a Macrocyclic Inhibitor of Anaplastic Lymphoma Kinase (ALK) and c-ros Oncogene 1 (ROS1) with Preclinical Brain Exposure and Broad-Spectrum Potency against ALK-Resistant Mutations</span></div><div class="casAuthors">Johnson, Ted W.; Richardson, Paul F.; Bailey, Simon; Brooun, Alexei; Burke, Benjamin J.; Collins, Michael R.; Cui, J. Jean; Deal, Judith G.; Deng, Ya-Li; Dinh, Dac; Engstrom, Lars D.; He, Mingying; Hoffman, Jacqui; Hoffman, Robert L.; Huang, Qinhua; Kania, Robert S.; Kath, John C.; Lam, Hieu; Lam, Justine L.; Le, Phuong T.; Lingardo, Laura; Liu, Wei; McTigue, Michele; Palmer, Cynthia L.; Sach, Neal W.; Smeal, Tod; Smith, Graham L.; Stewart, Albert E.; Timofeevski, Sergei; Zhu, Huichun; Zhu, Jinjiang; Zou, Helen Y.; Edwards, Martin P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4720-4744</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Although crizotinib demonstrates robust efficacy in anaplastic lymphoma kinase (ALK)-pos. non-small-cell lung carcinoma patients, progression during treatment eventually develops.  Resistant patient samples revealed a variety of point mutations in the kinase domain of ALK, including the L1196M gatekeeper mutation.  In addn., some patients progress due to cancer metastasis in the brain.  Using structure-based drug design, lipophilic efficiency, and phys.-property-based optimization, highly potent macrocyclic ALK inhibitors were prepd. with good absorption, distribution, metab., and excretion (ADME), low propensity for p-glycoprotein 1-mediated efflux, and good passive permeability.  These structurally unusual macrocyclic inhibitors were potent against wild-type ALK and clin. reported ALK kinase domain mutations.  Significant synthetic challenges were overcome, utilizing novel transformations to enable the use of these macrocycles in drug discovery paradigms.  This work led to the discovery of 8k (PF-06463922), combining broad-spectrum potency, central nervous system ADME, and a high degree of kinase selectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqXkb49ad31bVg90H21EOLACvtfcHk0lhJfuEIYyDKLw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXnvVSgtL4%253D&md5=db21844f8e9a2f9ca5953bca56ad7b1c</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fjm500261q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500261q%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DT.%2BW.%26aulast%3DRichardson%26aufirst%3DP.%2BF.%26aulast%3DBailey%26aufirst%3DS.%26aulast%3DBrooun%26aufirst%3DA.%26aulast%3DBurke%26aufirst%3DB.%2BJ.%26aulast%3DCollins%26aufirst%3DM.%2BR.%26aulast%3DCui%26aufirst%3DJ.%2BJ.%26aulast%3DDeal%26aufirst%3DJ.%2BG.%26aulast%3DDeng%26aufirst%3DY.%2BL.%26aulast%3DDinh%26aufirst%3DD.%26aulast%3DEngstrom%26aufirst%3DL.%2BD.%26aulast%3DHe%26aufirst%3DM.%26aulast%3DHoffman%26aufirst%3DJ.%26aulast%3DHoffman%26aufirst%3DR.%2BL.%26aulast%3DHuang%26aufirst%3DQ.%26aulast%3DKania%26aufirst%3DR.%2BS.%26aulast%3DKath%26aufirst%3DJ.%2BC.%26aulast%3DLam%26aufirst%3DH.%26aulast%3DLam%26aufirst%3DJ.%2BL.%26aulast%3DLe%26aufirst%3DP.%2BT.%26aulast%3DLingardo%26aufirst%3DL.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DMcTigue%26aufirst%3DM.%26aulast%3DPalmer%26aufirst%3DC.%2BL.%26aulast%3DSach%26aufirst%3DN.%2BW.%26aulast%3DSmeal%26aufirst%3DT.%26aulast%3DSmith%26aufirst%3DG.%2BL.%26aulast%3DStewart%26aufirst%3DA.%2BE.%26aulast%3DTimofeevski%26aufirst%3DS.%26aulast%3DZhu%26aufirst%3DH.%26aulast%3DZhu%26aufirst%3DJ.%26aulast%3DZou%26aufirst%3DH.%2BY.%26aulast%3DEdwards%26aufirst%3DM.%2BP.%26atitle%3DDiscovery%2520of%2520%252810R%2529-7-amino-12-fluoro-2%252C10%252C16-trimethyl-15-oxo-10%252C15%252C16%252C17-tetrahydro-2H-8%252C4-%2528metheno%2529pyrazolo%255B4%252C3-h%255D%255B2%252C5%252C11%255D-benzoxadiazacyclotetradecine-3-carbonitrile%2520%2528PF-06463922%2529%252C%2520a%2520macrocyclic%2520inhibitor%2520of%2520anaplastic%2520lymphoma%2520kinase%2520%2528ALK%2529%2520and%2520c-ros%2520oncogene%25201%2520%2528ROS1%2529%2520with%2520preclinical%2520brain%2520exposure%2520and%2520broad-spectrum%2520potency%2520against%2520ALK-resistant%2520mutations%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D4720%26epage%3D4744%26doi%3D10.1021%2Fjm500261q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><div class="note"><p class="first last">For additional SAR see the followingpatent application:</p></div><span class="NLM_contrib-group">Brodney, M. A.; Davoren, J. E.; Garnsey, M. R.; Zhang, L.; O’Neil, S. V.</span><span> </span><span class="NLM_article-title">Pyridine derivatives as muscarinic m1 receptor positive allosteric modulators</span>. WO 2016009297,<span class="NLM_x"> </span><span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=M.+A.+Brodney&author=J.+E.+Davoren&author=M.+R.+Garnsey&author=L.+Zhang&author=S.+V.+O%E2%80%99Neil&title=Pyridine+derivatives+as+muscarinic+m1+receptor+positive+allosteric+modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBrodney%26aufirst%3DM.%2BA.%26atitle%3DPyridine%2520derivatives%2520as%2520muscarinic%2520m1%2520receptor%2520positive%2520allosteric%2520modulators%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Kenakin, T. P.</span> <span class="citation_source-book">A Pharmacology Primer: Techniques for More Effective and Strategic Drug Discovery</span>, <span class="NLM_edition">4</span>th ed.; <span class="NLM_publisher-name">Academic Press</span>: <span class="NLM_publisher-loc">San Diego, CA</span>,<span class="NLM_x"> </span><span class="NLM_year">2014</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">469</span><span class="NLM_x">–</span> <span class="NLM_lpage">470</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&pages=469-470&author=T.+P.+Kenakin&title=A+Pharmacology+Primer%3A+Techniques+for+More+Effective+and+Strategic+Drug+Discovery"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DKenakin%26aufirst%3DT.%2BP.%26btitle%3DA%2520Pharmacology%2520Primer%253A%2520Techniques%2520for%2520More%2520Effective%2520and%2520Strategic%2520Drug%2520Discovery%26pub%3DAcademic%2520Press%26date%3D2014%26spage%3D469%26epage%3D470" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="note"><p class="first last">FLIPR, IP1, and β-arrestin assays were run using three different cell lines with differing M1 expression levels (<i>B</i><sub>max</sub>), determined using [<sup>3</sup>H]NMS binding: FLIPR, 0.542 pmol/mg; IP1, 20.7 pmol/mg; β-arrestin, 33.2 pmol/mg.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Dasari, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gulledge, A. T.</span><span> </span><span class="NLM_article-title">M1 and M4 receptors modulate hippocampal pyramidal neurons</span> <span class="citation_source-journal">J. Neurophysiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">105</span><span class="NLM_x">, </span> <span class="NLM_fpage">779</span><span class="NLM_x">–</span> <span class="NLM_lpage">792</span><span class="refDoi"> DOI: 10.1152/jn.00686.2010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=10.1152%2Fjn.00686.2010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=21160001" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=1%3ACAS%3A280%3ADC%252BC3M7ns1GhsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2011&pages=779-792&author=S.+Dasariauthor=A.+T.+Gulledge&title=M1+and+M4+receptors+modulate+hippocampal+pyramidal+neurons&doi=10.1152%2Fjn.00686.2010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32aR"><div class="casContent"><span class="casTitleNuber">32a</span><div class="casTitle"><span class="NLM_cas:atitle">M1 and M4 receptors modulate hippocampal pyramidal neurons</span></div><div class="casAuthors">Dasari Sameera; Gulledge Allan T</div><div class="citationInfo"><span class="NLM_cas:title">Journal of neurophysiology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">105</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">779-92</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Acetylcholine (ACh), acting at muscarinic ACh receptors (mAChRs), modulates the excitability and synaptic connectivity of hippocampal pyramidal neurons.  CA1 pyramidal neurons respond to transient ("phasic") mAChR activation with biphasic responses in which inhibition is followed by excitation, whereas prolonged ("tonic") mAChR activation increases CA1 neuron excitability.  Both phasic and tonic mAChR activation excites pyramidal neurons in the CA3 region, yet ACh suppresses glutamate release at the CA3-to-CA1 synapse (the Schaffer-collateral pathway).  Using mice genetically lacking specific mAChRs (mAChR knockout mice), we identified the mAChR subtypes responsible for cholinergic modulation of hippocampal pyramidal neuron excitability and synaptic transmission.  Knockout of M1 receptors significantly reduced, or eliminated, most phasic and tonic cholinergic responses in CA1 and CA3 pyramidal neurons.  On the other hand, in the absence of other G(q)-linked mAChRs (M3 and M5), M1 receptors proved sufficient for all postsynaptic cholinergic effects on CA1 and CA3 pyramidal neuron excitability.  M3 receptors were able to participate in tonic depolarization of CA1 neurons, but otherwise contributed little to cholinergic responses.  At the Schaffer-collateral synapse, bath application of the cholinergic agonist carbachol suppressed stratum radiatum-evoked excitatory postsynaptic potentials (EPSPs) in wild-type CA1 neurons and in CA1 neurons from mice lacking M1 or M2 receptors.  However, Schaffer-collateral EPSPs were not significantly suppressed by carbachol in neurons lacking M4 receptors.  We therefore conclude that M1 and M4 receptors are the major mAChR subtypes responsible for direct cholinergic modulation of the excitatory hippocampal circuit.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTVYbKOx7U120mhnSqMnvzDfW6udTcc2eY8COpUSeGgILntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3M7ns1GhsA%253D%253D&md5=2ec39251cc89ce5ed15cbf36aa9261f4</span></div><a href="/servlet/linkout?suffix=cit32a&amp;dbid=16384&amp;doi=10.1152%2Fjn.00686.2010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fjn.00686.2010%26sid%3Dliteratum%253Aachs%26aulast%3DDasari%26aufirst%3DS.%26aulast%3DGulledge%26aufirst%3DA.%2BT.%26atitle%3DM1%2520and%2520M4%2520receptors%2520modulate%2520hippocampal%2520pyramidal%2520neurons%26jtitle%3DJ.%2520Neurophysiol.%26date%3D2011%26volume%3D105%26spage%3D779%26epage%3D792%26doi%3D10.1152%2Fjn.00686.2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit32b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Langmead, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Austin, N. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Branch, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchanan, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forbes, I. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fry, V. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hagan, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herdon, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeggo, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kew, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mazzali, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melarange, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pardoe, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Randall, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roopun, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Starr, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teriakidis, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whittington, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, J.</span><span> </span><span class="NLM_article-title">Characterization of a CNS penetrant, selective M1 muscarinic receptor agonist, 77-LH-28-1</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">154</span><span class="NLM_x">, </span> <span class="NLM_fpage">1104</span><span class="NLM_x">–</span> <span class="NLM_lpage">1115</span><span class="refDoi"> DOI: 10.1038/bjp.2008.152</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=10.1038%2Fbjp.2008.152" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=18454168" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=1%3ACAS%3A528%3ADC%252BD1cXnvVGrurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=154&publication_year=2008&pages=1104-1115&author=C.+J.+Langmeadauthor=N.+E.+Austinauthor=C.+L.+Branchauthor=J.+T.+Brownauthor=K.+A.+Buchananauthor=C.+H.+Daviesauthor=I.+T.+Forbesauthor=V.+A.+Fryauthor=J.+J.+Haganauthor=H.+J.+Herdonauthor=G.+A.+Jonesauthor=R.+Jeggoauthor=J.+N.+Kewauthor=A.+Mazzaliauthor=R.+Melarangeauthor=N.+Patelauthor=J.+Pardoeauthor=A.+D.+Randallauthor=C.+Robertsauthor=A.+Roopunauthor=K.+R.+Starrauthor=A.+Teriakidisauthor=M.+D.+Woodauthor=M.+Whittingtonauthor=Z.+Wuauthor=J.+Watson&title=Characterization+of+a+CNS+penetrant%2C+selective+M1+muscarinic+receptor+agonist%2C+77-LH-28-1&doi=10.1038%2Fbjp.2008.152"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32bR"><div class="casContent"><span class="casTitleNuber">32b</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of a CNS penetrant, selective M1 muscarinic receptor agonist, 77-LH-28-1</span></div><div class="casAuthors">Langmead, C. J.; Austin, N. E.; Branch, C. L.; Brown, J. T.; Buchanan, K. A.; Davies, C. H.; Forbes, I. T.; Fry, V. A. H.; Hagan, J. J.; Herdon, H. J.; Jones, G. A.; Jeggo, R.; Kew, J. N. C.; Mazzali, A.; Melarange, R.; Patel, N.; Pardoe, J.; Randall, A. D.; Roberts, C.; Roopun, A.; Starr, K. R.; Teriakidis, A.; Wood, M. D.; Whittington, M.; Wu, Z.; Watson, J.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">154</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1104-1115</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Background and purpose: M1 muscarinic ACh receptors (mAChRs) represent an attractive drug target for the treatment of cognitive deficits assocd. with diseases such as Alzheimer's disease and schizophrenia.  However, the discovery of subtype-selective mAChR agonists has been hampered by the high degree of conservation of the orthosteric ACh-binding site among mAChR subtypes.  The advent of functional screening assays has enabled the identification of agonists such as AC-42 (4-n-butyl-1-[4-(2-methylphenyl)-4-oxo-1-butyl]-piperidine), which bind to an allosteric site and selectively activate the M1 mAChR subtype.  However, studies with this compd. have been limited to recombinantly expressed mAChRs.  Exptl. approach: In this study, we have compared the pharmacol. profile of AC-42 and a close structural analog, 77-LH-28-1 (1-[3-(4-butyl-1-piperidinyl)propyl]-3,4-dihydro-2(1H)-quinolinone) at human recombinant, and rat native, mAChRs by calcium mobilization, inositol phosphate accumulation and both in vitro and in vivo electrophysiol.  Key results: Calcium mobilization and inositol phosphate accumulation assays revealed that both AC-42 and 77-LH-28-1 display high selectivity to activate the M1 mAChR over other mAChR subtypes.  Furthermore, 77-LH-28-1(I), but not AC-42, acted as an agonist at rat hippocampal M1 receptors, as demonstrated by its ability to increase cell firing and initiate gamma frequency network oscillations.  Finally, 77-LH-28-1 stimulated cell firing in the rat hippocampus in vivo following s.c. administration.  Conclusions and implications: These data suggest that 77-LH-28-1 is a potent, selective, bioavailable and brain-penetrant agonist at the M1 mAChR and therefore that it represents a better tool than AC-42, with which to study the pharmacol. of the M1 mAChR.  British Journal of Pharmacol. (2008) 154, 1104-1115; doi:10.1038/bjp.2008.152; published online 5 May 2008.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5pNVy427ynLVg90H21EOLACvtfcHk0lhSfwR5yI3FaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXnvVGrurc%253D&md5=8eeb8522c09910e1a13f9832f775f846</span></div><a href="/servlet/linkout?suffix=cit32b&amp;dbid=16384&amp;doi=10.1038%2Fbjp.2008.152&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fbjp.2008.152%26sid%3Dliteratum%253Aachs%26aulast%3DLangmead%26aufirst%3DC.%2BJ.%26aulast%3DAustin%26aufirst%3DN.%2BE.%26aulast%3DBranch%26aufirst%3DC.%2BL.%26aulast%3DBrown%26aufirst%3DJ.%2BT.%26aulast%3DBuchanan%26aufirst%3DK.%2BA.%26aulast%3DDavies%26aufirst%3DC.%2BH.%26aulast%3DForbes%26aufirst%3DI.%2BT.%26aulast%3DFry%26aufirst%3DV.%2BA.%26aulast%3DHagan%26aufirst%3DJ.%2BJ.%26aulast%3DHerdon%26aufirst%3DH.%2BJ.%26aulast%3DJones%26aufirst%3DG.%2BA.%26aulast%3DJeggo%26aufirst%3DR.%26aulast%3DKew%26aufirst%3DJ.%2BN.%26aulast%3DMazzali%26aufirst%3DA.%26aulast%3DMelarange%26aufirst%3DR.%26aulast%3DPatel%26aufirst%3DN.%26aulast%3DPardoe%26aufirst%3DJ.%26aulast%3DRandall%26aufirst%3DA.%2BD.%26aulast%3DRoberts%26aufirst%3DC.%26aulast%3DRoopun%26aufirst%3DA.%26aulast%3DStarr%26aufirst%3DK.%2BR.%26aulast%3DTeriakidis%26aufirst%3DA.%26aulast%3DWood%26aufirst%3DM.%2BD.%26aulast%3DWhittington%26aufirst%3DM.%26aulast%3DWu%26aufirst%3DZ.%26aulast%3DWatson%26aufirst%3DJ.%26atitle%3DCharacterization%2520of%2520a%2520CNS%2520penetrant%252C%2520selective%2520M1%2520muscarinic%2520receptor%2520agonist%252C%252077-LH-28-1%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2008%26volume%3D154%26spage%3D1104%26epage%3D1115%26doi%3D10.1038%2Fbjp.2008.152" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Ehlert, F. J.</span><span> </span><span class="NLM_article-title">Analysis of allosterism in functional assays. J</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">315</span><span class="NLM_x">, </span> <span class="NLM_fpage">740</span><span class="NLM_x">–</span> <span class="NLM_lpage">754</span><span class="refDoi"> DOI: 10.1124/jpet.105.090886</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=10.1124%2Fjpet.105.090886" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=16046613" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFyhtr%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=315&publication_year=2005&pages=740-754&author=F.+J.+Ehlert&title=Analysis+of+allosterism+in+functional+assays.+J&doi=10.1124%2Fjpet.105.090886"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33aR"><div class="casContent"><span class="casTitleNuber">33a</span><div class="casTitle"><span class="NLM_cas:atitle">Analysis of allosterism in functional assays</span></div><div class="casAuthors">Ehlert, Frederick J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">315</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">740-754</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The theor. basis for analyzing the effects of an allosteric modulator on the response to an agonist is described.  The effects of an allosteric modulator on the concn.-response curve to an agonist can be attributed to changes in the obsd. dissocn. const. and intrinsic efficacy of the agonist-receptor complex.  Each of these two changes can be represented by a coeff. or factor.  It is possible to est. the ratio of the coeff. of change in agonist efficacy divided by that for the agonist dissocn. const.  This ratio is designated as the relative activity (RA) of the agonist in the presence of the allosteric modulator.  The RA value can be estd. for each concn. of allosteric modulator by nonlinear regression anal., regardless of the shape of the concn.-response curve.  Regression anal. of the RA values against the concn. of allosteric modulator yields ests. of the dissocn. const. (KA) of the allosteric modulator and the maximal RA value.  If the concn.-response curve to the agonist obeys a logistic function and the allosteric modulator influences the maximal response, it is possible to distinguish between the maximal change in affinity from that of efficacy.  If the agonist concn.-response curve obeys a logistic equation with a Hill slope of 1, the RA values can be estd. easily from the agonist EC50 and Emax values.  This anal. illustrates the utility of the RA value in quantifying allosteric effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKvK9-uIW607Vg90H21EOLACvtfcHk0lhSfwR5yI3FaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFyhtr%252FO&md5=0cb5a02f65f93990511d12fb06f5da12</span></div><a href="/servlet/linkout?suffix=cit33a&amp;dbid=16384&amp;doi=10.1124%2Fjpet.105.090886&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.105.090886%26sid%3Dliteratum%253Aachs%26aulast%3DEhlert%26aufirst%3DF.%2BJ.%26atitle%3DAnalysis%2520of%2520allosterism%2520in%2520functional%2520assays.%2520J%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2005%26volume%3D315%26spage%3D740%26epage%3D754%26doi%3D10.1124%2Fjpet.105.090886" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit33b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Kenakin, T.</span><span> </span><span class="NLM_article-title">New concepts in drug discovery: collateral efficacy and permissive antagonism</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">919</span><span class="NLM_x">–</span> <span class="NLM_lpage">927</span><span class="refDoi"> DOI: 10.1038/nrd1875</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=10.1038%2Fnrd1875" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=16264435" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFKlsLfO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2005&pages=919-927&author=T.+Kenakin&title=New+concepts+in+drug+discovery%3A+collateral+efficacy+and+permissive+antagonism&doi=10.1038%2Fnrd1875"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33bR"><div class="casContent"><span class="casTitleNuber">33b</span><div class="casTitle"><span class="NLM_cas:atitle">New Concepts in Drug Discovery: Collateral Efficacy and Permissive Antagonism</span></div><div class="casAuthors">Kenakin, Terry</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">919-927</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  New perspectives on the complexity of G-protein-coupled receptor (GPCR) signaling and the increased resoln. of existing tools for studying GPCR behavior has led to the conception of new hypotheses that affect the discovery of drugs acting at GPCRs.  Taking into consideration the novel concepts of collateral efficacy and permissive antagonism in the search for synthetic agonists and antagonists, resp., will be essential in the search for drugs with unique therapeutic profiles.  Here, the design of drugs against HIV is used as an example of how these concepts might be taken into consideration for GPCR-targeted drugs in general.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp26TMWCy0fUrVg90H21EOLACvtfcHk0lhOXOKjRGrpnA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFKlsLfO&md5=b7e09bcb4f73d52b4ab80f521ab78a64</span></div><a href="/servlet/linkout?suffix=cit33b&amp;dbid=16384&amp;doi=10.1038%2Fnrd1875&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd1875%26sid%3Dliteratum%253Aachs%26aulast%3DKenakin%26aufirst%3DT.%26atitle%3DNew%2520concepts%2520in%2520drug%2520discovery%253A%2520collateral%2520efficacy%2520and%2520permissive%2520antagonism%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2005%26volume%3D4%26spage%3D919%26epage%3D927%26doi%3D10.1038%2Fnrd1875" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit33c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Price, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baillie, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevenson, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Easson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goodwin, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McLean, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McIntosh, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goodwin, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westwood, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marrs, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomson, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cowley, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christopoulos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pertwee, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ross, R. A.</span><span> </span><span class="NLM_article-title">Allosteric modulation of the cannabinoid CB1 receptor</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">1484</span><span class="NLM_x">–</span> <span class="NLM_lpage">1495</span><span class="refDoi"> DOI: 10.1124/mol.105.016162</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=10.1124%2Fmol.105.016162" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=16113085" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtF2it7nM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2005&pages=1484-1495&author=M.+R.+Priceauthor=G.+L.+Baillieauthor=A.+Thomasauthor=L.+A.+Stevensonauthor=M.+Eassonauthor=R.+Goodwinauthor=A.+McLeanauthor=L.+McIntoshauthor=G.+Goodwinauthor=G.+Walkerauthor=P.+Westwoodauthor=J.+Marrsauthor=F.+Thomsonauthor=P.+Cowleyauthor=A.+Christopoulosauthor=R.+G.+Pertweeauthor=R.+A.+Ross&title=Allosteric+modulation+of+the+cannabinoid+CB1+receptor&doi=10.1124%2Fmol.105.016162"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33cR"><div class="casContent"><span class="casTitleNuber">33c</span><div class="casTitle"><span class="NLM_cas:atitle">Allosteric modulation of the cannabinoid CB1 receptor</span></div><div class="casAuthors">Price, Martin R.; Baillie, Gemma L.; Thomas, Adele; Stevenson, Lesley A.; Easson, Morag; Goodwin, Richard; McLean, Adele; McIntosh, Lorraine; Goodwin, Gillian; Walker, Glenn; Westwood, Paul; Marrs, Julia; Thomson, Fiona; Cowley, Phillip; Christopoulos, Arthur; Pertwee, Roger G.; Ross, Ruth A.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1484-1495</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">0026-895X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The authors investigated the pharmacol. of three novel compds., Org 27569, Org 27759 and Org 29647 at the cannabinoid CB1 receptor.  In equil. binding assays, the Org compds. significantly increased the binding of the CB1 receptor agonist [3H]CP 55,940 [(1R,3R,4R)-3-[2-hydroxy-4-(1,1-dimethylheptyl)phenyl]-4-(3-hydroxypropyl) cyclohexan-1-ol], indicative of a pos. cooperative allosteric effect.  The same compds. caused a significant, but incomplete, decrease in the specific binding of the CB1 receptor inverse agonist [3H]SR 141716A [N-(piperidin-1-yl)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H -pyrazole-3-carboximide hydrochloride], indicative of a limited neg. binding cooperativity.  Anal. of the data according to an allosteric ternary complex model revealed that the estd. affinity of each Org compd. was not significantly different when the radioligand was [3H]CP 55,940 or [3H]SR 141716A.  However, the estd. cooperatively factor for the interaction between modulator and radioligand was greater than 1 when detd. against [3H]CP 55,940 and less than 1 when detd. against [3H]SR 141716A.  [3H]CP 55,940 dissocn. kinetic studies also validated the allosteric nature of the Org compds., because they all significantly decreased radioligand dissocn.  These data suggest that the Org compds. bind allosterically to the CB1 receptor and elicit a conformational change that increases agonist affinity for the orthosteric binding site.  In contrast to the binding assays, however, the Org compds. behaved as insurmountable antagonists of receptor function; in the reporter gene assay, the guanosine 5'-O-(3-[35S]thio)triphosphate binding assay and the mouse vas deferens assay they elicited a significant redn. in the Emax value for CB1 receptor agonists.  The data presented clearly demonstrate, for the first time, that the cannabinoid CB1 receptor contains an allosteric binding site that can be recognized by synthetic small mol. ligands.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq98nUa2ffQ7bVg90H21EOLACvtfcHk0lhOXOKjRGrpnA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtF2it7nM&md5=a342d304a8157b1e7b962755a775154d</span></div><a href="/servlet/linkout?suffix=cit33c&amp;dbid=16384&amp;doi=10.1124%2Fmol.105.016162&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.105.016162%26sid%3Dliteratum%253Aachs%26aulast%3DPrice%26aufirst%3DM.%2BR.%26aulast%3DBaillie%26aufirst%3DG.%2BL.%26aulast%3DThomas%26aufirst%3DA.%26aulast%3DStevenson%26aufirst%3DL.%2BA.%26aulast%3DEasson%26aufirst%3DM.%26aulast%3DGoodwin%26aufirst%3DR.%26aulast%3DMcLean%26aufirst%3DA.%26aulast%3DMcIntosh%26aufirst%3DL.%26aulast%3DGoodwin%26aufirst%3DG.%26aulast%3DWalker%26aufirst%3DG.%26aulast%3DWestwood%26aufirst%3DP.%26aulast%3DMarrs%26aufirst%3DJ.%26aulast%3DThomson%26aufirst%3DF.%26aulast%3DCowley%26aufirst%3DP.%26aulast%3DChristopoulos%26aufirst%3DA.%26aulast%3DPertwee%26aufirst%3DR.%2BG.%26aulast%3DRoss%26aufirst%3DR.%2BA.%26atitle%3DAllosteric%2520modulation%2520of%2520the%2520cannabinoid%2520CB1%2520receptor%26jtitle%3DMol.%2520Pharmacol.%26date%3D2005%26volume%3D68%26spage%3D1484%26epage%3D1495%26doi%3D10.1124%2Fmol.105.016162" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Kenakin, T.</span><span> </span><span class="NLM_article-title">Gaddum Memorial Lecture 2014: receptors as an evolving concept: from switches to biased microprocessors</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">172</span><span class="NLM_x">, </span> <span class="NLM_fpage">4238</span><span class="NLM_x">–</span> <span class="NLM_lpage">4253</span><span class="refDoi"> DOI: 10.1111/bph.13217</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=10.1111%2Fbph.13217" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=26075971" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtF2hs7zJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=172&publication_year=2015&pages=4238-4253&author=T.+Kenakin&title=Gaddum+Memorial+Lecture+2014%3A+receptors+as+an+evolving+concept%3A+from+switches+to+biased+microprocessors&doi=10.1111%2Fbph.13217"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Gaddum Memorial Lecture 2014: receptors as an evolving concept: from switches to biased microprocessors</span></div><div class="casAuthors">Kenakin, Terry</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">172</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">4238-4253</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Pharmacol. models used to describe drug agonism and antagonism have evolved over the past 20 years from a parsimonious model describing single active and inactive receptor states to models of multiconformational receptor systems modified by ligand conformational selection.  These latter models describe the obsd., presently underexploited, pharmacol. mechanism of ligand-directed biased signalling.  Biased signals can be quantified with transduction coeffs. (ΔΔLog(τ/KA) values), a scale grounded in the Black/Leff operational model; this enables the optimization of biased profiles through medicinal chem.  The past decades have also brought the availability of new technologies to measure multiple functional effects mediated by seven transmembrane receptors.  These have confirmed that drugs can have many efficacies, which may be collaterally linked, that is there is no linear sequence of activities required.  In addn., new functional screening assays have introduced increasing nos. of allosteric ligands into drug discovery.  These mols. are permissive (they do not necessarily preclude endogenous signalling in vivo); therefore, they may allow better fine tuning of pathol. physiol.  The permissive quality of allosteric ligands can also change the quality of endogenous signalling efficacy ('induced bias') as well as the quantity of signal; in this regard, indexes related to ΔΔLog(τ/KA) values (namely ΔLog(αβ) values) can be used to quantify these effects for optimization in the drug discovery process.  All of these added scales of drug activity will, hopefully, allow better targeting of candidate mols. towards therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrK9AlxGN4g27Vg90H21EOLACvtfcHk0lhOXOKjRGrpnA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtF2hs7zJ&md5=f360ac4ff8a9301d598215881b007680</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1111%2Fbph.13217&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbph.13217%26sid%3Dliteratum%253Aachs%26aulast%3DKenakin%26aufirst%3DT.%26atitle%3DGaddum%2520Memorial%2520Lecture%25202014%253A%2520receptors%2520as%2520an%2520evolving%2520concept%253A%2520from%2520switches%2520to%2520biased%2520microprocessors%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2015%26volume%3D172%26spage%3D4238%26epage%3D4253%26doi%3D10.1111%2Fbph.13217" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="note"><p class="first last">Agonist EC<sub>50</sub> in the M1 FLIPR assay was highly variable. See <a href="/doi/suppl/10.1021/acs.jmedchem.6b00544/suppl_file/jm6b00544_si_002.pdf" class="ext-link">Supporting Information</a> for more detail.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Ehlert, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, E. A.</span><span> </span><span class="NLM_article-title">Functional role of M2 muscarinic receptors in the guinea pig ileum</span> <span class="citation_source-journal">Life Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">965</span><span class="NLM_x">–</span> <span class="NLM_lpage">971</span><span class="refDoi"> DOI: 10.1016/0024-3205(94)00035-Q</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=10.1016%2F0024-3205%2894%2900035-Q" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=1995&pages=965-971&author=F.+J.+Ehlertauthor=E.+A.+Thomas&title=Functional+role+of+M2+muscarinic+receptors+in+the+guinea+pig+ileum&doi=10.1016%2F0024-3205%2894%2900035-Q"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36a&amp;dbid=16384&amp;doi=10.1016%2F0024-3205%2894%2900035-Q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0024-3205%252894%252900035-Q%26sid%3Dliteratum%253Aachs%26aulast%3DEhlert%26aufirst%3DF.%2BJ.%26aulast%3DThomas%26aufirst%3DE.%2BA.%26atitle%3DFunctional%2520role%2520of%2520M2%2520muscarinic%2520receptors%2520in%2520the%2520guinea%2520pig%2520ileum%26jtitle%3DLife%2520Sci.%26date%3D1995%26volume%3D56%26spage%3D965%26epage%3D971%26doi%3D10.1016%2F0024-3205%2894%2900035-Q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit36b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Ehlert, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffin, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawyer, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bailon, R.</span><span> </span><span class="NLM_article-title">A simple method for estimation of agonist activity at receptor subtypes: comparison of native and cloned M3 muscarinic receptors in guinea pig ileum and transfected cells</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">289</span><span class="NLM_x">, </span> <span class="NLM_fpage">981</span><span class="NLM_x">–</span> <span class="NLM_lpage">992</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=10215678" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=1%3ACAS%3A528%3ADyaK1MXislGis7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=289&publication_year=1999&pages=981-992&author=F.+J.+Ehlertauthor=M.+T.+Griffinauthor=G.+W.+Sawyerauthor=R.+Bailon&title=A+simple+method+for+estimation+of+agonist+activity+at+receptor+subtypes%3A+comparison+of+native+and+cloned+M3+muscarinic+receptors+in+guinea+pig+ileum+and+transfected+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36bR"><div class="casContent"><span class="casTitleNuber">36b</span><div class="casTitle"><span class="NLM_cas:atitle">A simple method for estimation of agonist activity at receptor subtypes: comparison of native and cloned M3 muscarinic receptors in guinea pig ileum and transfected cells</span></div><div class="casAuthors">Ehlert, Frederick J.; Griffin, Michael T.; Sawyer, Gregory W.; Bailon, Regina</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">289</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">981-992</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The authors describe a simple method for calcg. the pharmacol. activity of an agonist (A) relative to a std. agonist (S) using only the concn.-response curves of the two agonists.  In most situations, the authors show that the product of the ratios of maximal responses (Emax - A/Emax - S) and potencies (EC50 - S/EC50 - A) is equiv. to the product of the affinity and intrinsic efficacy of A expressed relative to that of S.  The authors refer to this term as the IRA value of A.  In a cooperative system where the concn.-response curve of the std. agonist is steep and that of the test agonist is flatter with a lower maximal response, the simple calcn. of IRA described above underestimates agonist activity; however, the authors also describe a means of correcting the IRA in this situation.  The authors have validated the authors anal. with modeling techniques and have shown exptl. that the IRA values of muscarinic agonists for stimulating contractions in the guinea pig ileum (M3 response) are in excellent agreement with those measured in the phosphoinositide assay on Chinese hamster ovary cells expressing the M3 muscarinic receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1mB3BMIxjZ7Vg90H21EOLACvtfcHk0liqnyQIa82EEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXislGis7Y%253D&md5=9ff89312ae34de8576f030fdf25ad3fb</span></div><a href="/servlet/linkout?suffix=cit36b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEhlert%26aufirst%3DF.%2BJ.%26aulast%3DGriffin%26aufirst%3DM.%2BT.%26aulast%3DSawyer%26aufirst%3DG.%2BW.%26aulast%3DBailon%26aufirst%3DR.%26atitle%3DA%2520simple%2520method%2520for%2520estimation%2520of%2520agonist%2520activity%2520at%2520receptor%2520subtypes%253A%2520comparison%2520of%2520native%2520and%2520cloned%2520M3%2520muscarinic%2520receptors%2520in%2520guinea%2520pig%2520ileum%2520and%2520transfected%2520cells%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1999%26volume%3D289%26spage%3D981%26epage%3D992" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="note"><p class="first last">A caveat to this data is that we did not determine if this is was a true agonist effect or if compound <b>38</b> is modulating an unknown endogenous level of acetylcholine.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="note"><p class="first last">To measure the effects of compound <b>38</b> on GPI in PAM mode, we combined compound <b>38</b> with 200 nM donepezil, an acetylcholinesterase inhibitor, which produced a contraction that was equivalent to an EC<sub>20</sub> of carbachol’s maximal response in this preparation.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Vanover, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Veinbergs, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, R. E.</span><span> </span><span class="NLM_article-title">Antipsychotic-like behavioral effects and cognitive enhancement by a potent and selective muscarinic M-sub-1 receptor agonist, AC-260584</span> <span class="citation_source-journal">Behav. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">122</span><span class="NLM_x">, </span> <span class="NLM_fpage">570</span><span class="NLM_x">–</span> <span class="NLM_lpage">575</span><span class="refDoi"> DOI: 10.1037/0735-7044.122.3.570</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=10.1037%2F0735-7044.122.3.570" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=122&publication_year=2008&pages=570-575&author=K.+E.+Vanoverauthor=I.+Veinbergsauthor=R.+E.+Davis&title=Antipsychotic-like+behavioral+effects+and+cognitive+enhancement+by+a+potent+and+selective+muscarinic+M-sub-1+receptor+agonist%2C+AC-260584&doi=10.1037%2F0735-7044.122.3.570"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39a&amp;dbid=16384&amp;doi=10.1037%2F0735-7044.122.3.570&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1037%252F0735-7044.122.3.570%26sid%3Dliteratum%253Aachs%26aulast%3DVanover%26aufirst%3DK.%2BE.%26aulast%3DVeinbergs%26aufirst%3DI.%26aulast%3DDavis%26aufirst%3DR.%2BE.%26atitle%3DAntipsychotic-like%2520behavioral%2520effects%2520and%2520cognitive%2520enhancement%2520by%2520a%2520potent%2520and%2520selective%2520muscarinic%2520M-sub-1%2520receptor%2520agonist%252C%2520AC-260584%26jtitle%3DBehav.%2520Neurosci.%26date%3D2008%26volume%3D122%26spage%3D570%26epage%3D575%26doi%3D10.1037%2F0735-7044.122.3.570" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit39b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Jones, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brady, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bubser, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tantawy, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kane, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bridges, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bradley, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peterson, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ansari, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baldwin, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kessler, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deutch, A. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lah, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levey, A. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindsley, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conn, P. J.</span><span> </span><span class="NLM_article-title">Novel selective allosteric activator of the M1 muscarinic acetylcholine receptor regulates amyloid processing and produces antipsychotic-like activity in rats</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">10422</span><span class="NLM_x">–</span> <span class="NLM_lpage">10433</span><span class="refDoi"> DOI: 10.1523/JNEUROSCI.1850-08.2008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=10.1523%2FJNEUROSCI.1850-08.2008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=18842902" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1GksLfF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2008&pages=10422-10433&author=C.+K.+Jonesauthor=A.+E.+Bradyauthor=A.+A.+Davisauthor=Z.+Xiangauthor=M.+Bubserauthor=M.+N.+Tantawyauthor=A.+S.+Kaneauthor=T.+M.+Bridgesauthor=J.+P.+Kennedyauthor=S.+R.+Bradleyauthor=T.+E.+Petersonauthor=M.+S.+Ansariauthor=R.+M.+Baldwinauthor=R.+M.+Kesslerauthor=A.+Y.+Deutchauthor=J.+J.+Lahauthor=A.+I.+Leveyauthor=C.+W.+Lindsleyauthor=P.+J.+Conn&title=Novel+selective+allosteric+activator+of+the+M1+muscarinic+acetylcholine+receptor+regulates+amyloid+processing+and+produces+antipsychotic-like+activity+in+rats&doi=10.1523%2FJNEUROSCI.1850-08.2008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39bR"><div class="casContent"><span class="casTitleNuber">39b</span><div class="casTitle"><span class="NLM_cas:atitle">Novel selective allosteric activator of the M1 muscarinic acetylcholine receptor regulates amyloid processing and produces antipsychotic-like activity in rats</span></div><div class="casAuthors">Jones, Carrie K.; Brady, Ashley E.; Davis, Albert A.; Xiang, Zixiu; Bubser, Michael; Tantawy, Mohammed Noor; Kane, Alexander S.; Bridges, Thomas M.; Kennedy, J. Phillip; Bradley, Stefania R.; Peterson, Todd E.; Ansari, M. Sib; Baldwin, Ronald M.; Kessler, Robert M.; Deutch, Ariel Y.; Lah, James J.; Levey, Allan I.; Lindsley, Craig W.; Conn, P. Jeffrey</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">41</span>),
    <span class="NLM_cas:pages">10422-10433</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Recent studies suggest that subtype-selective activators of M1/M4 muscarinic acetylcholine receptors (mAChRs) may offer a novel approach for the treatment of psychotic symptoms assocd. with schizophrenia and Alzheimer's disease.  Previously developed muscarinic agonists have provided clin. data in support of this hypothesis, but failed in clin. development because of a lack of true subtype specificity and adverse effects assocd. with activation of other mAChR subtypes.  We now report characterization of a novel highly selective agonist for the M1 receptor with no agonist activity at any of the other mAChR subtypes, termed TBPB [1-((1'-2-methylbenzyl)-1,4'-bipiperidin-4-yl)-1H-benzo[d]imidazol-2(3H)-one].  Mutagenesis and mol. pharmacol. studies revealed that TBPB activates M1 through an allosteric site rather than the orthosteric acetylcholine binding site, which is likely crit. for its unprecedented selectivity.  Whole-cell patch-clamp recordings demonstrated that activation of M1 by TBPB potentiates NMDA receptor currents in hippocampal pyramidal cells but does not alter excitatory or inhibitory synaptic transmission, responses thought to be mediated by M2 and M4.  TBPB was efficacious in models predictive of antipsychotic-like activity in rats at doses that did not produce catalepsy or peripheral adverse effects of other mAChR agonists.  Finally, TBPB had effects on the processing of the amyloid precursor protein toward the non-amyloidogenic pathway and decreased Aβ prodn. in vitro.  Together, these data suggest that selective activation of M1 may provide a novel approach for the treatment of symptoms assocd. with schizophrenia and Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5LP3cEBPDvbVg90H21EOLACvtfcHk0liqnyQIa82EEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1GksLfF&md5=25b306eb2aa00bdce1c08ad24bd59b35</span></div><a href="/servlet/linkout?suffix=cit39b&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.1850-08.2008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.1850-08.2008%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DC.%2BK.%26aulast%3DBrady%26aufirst%3DA.%2BE.%26aulast%3DDavis%26aufirst%3DA.%2BA.%26aulast%3DXiang%26aufirst%3DZ.%26aulast%3DBubser%26aufirst%3DM.%26aulast%3DTantawy%26aufirst%3DM.%2BN.%26aulast%3DKane%26aufirst%3DA.%2BS.%26aulast%3DBridges%26aufirst%3DT.%2BM.%26aulast%3DKennedy%26aufirst%3DJ.%2BP.%26aulast%3DBradley%26aufirst%3DS.%2BR.%26aulast%3DPeterson%26aufirst%3DT.%2BE.%26aulast%3DAnsari%26aufirst%3DM.%2BS.%26aulast%3DBaldwin%26aufirst%3DR.%2BM.%26aulast%3DKessler%26aufirst%3DR.%2BM.%26aulast%3DDeutch%26aufirst%3DA.%2BY.%26aulast%3DLah%26aufirst%3DJ.%2BJ.%26aulast%3DLevey%26aufirst%3DA.%2BI.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26aulast%3DConn%26aufirst%3DP.%2BJ.%26atitle%3DNovel%2520selective%2520allosteric%2520activator%2520of%2520the%2520M1%2520muscarinic%2520acetylcholine%2520receptor%2520regulates%2520amyloid%2520processing%2520and%2520produces%2520antipsychotic-like%2520activity%2520in%2520rats%26jtitle%3DJ.%2520Neurosci.%26date%3D2008%26volume%3D28%26spage%3D10422%26epage%3D10433%26doi%3D10.1523%2FJNEUROSCI.1850-08.2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Popiolek, M.; Nguyen, D.; Reinhart, V.; Edgerton, J.; Harms, J.; Lotarski, S. M.; Steyn, S. J.; Davoren, J. E.; Grimwood, S.</span>, <span> </span><span class="NLM_article-title">Quantifying CNS M1 muscarinic aetylcholine receptor modulation using an in-vivo IP1 accumulation assay</span>. Unpublished results.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Popiolek%2C+M.%3B+Nguyen%2C+D.%3B+Reinhart%2C+V.%3B+Edgerton%2C+J.%3B+Harms%2C+J.%3B+Lotarski%2C+S.+M.%3B+Steyn%2C+S.+J.%3B+Davoren%2C+J.+E.%3B+Grimwood%2C+S.%2C+Quantifying+CNS+M1+muscarinic+aetylcholine+receptor+modulation+using+an+in-vivo+IP1+accumulation+assay.+Unpublished+results."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DPopiolek%26aufirst%3DM.%26atitle%3DQuantifying%2520CNS%2520M1%2520muscarinic%2520aetylcholine%2520receptor%2520modulation%2520using%2520an%2520in-vivo%2520IP1%2520accumulation%2520assay" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Tracy, J. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monaco, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giovannetti, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abraham, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Josiassen, R. C.</span><span> </span><span class="NLM_article-title">Anticholinergicity and cognitive processing in chronic schizophrenia</span> <span class="citation_source-journal">Biol. Psychol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">22</span><span class="refDoi"> DOI: 10.1016/S0301-0511(00)00083-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=10.1016%2FS0301-0511%2800%2900083-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=11240312" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=1%3ACAS%3A280%3ADC%252BD3MzmvVCgtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2001&pages=1-22&author=J.+I.+Tracyauthor=C.+Monacoauthor=T.+Giovannettiauthor=G.+Abrahamauthor=R.+C.+Josiassen&title=Anticholinergicity+and+cognitive+processing+in+chronic+schizophrenia&doi=10.1016%2FS0301-0511%2800%2900083-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41aR"><div class="casContent"><span class="casTitleNuber">41a</span><div class="casTitle"><span class="NLM_cas:atitle">Anticholinergicity and cognitive processing in chronic schizophrenia</span></div><div class="casAuthors">Tracy J I; Monaco C; Giovannetti T; Abraham G; Josiassen R C</div><div class="citationInfo"><span class="NLM_cas:title">Biological psychology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-22</span>
        ISSN:<span class="NLM_cas:issn">0301-0511</span>.
    </div><div class="casAbstract">Patients with chronic schizophrenia suffer from alterations in cholinergic functioning due to several factors, including the disease diathesis and pharmacologic treatments.  Acetylcholine-cognition relationships are well explored in normals but are unclear in schizophrenia.  Prior work indicated serum anticholinergicity does not cause global cognitive impairment in this group (Tracy et al., 1998a), raising the possibility that anticholinergicity normalizes an abnormal hyperactive cholinergic state.  Serum anticholinergic levels were determined in 38 chronic schizophrenia patients using an established radioreceptor assay method.  Six cognitive functions associated with cholinergic tone in normals were tested.  The potential role of autonomic arousal and cigarette smoking were also assessed as both have been linked to cholinergic functioning.  Regression analyses showed measures of inhibitory executive control and effortful memory accounted for a greater proportion of the variance in the anticholinergicity measure compared to the other variables.  The data demonstrate a relationship between high anticholinergicity and worse performance on two types of attention-resource demanding cognitive processes and do not support the notion that reduced cholinergic tone normalizes a hyperactive cortical acetylcholine substrate.  Relevant neuroanatomic structures and implications for models of cognitive deficits in schizophrenia are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTo4csLrgw5B-2qxNLjzXe8fW6udTcc2eZr8okBGPPnKLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3MzmvVCgtQ%253D%253D&md5=ffa863c5e0ef48cf746192cba065389c</span></div><a href="/servlet/linkout?suffix=cit41a&amp;dbid=16384&amp;doi=10.1016%2FS0301-0511%2800%2900083-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0301-0511%252800%252900083-1%26sid%3Dliteratum%253Aachs%26aulast%3DTracy%26aufirst%3DJ.%2BI.%26aulast%3DMonaco%26aufirst%3DC.%26aulast%3DGiovannetti%26aufirst%3DT.%26aulast%3DAbraham%26aufirst%3DG.%26aulast%3DJosiassen%26aufirst%3DR.%2BC.%26atitle%3DAnticholinergicity%2520and%2520cognitive%2520processing%2520in%2520chronic%2520schizophrenia%26jtitle%3DBiol.%2520Psychol.%26date%3D2001%26volume%3D56%26spage%3D1%26epage%3D22%26doi%3D10.1016%2FS0301-0511%2800%2900083-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit41b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Vinogradov, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warm, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holland, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirshner, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pollock, B. G.</span><span> </span><span class="NLM_article-title">The cognitive cost of anticholinergic burden: decreased response to cognitive training in schizophrenia</span> <span class="citation_source-journal">Am. J. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">166</span><span class="NLM_x">, </span> <span class="NLM_fpage">1055</span><span class="NLM_x">–</span> <span class="NLM_lpage">1062</span><span class="refDoi"> DOI: 10.1176/appi.ajp.2009.09010017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=10.1176%2Fappi.ajp.2009.09010017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=19570929" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=1%3ACAS%3A280%3ADC%252BD1MrpsFagsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=166&publication_year=2009&pages=1055-1062&author=S.+Vinogradovauthor=M.+Fisherauthor=H.+Warmauthor=C.+Hollandauthor=M.+A.+Kirshnerauthor=B.+G.+Pollock&title=The+cognitive+cost+of+anticholinergic+burden%3A+decreased+response+to+cognitive+training+in+schizophrenia&doi=10.1176%2Fappi.ajp.2009.09010017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41bR"><div class="casContent"><span class="casTitleNuber">41b</span><div class="casTitle"><span class="NLM_cas:atitle">The cognitive cost of anticholinergic burden: decreased response to cognitive training in schizophrenia</span></div><div class="casAuthors">Vinogradov Sophia; Fisher Melissa; Warm Heather; Holland Christine; Kirshner Margaret A; Pollock Bruce G</div><div class="citationInfo"><span class="NLM_cas:title">The American journal of psychiatry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">166</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1055-62</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">OBJECTIVE:  Schizophrenia is treated with medications that raise serum anticholinergic activity and are known to adversely affect cognition.  The authors examined the relationship between serum anticholinergic activity and baseline cognitive performance and response to computerized cognitive training in outpatients with schizophrenia.  METHOD:  Fifty-five patients were randomly assigned to either computerized cognitive training or a computer games control condition.  A neurocognitive battery based on the Measurement and Treatment Research to Improve Cognition in Schizophrenia (MATRICS) initiative was performed at baseline and after the intervention.  Serum anticholinergic activity, measured at study entry by radioreceptor assay, was available for 49 patients.  RESULTS:  Serum anticholinergic activity showed a significant negative correlation with baseline performance in verbal working memory and verbal learning and memory, accounting for 7% of the variance in these measures, independent of age, IQ, or symptom severity.  Patients in the cognitive training condition (N=25) showed a significant gain in global cognition compared to those in the control condition, but this improvement was negatively correlated with anticholinergic burden.  Serum anticholinergic activity uniquely accounted for 20% of the variance in global cognition change, independent of age, IQ, or symptom severity.  CONCLUSIONS:  Serum anticholinergic activity in schizophrenia patients shows a significant association with impaired performance in MATRICS-based measures of verbal working memory and verbal learning and memory and is significantly associated with a lowered response to an intensive course of computerized cognitive training.  These findings underscore the cognitive cost of medications that carry a high anticholinergic burden.  The findings also have implications for the design and evaluation of cognitive treatments for schizophrenia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSSzVfjWI3hq0kUaC_kzhvyfW6udTcc2ebsNDKTmUCnO7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1MrpsFagsg%253D%253D&md5=79f0d2ccc76d80d4eb6b469d5f733f2c</span></div><a href="/servlet/linkout?suffix=cit41b&amp;dbid=16384&amp;doi=10.1176%2Fappi.ajp.2009.09010017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1176%252Fappi.ajp.2009.09010017%26sid%3Dliteratum%253Aachs%26aulast%3DVinogradov%26aufirst%3DS.%26aulast%3DFisher%26aufirst%3DM.%26aulast%3DWarm%26aufirst%3DH.%26aulast%3DHolland%26aufirst%3DC.%26aulast%3DKirshner%26aufirst%3DM.%2BA.%26aulast%3DPollock%26aufirst%3DB.%2BG.%26atitle%3DThe%2520cognitive%2520cost%2520of%2520anticholinergic%2520burden%253A%2520decreased%2520response%2520to%2520cognitive%2520training%2520in%2520schizophrenia%26jtitle%3DAm.%2520J.%2520Psychiatry%26date%3D2009%26volume%3D166%26spage%3D1055%26epage%3D1062%26doi%3D10.1176%2Fappi.ajp.2009.09010017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit41c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Minzenberg, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poole, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benton, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vinogradov, S.</span><span> </span><span class="NLM_article-title">Association of anticholinergic load with impairment of complex attention and memory in schizophrenia</span> <span class="citation_source-journal">Am. J. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">161</span><span class="NLM_x">, </span> <span class="NLM_fpage">116</span><span class="NLM_x">–</span> <span class="NLM_lpage">124</span><span class="refDoi"> DOI: 10.1176/appi.ajp.161.1.116</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=10.1176%2Fappi.ajp.161.1.116" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=14702259" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=1%3ACAS%3A280%3ADC%252BD2c%252FgsF2mtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=161&publication_year=2004&pages=116-124&author=M.+J.+Minzenbergauthor=J.+H.+Pooleauthor=C.+Bentonauthor=S.+Vinogradov&title=Association+of+anticholinergic+load+with+impairment+of+complex+attention+and+memory+in+schizophrenia&doi=10.1176%2Fappi.ajp.161.1.116"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41cR"><div class="casContent"><span class="casTitleNuber">41c</span><div class="casTitle"><span class="NLM_cas:atitle">Association of anticholinergic load with impairment of complex attention and memory in schizophrenia</span></div><div class="casAuthors">Minzenberg Michael J; Poole John H; Benton Cynthia; Vinogradov Sophia</div><div class="citationInfo"><span class="NLM_cas:title">The American journal of psychiatry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">161</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">116-24</span>
        ISSN:<span class="NLM_cas:issn">0002-953X</span>.
    </div><div class="casAbstract">OBJECTIVE:  The authors' goals were 1) to establish a clinically useful standard index of the relative anticholinergic potency of psychiatric medications; 2) to determine which cognitive functions are most affected by the administration of anticholinergic medications to patients with schizophrenia; and 3) to compare in vitro and clinically derived indexes of anticholinergic load in predicting these cognitive impairments.  METHOD:  One hundred six clinically stable patients with schizophrenia were given a brief neuropsychological battery and evaluated on a standard symptom rating scale.  The anticholinergic load associated with their psychiatric medications was estimated by using 1) a pharmacological index, calculated from a compilation of published studies reporting in vitro brain muscarinic receptor antagonism, and 2) a clinical index, based on clinician ratings of the anticholinergic side effects of medications.  The authors analyzed the correlations of both indexes with the neuropsychological measures and with summary neuropsychological factor scores.  RESULTS:  The clinical and pharmacological anticholinergic indexes were highly correlated with each other and showed virtually identical associations with neuropsychological measures.  Anticholinergic load was associated with lower scores on measures of attention and declarative memory, including several measures of auditory and visual memory and two tests of complex attention, but was unrelated to intelligence, simple attention, working memory, executive functions, conceptual fluency, or motor speed.  CONCLUSIONS:  This pattern of cognitive impairment with central cholinergic antagonism is consistent with emerging models of the functional anatomy of ascending forebrain cholinergic subsystems.  Both pharmacological and clinical indexes show utility in predicting the effects of anticholinergic load on cognition in schizophrenia.  Doses of psychiatric medication within the range of routine pharmacotherapy practice may have clinically significant effects on memory and complex attention in patients with schizophrenia; these effects may contribute as much as one-third to two-thirds of the memory deficit typically seen in patients with schizophrenia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQq9SPY1Vvv46e0F5ixvZgXfW6udTcc2ebsNDKTmUCnO7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2c%252FgsF2mtw%253D%253D&md5=8ff96909be81fbf2bdd00cca20f2971e</span></div><a href="/servlet/linkout?suffix=cit41c&amp;dbid=16384&amp;doi=10.1176%2Fappi.ajp.161.1.116&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1176%252Fappi.ajp.161.1.116%26sid%3Dliteratum%253Aachs%26aulast%3DMinzenberg%26aufirst%3DM.%2BJ.%26aulast%3DPoole%26aufirst%3DJ.%2BH.%26aulast%3DBenton%26aufirst%3DC.%26aulast%3DVinogradov%26aufirst%3DS.%26atitle%3DAssociation%2520of%2520anticholinergic%2520load%2520with%2520impairment%2520of%2520complex%2520attention%2520and%2520memory%2520in%2520schizophrenia%26jtitle%3DAm.%2520J.%2520Psychiatry%26date%3D2004%26volume%3D161%26spage%3D116%26epage%3D124%26doi%3D10.1176%2Fappi.ajp.161.1.116" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Kumari, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soni, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathew, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharma, T.</span><span> </span><span class="NLM_article-title">Prepulse inhibition of the startle response in men with schizophrenia: effects of age of onset of illness, symptoms, and medication</span> <span class="citation_source-journal">Arch. Gen. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">609</span><span class="NLM_x">–</span> <span class="NLM_lpage">614</span><span class="refDoi"> DOI: 10.1001/archpsyc.57.6.609</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=10.1001%2Farchpsyc.57.6.609" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=10839340" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=1%3ACAS%3A280%3ADC%252BD3c3ps1Wmsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2000&pages=609-614&author=V.+Kumariauthor=W.+Soniauthor=V.+M.+Mathewauthor=T.+Sharma&title=Prepulse+inhibition+of+the+startle+response+in+men+with+schizophrenia%3A+effects+of+age+of+onset+of+illness%2C+symptoms%2C+and+medication&doi=10.1001%2Farchpsyc.57.6.609"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Prepulse inhibition of the startle response in men with schizophrenia: effects of age of onset of illness, symptoms, and medication</span></div><div class="casAuthors">Kumari V; Soni W; Mathew V M; Sharma T</div><div class="citationInfo"><span class="NLM_cas:title">Archives of general psychiatry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">609-14</span>
        ISSN:<span class="NLM_cas:issn">0003-990X</span>.
    </div><div class="casAbstract">BACKGROUND:  Prepulse inhibition of the startle reflex response refers to the ability of a weak prestimulus to transiently inhibit the response to a closely following strong sensory stimulus.  This effect represents an operational index of sensorimotor gating and is found to be deficient in schizophrenia.  Prepulse inhibition deficits in schizophrenia seem to be partially normalized by typical antipsychotics and more fully by some atypical antipsychotics.  Early onset of schizophrenia, particularly in men, has been associated with abnormal brain maturation, profound neuropsychological deficits, and less responsiveness to antipsychotic medication.  We evaluated the effects of the age of onset of illness, current positive and negative symptoms, and the type of medication (typical vs atypical) on prepulse inhibition of the startle response in schizophrenia.  METHODS:  Thirty-eight male schizophrenic patients and 20 healthy male controls underwent testing for prepulse inhibition of the acoustic startle response.  RESULTS:  Earlier onset of illness was associated with reduced prepulse inhibition, while adult onset of illness was not.  No significant relationships occurred between current symptoms and prepulse inhibition.  Patients given typical, but not atypical, antipsychotics exhibited less prepulse inhibition compared with healthy controls.  CONCLUSION:  Early onset of illness is associated with profound deficits in prepulse inhibition of the startle response in men with schizophrenia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ0gLxkR5OJveRS7coPn-RtfW6udTcc2eaICnKIAAxSa7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3c3ps1Wmsg%253D%253D&md5=e7131d6e9bb0f2954521eeb0464bb5d6</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1001%2Farchpsyc.57.6.609&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1001%252Farchpsyc.57.6.609%26sid%3Dliteratum%253Aachs%26aulast%3DKumari%26aufirst%3DV.%26aulast%3DSoni%26aufirst%3DW.%26aulast%3DMathew%26aufirst%3DV.%2BM.%26aulast%3DSharma%26aufirst%3DT.%26atitle%3DPrepulse%2520inhibition%2520of%2520the%2520startle%2520response%2520in%2520men%2520with%2520schizophrenia%253A%2520effects%2520of%2520age%2520of%2520onset%2520of%2520illness%252C%2520symptoms%252C%2520and%2520medication%26jtitle%3DArch.%2520Gen.%2520Psychiatry%26date%3D2000%26volume%3D57%26spage%3D609%26epage%3D614%26doi%3D10.1001%2Farchpsyc.57.6.609" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="note"><p class="first last">Data from the individual decibels is in the <a href="/doi/suppl/10.1021/acs.jmedchem.6b00544/suppl_file/jm6b00544_si_002.pdf" class="ext-link">Supporting Information</a>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="note"><p class="first last">In dog, it was challenging to obtain high plasma exposures due to <b>38</b>’s low thermodynamic solubility (2.7 μg/mL at pH 6.5) that limited absorption. To improve exposure, the formulation was changed to a spray dried dispersion (SDD).</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Alt, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pendri, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertekap, R. L.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benitex, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nophsker, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rockwell, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burford, N. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sum, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herbst, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrante, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hendricson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cvijic, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westphal, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Connell, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banks, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gentles, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jenkins, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loy, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macor, J. E.</span><span> </span><span class="NLM_article-title">Evidence for classical cholinergic toxicity associated with selective activation of M1 muscarinic receptors</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">356</span><span class="NLM_x">, </span> <span class="NLM_fpage">293</span><span class="NLM_x">–</span> <span class="NLM_lpage">304</span><span class="refDoi"> DOI: 10.1124/jpet.115.226910</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=10.1124%2Fjpet.115.226910" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=26582730" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=1%3ACAS%3A528%3ADC%252BC28XpvVelsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=356&publication_year=2016&pages=293-304&author=A.+Altauthor=A.+Pendriauthor=R.+L.+Bertekapauthor=G.+Liauthor=Y.+Benitexauthor=M.+Nophskerauthor=K.+L.+Rockwellauthor=N.+T.+Burfordauthor=C.+S.+Sumauthor=J.+Chenauthor=J.+J.+Herbstauthor=M.+Ferranteauthor=A.+Hendricsonauthor=M.+E.+Cvijicauthor=R.+S.+Westphalauthor=J.+O%E2%80%99Connellauthor=M.+Banksauthor=L.+Zhangauthor=R.+G.+Gentlesauthor=S.+Jenkinsauthor=J.+Loyauthor=J.+E.+Macor&title=Evidence+for+classical+cholinergic+toxicity+associated+with+selective+activation+of+M1+muscarinic+receptors&doi=10.1124%2Fjpet.115.226910"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Evidence for classical cholinergic toxicity associated with selective activation of M1 muscarinic receptors</span></div><div class="casAuthors">Alt, Andrew; Pendri, Annapurna; Bertekap, Robert L., Jr.; Li, Guo; Benitex, Yulia; Nophsker, Michelle; Rockwell, Kristin L.; Burford, Neil T.; Sum, Chi Shing; Chen, Jing; Herbst, John J.; Ferrante, Meredith; Hendricson, Adam; Cvijic, Mary Ellen; Westphal, Ryan S.; O'Connell, Jonathan; Banks, Martyn; Zhang, Litao; Gentles, Robert G.; Jenkins, Susan; Loy, James; Macor, John E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">356</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">293-304</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The muscarinic acetylcholine receptor subtype 1 (M1) receptors play an important role in cognition and memory, and are considered to be attractive targets for the development of novel medications to treat cognitive impairments seen in schizophrenia and Alzheimer's disease.  Indeed, the M1 agonist xanomeline has been shown to produce beneficial cognitive effects in both Alzheimer's disease and schizophrenia patients.  Unfortunately, the therapeutic utility of xanomeline was limited by cholinergic side effects (sweating, salivation, gastrointestinal distress), which are believed to result from nonselective activation of other muscarinic receptor subtypes such as M2 and M3.  Therefore, drug discovery efforts targeting the M1 receptor have focused on the discovery of compds. with improved selectivity profiles.  Recently, allosteric M1 receptor ligands have been described, which exhibit excellent selectivity for M1 over other muscarinic receptor subtypes.  In the current study, the following three compds. with mixed agonist/pos. allosteric modulator activities that are highly functionally selective for the M1 receptor were tested in rats, dogs, and cynomologous monkeys: (3-((1S,2S)-2-hydrocyclohexyl)-6-((6-(1-methyl-1H-pyrazol-4-yl)pyridin-3-yl)methyl)benzo[h]quinazolin-4(3H)-one; 1-((4-cyano-4-(pyridin-2-yl)piperidin-1-yl)methyl)-4-oxo-4H-quinolizine-3-carboxylic acid; and (R)-Et 3-(2-methylbenzamido)-[1,4'-bipiperidine]-1'-carboxylate).  Despite their selectivity for the M1 receptor, all three compds. elicited cholinergic side effects such as salivation, diarrhea, and emesis.  These effects could not be explained by activity at other muscarinic receptor subtypes, or by activity at other receptors tested.  Together, these results suggest that activation of M1 receptors alone is sufficient to produce unwanted cholinergic side effects such as those seen with xanomeline.  This has important implications for the development of M1 receptor-targeted therapeutics since it suggests that dose-limiting cholinergic side effects still reside in M1 receptor selective activators.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4zRN2771-9bVg90H21EOLACvtfcHk0lhbsLcj4EvNKg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XpvVelsLo%253D&md5=6cf55475ab7da402a6e08099bfc0f030</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1124%2Fjpet.115.226910&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.115.226910%26sid%3Dliteratum%253Aachs%26aulast%3DAlt%26aufirst%3DA.%26aulast%3DPendri%26aufirst%3DA.%26aulast%3DBertekap%26aufirst%3DR.%2BL.%26aulast%3DLi%26aufirst%3DG.%26aulast%3DBenitex%26aufirst%3DY.%26aulast%3DNophsker%26aufirst%3DM.%26aulast%3DRockwell%26aufirst%3DK.%2BL.%26aulast%3DBurford%26aufirst%3DN.%2BT.%26aulast%3DSum%26aufirst%3DC.%2BS.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DHerbst%26aufirst%3DJ.%2BJ.%26aulast%3DFerrante%26aufirst%3DM.%26aulast%3DHendricson%26aufirst%3DA.%26aulast%3DCvijic%26aufirst%3DM.%2BE.%26aulast%3DWestphal%26aufirst%3DR.%2BS.%26aulast%3DO%25E2%2580%2599Connell%26aufirst%3DJ.%26aulast%3DBanks%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DGentles%26aufirst%3DR.%2BG.%26aulast%3DJenkins%26aufirst%3DS.%26aulast%3DLoy%26aufirst%3DJ.%26aulast%3DMacor%26aufirst%3DJ.%2BE.%26atitle%3DEvidence%2520for%2520classical%2520cholinergic%2520toxicity%2520associated%2520with%2520selective%2520activation%2520of%2520M1%2520muscarinic%2520receptors%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2016%26volume%3D356%26spage%3D293%26epage%3D304%26doi%3D10.1124%2Fjpet.115.226910" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Cruickshank, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brudzynski, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McLachlan, R. S.</span><span> </span><span class="NLM_article-title">Involvement of M1 muscarinic receptors in the initiation of cholinergically induced epileptic seizures in the rat brain</span> <span class="citation_source-journal">Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">643</span><span class="NLM_x">, </span> <span class="NLM_fpage">125</span><span class="NLM_x">–</span> <span class="NLM_lpage">129</span><span class="refDoi"> DOI: 10.1016/0006-8993(94)90017-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=10.1016%2F0006-8993%2894%2990017-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=8032910" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=1%3ACAS%3A528%3ADyaK2cXivFGrtrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=643&publication_year=1994&pages=125-129&author=J.+W.+Cruickshankauthor=S.+M.+Brudzynskiauthor=R.+S.+McLachlan&title=Involvement+of+M1+muscarinic+receptors+in+the+initiation+of+cholinergically+induced+epileptic+seizures+in+the+rat+brain&doi=10.1016%2F0006-8993%2894%2990017-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46aR"><div class="casContent"><span class="casTitleNuber">46a</span><div class="casTitle"><span class="NLM_cas:atitle">Involvement of M1 muscarinic receptors in the initiation of cholinergically induced epileptic seizures in the rat brain</span></div><div class="casAuthors">Cruickshank, James W.; Brudzynski, Stefan M.; McLachlan, Richard S.</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">643</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">125-9</span>CODEN:
                <span class="NLM_cas:coden">BRREAP</span>;
        ISSN:<span class="NLM_cas:issn">0006-8993</span>.
    </div><div class="casAbstract">The present study was designed to det. the types of acetylcholine receptors involved in the initiation of epileptic seizures from the zona incerta and surrounding structures by cholinergic stimulation in rats.  Unilateral intracerebral microinjection of the mixed muscarinic and nicotinic agonist carbachol (3 μg) produced generalized seizures in 12 of 20 rats studied.  Local pretreatment with equimolar doses of acetylcholine receptor antagonists was used as a method of detg. the receptor type involved in the initiation of cholinergically induced seizures in the rat diencephalon.  Pretreatment with the M1 muscarinic receptor antagonist, pirenzepine (7 μg), abolished carbachol-induced seizures in 91% of the animals tested.  The M2 muscarinic receptor antagonist, methoctramine (12 μg) and the nicotinic receptor antagonist, mecamylamine (3 μg), were relatively ineffective in antagonizing seizures in 9% and 27%, resp.  The results suggest that M1 muscarinic receptors are preferentially involved in the initiation of generalized epileptic seizures in the basal diencephalon of the rat.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1KFGgI9np_rVg90H21EOLACvtfcHk0liF2ca4ZIKX3w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXivFGrtrg%253D&md5=b60f88c71cacb00217841df372c67408</span></div><a href="/servlet/linkout?suffix=cit46a&amp;dbid=16384&amp;doi=10.1016%2F0006-8993%2894%2990017-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-8993%252894%252990017-5%26sid%3Dliteratum%253Aachs%26aulast%3DCruickshank%26aufirst%3DJ.%2BW.%26aulast%3DBrudzynski%26aufirst%3DS.%2BM.%26aulast%3DMcLachlan%26aufirst%3DR.%2BS.%26atitle%3DInvolvement%2520of%2520M1%2520muscarinic%2520receptors%2520in%2520the%2520initiation%2520of%2520cholinergically%2520induced%2520epileptic%2520seizures%2520in%2520the%2520rat%2520brain%26jtitle%3DBrain%2520Res.%26date%3D1994%26volume%3D643%26spage%3D125%26epage%3D129%26doi%3D10.1016%2F0006-8993%2894%2990017-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit46b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Hamilton, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loose, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levey, A. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hille, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKnight, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Idzerda, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nathanson, N. M.</span><span> </span><span class="NLM_article-title">Disruption of the m1 receptor gene ablates muscarinic receptor-dependent M current regulation and seizure activity in mice</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">94</span><span class="NLM_x">, </span> <span class="NLM_fpage">13311</span><span class="NLM_x">–</span> <span class="NLM_lpage">13316</span><span class="refDoi"> DOI: 10.1073/pnas.94.24.13311</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=10.1073%2Fpnas.94.24.13311" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=1997&pages=13311-13316&author=S.+E.+Hamiltonauthor=M.+D.+Looseauthor=M.+Qiauthor=A.+I.+Leveyauthor=B.+Hilleauthor=G.+S.+McKnightauthor=R.+L.+Idzerdaauthor=N.+M.+Nathanson&title=Disruption+of+the+m1+receptor+gene+ablates+muscarinic+receptor-dependent+M+current+regulation+and+seizure+activity+in+mice&doi=10.1073%2Fpnas.94.24.13311"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46b&amp;dbid=16384&amp;doi=10.1073%2Fpnas.94.24.13311&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.94.24.13311%26sid%3Dliteratum%253Aachs%26aulast%3DHamilton%26aufirst%3DS.%2BE.%26aulast%3DLoose%26aufirst%3DM.%2BD.%26aulast%3DQi%26aufirst%3DM.%26aulast%3DLevey%26aufirst%3DA.%2BI.%26aulast%3DHille%26aufirst%3DB.%26aulast%3DMcKnight%26aufirst%3DG.%2BS.%26aulast%3DIdzerda%26aufirst%3DR.%2BL.%26aulast%3DNathanson%26aufirst%3DN.%2BM.%26atitle%3DDisruption%2520of%2520the%2520m1%2520receptor%2520gene%2520ablates%2520muscarinic%2520receptor-dependent%2520M%2520current%2520regulation%2520and%2520seizure%2520activity%2520in%2520mice%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1997%26volume%3D94%26spage%3D13311%26epage%3D13316%26doi%3D10.1073%2Fpnas.94.24.13311" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><a href="http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292340.pdf" class="extLink">http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292340.pdf</a> (accessed February 11,<span class="NLM_x"> </span><span class="NLM_year">2016</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=http%3A%2F%2Fwww.fda.gov%2Fdownloads%2Fdrugs%2Fguidancecomplianceregulatoryinformation%2Fguidances%2Fucm292340.pdf+%28accessed+February+11%2C+2016%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group">Friesen, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shanker, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crew, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smithey, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curatolo, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nightingale, J. A.</span><span> </span><span class="NLM_article-title">Hydroxypropyl methylcellulose acetate succinate-based spray-dried dispersions: an overview</span> <span class="citation_source-journal">Mol. Pharmaceutics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">1003</span><span class="NLM_x">–</span> <span class="NLM_lpage">1019</span><span class="refDoi"> DOI: 10.1021/mp8000793</span> </span><div class="citationLinks">[<a href="/doi/10.1021/mp8000793" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVSntb3F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2008&pages=1003-1019&author=D.+T.+Friesenauthor=R.+Shankerauthor=M.+Crewauthor=D.+T.+Smitheyauthor=W.+J.+Curatoloauthor=J.+A.+Nightingale&title=Hydroxypropyl+methylcellulose+acetate+succinate-based+spray-dried+dispersions%3A+an+overview&doi=10.1021%2Fmp8000793"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Hydroxypropyl Methylcellulose Acetate Succinate-Based Spray-Dried Dispersions: An Overview</span></div><div class="casAuthors">Friesen, Dwayne T.; Shanker, Ravi; Crew, Marshall; Smithey, Daniel T.; Curatolo, W. J.; Nightingale, J. A. S.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmaceutics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1003-1019</span>CODEN:
                <span class="NLM_cas:coden">MPOHBP</span>;
        ISSN:<span class="NLM_cas:issn">1543-8384</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Spray-dried dispersions (SDDs) of low-soly. drugs have been prepd. using the polymer hydroxypropyl methylcellulose acetate succinate (HPMCAS).  For a variety of drug structures, these SDDs provide supersatn. in in vitro dissoln. detns. and large bioavailability increases in vivo.  In bile-salt/lecithin in vitro solns., these SDDs provide amorphous drug/polymer colloids and an increased concn. of free drug and drug in micelles relative to cryst. or amorphous drug.  As dry powders, the SDDs are a single amorphous phase in which the drug remains amorphous and dispersed and does not crystallize over storage times relevant for practical drug products.  A melting temp. (Tm)/glass-transition temp. (Tg) (K/K) vs. log P map for 139 compds. formulated as SDDs provides a perspective on an appropriate formulation strategy for low-soly. drugs with various phys. properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqf-Shnc2vArbVg90H21EOLACvtfcHk0liF2ca4ZIKX3w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVSntb3F&md5=fde03d051c36ecaeb377c4591e6d51fe</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1021%2Fmp8000793&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fmp8000793%26sid%3Dliteratum%253Aachs%26aulast%3DFriesen%26aufirst%3DD.%2BT.%26aulast%3DShanker%26aufirst%3DR.%26aulast%3DCrew%26aufirst%3DM.%26aulast%3DSmithey%26aufirst%3DD.%2BT.%26aulast%3DCuratolo%26aufirst%3DW.%2BJ.%26aulast%3DNightingale%26aufirst%3DJ.%2BA.%26atitle%3DHydroxypropyl%2520methylcellulose%2520acetate%2520succinate-based%2520spray-dried%2520dispersions%253A%2520an%2520overview%26jtitle%3DMol.%2520Pharmaceutics%26date%3D2008%26volume%3D5%26spage%3D1003%26epage%3D1019%26doi%3D10.1021%2Fmp8000793" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1a','cit1b','cit1c','cit1d'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':[],'ref8':['cit8'],'ref9':[],'ref10':['cit10a','cit10b','cit10c'],'ref11':['cit11a','cit11b','cit11c','cit11d','cit11e','cit11f','cit11g','cit11h'],'ref12':['cit12a','cit12b','cit12c','cit12d','cit12e','cit12f','cit12g','cit12h','cit12i','cit12j','cit12k','cit12l','cit12m','cit12n','cit12o','cit12p','cit12q','cit12r','cit12s','cit12t','cit12u','cit12v','cit12w','cit12x','cit12y','cit12z','cit12aa','cit12ab','cit12ac','cit12ad','cit12ae'],'ref13':[],'ref14':['cit14a','cit14b','cit14c','cit14d','cit14e','cit14f','cit14g','cit14h','cit14i','cit14j','cit14k','cit14l','cit14m','cit14n','cit14o','cit14p','cit14q','cit14r','cit14s','cit14t','cit14u','cit14v','cit14w','cit14x','cit14y','cit14z','cit14aa'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17a','cit17b'],'ref18':[],'ref19':['cit19'],'ref20':[],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':[],'ref32':['cit32a','cit32b'],'ref33':['cit33a','cit33b','cit33c'],'ref34':['cit34'],'ref35':[],'ref36':['cit36a','cit36b'],'ref37':[],'ref38':[],'ref39':['cit39a','cit39b'],'ref40':['cit40'],'ref41':['cit41a','cit41b','cit41c'],'ref42':['cit42'],'ref43':[],'ref44':[],'ref45':['cit45'],'ref46':['cit46a','cit46b'],'ref47':['cit47'],'ref48':['cit48']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 52 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Woohyeong Lee, Changhoon Shin, Soo Eun Park, <span class="NLM_string-name hlFld-ContribAuthor">Jung Min Joo</span>. </span><span class="cited-content_cbyCitation_article-title">Regio- and Stereoselective Synthesis of Thiazole-Containing Triarylethylenes by Hydroarylation of Alkynes. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2019,</strong> <em>84 </em>
                                    (20)
                                     , 12913-12924. <a href="https://doi.org/10.1021/acs.joc.9b01619" title="DOI URL">https://doi.org/10.1021/acs.joc.9b01619</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.9b01619&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.9b01619%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DRegio-%252Band%252BStereoselective%252BSynthesis%252Bof%252BThiazole-Containing%252BTriarylethylenes%252Bby%252BHydroarylation%252Bof%252BAlkynes%26aulast%3DLee%26aufirst%3DWoohyeong%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D17062019%26date%3D21082019%26date%3D12082019%26volume%3D84%26issue%3D20%26spage%3D12913%26epage%3D12924" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Julie
L. Engers, Aaron M. Bender, Jacob J. Kalbfleisch, Hyekyung P. Cho, Kaelyn S. Lingenfelter, Vincent B. Luscombe, Changho Han, Bruce J. Melancon, Anna L. Blobaum, Jonathan W. Dickerson, Jerri M. Rook, Colleen M. Niswender, Kyle A. Emmitte, P. Jeffrey Conn, <span class="NLM_string-name hlFld-ContribAuthor">Craig W. Lindsley</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of Tricyclic Triazolo- and Imidazopyridine Lactams as M1 Positive Allosteric Modulators. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2019,</strong> <em>10 </em>
                                    (3)
                                     , 1035-1042. <a href="https://doi.org/10.1021/acschemneuro.8b00311" title="DOI URL">https://doi.org/10.1021/acschemneuro.8b00311</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.8b00311&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.8b00311%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DDiscovery%252Bof%252BTricyclic%252BTriazolo-%252Band%252BImidazopyridine%252BLactams%252Bas%252BM1%252BPositive%252BAllosteric%252BModulators%26aulast%3DEngers%26aufirst%3DJulie%2BL.%26date%3D2019%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D25062018%26date%3D07082018%26date%3D09082018%26date%3D07082018%26volume%3D10%26issue%3D3%26spage%3D1035%26epage%3D1042" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Michael Popiolek, Yael Mandelblat-Cerf, Damon Young, Jonathan Garst-Orozco, Susan M. Lotarski, Eda Stark, Melissa Kramer, Christopher R. Butler, <span class="NLM_string-name hlFld-ContribAuthor">Rouba Kozak</span>. </span><span class="cited-content_cbyCitation_article-title">In Vivo Modulation of Hippocampal Excitability by M4 Muscarinic Acetylcholine Receptor Activator: Implications for Treatment of Alzheimer’s Disease and Schizophrenic Patients. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2019,</strong> <em>10 </em>
                                    (3)
                                     , 1091-1098. <a href="https://doi.org/10.1021/acschemneuro.8b00496" title="DOI URL">https://doi.org/10.1021/acschemneuro.8b00496</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.8b00496&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.8b00496%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DIn%252BVivo%252BModulation%252Bof%252BHippocampal%252BExcitability%252Bby%252BM4%252BMuscarinic%252BAcetylcholine%252BReceptor%252BActivator%25253A%252BImplications%252Bfor%252BTreatment%252Bof%252BAlzheimer%2525E2%252580%252599s%252BDisease%252Band%252BSchizophrenic%252BPatients%26aulast%3DPopiolek%26aufirst%3DMichael%26date%3D2019%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D17092018%26date%3D17102018%26date%3D26102018%26date%3D17102018%26volume%3D10%26issue%3D3%26spage%3D1091%26epage%3D1098" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Manuela Jörg, Emma T. van der Westhuizen, Elham Khajehali, Wessel A. C. Burger, Jonathan M. White, Kwok H. C. Choy, Andrew B. Tobin, Patrick M. Sexton, Celine Valant, Ben Capuano, Arthur Christopoulos, <span class="NLM_string-name hlFld-ContribAuthor">Peter J. Scammells</span>. </span><span class="cited-content_cbyCitation_article-title">6-Phenylpyrimidin-4-ones as Positive Allosteric Modulators at the M1 mAChR: The Determinants of Allosteric Activity. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2019,</strong> <em>10 </em>
                                    (3)
                                     , 1099-1114. <a href="https://doi.org/10.1021/acschemneuro.8b00613" title="DOI URL">https://doi.org/10.1021/acschemneuro.8b00613</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.8b00613&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.8b00613%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3D6-Phenylpyrimidin-4-ones%252Bas%252BPositive%252BAllosteric%252BModulators%252Bat%252Bthe%252BM1%252BmAChR%25253A%252BThe%252BDeterminants%252Bof%252BAllosteric%252BActivity%26aulast%3DJ%25C3%25B6rg%26aufirst%3DManuela%26date%3D2019%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D06112018%26date%3D14122018%26date%3D28122018%26date%3D14122018%26volume%3D10%26issue%3D3%26spage%3D1099%26epage%3D1114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Catherine
A. Thorn, Joshua Moon, Clinton A. Bourbonais, John Harms, Jeremy R. Edgerton, Eda Stark, Stefanus J. Steyn, Christopher R. Butter, John T. Lazzaro, Rebecca E. O’Connor, <span class="NLM_string-name hlFld-ContribAuthor">Michael Popiolek</span>. </span><span class="cited-content_cbyCitation_article-title">Striatal, Hippocampal, and Cortical Networks Are Differentially Responsive to the M4- and M1-Muscarinic Acetylcholine Receptor Mediated Effects of Xanomeline. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2019,</strong> <em>10 </em>
                                    (3)
                                     , 1753-1764. <a href="https://doi.org/10.1021/acschemneuro.8b00625" title="DOI URL">https://doi.org/10.1021/acschemneuro.8b00625</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.8b00625&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.8b00625%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DStriatal%25252C%252BHippocampal%25252C%252Band%252BCortical%252BNetworks%252BAre%252BDifferentially%252BResponsive%252Bto%252Bthe%252BM4-%252Band%252BM1-Muscarinic%252BAcetylcholine%252BReceptor%252BMediated%252BEffects%252Bof%252BXanomeline%26aulast%3DThorn%26aufirst%3DCatherine%2BA.%26date%3D2019%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D12112018%26date%3D27112018%26date%3D11122018%26date%3D27112018%26volume%3D10%26issue%3D3%26spage%3D1753%26epage%3D1764" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Hannah
M. S. Haley, Adam G. Hill, Alexander I. Greenwood, Eric M. Woerly, Chad M. Rienstra, <span class="NLM_string-name hlFld-ContribAuthor">Martin D. Burke</span>. </span><span class="cited-content_cbyCitation_article-title">Peridinin Is an Exceptionally Potent and Membrane-Embedded Inhibitor of Bilayer Lipid Peroxidation. </span><span class="cited-content_cbyCitation_journal-name">Journal of the American Chemical Society</span><span> <strong>2018,</strong> <em>140 </em>
                                    (45)
                                     , 15227-15240. <a href="https://doi.org/10.1021/jacs.8b06933" title="DOI URL">https://doi.org/10.1021/jacs.8b06933</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jacs.8b06933&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjacs.8b06933%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520the%2520American%2520Chemical%2520Society%26atitle%3DPeridinin%252BIs%252Ban%252BExceptionally%252BPotent%252Band%252BMembrane-Embedded%252BInhibitor%252Bof%252BBilayer%252BLipid%252BPeroxidation%26aulast%3DHaley%26aufirst%3DHannah%2BM.%2BS.%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D02072018%26date%3D02112018%26date%3D16102018%26volume%3D140%26issue%3D45%26spage%3D15227%26epage%3D15240" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Jerri
M. Rook, Jeanette L. Bertron, Hyekyung P. Cho, Pedro M. Garcia-Barrantes, Sean P. Moran, James T. Maksymetz, Kellie D. Nance, Jonathan W. Dickerson, Daniel H. Remke, Sichen Chang, Joel M. Harp, Anna L. Blobaum, Colleen M. Niswender, Carrie K. Jones, Shaun R. Stauffer, P. Jeffrey Conn, <span class="NLM_string-name hlFld-ContribAuthor">Craig W. Lindsley</span>. </span><span class="cited-content_cbyCitation_article-title">A Novel M1 PAM VU0486846 Exerts Efficacy in Cognition Models without Displaying Agonist Activity or Cholinergic Toxicity. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2018,</strong> <em>9 </em>
                                    (9)
                                     , 2274-2285. <a href="https://doi.org/10.1021/acschemneuro.8b00131" title="DOI URL">https://doi.org/10.1021/acschemneuro.8b00131</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.8b00131&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.8b00131%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DA%252BNovel%252BM1%252BPAM%252BVU0486846%252BExerts%252BEfficacy%252Bin%252BCognition%252BModels%252Bwithout%252BDisplaying%252BAgonist%252BActivity%252Bor%252BCholinergic%252BToxicity%26aulast%3DRook%26aufirst%3DJerri%2BM.%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D20032018%26date%3D27042018%26date%3D08052018%26date%3D27042018%26volume%3D9%26issue%3D9%26spage%3D2274%26epage%3D2285" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Julie L. Engers, Elizabeth S. Childress, Madeline F. Long, Rory A. Capstick, Vincent B. Luscombe, Hekyung P. Cho, Jonathan W. Dickerson, Jerri M. Rook, Anna L. Blobaum, Colleen M. Niswender, Darren W. Engers, P. Jeffrey Conn, <span class="NLM_string-name hlFld-ContribAuthor">Craig W. Lindsley</span>. </span><span class="cited-content_cbyCitation_article-title">VU6007477, a Novel M1 PAM Based on a Pyrrolo[2,3-b]pyridine Carboxamide Core Devoid of Cholinergic Adverse Events. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2018,</strong> <em>9 </em>
                                    (9)
                                     , 917-922. <a href="https://doi.org/10.1021/acsmedchemlett.8b00261" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.8b00261</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.8b00261&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.8b00261%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DVU6007477%25252C%252Ba%252BNovel%252BM1%252BPAM%252BBased%252Bon%252Ba%252BPyrrolo%25255B2%25252C3-b%25255Dpyridine%252BCarboxamide%252BCore%252BDevoid%252Bof%252BCholinergic%252BAdverse%252BEvents%26aulast%3DEngers%26aufirst%3DJulie%2BL.%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D07062018%26date%3D04092018%26date%3D05092018%26date%3D04092018%26volume%3D9%26issue%3D9%26spage%3D917%26epage%3D922" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Robert J. Young, <span class="NLM_string-name hlFld-ContribAuthor">Paul D. Leeson</span>. </span><span class="cited-content_cbyCitation_article-title">Mapping the Efficiency and Physicochemical Trajectories of Successful Optimizations. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (15)
                                     , 6421-6467. <a href="https://doi.org/10.1021/acs.jmedchem.8b00180" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00180</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00180&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b00180%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DMapping%252Bthe%252BEfficiency%252Band%252BPhysicochemical%252BTrajectories%252Bof%252BSuccessful%252BOptimizations%26aulast%3DYoung%26aufirst%3DRobert%2BJ.%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D03022018%26date%3D25042018%26date%3D05042018%26volume%3D61%26issue%3D15%26spage%3D6421%26epage%3D6467" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Douglas C. Beshore, Christina N. Di Marco, Ronald K. Chang, Thomas J. Greshock, Lei Ma, Marion Wittmann, Matthew A. Seager, Kenneth A. Koeplinger, Charles D. Thompson, Joy Fuerst, George D. Hartman, Mark T. Bilodeau, William J. Ray, <span class="NLM_string-name hlFld-ContribAuthor">Scott D. Kuduk</span>. </span><span class="cited-content_cbyCitation_article-title">MK-7622: A First-in-Class M1 Positive Allosteric Modulator Development Candidate. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2018,</strong> <em>9 </em>
                                    (7)
                                     , 652-656. <a href="https://doi.org/10.1021/acsmedchemlett.8b00095" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.8b00095</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.8b00095&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.8b00095%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DMK-7622%25253A%252BA%252BFirst-in-Class%252BM1%252BPositive%252BAllosteric%252BModulator%252BDevelopment%252BCandidate%26aulast%3DBeshore%26aufirst%3DDouglas%2BC.%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D24022018%26date%3D30042018%26date%3D04052018%26date%3D30042018%26volume%3D9%26issue%3D7%26spage%3D652%26epage%3D656" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Jennie Liao, Weiye Guan, Brian P. Boscoe, Joseph W. Tucker, John W. Tomlin, Michelle R. Garnsey, <span class="NLM_string-name hlFld-ContribAuthor">Mary P. Watson</span>. </span><span class="cited-content_cbyCitation_article-title">Transforming Benzylic Amines into Diarylmethanes: Cross-Couplings of Benzylic Pyridinium Salts via C–N Bond Activation. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2018,</strong> <em>20 </em>
                                    (10)
                                     , 3030-3033. <a href="https://doi.org/10.1021/acs.orglett.8b01062" title="DOI URL">https://doi.org/10.1021/acs.orglett.8b01062</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.8b01062&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.8b01062%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DTransforming%252BBenzylic%252BAmines%252Binto%252BDiarylmethanes%25253A%252BCross-Couplings%252Bof%252BBenzylic%252BPyridinium%252BSalts%252Bvia%252BC%2525E2%252580%252593N%252BBond%252BActivation%26aulast%3DLiao%26aufirst%3DJennie%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D04042018%26date%3D10052018%26volume%3D20%26issue%3D10%26spage%3D3030%26epage%3D3033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Juliana
C. C. Dallagnol, Elham Khajehali, Emma T. van der Westhuizen, Manuela Jörg, Celine Valant, Alan G. Gonçalves, Ben Capuano, Arthur Christopoulos, <span class="NLM_string-name hlFld-ContribAuthor">Peter J. Scammells</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and Pharmacological Evaluation of Heterocyclic Carboxamides: Positive Allosteric Modulators of the M1 Muscarinic Acetylcholine Receptor with Weak Agonist Activity and Diverse Modulatory Profiles. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (7)
                                     , 2875-2894. <a href="https://doi.org/10.1021/acs.jmedchem.7b01812" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b01812</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b01812&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b01812%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252BPharmacological%252BEvaluation%252Bof%252BHeterocyclic%252BCarboxamides%25253A%252BPositive%252BAllosteric%252BModulators%252Bof%252Bthe%252BM1%252BMuscarinic%252BAcetylcholine%252BReceptor%252Bwith%252BWeak%252BAgonist%252BActivity%252Band%252BDiverse%252BModulatory%252BProfiles%26aulast%3DDallagnol%26aufirst%3DJuliana%2BC.%2BC.%26date%3D2018%26date%3D2018%26date%3D2017%26date%3D10122017%26date%3D23032018%26date%3D15032018%26volume%3D61%26issue%3D7%26spage%3D2875%26epage%3D2894" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jennifer E.  Davoren</span>, <span class="hlFld-ContribAuthor ">Michelle  Garnsey</span>, <span class="hlFld-ContribAuthor ">Betty  Pettersen</span>, <span class="hlFld-ContribAuthor ">Michael A.  Brodney</span>, <span class="hlFld-ContribAuthor ">Jeremy R.  Edgerton</span>, <span class="hlFld-ContribAuthor ">Jean-Philippe  Fortin</span>, <span class="hlFld-ContribAuthor ">Sarah  Grimwood</span>, <span class="hlFld-ContribAuthor ">Anthony R.  Harris</span>, <span class="hlFld-ContribAuthor ">Stephen  Jenkinson</span>, <span class="hlFld-ContribAuthor ">Terry  Kenakin</span>, <span class="hlFld-ContribAuthor ">John T.  Lazzaro</span>, <span class="hlFld-ContribAuthor ">Che-Wah  Lee</span>, <span class="hlFld-ContribAuthor ">Susan M.  Lotarski</span>, <span class="hlFld-ContribAuthor ">Lisa  Nottebaum</span>, <span class="hlFld-ContribAuthor ">Steven V.  O’Neil</span>, <span class="hlFld-ContribAuthor ">Michael  Popiolek</span>, <span class="hlFld-ContribAuthor ">Simeon  Ramsey</span>, <span class="hlFld-ContribAuthor ">Stefanus J.  Steyn</span>, <span class="hlFld-ContribAuthor ">Catherine A.  Thorn</span>, <span class="hlFld-ContribAuthor ">Lei  Zhang</span>, and <span class="hlFld-ContribAuthor ">Damien  Webb</span>  . </span><span class="cited-content_cbyCitation_article-title">Design and Synthesis of γ- and δ-Lactam M1 Positive Allosteric Modulators (PAMs): Convulsion and Cholinergic Toxicity of an M1-Selective PAM with Weak Agonist Activity. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (15)
                                     , 6649-6663. <a href="https://doi.org/10.1021/acs.jmedchem.7b00597" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b00597</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b00597&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b00597%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%252Band%252BSynthesis%252Bof%252B%2525CE%2525B3-%252Band%252B%2525CE%2525B4-Lactam%252BM1%252BPositive%252BAllosteric%252BModulators%252B%252528PAMs%252529%25253A%252BConvulsion%252Band%252BCholinergic%252BToxicity%252Bof%252Ban%252BM1-Selective%252BPAM%252Bwith%252BWeak%252BAgonist%252BActivity%26aulast%3DDavoren%26aufirst%3DJennifer%2BE.%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D20042017%26date%3D26072017%26date%3D10082017%26date%3D09062017%26volume%3D60%26issue%3D15%26spage%3D6649%26epage%3D6663" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jerri M.  Rook</span>, <span class="hlFld-ContribAuthor ">Masahito  Abe</span>, <span class="hlFld-ContribAuthor ">Hyekyung P.  Cho</span>, <span class="hlFld-ContribAuthor ">Kellie D.  Nance</span>, <span class="hlFld-ContribAuthor ">Vincent B.  Luscombe</span>, <span class="hlFld-ContribAuthor ">Jeffrey J.  Adams</span>, <span class="hlFld-ContribAuthor ">Jonathan W.  Dickerson</span>, <span class="hlFld-ContribAuthor ">Daniel H.  Remke</span>, <span class="hlFld-ContribAuthor ">Pedro M.  Garcia-Barrantes</span>, <span class="hlFld-ContribAuthor ">Darren W.  Engers</span>, <span class="hlFld-ContribAuthor ">Julie L.  Engers</span>, <span class="hlFld-ContribAuthor ">Sichen  Chang</span>, <span class="hlFld-ContribAuthor ">Jarrett J.  Foster</span>, <span class="hlFld-ContribAuthor ">Anna L.  Blobaum</span>, <span class="hlFld-ContribAuthor ">Colleen M.  Niswender</span>, <span class="hlFld-ContribAuthor ">Carrie K.  Jones</span>, <span class="hlFld-ContribAuthor ">P. Jeffrey  Conn</span>, and <span class="hlFld-ContribAuthor ">Craig W.  Lindsley</span>  . </span><span class="cited-content_cbyCitation_article-title">Diverse Effects on M1 Signaling and Adverse Effect Liability within a Series of M1 Ago-PAMs. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2017,</strong> <em>8 </em>
                                    (4)
                                     , 866-883. <a href="https://doi.org/10.1021/acschemneuro.6b00429" title="DOI URL">https://doi.org/10.1021/acschemneuro.6b00429</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.6b00429&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.6b00429%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DDiverse%252BEffects%252Bon%252BM1%252BSignaling%252Band%252BAdverse%252BEffect%252BLiability%252Bwithin%252Ba%252BSeries%252Bof%252BM1%252BAgo-PAMs%26aulast%3DRook%26aufirst%3DJerri%2BM.%26date%3D2017%26date%3D2017%26date%3D2016%26date%3D2016%26date%3D07122016%26date%3D21122016%26date%3D10012017%26date%3D19042017%26date%3D21122016%26volume%3D8%26issue%3D4%26spage%3D866%26epage%3D883" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michael  Popiolek</span>, <span class="hlFld-ContribAuthor ">David P.  Nguyen</span>, <span class="hlFld-ContribAuthor ">Veronica  Reinhart</span>, <span class="hlFld-ContribAuthor ">Jeremy R.  Edgerton</span>, <span class="hlFld-ContribAuthor ">John  Harms</span>, <span class="hlFld-ContribAuthor ">Susan M.  Lotarski</span>, <span class="hlFld-ContribAuthor ">Stefanus J.  Steyn</span>, <span class="hlFld-ContribAuthor ">Jennifer E.  Davoren</span>, and <span class="hlFld-ContribAuthor ">Sarah  Grimwood</span>  . </span><span class="cited-content_cbyCitation_article-title">Inositol Phosphate Accumulation in Vivo Provides a Measure of Muscarinic M1 Receptor Activation. </span><span class="cited-content_cbyCitation_journal-name">Biochemistry</span><span> <strong>2016,</strong> <em>55 </em>
                                    (51)
                                     , 7073-7085. <a href="https://doi.org/10.1021/acs.biochem.6b00688" title="DOI URL">https://doi.org/10.1021/acs.biochem.6b00688</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.biochem.6b00688&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.biochem.6b00688%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemistry%26atitle%3DInositol%252BPhosphate%252BAccumulation%252Bin%252BVivo%252BProvides%252Ba%252BMeasure%252Bof%252BMuscarinic%252BM1%252BReceptor%252BActivation%26aulast%3DPopiolek%26aufirst%3DMichael%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D06072016%26date%3D26112016%26date%3D13122016%26date%3D27122016%26date%3D28112016%26volume%3D55%26issue%3D51%26spage%3D7073%26epage%3D7085" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Paul K.  Spearing</span>, <span class="hlFld-ContribAuthor ">Hyekyung P.  Cho</span>, <span class="hlFld-ContribAuthor ">Vincent B.  Luscombe</span>, <span class="hlFld-ContribAuthor ">Anna L.  Blobaum</span>, <span class="hlFld-ContribAuthor ">Olivier  Boutaud</span>, <span class="hlFld-ContribAuthor ">Darren W.  Engers</span>, <span class="hlFld-ContribAuthor ">Alice L.  Rodriguez</span>, <span class="hlFld-ContribAuthor ">Colleen M.  Niswender</span>, <span class="hlFld-ContribAuthor ">P.  Jeffrey Conn</span>, <span class="hlFld-ContribAuthor ">Craig W.  Lindsley</span>, <span class="hlFld-ContribAuthor ">Aaron M.  Bender</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of a novel class of heteroaryl-pyrrolidinones as positive allosteric modulators of the muscarinic acetylcholine receptor M1. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2021,</strong> <em>47 </em>, 128193. <a href="https://doi.org/10.1016/j.bmcl.2021.128193" title="DOI URL">https://doi.org/10.1016/j.bmcl.2021.128193</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2021.128193&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2021.128193%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252Ba%252Bnovel%252Bclass%252Bof%252Bheteroaryl-pyrrolidinones%252Bas%252Bpositive%252Ballosteric%252Bmodulators%252Bof%252Bthe%252Bmuscarinic%252Bacetylcholine%252Breceptor%252BM1%26aulast%3DSpearing%26aufirst%3DPaul%2BK.%26date%3D2021%26volume%3D47%26spage%3D128193" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wei  Yin</span>, <span class="hlFld-ContribAuthor ">Fahimeh  Mamashli</span>, <span class="hlFld-ContribAuthor ">Derek L.  Buhl</span>, <span class="hlFld-ContribAuthor ">Polyna  Khudyakov</span>, <span class="hlFld-ContribAuthor ">Dmitri  Volfson</span>, <span class="hlFld-ContribAuthor ">Ferenc  Martenyi</span>, <span class="hlFld-ContribAuthor ">Hakop  Gevorkyan</span>, <span class="hlFld-ContribAuthor ">Laura  Rosen</span>, <span class="hlFld-ContribAuthor ">Arthur A.  Simen</span>. </span><span class="cited-content_cbyCitation_article-title">Safety, pharmacokinetics and quantitative EEG modulation of TAK‐071, a novel muscarinic M1 receptor positive allosteric modulator, in healthy subjects. </span><span class="cited-content_cbyCitation_journal-name">British Journal of Clinical Pharmacology</span><span> <strong>2021,</strong> <em>9 </em><a href="https://doi.org/10.1111/bcp.14975" title="DOI URL">https://doi.org/10.1111/bcp.14975</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/bcp.14975&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fbcp.14975%26sid%3Dliteratum%253Aachs%26jtitle%3DBritish%2520Journal%2520of%2520Clinical%2520Pharmacology%26atitle%3DSafety%25252C%252Bpharmacokinetics%252Band%252Bquantitative%252BEEG%252Bmodulation%252Bof%252BTAK%2525E2%252580%252590071%25252C%252Ba%252Bnovel%252Bmuscarinic%252BM1%252Breceptor%252Bpositive%252Ballosteric%252Bmodulator%25252C%252Bin%252Bhealthy%252Bsubjects%26aulast%3DYin%26aufirst%3DWei%26date%3D2021%26date%3D2021%26volume%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Charlotte  Bakker</span>, <span class="hlFld-ContribAuthor ">Tim  Tasker</span>, <span class="hlFld-ContribAuthor ">Jan  Liptrot</span>, <span class="hlFld-ContribAuthor ">Ellen P.  Hart</span>, <span class="hlFld-ContribAuthor ">Erica S.  Klaassen</span>, <span class="hlFld-ContribAuthor ">Samantha  Prins</span>, <span class="hlFld-ContribAuthor ">Thalia F.  Doef</span>, <span class="hlFld-ContribAuthor ">Giles A.  Brown</span>, <span class="hlFld-ContribAuthor ">Alastair  Brown</span>, <span class="hlFld-ContribAuthor ">Miles  Congreve</span>, <span class="hlFld-ContribAuthor ">Malcolm  Weir</span>, <span class="hlFld-ContribAuthor ">Fiona H.  Marshall</span>, <span class="hlFld-ContribAuthor ">David M.  Cross</span>, <span class="hlFld-ContribAuthor ">Geert Jan  Groeneveld</span>, <span class="hlFld-ContribAuthor ">Pradeep J.  Nathan</span>. </span><span class="cited-content_cbyCitation_article-title">First‐in‐man study to investigate safety, pharmacokinetics and exploratory pharmacodynamics of HTL0018318, a novel M
              1
              ‐receptor partial agonist for the treatment of dementias. </span><span class="cited-content_cbyCitation_journal-name">British Journal of Clinical Pharmacology</span><span> <strong>2021,</strong> <em>87 </em>
                                    (7)
                                     , 2945-2955. <a href="https://doi.org/10.1111/bcp.14710" title="DOI URL">https://doi.org/10.1111/bcp.14710</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/bcp.14710&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fbcp.14710%26sid%3Dliteratum%253Aachs%26jtitle%3DBritish%2520Journal%2520of%2520Clinical%2520Pharmacology%26atitle%3DFirst%2525E2%252580%252590in%2525E2%252580%252590man%252Bstudy%252Bto%252Binvestigate%252Bsafety%25252C%252Bpharmacokinetics%252Band%252Bexploratory%252Bpharmacodynamics%252Bof%252BHTL0018318%25252C%252Ba%252Bnovel%252BM%252B1%252B%2525E2%252580%252590receptor%252Bpartial%252Bagonist%252Bfor%252Bthe%252Btreatment%252Bof%252Bdementias%26aulast%3DBakker%26aufirst%3DCharlotte%26date%3D2021%26date%3D2021%26volume%3D87%26issue%3D7%26spage%3D2945%26epage%3D2955" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Daniel J.  Foster</span>, <span class="hlFld-ContribAuthor ">Zoey K.  Bryant</span>, <span class="hlFld-ContribAuthor ">P. Jeffrey  Conn</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting muscarinic receptors to treat schizophrenia. </span><span class="cited-content_cbyCitation_journal-name">Behavioural Brain Research</span><span> <strong>2021,</strong> <em>405 </em>, 113201. <a href="https://doi.org/10.1016/j.bbr.2021.113201" title="DOI URL">https://doi.org/10.1016/j.bbr.2021.113201</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bbr.2021.113201&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bbr.2021.113201%26sid%3Dliteratum%253Aachs%26jtitle%3DBehavioural%2520Brain%2520Research%26atitle%3DTargeting%252Bmuscarinic%252Breceptors%252Bto%252Btreat%252Bschizophrenia%26aulast%3DFoster%26aufirst%3DDaniel%2BJ.%26date%3D2021%26volume%3D405%26spage%3D113201" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Emma T.  van der Westhuizen</span>, <span class="hlFld-ContribAuthor ">K. H. Christopher  Choy</span>, <span class="hlFld-ContribAuthor ">Celine  Valant</span>, <span class="hlFld-ContribAuthor ">Simon  McKenzie-Nickson</span>, <span class="hlFld-ContribAuthor ">Sophie J.  Bradley</span>, <span class="hlFld-ContribAuthor ">Andrew B.  Tobin</span>, <span class="hlFld-ContribAuthor ">Patrick M.  Sexton</span>, <span class="hlFld-ContribAuthor ">Arthur  Christopoulos</span>. </span><span class="cited-content_cbyCitation_article-title">Fine Tuning Muscarinic Acetylcholine Receptor Signaling Through Allostery and Bias. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Pharmacology</span><span> <strong>2021,</strong> <em>11 </em><a href="https://doi.org/10.3389/fphar.2020.606656" title="DOI URL">https://doi.org/10.3389/fphar.2020.606656</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fphar.2020.606656&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffphar.2020.606656%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Pharmacology%26atitle%3DFine%252BTuning%252BMuscarinic%252BAcetylcholine%252BReceptor%252BSignaling%252BThrough%252BAllostery%252Band%252BBias%26aulast%3Dvan%2Bder%2BWesthuizen%26aufirst%3DEmma%2BT.%26date%3D2021%26date%3D2021%26volume%3D11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Manuela  Jörg</span>, <span class="hlFld-ContribAuthor ">Elham  Khajehali</span>, <span class="hlFld-ContribAuthor ">Emma T.  Westhuizen</span>, <span class="hlFld-ContribAuthor ">K. H.  C. Choy</span>, <span class="hlFld-ContribAuthor ">David M.  Shackleford</span>, <span class="hlFld-ContribAuthor ">Andrew B.  Tobin</span>, <span class="hlFld-ContribAuthor ">Patrick M.  Sexton</span>, <span class="hlFld-ContribAuthor ">Celine  Valant</span>, <span class="hlFld-ContribAuthor ">Ben  Capuano</span>, <span class="hlFld-ContribAuthor ">Arthur  Christopoulos</span>, <span class="hlFld-ContribAuthor ">Peter J.  Scammells</span>. </span><span class="cited-content_cbyCitation_article-title">Development of Novel 4‐Arylpyridin‐2‐one and 6‐Arylpyrimidin‐4‐one Positive Allosteric Modulators of the M
              1
              Muscarinic Acetylcholine Receptor. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2021,</strong> <em>16 </em>
                                    (1)
                                     , 216-233. <a href="https://doi.org/10.1002/cmdc.202000540" title="DOI URL">https://doi.org/10.1002/cmdc.202000540</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.202000540&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.202000540%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DDevelopment%252Bof%252BNovel%252B4%2525E2%252580%252590Arylpyridin%2525E2%252580%2525902%2525E2%252580%252590one%252Band%252B6%2525E2%252580%252590Arylpyrimidin%2525E2%252580%2525904%2525E2%252580%252590one%252BPositive%252BAllosteric%252BModulators%252Bof%252Bthe%252BM%252B1%252BMuscarinic%252BAcetylcholine%252BReceptor%26aulast%3DJ%25C3%25B6rg%26aufirst%3DManuela%26date%3D2021%26date%3D2020%26volume%3D16%26issue%3D1%26spage%3D216%26epage%3D233" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pia  Weikop</span>, <span class="hlFld-ContribAuthor ">Kathrine L.  Jensen</span>, <span class="hlFld-ContribAuthor ">Morgane  Thomsen</span>. </span><span class="cited-content_cbyCitation_article-title">Effects of muscarinic M1 receptor stimulation on reinforcing and neurochemical effects of cocaine in rats. </span><span class="cited-content_cbyCitation_journal-name">Neuropsychopharmacology</span><span> <strong>2020,</strong> <em>45 </em>
                                    (12)
                                     , 1994-2002. <a href="https://doi.org/10.1038/s41386-020-0684-1" title="DOI URL">https://doi.org/10.1038/s41386-020-0684-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41386-020-0684-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41386-020-0684-1%26sid%3Dliteratum%253Aachs%26jtitle%3DNeuropsychopharmacology%26atitle%3DEffects%252Bof%252Bmuscarinic%252BM1%252Breceptor%252Bstimulation%252Bon%252Breinforcing%252Band%252Bneurochemical%252Beffects%252Bof%252Bcocaine%252Bin%252Brats%26aulast%3DWeikop%26aufirst%3DPia%26date%3D2020%26date%3D2020%26volume%3D45%26issue%3D12%26spage%3D1994%26epage%3D2002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sophie J.  Bradley</span>, <span class="hlFld-ContribAuthor ">Colin  Molloy</span>, <span class="hlFld-ContribAuthor ">Paulina  Valuskova</span>, <span class="hlFld-ContribAuthor ">Louis  Dwomoh</span>, <span class="hlFld-ContribAuthor ">Miriam  Scarpa</span>, <span class="hlFld-ContribAuthor ">Mario  Rossi</span>, <span class="hlFld-ContribAuthor ">Lisa  Finlayson</span>, <span class="hlFld-ContribAuthor ">Kjell A.  Svensson</span>, <span class="hlFld-ContribAuthor ">Eyassu  Chernet</span>, <span class="hlFld-ContribAuthor ">Vanessa N.  Barth</span>, <span class="hlFld-ContribAuthor ">Karolina  Gherbi</span>, <span class="hlFld-ContribAuthor ">David A.  Sykes</span>, <span class="hlFld-ContribAuthor ">Caroline A.  Wilson</span>, <span class="hlFld-ContribAuthor ">Rajendra  Mistry</span>, <span class="hlFld-ContribAuthor ">Patrick M.  Sexton</span>, <span class="hlFld-ContribAuthor ">Arthur  Christopoulos</span>, <span class="hlFld-ContribAuthor ">Adrian J.  Mogg</span>, <span class="hlFld-ContribAuthor ">Elizabeth M.  Rosethorne</span>, <span class="hlFld-ContribAuthor ">Shuzo  Sakata</span>, <span class="hlFld-ContribAuthor ">R. A.  John Challiss</span>, <span class="hlFld-ContribAuthor ">Lisa M.  Broad</span>, <span class="hlFld-ContribAuthor ">Andrew B.  Tobin</span>. </span><span class="cited-content_cbyCitation_article-title">Biased M1-muscarinic-receptor-mutant mice inform the design of next-generation drugs. </span><span class="cited-content_cbyCitation_journal-name">Nature Chemical Biology</span><span> <strong>2020,</strong> <em>16 </em>
                                    (3)
                                     , 240-249. <a href="https://doi.org/10.1038/s41589-019-0453-9" title="DOI URL">https://doi.org/10.1038/s41589-019-0453-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41589-019-0453-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41589-019-0453-9%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Chemical%2520Biology%26atitle%3DBiased%252BM1-muscarinic-receptor-mutant%252Bmice%252Binform%252Bthe%252Bdesign%252Bof%252Bnext-generation%252Bdrugs%26aulast%3DBradley%26aufirst%3DSophie%2BJ.%26date%3D2020%26date%3D2020%26volume%3D16%26issue%3D3%26spage%3D240%26epage%3D249" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Takao  Mandai</span>, <span class="hlFld-ContribAuthor ">Yuu  Sako</span>, <span class="hlFld-ContribAuthor ">Emi  Kurimoto</span>, <span class="hlFld-ContribAuthor ">Yuji  Shimizu</span>, <span class="hlFld-ContribAuthor ">Minoru  Nakamura</span>, <span class="hlFld-ContribAuthor ">Makoto  Fushimi</span>, <span class="hlFld-ContribAuthor ">Ryouta  Maeda</span>, <span class="hlFld-ContribAuthor ">Maki  Miyamoto</span>, <span class="hlFld-ContribAuthor ">Haruhide  Kimura</span>. </span><span class="cited-content_cbyCitation_article-title">T‐495, a novel low cooperative M
              1
              receptor positive allosteric modulator, improves memory deficits associated with cholinergic dysfunction and is characterized by low gastrointestinal side effect risk. </span><span class="cited-content_cbyCitation_journal-name">Pharmacology Research & Perspectives</span><span> <strong>2020,</strong> <em>8 </em>
                                    (1)
                                     <a href="https://doi.org/10.1002/prp2.560" title="DOI URL">https://doi.org/10.1002/prp2.560</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/prp2.560&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fprp2.560%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacology%2520Research%2520%2526%2520Perspectives%26atitle%3DT%2525E2%252580%252590495%25252C%252Ba%252Bnovel%252Blow%252Bcooperative%252BM%252B1%252Breceptor%252Bpositive%252Ballosteric%252Bmodulator%25252C%252Bimproves%252Bmemory%252Bdeficits%252Bassociated%252Bwith%252Bcholinergic%252Bdysfunction%252Band%252Bis%252Bcharacterized%252Bby%252Blow%252Bgastrointestinal%252Bside%252Beffect%252Brisk%26aulast%3DMandai%26aufirst%3DTakao%26date%3D2020%26date%3D2020%26volume%3D8%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shofiul  Azam</span>, <span class="hlFld-ContribAuthor ">Md. Ezazul  Haque</span>, <span class="hlFld-ContribAuthor ">Md.  Jakaria</span>, <span class="hlFld-ContribAuthor ">Song-Hee  Jo</span>, <span class="hlFld-ContribAuthor ">In-Su  Kim</span>, <span class="hlFld-ContribAuthor ">Dong-Kug  Choi</span>. </span><span class="cited-content_cbyCitation_article-title">G-Protein-Coupled Receptors in CNS: A Potential Therapeutic Target for Intervention in Neurodegenerative Disorders and Associated Cognitive Deficits. </span><span class="cited-content_cbyCitation_journal-name">Cells</span><span> <strong>2020,</strong> <em>9 </em>
                                    (2)
                                     , 506. <a href="https://doi.org/10.3390/cells9020506" title="DOI URL">https://doi.org/10.3390/cells9020506</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cells9020506&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcells9020506%26sid%3Dliteratum%253Aachs%26jtitle%3DCells%26atitle%3DG-Protein-Coupled%252BReceptors%252Bin%252BCNS%25253A%252BA%252BPotential%252BTherapeutic%252BTarget%252Bfor%252BIntervention%252Bin%252BNeurodegenerative%252BDisorders%252Band%252BAssociated%252BCognitive%252BDeficits%26aulast%3DAzam%26aufirst%3DShofiul%26date%3D2020%26date%3D2020%26volume%3D9%26issue%3D2%26spage%3D506" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Miriam  Scarpa</span>, <span class="hlFld-ContribAuthor ">Sarah  Hesse</span>, <span class="hlFld-ContribAuthor ">Sophie J.  Bradley</span>. </span><span class="cited-content_cbyCitation_article-title">M1 muscarinic acetylcholine receptors: A therapeutic strategy for symptomatic and disease-modifying effects in Alzheimer's disease?. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,, 277-310. <a href="https://doi.org/10.1016/bs.apha.2019.12.003" title="DOI URL">https://doi.org/10.1016/bs.apha.2019.12.003</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/bs.apha.2019.12.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fbs.apha.2019.12.003%26sid%3Dliteratum%253Aachs%26atitle%3DM1%252Bmuscarinic%252Bacetylcholine%252Breceptors%25253A%252BA%252Btherapeutic%252Bstrategy%252Bfor%252Bsymptomatic%252Band%252Bdisease-modifying%252Beffects%252Bin%252BAlzheimer%252527s%252Bdisease%25253F%26aulast%3DScarpa%26aufirst%3DMiriam%26date%3D2020%26spage%3D277%26epage%3D310%26pub%3DElsevier%26atitle%3DFrom%252BStructure%252Bto%252BClinical%252BDevelopment%25253A%252BAllosteric%252BModulation%252Bof%252BG%252BProtein-Coupled%252BReceptors%26date%3D2020%26volume%3D88" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Scott A.  Hollingsworth</span>, <span class="hlFld-ContribAuthor ">Brendan  Kelly</span>, <span class="hlFld-ContribAuthor ">Celine  Valant</span>, <span class="hlFld-ContribAuthor ">Jordan Arthur  Michaelis</span>, <span class="hlFld-ContribAuthor ">Olivia  Mastromihalis</span>, <span class="hlFld-ContribAuthor ">Geoff  Thompson</span>, <span class="hlFld-ContribAuthor ">A. J.  Venkatakrishnan</span>, <span class="hlFld-ContribAuthor ">Samuel  Hertig</span>, <span class="hlFld-ContribAuthor ">Peter J.  Scammells</span>, <span class="hlFld-ContribAuthor ">Patrick M.  Sexton</span>, <span class="hlFld-ContribAuthor ">Christian C.  Felder</span>, <span class="hlFld-ContribAuthor ">Arthur  Christopoulos</span>, <span class="hlFld-ContribAuthor ">Ron O.  Dror</span>. </span><span class="cited-content_cbyCitation_article-title">Cryptic pocket formation underlies allosteric modulator selectivity at muscarinic GPCRs. </span><span class="cited-content_cbyCitation_journal-name">Nature Communications</span><span> <strong>2019,</strong> <em>10 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41467-019-11062-7" title="DOI URL">https://doi.org/10.1038/s41467-019-11062-7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41467-019-11062-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41467-019-11062-7%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Communications%26atitle%3DCryptic%252Bpocket%252Bformation%252Bunderlies%252Ballosteric%252Bmodulator%252Bselectivity%252Bat%252Bmuscarinic%252BGPCRs%26aulast%3DHollingsworth%26aufirst%3DScott%2BA.%26date%3D2019%26date%3D2019%26volume%3D10%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shotaro  Miura</span>, <span class="hlFld-ContribAuthor ">Koichiro  Fukuda</span>, <span class="hlFld-ContribAuthor ">Shinichi  Masada</span>, <span class="hlFld-ContribAuthor ">Hirotsugu  Usutani</span>, <span class="hlFld-ContribAuthor ">Makoto  Kanematsu</span>, <span class="hlFld-ContribAuthor ">David G.  Cork</span>, <span class="hlFld-ContribAuthor ">Tetsuji  Kawamoto</span>. </span><span class="cited-content_cbyCitation_article-title">Rapid and efficient synthesis of a novel cholinergic muscarinic M
              1
              receptor positive allosteric modulator using flash chemistry. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2019,</strong> <em>17 </em>
                                    (35)
                                     , 8166-8174. <a href="https://doi.org/10.1039/C9OB01718F" title="DOI URL">https://doi.org/10.1039/C9OB01718F</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C9OB01718F&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC9OB01718F%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DRapid%252Band%252Befficient%252Bsynthesis%252Bof%252Ba%252Bnovel%252Bcholinergic%252Bmuscarinic%252BM%252B1%252Breceptor%252Bpositive%252Ballosteric%252Bmodulator%252Busing%252Bflash%252Bchemistry%26aulast%3DMiura%26aufirst%3DShotaro%26date%3D2019%26date%3D2019%26volume%3D17%26issue%3D35%26spage%3D8166%26epage%3D8174" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Guilherme Martins  Silva</span>, <span class="hlFld-ContribAuthor ">Mariana Pegrucci  Barcelos</span>, <span class="hlFld-ContribAuthor ">João Gabriel Curtolo  Poiani</span>, <span class="hlFld-ContribAuthor ">Lorane Izabel da Silva  Hage‐Melim</span>, <span class="hlFld-ContribAuthor ">Carlos Henrique Tomich de Paula  da Silva</span>. </span><span class="cited-content_cbyCitation_article-title">Allosteric Modulators of Potential Targets Related to Alzheimer's Disease: a Review. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2019,</strong> <em>14 </em>
                                    (16)
                                     , 1467-1483. <a href="https://doi.org/10.1002/cmdc.201900299" title="DOI URL">https://doi.org/10.1002/cmdc.201900299</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201900299&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201900299%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DAllosteric%252BModulators%252Bof%252BPotential%252BTargets%252BRelated%252Bto%252BAlzheimer%252527s%252BDisease%25253A%252Ba%252BReview%26aulast%3DSilva%26aufirst%3DGuilherme%2BMartins%26date%3D2019%26date%3D2019%26volume%3D14%26issue%3D16%26spage%3D1467%26epage%3D1483" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Takao  Mandai</span>, <span class="hlFld-ContribAuthor ">Maki  Kasahara</span>, <span class="hlFld-ContribAuthor ">Emi  Kurimoto</span>, <span class="hlFld-ContribAuthor ">Maiko  Tanaka</span>, <span class="hlFld-ContribAuthor ">Motohisa  Suzuki</span>, <span class="hlFld-ContribAuthor ">Atsushi  Nakatani</span>, <span class="hlFld-ContribAuthor ">Haruhide  Kimura</span>. </span><span class="cited-content_cbyCitation_article-title">In Vivo Pharmacological Comparison of TAK-071, a Positive Allosteric Modulator of Muscarinic M1 Receptor, and Xanomeline, an Agonist of Muscarinic M1/M4 Receptor, in Rodents. </span><span class="cited-content_cbyCitation_journal-name">Neuroscience</span><span> <strong>2019,</strong> <em>414 </em>, 60-76. <a href="https://doi.org/10.1016/j.neuroscience.2019.07.003" title="DOI URL">https://doi.org/10.1016/j.neuroscience.2019.07.003</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.neuroscience.2019.07.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.neuroscience.2019.07.003%26sid%3Dliteratum%253Aachs%26jtitle%3DNeuroscience%26atitle%3DIn%252BVivo%252BPharmacological%252BComparison%252Bof%252BTAK-071%25252C%252Ba%252BPositive%252BAllosteric%252BModulator%252Bof%252BMuscarinic%252BM1%252BReceptor%25252C%252Band%252BXanomeline%25252C%252Ban%252BAgonist%252Bof%252BMuscarinic%252BM1%25252FM4%252BReceptor%25252C%252Bin%252BRodents%26aulast%3DMandai%26aufirst%3DTakao%26date%3D2019%26volume%3D414%26spage%3D60%26epage%3D76" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Terry  Kenakin</span>. </span><span class="cited-content_cbyCitation_article-title">Prescient Indices of Activity: The Application of Functional System Sensitivity to Measurement of Drug Effect. </span><span class="cited-content_cbyCitation_journal-name">Trends in Pharmacological Sciences</span><span> <strong>2019,</strong> <em>40 </em>
                                    (7)
                                     , 529-539. <a href="https://doi.org/10.1016/j.tips.2019.04.007" title="DOI URL">https://doi.org/10.1016/j.tips.2019.04.007</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tips.2019.04.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tips.2019.04.007%26sid%3Dliteratum%253Aachs%26jtitle%3DTrends%2520in%2520Pharmacological%2520Sciences%26atitle%3DPrescient%252BIndices%252Bof%252BActivity%25253A%252BThe%252BApplication%252Bof%252BFunctional%252BSystem%252BSensitivity%252Bto%252BMeasurement%252Bof%252BDrug%252BEffect%26aulast%3DKenakin%26aufirst%3DTerry%26date%3D2019%26volume%3D40%26issue%3D7%26spage%3D529%26epage%3D539" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Terry  Kenakin</span>, . </span><span class="cited-content_cbyCitation_article-title">Biased Receptor Signaling in Drug Discovery. </span><span class="cited-content_cbyCitation_journal-name">Pharmacological Reviews</span><span> <strong>2019,</strong> <em>71 </em>
                                    (2)
                                     , 267-315. <a href="https://doi.org/10.1124/pr.118.016790" title="DOI URL">https://doi.org/10.1124/pr.118.016790</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1124/pr.118.016790&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1124%2Fpr.118.016790%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacological%2520Reviews%26atitle%3DBiased%252BReceptor%252BSignaling%252Bin%252BDrug%252BDiscovery%26aulast%3DKenakin%26aufirst%3DTerry%26date%3D2019%26date%3D2019%26volume%3D71%26issue%3D2%26spage%3D267%26epage%3D315" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Laura B.  Teal</span>, <span class="hlFld-ContribAuthor ">Robert W.  Gould</span>, <span class="hlFld-ContribAuthor ">Andrew S.  Felts</span>, <span class="hlFld-ContribAuthor ">Carrie K.  Jones</span>. </span><span class="cited-content_cbyCitation_article-title">Selective allosteric modulation of muscarinic acetylcholine receptors for the treatment of schizophrenia and substance use disorders. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2019,</strong>,, 153-196. <a href="https://doi.org/10.1016/bs.apha.2019.05.001" title="DOI URL">https://doi.org/10.1016/bs.apha.2019.05.001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/bs.apha.2019.05.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fbs.apha.2019.05.001%26sid%3Dliteratum%253Aachs%26atitle%3DSelective%252Ballosteric%252Bmodulation%252Bof%252Bmuscarinic%252Bacetylcholine%252Breceptors%252Bfor%252Bthe%252Btreatment%252Bof%252Bschizophrenia%252Band%252Bsubstance%252Buse%252Bdisorders%26aulast%3DTeal%26aufirst%3DLaura%2BB.%26date%3D2019%26spage%3D153%26epage%3D196%26pub%3DElsevier%26atitle%3DNeuropsychotherapeutics%26date%3D2019%26volume%3D86" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Elham  Khajehali</span>, <span class="hlFld-ContribAuthor ">Celine  Valant</span>, <span class="hlFld-ContribAuthor ">Manuela  Jörg</span>, <span class="hlFld-ContribAuthor ">Andrew B.  Tobin</span>, <span class="hlFld-ContribAuthor ">P. Jeffrey  Conn</span>, <span class="hlFld-ContribAuthor ">Craig W.  Lindsley</span>, <span class="hlFld-ContribAuthor ">Patrick M.  Sexton</span>, <span class="hlFld-ContribAuthor ">Peter J.  Scammells</span>, <span class="hlFld-ContribAuthor ">Arthur  Christopoulos</span>. </span><span class="cited-content_cbyCitation_article-title">Probing the binding site of novel selective positive allosteric modulators at the M1 muscarinic acetylcholine receptor. </span><span class="cited-content_cbyCitation_journal-name">Biochemical Pharmacology</span><span> <strong>2018,</strong> <em>154 </em>, 243-254. <a href="https://doi.org/10.1016/j.bcp.2018.05.009" title="DOI URL">https://doi.org/10.1016/j.bcp.2018.05.009</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bcp.2018.05.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bcp.2018.05.009%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemical%2520Pharmacology%26atitle%3DProbing%252Bthe%252Bbinding%252Bsite%252Bof%252Bnovel%252Bselective%252Bpositive%252Ballosteric%252Bmodulators%252Bat%252Bthe%252BM1%252Bmuscarinic%252Bacetylcholine%252Breceptor%26aulast%3DKhajehali%26aufirst%3DElham%26date%3D2018%26volume%3D154%26spage%3D243%26epage%3D254" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Samantha E.  Yohn</span>, <span class="hlFld-ContribAuthor ">P. Jeffrey  Conn</span>. </span><span class="cited-content_cbyCitation_article-title">Positive allosteric modulation of M 1 and M 4 muscarinic receptors as potential therapeutic treatments for schizophrenia. </span><span class="cited-content_cbyCitation_journal-name">Neuropharmacology</span><span> <strong>2018,</strong> <em>136 </em>, 438-448. <a href="https://doi.org/10.1016/j.neuropharm.2017.09.012" title="DOI URL">https://doi.org/10.1016/j.neuropharm.2017.09.012</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.neuropharm.2017.09.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.neuropharm.2017.09.012%26sid%3Dliteratum%253Aachs%26jtitle%3DNeuropharmacology%26atitle%3DPositive%252Ballosteric%252Bmodulation%252Bof%252BM%252B1%252Band%252BM%252B4%252Bmuscarinic%252Breceptors%252Bas%252Bpotential%252Btherapeutic%252Btreatments%252Bfor%252Bschizophrenia%26aulast%3DYohn%26aufirst%3DSamantha%2BE.%26date%3D2018%26volume%3D136%26spage%3D438%26epage%3D448" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">E.P.  Lebois</span>, <span class="hlFld-ContribAuthor ">C.  Thorn</span>, <span class="hlFld-ContribAuthor ">J.R.  Edgerton</span>, <span class="hlFld-ContribAuthor ">M.  Popiolek</span>, <span class="hlFld-ContribAuthor ">S.  Xi</span>. </span><span class="cited-content_cbyCitation_article-title">Muscarinic receptor subtype distribution in the central nervous system and relevance to aging and Alzheimer's disease. </span><span class="cited-content_cbyCitation_journal-name">Neuropharmacology</span><span> <strong>2018,</strong> <em>136 </em>, 362-373. <a href="https://doi.org/10.1016/j.neuropharm.2017.11.018" title="DOI URL">https://doi.org/10.1016/j.neuropharm.2017.11.018</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.neuropharm.2017.11.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.neuropharm.2017.11.018%26sid%3Dliteratum%253Aachs%26jtitle%3DNeuropharmacology%26atitle%3DMuscarinic%252Breceptor%252Bsubtype%252Bdistribution%252Bin%252Bthe%252Bcentral%252Bnervous%252Bsystem%252Band%252Brelevance%252Bto%252Baging%252Band%252BAlzheimer%252527s%252Bdisease%26aulast%3DLebois%26aufirst%3DE.P.%26date%3D2018%26volume%3D136%26spage%3D362%26epage%3D373" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Christian C.  Felder</span>, <span class="hlFld-ContribAuthor ">Paul J.  Goldsmith</span>, <span class="hlFld-ContribAuthor ">Kimberley  Jackson</span>, <span class="hlFld-ContribAuthor ">Helen E.  Sanger</span>, <span class="hlFld-ContribAuthor ">David A.  Evans</span>, <span class="hlFld-ContribAuthor ">Adrian J.  Mogg</span>, <span class="hlFld-ContribAuthor ">Lisa M.  Broad</span>. </span><span class="cited-content_cbyCitation_article-title">Current status of muscarinic M1 and M4 receptors as drug targets for neurodegenerative diseases. </span><span class="cited-content_cbyCitation_journal-name">Neuropharmacology</span><span> <strong>2018,</strong> <em>136 </em>, 449-458. <a href="https://doi.org/10.1016/j.neuropharm.2018.01.028" title="DOI URL">https://doi.org/10.1016/j.neuropharm.2018.01.028</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.neuropharm.2018.01.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.neuropharm.2018.01.028%26sid%3Dliteratum%253Aachs%26jtitle%3DNeuropharmacology%26atitle%3DCurrent%252Bstatus%252Bof%252Bmuscarinic%252BM1%252Band%252BM4%252Breceptors%252Bas%252Bdrug%252Btargets%252Bfor%252Bneurodegenerative%252Bdiseases%26aulast%3DFelder%26aufirst%3DChristian%2BC.%26date%3D2018%26volume%3D136%26spage%3D449%26epage%3D458" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sean P.  Moran</span>, <span class="hlFld-ContribAuthor ">Jonathan W.  Dickerson</span>, <span class="hlFld-ContribAuthor ">Hyekyung P.  Cho</span>, <span class="hlFld-ContribAuthor ">Zixiu  Xiang</span>, <span class="hlFld-ContribAuthor ">James  Maksymetz</span>, <span class="hlFld-ContribAuthor ">Daniel H.  Remke</span>, <span class="hlFld-ContribAuthor ">Xiaohui  Lv</span>, <span class="hlFld-ContribAuthor ">Catherine A.  Doyle</span>, <span class="hlFld-ContribAuthor ">Deepa H.  Rajan</span>, <span class="hlFld-ContribAuthor ">Colleen M.  Niswender</span>, <span class="hlFld-ContribAuthor ">Darren W.  Engers</span>, <span class="hlFld-ContribAuthor ">Craig W.  Lindsley</span>, <span class="hlFld-ContribAuthor ">Jerri M.  Rook</span>, <span class="hlFld-ContribAuthor ">P. Jeffrey  Conn</span>. </span><span class="cited-content_cbyCitation_article-title">M1-positive allosteric modulators lacking agonist activity provide the optimal profile for enhancing cognition. </span><span class="cited-content_cbyCitation_journal-name">Neuropsychopharmacology</span><span> <strong>2018,</strong> <em>43 </em>
                                    (8)
                                     , 1763-1771. <a href="https://doi.org/10.1038/s41386-018-0033-9" title="DOI URL">https://doi.org/10.1038/s41386-018-0033-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41386-018-0033-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41386-018-0033-9%26sid%3Dliteratum%253Aachs%26jtitle%3DNeuropsychopharmacology%26atitle%3DM1-positive%252Ballosteric%252Bmodulators%252Blacking%252Bagonist%252Bactivity%252Bprovide%252Bthe%252Boptimal%252Bprofile%252Bfor%252Benhancing%252Bcognition%26aulast%3DMoran%26aufirst%3DSean%2BP.%26date%3D2018%26date%3D2018%26volume%3D43%26issue%3D8%26spage%3D1763%26epage%3D1771" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Emma T.  van der Westhuizen</span>, <span class="hlFld-ContribAuthor ">Arthur  Spathis</span>, <span class="hlFld-ContribAuthor ">Elham  Khajehali</span>, <span class="hlFld-ContribAuthor ">Manuela  Jörg</span>, <span class="hlFld-ContribAuthor ">Shailesh N.  Mistry</span>, <span class="hlFld-ContribAuthor ">Ben  Capuano</span>, <span class="hlFld-ContribAuthor ">Andrew B.  Tobin</span>, <span class="hlFld-ContribAuthor ">Patrick M.  Sexton</span>, <span class="hlFld-ContribAuthor ">Peter J.  Scammells</span>, <span class="hlFld-ContribAuthor ">Celine  Valant</span>, <span class="hlFld-ContribAuthor ">Arthur  Christopoulos</span>. </span><span class="cited-content_cbyCitation_article-title">Assessment of the Molecular Mechanisms of Action of Novel 4-Phenylpyridine-2-One and 6-Phenylpyrimidin-4-One Allosteric Modulators at the M
              1
              Muscarinic Acetylcholine Receptors. </span><span class="cited-content_cbyCitation_journal-name">Molecular Pharmacology</span><span> <strong>2018,</strong> <em>94 </em>
                                    (1)
                                     , 770-783. <a href="https://doi.org/10.1124/mol.118.111633" title="DOI URL">https://doi.org/10.1124/mol.118.111633</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1124/mol.118.111633&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1124%2Fmol.118.111633%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Pharmacology%26atitle%3DAssessment%252Bof%252Bthe%252BMolecular%252BMechanisms%252Bof%252BAction%252Bof%252BNovel%252B4-Phenylpyridine-2-One%252Band%252B6-Phenylpyrimidin-4-One%252BAllosteric%252BModulators%252Bat%252Bthe%252BM%252B1%252BMuscarinic%252BAcetylcholine%252BReceptors%26aulast%3Dvan%2Bder%2BWesthuizen%26aufirst%3DEmma%2BT.%26date%3D2018%26date%3D2018%26volume%3D94%26issue%3D1%26spage%3D770%26epage%3D783" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michael A.  Brodney</span>, <span class="hlFld-ContribAuthor ">Raman  Sharma</span>, <span class="hlFld-ContribAuthor ">John T.  Lazzaro</span>, <span class="hlFld-ContribAuthor ">Gregory S.  Walker</span>, <span class="hlFld-ContribAuthor ">R.  Scott Obach</span>. </span><span class="cited-content_cbyCitation_article-title">Harnessing biosynthesis and quantitative NMR for late stage functionalization of lead molecules: Application to the M1 positive allosteric modulator (PAM) program. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2018,</strong> <em>28 </em>
                                    (11)
                                     , 2068-2073. <a href="https://doi.org/10.1016/j.bmcl.2018.04.054" title="DOI URL">https://doi.org/10.1016/j.bmcl.2018.04.054</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2018.04.054&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2018.04.054%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DHarnessing%252Bbiosynthesis%252Band%252Bquantitative%252BNMR%252Bfor%252Blate%252Bstage%252Bfunctionalization%252Bof%252Blead%252Bmolecules%25253A%252BApplication%252Bto%252Bthe%252BM1%252Bpositive%252Ballosteric%252Bmodulator%252B%252528PAM%252529%252Bprogram%26aulast%3DBrodney%26aufirst%3DMichael%2BA.%26date%3D2018%26volume%3D28%26issue%3D11%26spage%3D2068%26epage%3D2073" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sophie J.  Bradley</span>, <span class="hlFld-ContribAuthor ">Colin  Molloy</span>, <span class="hlFld-ContribAuthor ">Christoffer  Bundgaard</span>, <span class="hlFld-ContribAuthor ">Adrian J.  Mogg</span>, <span class="hlFld-ContribAuthor ">Karen J.  Thompson</span>, <span class="hlFld-ContribAuthor ">Louis  Dwomoh</span>, <span class="hlFld-ContribAuthor ">Helen E.  Sanger</span>, <span class="hlFld-ContribAuthor ">Michael D.  Crabtree</span>, <span class="hlFld-ContribAuthor ">Simon M.  Brooke</span>, <span class="hlFld-ContribAuthor ">Patrick M.  Sexton</span>, <span class="hlFld-ContribAuthor ">Christian C.  Felder</span>, <span class="hlFld-ContribAuthor ">Arthur  Christopoulos</span>, <span class="hlFld-ContribAuthor ">Lisa M.  Broad</span>, <span class="hlFld-ContribAuthor ">Andrew B.  Tobin</span>, <span class="hlFld-ContribAuthor ">Christopher J.  Langmead</span>. </span><span class="cited-content_cbyCitation_article-title">Bitopic Binding Mode of an M
              1
              Muscarinic Acetylcholine Receptor Agonist Associated with Adverse Clinical Trial Outcomes. </span><span class="cited-content_cbyCitation_journal-name">Molecular Pharmacology</span><span> <strong>2018,</strong> <em>93 </em>
                                    (6)
                                     , 645-656. <a href="https://doi.org/10.1124/mol.118.111872" title="DOI URL">https://doi.org/10.1124/mol.118.111872</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1124/mol.118.111872&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1124%2Fmol.118.111872%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Pharmacology%26atitle%3DBitopic%252BBinding%252BMode%252Bof%252Ban%252BM%252B1%252BMuscarinic%252BAcetylcholine%252BReceptor%252BAgonist%252BAssociated%252Bwith%252BAdverse%252BClinical%252BTrial%252BOutcomes%26aulast%3DBradley%26aufirst%3DSophie%2BJ.%26date%3D2018%26date%3D2018%26volume%3D93%26issue%3D6%26spage%3D645%26epage%3D656" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Daniel E.  O’Brien</span>, <span class="hlFld-ContribAuthor ">Douglas M.  Shaw</span>, <span class="hlFld-ContribAuthor ">Hyekyung P.  Cho</span>, <span class="hlFld-ContribAuthor ">Alan J.  Cross</span>, <span class="hlFld-ContribAuthor ">Steven S.  Wesolowski</span>, <span class="hlFld-ContribAuthor ">Andrew S.  Felts</span>, <span class="hlFld-ContribAuthor ">Jonas  Bergare</span>, <span class="hlFld-ContribAuthor ">Charles S.  Elmore</span>, <span class="hlFld-ContribAuthor ">Craig W.  Lindsley</span>, <span class="hlFld-ContribAuthor ">Colleen M.  Niswender</span>, <span class="hlFld-ContribAuthor ">P. Jeffrey  Conn</span>. </span><span class="cited-content_cbyCitation_article-title">Differential Pharmacology and Binding of mGlu
              2
              Receptor Allosteric Modulators. </span><span class="cited-content_cbyCitation_journal-name">Molecular Pharmacology</span><span> <strong>2018,</strong> <em>93 </em>
                                    (5)
                                     , 526-540. <a href="https://doi.org/10.1124/mol.117.110114" title="DOI URL">https://doi.org/10.1124/mol.117.110114</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1124/mol.117.110114&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1124%2Fmol.117.110114%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Pharmacology%26atitle%3DDifferential%252BPharmacology%252Band%252BBinding%252Bof%252BmGlu%252B2%252BReceptor%252BAllosteric%252BModulators%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DDaniel%2BE.%26date%3D2018%26date%3D2018%26volume%3D93%26issue%3D5%26spage%3D526%26epage%3D540" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Melanie  Trobe</span>, <span class="hlFld-ContribAuthor ">Martin D.  Burke</span>. </span><span class="cited-content_cbyCitation_article-title">The Molecular Industrial Revolution: Automated Synthesis of Small Molecules. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie International Edition</span><span> <strong>2018,</strong> <em>57 </em>
                                    (16)
                                     , 4192-4214. <a href="https://doi.org/10.1002/anie.201710482" title="DOI URL">https://doi.org/10.1002/anie.201710482</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/anie.201710482&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fanie.201710482%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%2520International%2520Edition%26atitle%3DThe%252BMolecular%252BIndustrial%252BRevolution%25253A%252BAutomated%252BSynthesis%252Bof%252BSmall%252BMolecules%26aulast%3DTrobe%26aufirst%3DMelanie%26date%3D2018%26date%3D2018%26volume%3D57%26issue%3D16%26spage%3D4192%26epage%3D4214" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Melanie  Trobe</span>, <span class="hlFld-ContribAuthor ">Martin D.  Burke</span>. </span><span class="cited-content_cbyCitation_article-title">Die molekulare industrielle Revolution: zur automatisierten Synthese organischer Verbindungen. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie</span><span> <strong>2018,</strong> <em>130 </em>
                                    (16)
                                     , 4266-4288. <a href="https://doi.org/10.1002/ange.201710482" title="DOI URL">https://doi.org/10.1002/ange.201710482</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ange.201710482&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fange.201710482%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%26atitle%3DDie%252Bmolekulare%252Bindustrielle%252BRevolution%25253A%252Bzur%252Bautomatisierten%252BSynthese%252Borganischer%252BVerbindungen%26aulast%3DTrobe%26aufirst%3DMelanie%26date%3D2018%26date%3D2018%26volume%3D130%26issue%3D16%26spage%3D4266%26epage%3D4288" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Magdalena  Korczynska</span>, <span class="hlFld-ContribAuthor ">Mary J.  Clark</span>, <span class="hlFld-ContribAuthor ">Celine  Valant</span>, <span class="hlFld-ContribAuthor ">Jun  Xu</span>, <span class="hlFld-ContribAuthor ">Ee Von  Moo</span>, <span class="hlFld-ContribAuthor ">Sabine  Albold</span>, <span class="hlFld-ContribAuthor ">Dahlia R.  Weiss</span>, <span class="hlFld-ContribAuthor ">Hayarpi  Torosyan</span>, <span class="hlFld-ContribAuthor ">Weijiao  Huang</span>, <span class="hlFld-ContribAuthor ">Andrew C.  Kruse</span>, <span class="hlFld-ContribAuthor ">Brent R.  Lyda</span>, <span class="hlFld-ContribAuthor ">Lauren T.  May</span>, <span class="hlFld-ContribAuthor ">Jo-Anne  Baltos</span>, <span class="hlFld-ContribAuthor ">Patrick M.  Sexton</span>, <span class="hlFld-ContribAuthor ">Brian K.  Kobilka</span>, <span class="hlFld-ContribAuthor ">Arthur  Christopoulos</span>, <span class="hlFld-ContribAuthor ">Brian K.  Shoichet</span>, <span class="hlFld-ContribAuthor ">Roger K.  Sunahara</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-based discovery of selective positive allosteric modulators of antagonists for the M
              2
              muscarinic acetylcholine receptor. </span><span class="cited-content_cbyCitation_journal-name">Proceedings of the National Academy of Sciences</span><span> <strong>2018,</strong> <em>115 </em>
                                    (10)
                                     , E2419-E2428. <a href="https://doi.org/10.1073/pnas.1718037115" title="DOI URL">https://doi.org/10.1073/pnas.1718037115</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1073/pnas.1718037115&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1073%2Fpnas.1718037115%26sid%3Dliteratum%253Aachs%26jtitle%3DProceedings%2520of%2520the%2520National%2520Academy%2520of%2520Sciences%26atitle%3DStructure-based%252Bdiscovery%252Bof%252Bselective%252Bpositive%252Ballosteric%252Bmodulators%252Bof%252Bantagonists%252Bfor%252Bthe%252BM%252B2%252Bmuscarinic%252Bacetylcholine%252Breceptor%26aulast%3DKorczynska%26aufirst%3DMagdalena%26date%3D2018%26date%3D2018%26volume%3D115%26issue%3D10%26spage%3DE2419%26epage%3DE2428" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jonathan W.  Lehmann</span>, <span class="hlFld-ContribAuthor ">Daniel J.  Blair</span>, <span class="hlFld-ContribAuthor ">Martin D.  Burke</span>. </span><span class="cited-content_cbyCitation_article-title">Towards the generalized iterative synthesis of small molecules. </span><span class="cited-content_cbyCitation_journal-name">Nature Reviews Chemistry</span><span> <strong>2018,</strong> <em>2 </em>
                                    (2)
                                     <a href="https://doi.org/10.1038/s41570-018-0115" title="DOI URL">https://doi.org/10.1038/s41570-018-0115</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41570-018-0115&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41570-018-0115%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Reviews%2520Chemistry%26atitle%3DTowards%252Bthe%252Bgeneralized%252Biterative%252Bsynthesis%252Bof%252Bsmall%252Bmolecules%26aulast%3DLehmann%26aufirst%3DJonathan%2BW.%26date%3D2018%26date%3D2018%26volume%3D2%26issue%3D2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alexander  Flohr</span>, <span class="hlFld-ContribAuthor ">Roman  Hutter</span>, <span class="hlFld-ContribAuthor ">Barbara  Mueller</span>, <span class="hlFld-ContribAuthor ">Claudia  Bohnert</span>, <span class="hlFld-ContribAuthor ">Mélanie  Pellisson</span>, <span class="hlFld-ContribAuthor ">Hervé  Schaffhauser</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of the first low-shift positive allosteric modulators for the muscarinic M1 receptor. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2017,</strong> <em>27 </em>
                                    (24)
                                     , 5415-5419. <a href="https://doi.org/10.1016/j.bmcl.2017.11.008" title="DOI URL">https://doi.org/10.1016/j.bmcl.2017.11.008</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2017.11.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2017.11.008%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252Bthe%252Bfirst%252Blow-shift%252Bpositive%252Ballosteric%252Bmodulators%252Bfor%252Bthe%252Bmuscarinic%252BM1%252Breceptor%26aulast%3DFlohr%26aufirst%3DAlexander%26date%3D2017%26volume%3D27%26issue%3D24%26spage%3D5415%26epage%3D5419" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Masanori  Miyauchi</span>, <span class="hlFld-ContribAuthor ">Nichole M  Neugebauer</span>, <span class="hlFld-ContribAuthor ">Tatsuya  Sato</span>, <span class="hlFld-ContribAuthor ">Hossein  Ardehali</span>, <span class="hlFld-ContribAuthor ">Herbert Y  Meltzer</span>. </span><span class="cited-content_cbyCitation_article-title">Muscarinic receptor signaling contributes to atypical antipsychotic drug reversal of the phencyclidine-induced deficit in novel object recognition in rats. </span><span class="cited-content_cbyCitation_journal-name">Journal of Psychopharmacology</span><span> <strong>2017,</strong> <em>31 </em>
                                    (12)
                                     , 1588-1604. <a href="https://doi.org/10.1177/0269881117731278" title="DOI URL">https://doi.org/10.1177/0269881117731278</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1177/0269881117731278&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1177%2F0269881117731278%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Psychopharmacology%26atitle%3DMuscarinic%252Breceptor%252Bsignaling%252Bcontributes%252Bto%252Batypical%252Bantipsychotic%252Bdrug%252Breversal%252Bof%252Bthe%252Bphencyclidine-induced%252Bdeficit%252Bin%252Bnovel%252Bobject%252Brecognition%252Bin%252Brats%26aulast%3DMiyauchi%26aufirst%3DMasanori%26date%3D2017%26date%3D2017%26volume%3D31%26issue%3D12%26spage%3D1588%26epage%3D1604" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yajun  Zheng</span>, <span class="hlFld-ContribAuthor ">Colin M.  Tice</span>, <span class="hlFld-ContribAuthor ">Suresh B.  Singh</span>. </span><span class="cited-content_cbyCitation_article-title">Conformational control in structure-based drug design. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2017,</strong> <em>27 </em>
                                    (13)
                                     , 2825-2837. <a href="https://doi.org/10.1016/j.bmcl.2017.04.079" title="DOI URL">https://doi.org/10.1016/j.bmcl.2017.04.079</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2017.04.079&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2017.04.079%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DConformational%252Bcontrol%252Bin%252Bstructure-based%252Bdrug%252Bdesign%26aulast%3DZheng%26aufirst%3DYajun%26date%3D2017%26volume%3D27%26issue%3D13%26spage%3D2825%26epage%3D2837" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shawn  Johnstone</span>, <span class="hlFld-ContribAuthor ">Jeffrey S.  Albert</span>. </span><span class="cited-content_cbyCitation_article-title">Pharmacological property optimization for allosteric ligands: A medicinal chemistry perspective. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2017,</strong> <em>27 </em>
                                    (11)
                                     , 2239-2258. <a href="https://doi.org/10.1016/j.bmcl.2017.03.084" title="DOI URL">https://doi.org/10.1016/j.bmcl.2017.03.084</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2017.03.084&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2017.03.084%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DPharmacological%252Bproperty%252Boptimization%252Bfor%252Ballosteric%252Bligands%25253A%252BA%252Bmedicinal%252Bchemistry%252Bperspective%26aulast%3DJohnstone%26aufirst%3DShawn%26date%3D2017%26volume%3D27%26issue%3D11%26spage%3D2239%26epage%3D2258" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Daniel J.  Foster</span>, <span class="hlFld-ContribAuthor ">P. Jeffrey  Conn</span>. </span><span class="cited-content_cbyCitation_article-title">Allosteric Modulation of GPCRs: New Insights and Potential Utility for Treatment of Schizophrenia and Other CNS Disorders. </span><span class="cited-content_cbyCitation_journal-name">Neuron</span><span> <strong>2017,</strong> <em>94 </em>
                                    (3)
                                     , 431-446. <a href="https://doi.org/10.1016/j.neuron.2017.03.016" title="DOI URL">https://doi.org/10.1016/j.neuron.2017.03.016</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.neuron.2017.03.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.neuron.2017.03.016%26sid%3Dliteratum%253Aachs%26jtitle%3DNeuron%26atitle%3DAllosteric%252BModulation%252Bof%252BGPCRs%25253A%252BNew%252BInsights%252Band%252BPotential%252BUtility%252Bfor%252BTreatment%252Bof%252BSchizophrenia%252Band%252BOther%252BCNS%252BDisorders%26aulast%3DFoster%26aufirst%3DDaniel%2BJ.%26date%3D2017%26volume%3D94%26issue%3D3%26spage%3D431%26epage%3D446" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Robert  Lütjens</span>, <span class="hlFld-ContribAuthor ">Jean-Philippe  Rocher</span>. </span><span class="cited-content_cbyCitation_article-title">Recent advances in drug discovery of GPCR allosteric modulators for neurodegenerative disorders. </span><span class="cited-content_cbyCitation_journal-name">Current Opinion in Pharmacology</span><span> <strong>2017,</strong> <em>32 </em>, 91-95. <a href="https://doi.org/10.1016/j.coph.2017.01.001" title="DOI URL">https://doi.org/10.1016/j.coph.2017.01.001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.coph.2017.01.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.coph.2017.01.001%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Opinion%2520in%2520Pharmacology%26atitle%3DRecent%252Badvances%252Bin%252Bdrug%252Bdiscovery%252Bof%252BGPCR%252Ballosteric%252Bmodulators%252Bfor%252Bneurodegenerative%252Bdisorders%26aulast%3DL%25C3%25BCtjens%26aufirst%3DRobert%26date%3D2017%26volume%3D32%26spage%3D91%26epage%3D95" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_null" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00544/20160708/images/medium/jm-2016-005448_0019.gif" alt="" id="_i1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00544/20160708/images/large/jm-2016-005448_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00544&amp;id=f_null"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00544/20160708/images/medium/jm-2016-005448_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00544/20160708/images/large/jm-2016-005448_0001.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structural diversity of M<sub>1</sub> PAM chemotypes.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00544/20160708/images/large/jm-2016-005448_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00544&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00544/20160708/images/medium/jm-2016-005448_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00544/20160708/images/large/jm-2016-005448_0002.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Homology model of the active-state M<sub>1</sub> receptor with the orthosteric site (yellow) and the allosteric site (purple). The two sites are separated by a hydrogen bonded typrosine lid<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> located superficial to the agonist.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00544/20160708/images/large/jm-2016-005448_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00544&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00544/20160708/images/medium/jm-2016-005448_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00544/20160708/images/large/jm-2016-005448_0003.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Evolution of the pyridone M<sub>1</sub> PAM <b>11</b> from PQCA analogue <b>10</b>. The 6-methyl substitution on the pyridone core reinforces the bent three-dimensional geometry predicted by the docked pose in our homology mode to be optimal for binding.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00544/20160708/images/large/jm-2016-005448_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00544&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00544/20160708/images/medium/jm-2016-005448_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00544/20160708/images/large/jm-2016-005448_0010.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Pyridone M<sub>1</sub> PAMs<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00544/20160708/images/large/jm-2016-005448_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00544&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) B<sub>2</sub>pin<sub>2</sub>, Pd(dppf)Cl<sub>2</sub>·CH<sub>2</sub>Cl<sub>2</sub>, KOAc, toluene, 110 °C, 76%; (b) benzyl halide, Pd(PPh<sub>3</sub>)<sub>4</sub>, aq K<sub>2</sub>CO<sub>3</sub>, 110 °C, 85%; (c) NaOH, CH<sub>3</sub>OH, H<sub>2</sub>O, 80 °C, 58%; (d) amino alcohol, HATU, Et<sub>3</sub>N, DMF, rt, 45%; (e) NaOH, CH<sub>3</sub>OH, H<sub>2</sub>O, 92%; (f) amino alcohol, HATU, Et<sub>3</sub>N, DMF, rt, 85%; (g) B<sub>2</sub>pin<sub>2</sub>, Pd<sub>2</sub>(dba)<sub>3</sub>, PCy<sub>3</sub>, KOAc, dioxane, rt, 60%; (h) 2-(4-(bromomethyl)phenyl)-6-methyl-1,3,6,2-dioxazaborocane-4,8-dione, Pd(PPh<sub>3</sub>)<sub>4</sub>, KF (dry solid), CH<sub>3</sub>CN, 80 °C, 90%; (i) aq NaHCO<sub>3</sub>, THF, MeOH, rt, 77%; (j) heteroaryl halide, Pd(PPh<sub>3</sub>)<sub>4</sub>, aq K<sub>2</sub>CO<sub>3</sub>, dioxane, 80 °C; (k) amine or azole, Cu(OAc)<sub>2</sub>, aq NaHCO<sub>3</sub>, pyridine, 60 °C.</p></p></figure><figure data-id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00544/20160708/images/medium/jm-2016-005448_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00544/20160708/images/large/jm-2016-005448_0004.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Compound <b>11</b> docked in the allosteric site of the M<sub>1</sub> homology model with key interactions highlighted.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00544/20160708/images/large/jm-2016-005448_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00544&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00544/20160708/images/medium/jm-2016-005448_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00544/20160708/images/large/jm-2016-005448_0005.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Analysis of all synthesized pyridones comparing M<sub>1</sub> PAM potency (pEC<sub>50</sub>) to intrinsic clearance (HLM). Compounds are colored by their MDR ER: green, <2; yellow, 2–3; red, >3.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00544/20160708/images/large/jm-2016-005448_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00544&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch2" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00544/20160708/images/medium/jm-2016-005448_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00544/20160708/images/large/jm-2016-005448_0011.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Analogues with a Pyridine Core<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00544/20160708/images/large/jm-2016-005448_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00544&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) B<sub>2</sub>pin<sub>2</sub>, Pd(dppf)Cl<sub>2</sub>·CH<sub>2</sub>Cl<sub>2</sub>, KOAc, toluene, 100 °C, 20 h; (b) benzyl halide, Pd(dppf)Cl<sub>2</sub>·CH<sub>2</sub>Cl<sub>2</sub>, K<sub>2</sub>CO<sub>3</sub>, dioxane/H<sub>2</sub>O, 80 °C (50% over two steps). <b>28a</b>: R<sub>1</sub> = N-linked pyrazole. <b>28b</b>: R<sub>1</sub> = 4-oxazole. <b>28c</b>: R<sub>1</sub> = 4-thiazole. (c) NaOH, dioxane, H<sub>2</sub>O, rt, 85%; (d) amino alcohol, HATU, Et<sub>3</sub>N, rt, 90%.</p></p></figure><figure data-id="fig6" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00544/20160708/images/medium/jm-2016-005448_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00544/20160708/images/large/jm-2016-005448_0006.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Torsional energy scans for the carbonyl-core bond from compounds listed in <a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>, in 15° intervals using TeraChem 1.5 (DFT, B3LYP/6-31G**) in vacuo. Green shaded area represents the ideal angle whereby the amide carbonyl can make a through water hydrogen bond with Gln177.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00544/20160708/images/large/jm-2016-005448_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00544&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00544/20160708/images/medium/jm-2016-005448_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00544/20160708/images/large/jm-2016-005448_0007.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Functional dose–response curves for <b>38</b> in the presence (PAM mode) and absence (agonist mode) of an EC<sub>20</sub> of ACh in (A) M<sub>1</sub> FLIPR (agonist EC<sub>50</sub> ≥ 3.9 μM,<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> PAM EC<sub>50</sub> = 60 nM); (B) M<sub>1</sub> IP<sub>1</sub> (agonist EC<sub>50</sub> ≥ 9.2 μM, PAM EC<sub>50</sub> = 447 nM); (C) β-arrestin (agonist EC<sub>50</sub> = 3.9 μM, PAM EC<sub>50</sub> = 365 nM). (D) Functional concentration–response curves for compound <b>38</b> in the presence (PAM mode) and absence (agonist mode) of an EC<sub>20</sub> carbachol in hippocampal slice assay. Representative M<sub>1</sub> ACh shift data using (E) FLIPR, (F) β-arrestin, and (G) inhibition of [<sup>3</sup>H]NMS binding in the presence of fixed concentrations of agonist: crimson circle: 10 μM; red square: 3 μM; orange up triangle: 1 μM; brown down triangle: 0.3 μM; blue diamonds: 0.1 μM; black circle: 0 μM (H) Binding and functional parameters for <b>38</b> from the functional allosteric model: <sup><i>a</i></sup>intrinsic efficacy of ACh; <sup><i>b</i></sup>intrinsic efficacy of <b>38</b>; <sup><i>c</i></sup>functional cooperativity of <b>38</b> with ACh.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00544/20160708/images/large/jm-2016-005448_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00544&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00544/20160708/images/medium/jm-2016-005448_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00544/20160708/images/large/jm-2016-005448_0008.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. (A) Representative M<sub>1</sub>–M<sub>5</sub> PAM functional dose–response curves for compound <b>38</b> in the presence of EC<sub>20</sub> of ACh. M<sub>1,3,5</sub> used a FLIPR assay, while M<sub>2,4</sub> used a cAMP readout. Functional concentration–response curves for <b>38</b> in the absence (B, agonist mode) and presence (C, PAM mode) of an EC<sub>20</sub> donepezil ± the non-selective muscarinic antagonist atropine in the GPI tissue bath assay. Inhibition of [<sup>3</sup>H]NMS binding to M<sub>2</sub> (D) and M<sub>3</sub> (E) expressing cell lines by ACh in the presence of fixed concentrations of compound <b>38</b>: crimson circle: 10 μM; red square: 3 μM; orange up triangle: 1 μM; brown down triangle: 0.3 μM; blue diamonds: 0.1 μM; black circle: 0 μM. (F) Correlation between pEC<sub>50</sub> in the M<sub>1</sub> PAM FLIPR assay and pEC<sub>50</sub> in the PAM mode of the GPI tissue bath assay (color/shape by chemical series: red circle, azaindoles;<a onclick="showRef(event, 'cit14z'); return false;" href="javascript:void(0);" class="ref cit14z">(14z)</a> yellow down-triangle, pyridones; brown up-triangle, pyridines; blue box, literature standards; black diamond, undisclosed).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00544/20160708/images/large/jm-2016-005448_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00544&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00544/20160708/images/medium/jm-2016-005448_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00544/20160708/images/large/jm-2016-005448_0009.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Effects of compound <b>38</b> on (A) mouse striatal IP<sub>1</sub> levels, (B) mouse amphetamine-stimulated locomotor activity (aLMA), (C) rat scopolamine-induced Morris water maze (MWM) activity, and (D) rat amphetamine-induced prepulse inhibition (aPPI). Data shown are from 5, 10, and 15 dB (see <a href="/doi/suppl/10.1021/acs.jmedchem.6b00544/suppl_file/jm6b00544_si_002.pdf" class="ext-link">Supporting Information</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-13/acs.jmedchem.6b00544/20160708/images/large/jm-2016-005448_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00544&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i28">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_12780" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_12780" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 48 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Shirey, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brady, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bridges, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jadhav, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menon, U. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christian, E. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doherty, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quirk, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snyder, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lah, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levey, A. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicolle, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindsley, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conn, P. J.</span><span> </span><span class="NLM_article-title">A selective allosteric potentiator of the M1 muscarinic acetylcholine receptor increases activity of medial prefrontal cortical neurons and restores impairments in reversal learning</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">14271</span><span class="NLM_x">–</span> <span class="NLM_lpage">14286</span><span class="refDoi"> DOI: 10.1523/JNEUROSCI.3930-09.2009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=10.1523%2FJNEUROSCI.3930-09.2009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=19906975" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsVGrsrjL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2009&pages=14271-14286&author=J.+K.+Shireyauthor=A.+E.+Bradyauthor=P.+J.+Jonesauthor=A.+A.+Davisauthor=T.+M.+Bridgesauthor=J.+P.+Kennedyauthor=S.+B.+Jadhavauthor=U.+N.+Menonauthor=Z.+Xiangauthor=M.+L.+Watsonauthor=E.+P.+Christianauthor=J.+J.+Dohertyauthor=M.+C.+Quirkauthor=D.+H.+Snyderauthor=J.+J.+Lahauthor=A.+I.+Leveyauthor=M.+M.+Nicolleauthor=C.+W.+Lindsleyauthor=P.+J.+Conn&title=A+selective+allosteric+potentiator+of+the+M1+muscarinic+acetylcholine+receptor+increases+activity+of+medial+prefrontal+cortical+neurons+and+restores+impairments+in+reversal+learning&doi=10.1523%2FJNEUROSCI.3930-09.2009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1aR"><div class="casContent"><span class="casTitleNuber">1a</span><div class="casTitle"><span class="NLM_cas:atitle">A selective allosteric potentiator of the M1 muscarinic acetylcholine receptor increases activity of medial prefrontal cortical neurons and restores impairments in reversal learning</span></div><div class="casAuthors">Shirey, Jana K.; Brady, Ashley E.; Jones, Paulianda J.; Davis, Albert A.; Bridges, Thomas M.; Kennedy, J. Phillip; Jadhav, Satyawan B.; Menon, Usha N.; Xiang, Zixiu; Watson, Mona L.; Christian, Edward P.; Doherty, James J.; Quirk, Michael C.; Snyder, Dean H.; Lah, James J.; Levey, Allan I.; Nicolle, Michelle M.; Lindsley, Craig W.; Conn, P. Jeffrey</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">45</span>),
    <span class="NLM_cas:pages">14271-14286</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">M1 muscarinic acetylcholine receptors (mAChRs) may represent a viable target for treatment of disorders involving impaired cognitive function.  However, a major limitation to testing this hypothesis has been a lack of highly selective ligands for individual mAChR subtypes.  We now report the rigorous mol. characterization of a novel compd., benzylquinolone carboxylic acid (BQCA), which acts as a potent, highly selective pos. allosteric modulator (PAM) of the rat M1 receptor.  This compd. does not directly activate the receptor, but acts at an allosteric site to increase functional responses to orthosteric agonists.  Radioligand binding studies revealed that BQCA increases M1 receptor affinity for acetylcholine.  We found that activation of the M1 receptor by BQCA induces a robust inward current and increases spontaneous EPSCs in medial prefrontal cortex (mPFC) pyramidal cells, effects which are absent in acute slices from M1 receptor knock-out mice.  Furthermore, to det. the effect of BQCA on intact and functioning brain circuits, multiple single-unit recordings were obtained from the mPFC of rats that showed BQCA increases firing of mPFC pyramidal cells in vivo.  BQCA also restored discrimination reversal learning in a transgenic mouse model of Alzheimer's disease and was found to regulate non-amyloidogenic APP processing in vitro, suggesting that M1 receptor PAMs have the potential to provide both symptomatic and disease modifying effects in Alzheimer's disease patients.  Together, these studies provide compelling evidence that M1 receptor activation induces a dramatic excitation of PFC neurons and suggest that selectively activating the M1 mAChR subtype may ameliorate impairments in cognitive function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPy39j1-erZLVg90H21EOLACvtfcHk0lhOhm49-cEOTA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsVGrsrjL&md5=f9b017887d46ba34b925f747cea7ce3b</span></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.3930-09.2009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.3930-09.2009%26sid%3Dliteratum%253Aachs%26aulast%3DShirey%26aufirst%3DJ.%2BK.%26aulast%3DBrady%26aufirst%3DA.%2BE.%26aulast%3DJones%26aufirst%3DP.%2BJ.%26aulast%3DDavis%26aufirst%3DA.%2BA.%26aulast%3DBridges%26aufirst%3DT.%2BM.%26aulast%3DKennedy%26aufirst%3DJ.%2BP.%26aulast%3DJadhav%26aufirst%3DS.%2BB.%26aulast%3DMenon%26aufirst%3DU.%2BN.%26aulast%3DXiang%26aufirst%3DZ.%26aulast%3DWatson%26aufirst%3DM.%2BL.%26aulast%3DChristian%26aufirst%3DE.%2BP.%26aulast%3DDoherty%26aufirst%3DJ.%2BJ.%26aulast%3DQuirk%26aufirst%3DM.%2BC.%26aulast%3DSnyder%26aufirst%3DD.%2BH.%26aulast%3DLah%26aufirst%3DJ.%2BJ.%26aulast%3DLevey%26aufirst%3DA.%2BI.%26aulast%3DNicolle%26aufirst%3DM.%2BM.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26aulast%3DConn%26aufirst%3DP.%2BJ.%26atitle%3DA%2520selective%2520allosteric%2520potentiator%2520of%2520the%2520M1%2520muscarinic%2520acetylcholine%2520receptor%2520increases%2520activity%2520of%2520medial%2520prefrontal%2520cortical%2520neurons%2520and%2520restores%2520impairments%2520in%2520reversal%2520learning%26jtitle%3DJ.%2520Neurosci.%26date%3D2009%26volume%3D29%26spage%3D14271%26epage%3D14286%26doi%3D10.1523%2FJNEUROSCI.3930-09.2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit1b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Felder, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bymaster, F. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeLapp, N.</span><span> </span><span class="NLM_article-title">Therapeutic opportunities for muscarinic receptors in the central nervous system</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">4333</span><span class="NLM_x">–</span> <span class="NLM_lpage">4353</span><span class="refDoi"> DOI: 10.1021/jm990607u</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm990607u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=1%3ACAS%3A528%3ADC%252BD3cXotVGjurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=4333-4353&author=C.+C.+Felderauthor=F.+P.+Bymasterauthor=J.+Wardauthor=N.+DeLapp&title=Therapeutic+opportunities+for+muscarinic+receptors+in+the+central+nervous+system&doi=10.1021%2Fjm990607u"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1bR"><div class="casContent"><span class="casTitleNuber">1b</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic opportunities for muscarinic receptors in the central nervous system</span></div><div class="casAuthors">Felder, Christian C.; Bymaster, Frank P.; Ward, John; DeLapp, Neil</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">4333-4353</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review with 270 refs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqG8rbnUQnx97Vg90H21EOLACvtfcHk0lhOhm49-cEOTA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXotVGjurs%253D&md5=5958ba24baebc0ebec67cccfd66b6286</span></div><a href="/servlet/linkout?suffix=cit1b&amp;dbid=16384&amp;doi=10.1021%2Fjm990607u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm990607u%26sid%3Dliteratum%253Aachs%26aulast%3DFelder%26aufirst%3DC.%2BC.%26aulast%3DBymaster%26aufirst%3DF.%2BP.%26aulast%3DWard%26aufirst%3DJ.%26aulast%3DDeLapp%26aufirst%3DN.%26atitle%3DTherapeutic%2520opportunities%2520for%2520muscarinic%2520receptors%2520in%2520the%2520central%2520nervous%2520system%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D4333%26epage%3D4353%26doi%3D10.1021%2Fjm990607u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit1c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Ghoshal, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rook, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dickerson, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roop, G. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morrison, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jalan-Sakrikar, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamsal, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noetzel, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poslusney, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melancon, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stauffer, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daniels, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niswender, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindsley, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conn, P. J.</span><span> </span><span class="NLM_article-title">Potentiation of M1 muscarinic receptor reverses plasticity deficits and negative and cognitive symptoms in a schizophrenia mouse model</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">598</span><span class="NLM_x">–</span> <span class="NLM_lpage">610</span><span class="refDoi"> DOI: 10.1038/npp.2015.189</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=10.1038%2Fnpp.2015.189" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2016&pages=598-610&author=A.+Ghoshalauthor=J.+M.+Rookauthor=J.+W.+Dickersonauthor=G.+N.+Roopauthor=R.+D.+Morrisonauthor=N.+Jalan-Sakrikarauthor=A.+Lamsalauthor=M.+J.+Noetzelauthor=M.+S.+Poslusneyauthor=M.+R.+Woodauthor=B.+J.+Melanconauthor=S.+R.+Staufferauthor=Z.+Xiangauthor=J.+S.+Danielsauthor=C.+M.+Niswenderauthor=C.+K.+Jonesauthor=C.+W.+Lindsleyauthor=P.+J.+Conn&title=Potentiation+of+M1+muscarinic+receptor+reverses+plasticity+deficits+and+negative+and+cognitive+symptoms+in+a+schizophrenia+mouse+model&doi=10.1038%2Fnpp.2015.189"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1c&amp;dbid=16384&amp;doi=10.1038%2Fnpp.2015.189&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnpp.2015.189%26sid%3Dliteratum%253Aachs%26aulast%3DGhoshal%26aufirst%3DA.%26aulast%3DRook%26aufirst%3DJ.%2BM.%26aulast%3DDickerson%26aufirst%3DJ.%2BW.%26aulast%3DRoop%26aufirst%3DG.%2BN.%26aulast%3DMorrison%26aufirst%3DR.%2BD.%26aulast%3DJalan-Sakrikar%26aufirst%3DN.%26aulast%3DLamsal%26aufirst%3DA.%26aulast%3DNoetzel%26aufirst%3DM.%2BJ.%26aulast%3DPoslusney%26aufirst%3DM.%2BS.%26aulast%3DWood%26aufirst%3DM.%2BR.%26aulast%3DMelancon%26aufirst%3DB.%2BJ.%26aulast%3DStauffer%26aufirst%3DS.%2BR.%26aulast%3DXiang%26aufirst%3DZ.%26aulast%3DDaniels%26aufirst%3DJ.%2BS.%26aulast%3DNiswender%26aufirst%3DC.%2BM.%26aulast%3DJones%26aufirst%3DC.%2BK.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26aulast%3DConn%26aufirst%3DP.%2BJ.%26atitle%3DPotentiation%2520of%2520M1%2520muscarinic%2520receptor%2520reverses%2520plasticity%2520deficits%2520and%2520negative%2520and%2520cognitive%2520symptoms%2520in%2520a%2520schizophrenia%2520mouse%2520model%26jtitle%3DNeuropsychopharmacology%26date%3D2016%26volume%3D41%26spage%3D598%26epage%3D610%26doi%3D10.1038%2Fnpp.2015.189" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit1d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Foster, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conn, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rook, J. M.</span><span> </span><span class="NLM_article-title">Activation of M1 and M4 muscarinic receptors as potential treatments for Alzheimer’s disease and schizophrenia</span> <span class="citation_source-journal">Neuropsychiatr. Dis. Treat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">183</span><span class="NLM_x">–</span> <span class="NLM_lpage">191</span><span class="refDoi"> DOI: 10.2147/NDT.S55104</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=10.2147%2FNDT.S55104" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1d&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=24511233" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs12lsLvL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2014&pages=183-191&author=D.+J.+Fosterauthor=D.+L.+Choiauthor=P.+J.+Connauthor=J.+M.+Rook&title=Activation+of+M1+and+M4+muscarinic+receptors+as+potential+treatments+for+Alzheimer%E2%80%99s+disease+and+schizophrenia&doi=10.2147%2FNDT.S55104"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1dR"><div class="casContent"><span class="casTitleNuber">1d</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of M1 and M4 muscarinic receptors as potential treatments for Alzheimer's disease and schizophrenia</span></div><div class="casAuthors">Foster, Daniel J.; Choi, Derrick L.; Conn, P. Jeffrey; Rook, Jerri M.</div><div class="citationInfo"><span class="NLM_cas:title">Neuropsychiatric Disease and Treatment</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">183-191, 9</span>CODEN:
                <span class="NLM_cas:coden">NDTEAZ</span>;
        ISSN:<span class="NLM_cas:issn">1178-2021</span>.
    
            (<span class="NLM_cas:orgname">Dove Medical Press Ltd.</span>)
        </div><div class="casAbstract">A review.  Alzheimer's disease (AD) and schizophrenia (SZ) are neurol. disorders with overlapping symptomatol., including both cognitive deficits and behavioral disturbances.  Current clin. treatments for both disorders have limited efficacy accompanied by dose-limiting side effects, and ultimately fail to adequately address the broad range of symptoms obsd.  Novel therapeutic options for AD and SZ are needed to better manage the spectrum of symptoms with reduced adverse-effect liability.  Substantial evidence suggests that activation of muscarinic acetylcholine receptors (mAChRs) has the potential to treat both cognitive and psychosis-related symptoms assocd. with numerous central nervous system (CNS) disorders.  However, use of nonselective modulators of mAChRs is hampered by dose-limiting peripheral side effects that limit their clin. utility.  In order to maintain the clin. efficacy without the adverse-effect liability, efforts have been focused on the discovery of compds. that selectively modulate the centrally located M1 and M4 mAChR subtypes.  Previous drug discovery attempts have been thwarted by the highly conserved nature of the acetylcholine site across mAChR subtypes.  However, current efforts by our lab. and others have now focused on modulators that bind to allosteric sites on mAChRs, allowing these compds. to display unprecedented subtype selectivity.  Over the past couple of decades, the discovery of small mols. capable of selectively targeting the M1 or M4 mAChR subtypes has allowed researchers to elucidate the roles of these receptors in regulating cognitive and behavioral disturbances in preclin. animal models.  Here, we provide an overview of these promising preclin. and clin. studies, which suggest that M1- and M4-selective modulators represent viable novel targets with the potential to successfully address a broad range of symptoms obsd. in patients with AD and SZ.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1huQLY2kYMrVg90H21EOLACvtfcHk0lj9q9P79eIGig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs12lsLvL&md5=cb4b539ecd830e56559b11ad18358622</span></div><a href="/servlet/linkout?suffix=cit1d&amp;dbid=16384&amp;doi=10.2147%2FNDT.S55104&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2147%252FNDT.S55104%26sid%3Dliteratum%253Aachs%26aulast%3DFoster%26aufirst%3DD.%2BJ.%26aulast%3DChoi%26aufirst%3DD.%2BL.%26aulast%3DConn%26aufirst%3DP.%2BJ.%26aulast%3DRook%26aufirst%3DJ.%2BM.%26atitle%3DActivation%2520of%2520M1%2520and%2520M4%2520muscarinic%2520receptors%2520as%2520potential%2520treatments%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%2520and%2520schizophrenia%26jtitle%3DNeuropsychiatr.%2520Dis.%2520Treat.%26date%3D2014%26volume%3D10%26spage%3D183%26epage%3D191%26doi%3D10.2147%2FNDT.S55104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Korczyn, A. D.</span><span> </span><span class="NLM_article-title">Muscarinic M(1) agonists in the treatment of Alzheimer’s disease</span> <span class="citation_source-journal">Expert Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">2259</span><span class="NLM_x">–</span> <span class="NLM_lpage">2267</span><span class="refDoi"> DOI: 10.1517/13543784.9.10.2259</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=10.1517%2F13543784.9.10.2259" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2000&pages=2259-2267&author=A.+D.+Korczyn&title=Muscarinic+M%281%29+agonists+in+the+treatment+of+Alzheimer%E2%80%99s+disease&doi=10.1517%2F13543784.9.10.2259"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1517%2F13543784.9.10.2259&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543784.9.10.2259%26sid%3Dliteratum%253Aachs%26aulast%3DKorczyn%26aufirst%3DA.%2BD.%26atitle%3DMuscarinic%2520M%25281%2529%2520agonists%2520in%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2000%26volume%3D9%26spage%3D2259%26epage%3D2267%26doi%3D10.1517%2F13543784.9.10.2259" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Kruse, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ring, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manglik, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eitel, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hubner, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pardon, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valant, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sexton, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christopoulos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Felder, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gmeiner, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steyaert, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weis, W. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wess, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobilka, B. K.</span><span> </span><span class="NLM_article-title">Activation and allosteric modulation of a muscarinic acetylcholine receptor</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">504</span><span class="NLM_x">, </span> <span class="NLM_fpage">101</span><span class="NLM_x">–</span> <span class="NLM_lpage">106</span><span class="refDoi"> DOI: 10.1038/nature12735</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=10.1038%2Fnature12735" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=24256733" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvVyisLjP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=504&publication_year=2013&pages=101-106&author=A.+C.+Kruseauthor=A.+M.+Ringauthor=A.+Manglikauthor=J.+Huauthor=K.+Huauthor=K.+Eitelauthor=H.+Hubnerauthor=E.+Pardonauthor=C.+Valantauthor=P.+M.+Sextonauthor=A.+Christopoulosauthor=C.+C.+Felderauthor=P.+Gmeinerauthor=J.+Steyaertauthor=W.+I.+Weisauthor=K.+C.+Garciaauthor=J.+Wessauthor=B.+K.+Kobilka&title=Activation+and+allosteric+modulation+of+a+muscarinic+acetylcholine+receptor&doi=10.1038%2Fnature12735"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Activation and allosteric modulation of a muscarinic acetylcholine receptor</span></div><div class="casAuthors">Kruse, Andrew C.; Ring, Aaron M.; Manglik, Aashish; Hu, Jianxin; Hu, Kelly; Eitel, Katrin; Huebner, Harald; Pardon, Els; Valant, Celine; Sexton, Patrick M.; Christopoulos, Arthur; Felder, Christian C.; Gmeiner, Peter; Steyaert, Jan; Weis, William I.; Garcia, K. Christopher; Wess, Juergen; Kobilka, Brian K.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">504</span>
        (<span class="NLM_cas:issue">7478</span>),
    <span class="NLM_cas:pages">101-106</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Despite recent advances in crystallog. and the availability of G-protein-coupled receptor (GPCR) structures, little is known about the mechanism of their activation process, as only the β2 adrenergic receptor (β2AR) and rhodopsin have been crystd. in fully active conformations.  Here we report the structure of an agonist-bound, active state of the human M2 muscarinic acetylcholine receptor stabilized by a G-protein mimetic camelid antibody fragment isolated by conformational selection using yeast surface display.  In addn. to the expected changes in the intracellular surface, the structure reveals larger conformational changes in the extracellular region and orthosteric binding site than obsd. in the active states of the β2AR and rhodopsin.  We also report the structure of the M2 receptor simultaneously bound to the orthosteric agonist iperoxo and the pos. allosteric modulator LY2119620.  This structure reveals that LY2119620 recognizes a largely pre-formed binding site in the extracellular vestibule of the iperoxo-bound receptor, inducing a slight contraction of this outer binding pocket.  These structures offer important insights into the activation mechanism and allosteric modulation of muscarinic receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpOuUgQSB7Dd7Vg90H21EOLACvtfcHk0lj9q9P79eIGig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvVyisLjP&md5=ecddab0ab467321ac243b86bb82b71f8</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1038%2Fnature12735&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature12735%26sid%3Dliteratum%253Aachs%26aulast%3DKruse%26aufirst%3DA.%2BC.%26aulast%3DRing%26aufirst%3DA.%2BM.%26aulast%3DManglik%26aufirst%3DA.%26aulast%3DHu%26aufirst%3DJ.%26aulast%3DHu%26aufirst%3DK.%26aulast%3DEitel%26aufirst%3DK.%26aulast%3DHubner%26aufirst%3DH.%26aulast%3DPardon%26aufirst%3DE.%26aulast%3DValant%26aufirst%3DC.%26aulast%3DSexton%26aufirst%3DP.%2BM.%26aulast%3DChristopoulos%26aufirst%3DA.%26aulast%3DFelder%26aufirst%3DC.%2BC.%26aulast%3DGmeiner%26aufirst%3DP.%26aulast%3DSteyaert%26aufirst%3DJ.%26aulast%3DWeis%26aufirst%3DW.%2BI.%26aulast%3DGarcia%26aufirst%3DK.%2BC.%26aulast%3DWess%26aufirst%3DJ.%26aulast%3DKobilka%26aufirst%3DB.%2BK.%26atitle%3DActivation%2520and%2520allosteric%2520modulation%2520of%2520a%2520muscarinic%2520acetylcholine%2520receptor%26jtitle%3DNature%26date%3D2013%26volume%3D504%26spage%3D101%26epage%3D106%26doi%3D10.1038%2Fnature12735" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><a href="http://www.heptares.com/news/261/74/Heptares-Announces-Positive-Results-from-Phase-1b-Clinical-Trial-with-HTL9936-a-First-In-Class-Selective-Muscarinic-M1-Receptor-Agonist-for-Improving-Cognition-in-Dementia-and-Schizophrenia.html" class="extLink">http://www.heptares.com/news/261/74/Heptares-Announces-Positive-Results-from-Phase-1b-Clinical-Trial-with-HTL9936-a-First-In-Class-Selective-Muscarinic-M1-Receptor-Agonist-for-Improving-Cognition-in-Dementia-and-Schizophrenia.html</a> (accessed February 12,<span class="NLM_x"> </span><span class="NLM_year">2016</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=http%3A%2F%2Fwww.heptares.com%2Fnews%2F261%2F74%2FHeptares-Announces-Positive-Results-from-Phase-1b-Clinical-Trial-with-HTL9936-a-First-In-Class-Selective-Muscarinic-M1-Receptor-Agonist-for-Improving-Cognition-in-Dementia-and-Schizophrenia.html+%28accessed+February+12%2C+2016%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Ma, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seager, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wittmann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bickel, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burno, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graufelds, V. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pearson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCampbell, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaspar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shughrue, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Danziger, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Regan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flick, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pascarella, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doran, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kreatsoulas, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Veng, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindsley, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shipe, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuduk, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sur, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kinney, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seabrook, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ray, W. J.</span><span> </span><span class="NLM_article-title">Selective activation of the M<sub>1</sub> muscarinic acetylcholine receptor achieved by allosteric potentiation</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">106</span><span class="NLM_x">, </span> <span class="NLM_fpage">15950</span><span class="NLM_x">–</span> <span class="NLM_lpage">15955</span><span class="refDoi"> DOI: 10.1073/pnas.0900903106</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=10.1073%2Fpnas.0900903106" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=19717450" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFOqt7nL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2009&pages=15950-15955&author=L.+Maauthor=M.+A.+Seagerauthor=M.+Wittmannauthor=M.+Jacobsonauthor=D.+Bickelauthor=M.+Burnoauthor=K.+Jonesauthor=V.+K.+Graufeldsauthor=G.+Xuauthor=M.+Pearsonauthor=A.+McCampbellauthor=R.+Gasparauthor=P.+Shughrueauthor=A.+Danzigerauthor=C.+Reganauthor=R.+Flickauthor=D.+Pascarellaauthor=S.+Garsonauthor=S.+Doranauthor=C.+Kreatsoulasauthor=L.+Vengauthor=C.+W.+Lindsleyauthor=W.+Shipeauthor=S.+Kudukauthor=C.+Surauthor=G.+Kinneyauthor=G.+R.+Seabrookauthor=W.+J.+Ray&title=Selective+activation+of+the+M1+muscarinic+acetylcholine+receptor+achieved+by+allosteric+potentiation&doi=10.1073%2Fpnas.0900903106"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Selective activation of the M1 muscarinic acetylcholine receptor achieved by allosteric potentiation</span></div><div class="casAuthors">Ma, Lei; Seager, Matthew; Wittmann, Marion; Jacobson, Marlene; Bickel, Denise; Burno, Maryann; Jones, Keith; Graufelds, Valerie Kuzmick; Xu, Guangping; Pearson, Michelle; McCampbell, Alexander; Gaspar, Renee; Shughrue, Paul; Danziger, Andrew; Regan, Christopher; Flick, Rose; Pascarella, Danette; Garson, Susan; Doran, Scott; Kreatsoulas, Constantine; Veng, Lone; Lindsley, Craig W.; Shipe, William; Kuduk, Scott; Sur, Cyrille; Kinney, Gene; Seabrook, Guy R.; Ray, William J.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">106</span>
        (<span class="NLM_cas:issue">37</span>),
    <span class="NLM_cas:pages">15950-15955, S15950/1-S15950/9</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The forebrain cholinergic system promotes higher brain function in part by signaling through the M, muscarinic acetylcholine receptor (mAChR).  During Alzheimer's disease (AD), these cholinergic neurons degenerate, therefore selectively activating M1 receptors could improve cognitive function in these patients while avoiding unwanted peripheral responses assocd. with non-selective muscarinic agonists.  We describe here benzyl quinolone carboxylic acid (BQCA), a highly selective allosteric potentiator of the M1 mAChR.  BQCA reduces the concn. of ACh required to activate M1 up to 129-fold with an inflection point value of 845 nM.  No potentiation, agonism, or antagonism activity on other mAChRs is obsd. up to 100 ArM.  Furthermore studies in M1-/- mice demonstrates that BQCA requires M1 to promote inositol phosphate turnover in primary neurons and to increase c-fos and arc RNA expression and ERK phosphorylation in the brain.  Radioligand-binding assays, mol. modeling, and site-directed mutagenesis expts. indicate that BQCA acts at an allosteric site involving residues Y179 and W400.  BQCA reverses scopolamine-induced memory deficits in contextual fear conditioning, increases blood flow to the cerebral cortex, and increases wakefulness while reducing delta sleep.  In contrast to M1 allosteric agonists, which do not improve memory in scopolamine-challenged mice in contextual fear conditioning, BQCA induces 13-arrestin recruitment to M1, suggesting a role for this signal transduction mechanism in the cholinergic modulation of memory.  In summary, BQCA exploits an allosteric potentiation mechanism to provide selectivity for the M1 receptor and represents a promising therapeutic strategy for cognitive disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp0SGRL-coGErVg90H21EOLACvtfcHk0li6fvu__wUQyg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFOqt7nL&md5=4470732fd762f761a18d2bc96220dcb1</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0900903106&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0900903106%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DL.%26aulast%3DSeager%26aufirst%3DM.%2BA.%26aulast%3DWittmann%26aufirst%3DM.%26aulast%3DJacobson%26aufirst%3DM.%26aulast%3DBickel%26aufirst%3DD.%26aulast%3DBurno%26aufirst%3DM.%26aulast%3DJones%26aufirst%3DK.%26aulast%3DGraufelds%26aufirst%3DV.%2BK.%26aulast%3DXu%26aufirst%3DG.%26aulast%3DPearson%26aufirst%3DM.%26aulast%3DMcCampbell%26aufirst%3DA.%26aulast%3DGaspar%26aufirst%3DR.%26aulast%3DShughrue%26aufirst%3DP.%26aulast%3DDanziger%26aufirst%3DA.%26aulast%3DRegan%26aufirst%3DC.%26aulast%3DFlick%26aufirst%3DR.%26aulast%3DPascarella%26aufirst%3DD.%26aulast%3DGarson%26aufirst%3DS.%26aulast%3DDoran%26aufirst%3DS.%26aulast%3DKreatsoulas%26aufirst%3DC.%26aulast%3DVeng%26aufirst%3DL.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26aulast%3DShipe%26aufirst%3DW.%26aulast%3DKuduk%26aufirst%3DS.%26aulast%3DSur%26aufirst%3DC.%26aulast%3DKinney%26aufirst%3DG.%26aulast%3DSeabrook%26aufirst%3DG.%2BR.%26aulast%3DRay%26aufirst%3DW.%2BJ.%26atitle%3DSelective%2520activation%2520of%2520the%2520M1%2520muscarinic%2520acetylcholine%2520receptor%2520achieved%2520by%2520allosteric%2520potentiation%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2009%26volume%3D106%26spage%3D15950%26epage%3D15955%26doi%3D10.1073%2Fpnas.0900903106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Kuduk, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Marco, C. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pitts, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greshock, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wittmann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seager, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koeplinger, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartman, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bilodeau, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ray, W. J.</span><span> </span><span class="NLM_article-title">Discovery of a selective allosteric M1 receptor modulator with suitable development properties based on a quinolizidinone carboxylic acid scaffold</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">4773</span><span class="NLM_x">–</span> <span class="NLM_lpage">4780</span><span class="refDoi"> DOI: 10.1021/jm200400m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm200400m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=1%3ACAS%3A528%3ADC%252BC3MXnslKisbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=4773-4780&author=S.+D.+Kudukauthor=R.+K.+Changauthor=C.+N.+Di+Marcoauthor=D.+R.+Pittsauthor=T.+J.+Greshockauthor=L.+Maauthor=M.+Wittmannauthor=M.+A.+Seagerauthor=K.+A.+Koeplingerauthor=C.+D.+Thompsonauthor=G.+D.+Hartmanauthor=M.+T.+Bilodeauauthor=W.+J.+Ray&title=Discovery+of+a+selective+allosteric+M1+receptor+modulator+with+suitable+development+properties+based+on+a+quinolizidinone+carboxylic+acid+scaffold&doi=10.1021%2Fjm200400m"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a Selective Allosteric M1 Receptor Modulator with Suitable Development Properties Based on a Quinolizidinone Carboxylic Acid Scaffold</span></div><div class="casAuthors">Kuduk, Scott D.; Chang, Ronald K.; Di Marco, Christina N.; Pitts, Daniel R.; Greshock, Thomas J.; Ma, Lei; Wittmann, Marion; Seager, Matthew A.; Koeplinger, Kenneth A.; Thompson, Charles D.; Hartman, George D.; Bilodeau, Mark T.; Ray, William J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">4773-4780</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">One approach to ameliorate the cognitive decline in Alzheimer's disease (AD) has been to restore neuronal signaling from the basal forebrain cholinergic system via the activation of the M1 muscarinic receptor.  A no. of nonselective M1 muscarinic agonists have previously shown pos. effects on cognitive behaviors in AD patients, but were limited due to cholinergic adverse events thought to be mediated by the activation of the M2 to M5 subtypes.  One strategy to confer selectivity for M1 is the identification of pos. allosteric modulators, which would target an allosteric site on the M1 receptor rather than the highly conserved orthosteric acetylcholine binding site.  Quinoline carboxylic acids have been previously identified as highly selective M1 pos. allosteric modulators with good pharmacokinetic and in vivo properties.  Herein is described the optimization of a novel quinolizidinone carboxylic acid scaffold with 4-cyanopiperidines being a key discovery in terms of enhanced activity.  In particular, modulator 4i (I) gave high plasma free fractions, enhanced central nervous system (CNS) exposure, was efficacious in a rodent in vivo model of cognition, and afforded good physicochem. properties suitable for further preclin. evaluation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqyxzdyAvHaZrVg90H21EOLACvtfcHk0li6fvu__wUQyg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXnslKisbc%253D&md5=4e7dcc7278bc0af2e2430f3a4e8b7242</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1021%2Fjm200400m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200400m%26sid%3Dliteratum%253Aachs%26aulast%3DKuduk%26aufirst%3DS.%2BD.%26aulast%3DChang%26aufirst%3DR.%2BK.%26aulast%3DDi%2BMarco%26aufirst%3DC.%2BN.%26aulast%3DPitts%26aufirst%3DD.%2BR.%26aulast%3DGreshock%26aufirst%3DT.%2BJ.%26aulast%3DMa%26aufirst%3DL.%26aulast%3DWittmann%26aufirst%3DM.%26aulast%3DSeager%26aufirst%3DM.%2BA.%26aulast%3DKoeplinger%26aufirst%3DK.%2BA.%26aulast%3DThompson%26aufirst%3DC.%2BD.%26aulast%3DHartman%26aufirst%3DG.%2BD.%26aulast%3DBilodeau%26aufirst%3DM.%2BT.%26aulast%3DRay%26aufirst%3DW.%2BJ.%26atitle%3DDiscovery%2520of%2520a%2520selective%2520allosteric%2520M1%2520receptor%2520modulator%2520with%2520suitable%2520development%2520properties%2520based%2520on%2520a%2520quinolizidinone%2520carboxylic%2520acid%2520scaffold%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D4773%26epage%3D4780%26doi%3D10.1021%2Fjm200400m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="note"><p class="first last">The % homology (identity/similarity) at the allosteric binding site with M1: M2 (62/74%), M3 (64/78%), M4 (64/81%), M5 (78/83%).</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Abdul-Ridha, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lane, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mistry, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sexton, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scammells, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christopoulos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Canals, M.</span><span> </span><span class="NLM_article-title">Mechanistic insights into allosteric structure-function relationships at the M<sub>1</sub> muscarinic acetylcholine receptor</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">289</span><span class="NLM_x">, </span> <span class="NLM_fpage">33701</span><span class="NLM_x">–</span> <span class="NLM_lpage">33711</span><span class="refDoi"> DOI: 10.1074/jbc.M114.604967</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=10.1074%2Fjbc.M114.604967" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=25326383" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvF2rsbjI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=289&publication_year=2014&pages=33701-33711&author=A.+Abdul-Ridhaauthor=J.+R.+Laneauthor=S.+N.+Mistryauthor=L.+Lopezauthor=P.+M.+Sextonauthor=P.+J.+Scammellsauthor=A.+Christopoulosauthor=M.+Canals&title=Mechanistic+insights+into+allosteric+structure-function+relationships+at+the+M1+muscarinic+acetylcholine+receptor&doi=10.1074%2Fjbc.M114.604967"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanistic Insights into Allosteric Structure-Function Relationships at the M1 Muscarinic Acetylcholine Receptor</span></div><div class="casAuthors">Abdul-Ridha, Alaa; Lane, J. Robert; Mistry, Shailesh N.; Lopez, Laura; Sexton, Patrick M.; Scammells, Peter J.; Christopoulos, Arthur; Canals, Meritxell</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">289</span>
        (<span class="NLM_cas:issue">48</span>),
    <span class="NLM_cas:pages">33701-33711</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Benzylquinolone carboxylic acid (BQCA) is the first highly selective pos. allosteric modulator (PAM) for the M1 muscarinic acetylcholine receptor (mAChR), but it possesses low affinity for the allosteric site on the receptor.  More recent drug discovery efforts identified 3-((1S,2S)-2-hydroxycyclohexyl)-6-((6-(1-methyl-1H-pyrazol-4-yl)pyridin-3-yl)methyl)benzo[h]quinazolin-4(3H)-one (referred to herein as benzoquinazolinone 12) as a more potent M1 mAChR PAM with a structural ancestry originating from BQCA and related compds.  In the current study, we optimized the synthesis of and fully characterized the pharmacol. of benzoquinazolinone 12, finding that its improved potency derived from a 50-fold increase in allosteric site affinity as compared with BQCA, while retaining a similar level of pos. cooperativity with acetylcholine.  We then utilized site-directed mutagenesis and mol. modeling to validate the allosteric binding pocket we previously described for BQCA as a shared site for benzoquinazolinone 12 and provide a mol. basis for its improved activity at the M1 mAChR.  This includes a key role for hydrophobic and polar interactions with residues Tyr-179, in the second extracellular loop (ECL2) and Trp-4007.35 in transmembrane domain (TM) 7.  Collectively, this study highlights how the properties of affinity and cooperativity can be differentially modified on a common structural scaffold and identifies mol. features that can be exploited to tailor the development of M1 mAChR-targeting PAMs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpknjxCgLZYXLVg90H21EOLACvtfcHk0li6fvu__wUQyg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvF2rsbjI&md5=c85ea5d192d466a495ebd58545dd4dc4</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M114.604967&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M114.604967%26sid%3Dliteratum%253Aachs%26aulast%3DAbdul-Ridha%26aufirst%3DA.%26aulast%3DLane%26aufirst%3DJ.%2BR.%26aulast%3DMistry%26aufirst%3DS.%2BN.%26aulast%3DLopez%26aufirst%3DL.%26aulast%3DSexton%26aufirst%3DP.%2BM.%26aulast%3DScammells%26aufirst%3DP.%2BJ.%26aulast%3DChristopoulos%26aufirst%3DA.%26aulast%3DCanals%26aufirst%3DM.%26atitle%3DMechanistic%2520insights%2520into%2520allosteric%2520structure-function%2520relationships%2520at%2520the%2520M1%2520muscarinic%2520acetylcholine%2520receptor%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2014%26volume%3D289%26spage%3D33701%26epage%3D33711%26doi%3D10.1074%2Fjbc.M114.604967" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="note"><p class="first last">Values were calculated taking all residues within 7 Å of the PAM binding site of aligned homology models for M1, M3, M4, M5 prepared based on M2 (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4MQT">4MQT</a>). Identity and similarity values were calculated using “seqidentity” function from the Bio3D package in R.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Vardigan, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cannon, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Puri, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dancho, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koser, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wittmann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuduk, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renger, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uslaner, J. M.</span><span> </span><span class="NLM_article-title">Improved cognition without adverse effects: novel M1 muscarinic potentiator compares favorably to donepezil and xanomeline in rhesus monkey</span> <span class="citation_source-journal">Psychopharmacology (Berl)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">232</span><span class="NLM_x">, </span> <span class="NLM_fpage">1859</span><span class="NLM_x">–</span> <span class="NLM_lpage">1866</span><span class="refDoi"> DOI: 10.1007/s00213-014-3813-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=10.1007%2Fs00213-014-3813-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=25491927" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=1%3ACAS%3A280%3ADC%252BC2MzmslGltw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=232&publication_year=2015&pages=1859-1866&author=J.+D.+Vardiganauthor=C.+E.+Cannonauthor=V.+Puriauthor=M.+Danchoauthor=A.+Koserauthor=M.+Wittmannauthor=S.+D.+Kudukauthor=J.+J.+Rengerauthor=J.+M.+Uslaner&title=Improved+cognition+without+adverse+effects%3A+novel+M1+muscarinic+potentiator+compares+favorably+to+donepezil+and+xanomeline+in+rhesus+monkey&doi=10.1007%2Fs00213-014-3813-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10aR"><div class="casContent"><span class="casTitleNuber">10a</span><div class="casTitle"><span class="NLM_cas:atitle">Improved cognition without adverse effects: novel M1 muscarinic potentiator compares favorably to donepezil and xanomeline in rhesus monkey</span></div><div class="casAuthors">Vardigan Joshua D; Cannon Christopher E; Puri Vanita; Dancho Mandy; Koser AmyJo; Wittmann Marion; Kuduk Scott D; Renger John J; Uslaner Jason M</div><div class="citationInfo"><span class="NLM_cas:title">Psychopharmacology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">232</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1859-66</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">RATIONALE:  The standards of care for Alzheimer's disease, acetylcholinesterase inhibitors such as donepezil (Aricept®), are dose-limited due to adverse side-effects.  These adverse events lead to significant patient non-compliance, constraining the dose and magnitude of efficacy that can be achieved.  Non-selective muscarinic receptor orthosteric agonists such as Xanomeline have been shown to be effective in treating symptoms as well, but were also poorly tolerated.  Therefore, there is an unmet medical need for a symptomatic treatment that improves symptoms and is better tolerated.  METHODS:  We compared donepezil, xanomeline, and the novel selective muscarinic 1 receptor positive allosteric modulator PQCA in combination with donepezil in the object retrieval detour (ORD) cognition test in rhesus macaque.  Gastrointestinal (GI) side effects (salivation and feces output) were then assessed with all compounds to determine therapeutic window.  RESULTS:  All three compounds significantly reduced a scopolamine-induced deficit in ORD.  Consistent with what is observed clinically in patients, both donepezil and xanomeline produced significant GI effects in rhesus at doses equal to or less than a fivefold margin from the minimum effective dose that improves cognition.  In stark contrast, PQCA produced no GI side effects when tested at the same dose range.  CONCLUSIONS:  These data suggest M1 positive allosteric modulators have the potential to improve cognition in Alzheimer's disease with a greater therapeutic margin than the current standard of care, addressing an important unmet medical need.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSs79JpLH9cdoJKJbLTgsvCfW6udTcc2eZvxSdVztFZ4Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2MzmslGltw%253D%253D&md5=fe42c4d69929cfddab924411a136c1d1</span></div><a href="/servlet/linkout?suffix=cit10a&amp;dbid=16384&amp;doi=10.1007%2Fs00213-014-3813-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00213-014-3813-x%26sid%3Dliteratum%253Aachs%26aulast%3DVardigan%26aufirst%3DJ.%2BD.%26aulast%3DCannon%26aufirst%3DC.%2BE.%26aulast%3DPuri%26aufirst%3DV.%26aulast%3DDancho%26aufirst%3DM.%26aulast%3DKoser%26aufirst%3DA.%26aulast%3DWittmann%26aufirst%3DM.%26aulast%3DKuduk%26aufirst%3DS.%2BD.%26aulast%3DRenger%26aufirst%3DJ.%2BJ.%26aulast%3DUslaner%26aufirst%3DJ.%2BM.%26atitle%3DImproved%2520cognition%2520without%2520adverse%2520effects%253A%2520novel%2520M1%2520muscarinic%2520potentiator%2520compares%2520favorably%2520to%2520donepezil%2520and%2520xanomeline%2520in%2520rhesus%2520monkey%26jtitle%3DPsychopharmacology%2520%2528Berl%2529%26date%3D2015%26volume%3D232%26spage%3D1859%26epage%3D1866%26doi%3D10.1007%2Fs00213-014-3813-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit10b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Uslaner, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eddins, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Puri, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cannon, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sutcliffe, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chew, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pearson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vivian, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ray, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuduk, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wittmann, M.</span><span> </span><span class="NLM_article-title">The muscarinic M1 receptor positive allosteric modulator PQCA improves cognitive measures in rat, cynomolgus macaque, and rhesus macaque</span> <span class="citation_source-journal">Psychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">225</span><span class="NLM_x">, </span> <span class="NLM_fpage">21</span><span class="NLM_x">–</span> <span class="NLM_lpage">30</span><span class="refDoi"> DOI: 10.1007/s00213-012-2788-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=10.1007%2Fs00213-012-2788-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=22825578" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVOgtrzP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=225&publication_year=2013&pages=21-30&author=J.+M.+Uslanerauthor=D.+Eddinsauthor=V.+Puriauthor=C.+E.+Cannonauthor=J.+Sutcliffeauthor=C.+S.+Chewauthor=M.+Pearsonauthor=J.+A.+Vivianauthor=R.+K.+Changauthor=W.+J.+Rayauthor=S.+D.+Kudukauthor=M.+Wittmann&title=The+muscarinic+M1+receptor+positive+allosteric+modulator+PQCA+improves+cognitive+measures+in+rat%2C+cynomolgus+macaque%2C+and+rhesus+macaque&doi=10.1007%2Fs00213-012-2788-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10bR"><div class="casContent"><span class="casTitleNuber">10b</span><div class="casTitle"><span class="NLM_cas:atitle">The muscarinic M1 receptor positive allosteric modulator PQCA improves cognitive measures in rat, cynomolgus macaque, and rhesus macaque</span></div><div class="casAuthors">Uslaner, Jason M.; Eddins, Donnie; Puri, Vanita; Cannon, Christopher E.; Sutcliffe, Jane; Chew, Chan Sing; Pearson, Michelle; Vivian, Jeffrey A.; Chang, Ronald K.; Ray, William J.; Kuduk, Scott D.; Wittmann, Marion</div><div class="citationInfo"><span class="NLM_cas:title">Psychopharmacology (Heidelberg, Germany)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">225</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">21-30</span>CODEN:
                <span class="NLM_cas:coden">PSCHDL</span>;
        ISSN:<span class="NLM_cas:issn">0033-3158</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Rationale: The current stds. of care for Alzheimer's disease, acetylcholinesterase inhibitors, have limited efficacy due to a host of mechanism-related side effects arising from indiscriminate activation of muscarinic and nicotinic receptors.  The M1 muscarinic receptor is predominantly expressed in the brain in regions involved in cognition, and therefore selective activation of the M1 receptor would be expected to boost cognitive performance with reduced risk of peripheral side effects.  Objectives: Here we investigated whether the selective M1 muscarinic receptor pos. allosteric modulator, PQCA, improves cognitive performance and cerebral blood flow.  Results: PQCA attenuated a scopolamine-induced deficit in novel object recognition in rat, self-ordered spatial search in cynomolgus macaque, and the object retrieval detour task in rhesus macaque.  Beneficial effects in each of these assays and species were obsd. at similar plasma drug concns.  Furthermore, at similar drug concns. that were effective in the behavioral studies, PQCA increased blood flow in the frontal cortex of mice, providing a translational biomarker that could be used to guide dose selection for clin. studies.  Conclusions: These findings provide a framework for appropriately testing an M1 selective compd. in patients with Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrURcvS521RF7Vg90H21EOLACvtfcHk0lhhK-3e9sI4dw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVOgtrzP&md5=860d634a782a26e6b67207f3305585ff</span></div><a href="/servlet/linkout?suffix=cit10b&amp;dbid=16384&amp;doi=10.1007%2Fs00213-012-2788-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00213-012-2788-8%26sid%3Dliteratum%253Aachs%26aulast%3DUslaner%26aufirst%3DJ.%2BM.%26aulast%3DEddins%26aufirst%3DD.%26aulast%3DPuri%26aufirst%3DV.%26aulast%3DCannon%26aufirst%3DC.%2BE.%26aulast%3DSutcliffe%26aufirst%3DJ.%26aulast%3DChew%26aufirst%3DC.%2BS.%26aulast%3DPearson%26aufirst%3DM.%26aulast%3DVivian%26aufirst%3DJ.%2BA.%26aulast%3DChang%26aufirst%3DR.%2BK.%26aulast%3DRay%26aufirst%3DW.%2BJ.%26aulast%3DKuduk%26aufirst%3DS.%2BD.%26aulast%3DWittmann%26aufirst%3DM.%26atitle%3DThe%2520muscarinic%2520M1%2520receptor%2520positive%2520allosteric%2520modulator%2520PQCA%2520improves%2520cognitive%2520measures%2520in%2520rat%252C%2520cynomolgus%2520macaque%252C%2520and%2520rhesus%2520macaque%26jtitle%3DPsychopharmacology%26date%3D2013%26volume%3D225%26spage%3D21%26epage%3D30%26doi%3D10.1007%2Fs00213-012-2788-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit10c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Lange, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cannon, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drott, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuduk, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uslaner, J. M.</span><span> </span><span class="NLM_article-title">The M1 muscarinic positive allosteric modulator PQCA improves performance on translatable tests of memory and attention in rhesus monkeys</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">355</span><span class="NLM_x">, </span> <span class="NLM_fpage">442</span><span class="NLM_x">–</span> <span class="NLM_lpage">450</span><span class="refDoi"> DOI: 10.1124/jpet.115.226712</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=10.1124%2Fjpet.115.226712" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=26446308" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhslaks7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=355&publication_year=2015&pages=442-450&author=H.+S.+Langeauthor=C.+E.+Cannonauthor=J.+T.+Drottauthor=S.+D.+Kudukauthor=J.+M.+Uslaner&title=The+M1+muscarinic+positive+allosteric+modulator+PQCA+improves+performance+on+translatable+tests+of+memory+and+attention+in+rhesus+monkeys&doi=10.1124%2Fjpet.115.226712"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10cR"><div class="casContent"><span class="casTitleNuber">10c</span><div class="casTitle"><span class="NLM_cas:atitle">The M1 muscarinic positive allosteric modulator PQCA improves performance on translatable tests of memory and attention in rhesus monkeys</span></div><div class="casAuthors">Lange, Henry S.; Cannon, Christopher E.; Drott, Jason T.; Kuduk, Scott D.; Uslaner, Jason M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">355</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">442-450</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Improved treatment of Alzheimer disease (AD) is a significant unmet medical need that is becoming even more crit. given the rise in the no. of patients and the substantial economic burden.  The current stds. of care, acetylcholinesterase inhibitors (AChEIs), are hindered by gastrointestinal side effects owing to their nonselective activation of muscarinic and nicotinic receptors.  Recently, the highly selective M1 pos. allosteric modulator PQCA (1-(4-cyano-4-(pyridine-2-yl)piperidin-1-yl)methyl-4-oxo-4 H-quinolizine-3-carboxylic acid) has been demonstrated to improve cognition in a variety of rodent and nonhuman primate cognition models without producing significant gastrointestinal side effects.  Here we describe the effect of PQCA and the AChEI donepezil on two clin. relevant and highly translatable touchscreen cognition tasks in nonhuman primates: paired-assocs. learning (PAL) and the continuous-performance task (CPT).  Blockade of muscarinic signaling by scopolamine produced significant impairments in both PAL and CPT.  PQCA and donepezil attenuated the scopolamine deficits in both tasks, and the action of these two compds. was similar in magnitude.  In addn., the combination of subeffective doses of PQCA and donepezil enhanced PAL performance.  These results further suggest that M1-pos. allosteric modulators, either as monotherapy or as an add-on to current stds. of care, have potential to reduce the cognitive deficits assocd. with AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrOAPD1PIwsgbVg90H21EOLACvtfcHk0lhhK-3e9sI4dw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhslaks7w%253D&md5=19b01aa71aeeff840c3a4d48e3f918ea</span></div><a href="/servlet/linkout?suffix=cit10c&amp;dbid=16384&amp;doi=10.1124%2Fjpet.115.226712&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.115.226712%26sid%3Dliteratum%253Aachs%26aulast%3DLange%26aufirst%3DH.%2BS.%26aulast%3DCannon%26aufirst%3DC.%2BE.%26aulast%3DDrott%26aufirst%3DJ.%2BT.%26aulast%3DKuduk%26aufirst%3DS.%2BD.%26aulast%3DUslaner%26aufirst%3DJ.%2BM.%26atitle%3DThe%2520M1%2520muscarinic%2520positive%2520allosteric%2520modulator%2520PQCA%2520improves%2520performance%2520on%2520translatable%2520tests%2520of%2520memory%2520and%2520attention%2520in%2520rhesus%2520monkeys%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2015%26volume%3D355%26spage%3D442%26epage%3D450%26doi%3D10.1124%2Fjpet.115.226712" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Kuduk, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beshore, D. C.</span><span> </span><span class="NLM_article-title">SAR studies on carboxylic acid series M(1) selective positive allosteric modulators (PAMs)</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">1738</span><span class="NLM_x">–</span> <span class="NLM_lpage">1754</span><span class="refDoi"> DOI: 10.2174/1568026614666140826120224</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=10.2174%2F1568026614666140826120224" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=25176125" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhslGqurrL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2014&pages=1738-1754&author=S.+D.+Kudukauthor=D.+C.+Beshore&title=SAR+studies+on+carboxylic+acid+series+M%281%29+selective+positive+allosteric+modulators+%28PAMs%29&doi=10.2174%2F1568026614666140826120224"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11aR"><div class="casContent"><span class="casTitleNuber">11a</span><div class="casTitle"><span class="NLM_cas:atitle">SAR Studies on Carboxylic Acid Series M1 Selective Positive Allosteric Modulators (PAMs)</span></div><div class="casAuthors">Kuduk, Scott D.; Beshore, Douglas C.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">1738-1754</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  There is mounting evidence from preclin. and early proof-of-concept studies suggesting that selective modulation of the M1 muscarinic receptor is efficacious in cognitive models of Alzheimer's disease (AD).  A no. of nonselective M1 muscarinic agonists have previously shown pos. effects on cognitive function in AD patients, but were limited due to cholinergic adverse events thought to be mediated by pan activation of the M2 to M5 sub-types.  Thus, there is a need to identify selective activators of the M1 receptor to evaluate their potential in cognitive disorders.  One strategy to confer selectivity for M1 is the identification of allosteric agonists or pos. allosteric modulators, which would target an allosteric site on the M1 receptor rather than the highly conserved orthosteric acetylcholine binding site.  BQCA has been identified as a highly selective carboxylic acid M1 PAM and this review focuses on an extensive lead optimization campaign undertaken on this compd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYVW5CI2NUBrVg90H21EOLACvtfcHk0lgk44cXMtxtAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhslGqurrL&md5=2cc31d1a5534ee7861e89751c0b87625</span></div><a href="/servlet/linkout?suffix=cit11a&amp;dbid=16384&amp;doi=10.2174%2F1568026614666140826120224&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026614666140826120224%26sid%3Dliteratum%253Aachs%26aulast%3DKuduk%26aufirst%3DS.%2BD.%26aulast%3DBeshore%26aufirst%3DD.%2BC.%26atitle%3DSAR%2520studies%2520on%2520carboxylic%2520acid%2520series%2520M%25281%2529%2520selective%2520positive%2520allosteric%2520modulators%2520%2528PAMs%2529%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2014%26volume%3D14%26spage%3D1738%26epage%3D1754%26doi%3D10.2174%2F1568026614666140826120224" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit11b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Kuduk, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greshock, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ray, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wittmann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seager, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koeplinger, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartman, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bilodeau, M. T.</span><span> </span><span class="NLM_article-title">Identification of amides as carboxylic Acid surrogates for quinolizidinone-based M1 positive allosteric modulators</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">1070</span><span class="NLM_x">–</span> <span class="NLM_lpage">1074</span><span class="refDoi"> DOI: 10.1021/ml300280g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml300280g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref11/cit11b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsFSgs7rE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=1070-1074&author=S.+D.+Kudukauthor=R.+K.+Changauthor=T.+J.+Greshockauthor=W.+J.+Rayauthor=L.+Maauthor=M.+Wittmannauthor=M.+A.+Seagerauthor=K.+A.+Koeplingerauthor=C.+D.+Thompsonauthor=G.+D.+Hartmanauthor=M.+T.+Bilodeau&title=Identification+of+amides+as+carboxylic+Acid+surrogates+for+quinolizidinone-based+M1+positive+allosteric+modulators&doi=10.1021%2Fml300280g"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11bR"><div class="casContent"><span class="casTitleNuber">11b</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of Amides as Carboxylic Acid Surrogates for Quinolizidinone-Based M1 Positive Allosteric Modulators</span></div><div class="casAuthors">Kuduk, Scott D.; Chang, Ronald K.; Greshock, Thomas J.; Ray, William J.; Ma, Lei; Wittmann, Marion; Seager, Matthew A.; Koeplinger, Kenneth A.; Thompson, Charles D.; Hartman, George D.; Bilodeau, Mark T.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1070-1074</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Selective activation of the M1 muscarinic receptor via pos. allosteric modulation represents an approach to treat the cognitive decline in patients with Alzheimer's disease.  A series of amides were examd. as a replacement for the carboxylic acid moiety in a class of quinolizidinone carboxylic acid M1 muscarinic receptor pos. allosteric modulators, and leading pyran 4o (I) and cyclohexane 5c were found to possess good potency and in vivo efficacy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp0ldxuQ6OgkLVg90H21EOLACvtfcHk0lgk44cXMtxtAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsFSgs7rE&md5=d9f053e33ab39596a05d18a9821077b3</span></div><a href="/servlet/linkout?suffix=cit11b&amp;dbid=16384&amp;doi=10.1021%2Fml300280g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml300280g%26sid%3Dliteratum%253Aachs%26aulast%3DKuduk%26aufirst%3DS.%2BD.%26aulast%3DChang%26aufirst%3DR.%2BK.%26aulast%3DGreshock%26aufirst%3DT.%2BJ.%26aulast%3DRay%26aufirst%3DW.%2BJ.%26aulast%3DMa%26aufirst%3DL.%26aulast%3DWittmann%26aufirst%3DM.%26aulast%3DSeager%26aufirst%3DM.%2BA.%26aulast%3DKoeplinger%26aufirst%3DK.%2BA.%26aulast%3DThompson%26aufirst%3DC.%2BD.%26aulast%3DHartman%26aufirst%3DG.%2BD.%26aulast%3DBilodeau%26aufirst%3DM.%2BT.%26atitle%3DIdentification%2520of%2520amides%2520as%2520carboxylic%2520Acid%2520surrogates%2520for%2520quinolizidinone-based%2520M1%2520positive%2520allosteric%2520modulators%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D3%26spage%3D1070%26epage%3D1074%26doi%3D10.1021%2Fml300280g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit11c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Kuduk, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Marco, C. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saffold, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ray, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wittmann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koeplinger, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartman, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bilodeau, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beshore, D. C.</span><span> </span><span class="NLM_article-title">Identification of a methoxynaphthalene scaffold as a core replacement in quinolizidinone amide M(1) positive allosteric modulators</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">1417</span><span class="NLM_x">–</span> <span class="NLM_lpage">1420</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2014.01.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=10.1016%2Fj.bmcl.2014.01.012" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=1417-1420&author=S.+D.+Kudukauthor=C.+N.+Di+Marcoauthor=J.+R.+Saffoldauthor=W.+J.+Rayauthor=L.+Maauthor=M.+Wittmannauthor=K.+A.+Koeplingerauthor=C.+D.+Thompsonauthor=G.+D.+Hartmanauthor=M.+T.+Bilodeauauthor=D.+C.+Beshore&title=Identification+of+a+methoxynaphthalene+scaffold+as+a+core+replacement+in+quinolizidinone+amide+M%281%29+positive+allosteric+modulators&doi=10.1016%2Fj.bmcl.2014.01.012"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11c&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2014.01.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2014.01.012%26sid%3Dliteratum%253Aachs%26aulast%3DKuduk%26aufirst%3DS.%2BD.%26aulast%3DDi%2BMarco%26aufirst%3DC.%2BN.%26aulast%3DSaffold%26aufirst%3DJ.%2BR.%26aulast%3DRay%26aufirst%3DW.%2BJ.%26aulast%3DMa%26aufirst%3DL.%26aulast%3DWittmann%26aufirst%3DM.%26aulast%3DKoeplinger%26aufirst%3DK.%2BA.%26aulast%3DThompson%26aufirst%3DC.%2BD.%26aulast%3DHartman%26aufirst%3DG.%2BD.%26aulast%3DBilodeau%26aufirst%3DM.%2BT.%26aulast%3DBeshore%26aufirst%3DD.%2BC.%26atitle%3DIdentification%2520of%2520a%2520methoxynaphthalene%2520scaffold%2520as%2520a%2520core%2520replacement%2520in%2520quinolizidinone%2520amide%2520M%25281%2529%2520positive%2520allosteric%2520modulators%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D24%26spage%3D1417%26epage%3D1420%26doi%3D10.1016%2Fj.bmcl.2014.01.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit11d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Yang, Z. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wittmann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ray, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seager, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koeplinger, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartman, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bilodeau, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuduk, S. D.</span><span> </span><span class="NLM_article-title">Discovery of naphthyl-fused 5-membered lactams as a new class of m1 positive allosteric modulators</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">604</span><span class="NLM_x">–</span> <span class="NLM_lpage">608</span><span class="refDoi"> DOI: 10.1021/ml500055h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml500055h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref11/cit11d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=1%3ACAS%3A528%3ADC%252BC2cXivVaqs7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=604-608&author=Z.+Q.+Yangauthor=Y.+Shuauthor=L.+Maauthor=M.+Wittmannauthor=W.+J.+Rayauthor=M.+A.+Seagerauthor=K.+A.+Koeplingerauthor=C.+D.+Thompsonauthor=G.+D.+Hartmanauthor=M.+T.+Bilodeauauthor=S.+D.+Kuduk&title=Discovery+of+naphthyl-fused+5-membered+lactams+as+a+new+class+of+m1+positive+allosteric+modulators&doi=10.1021%2Fml500055h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11dR"><div class="casContent"><span class="casTitleNuber">11d</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Naphthyl-Fused 5-Membered Lactams as a New Class of M1 Positive Allosteric Modulators</span></div><div class="casAuthors">Yang, Zhi-Qiang; Shu, Youheng; Ma, Lei; Wittmann, Marion; Ray, William J.; Seager, Matthew A.; Koeplinger, Kenneth A.; Thompson, Charles D.; Hartman, George D.; Bilodeau, Mark T.; Kuduk, Scott D.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">604-608</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Selective activation of the M1 muscarinic receptor via pos. allosteric modulation represents an original approach to treat the cognitive decline in patients with Alzheimer's disease.  A series of naphthyl-fused 5-membered lactams were identified as a new class of M1 pos. allosteric modulators and were found to possess good potency and in vivo efficacy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrp0-UygW2fhrVg90H21EOLACvtfcHk0lgk44cXMtxtAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXivVaqs7o%253D&md5=a3858be25de507f8fee6003bb50edb67</span></div><a href="/servlet/linkout?suffix=cit11d&amp;dbid=16384&amp;doi=10.1021%2Fml500055h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml500055h%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DZ.%2BQ.%26aulast%3DShu%26aufirst%3DY.%26aulast%3DMa%26aufirst%3DL.%26aulast%3DWittmann%26aufirst%3DM.%26aulast%3DRay%26aufirst%3DW.%2BJ.%26aulast%3DSeager%26aufirst%3DM.%2BA.%26aulast%3DKoeplinger%26aufirst%3DK.%2BA.%26aulast%3DThompson%26aufirst%3DC.%2BD.%26aulast%3DHartman%26aufirst%3DG.%2BD.%26aulast%3DBilodeau%26aufirst%3DM.%2BT.%26aulast%3DKuduk%26aufirst%3DS.%2BD.%26atitle%3DDiscovery%2520of%2520naphthyl-fused%25205-membered%2520lactams%2520as%2520a%2520new%2520class%2520of%2520m1%2520positive%2520allosteric%2520modulators%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D5%26spage%3D604%26epage%3D608%26doi%3D10.1021%2Fml500055h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit11e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Kuduk, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Marco, C. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ray, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wittmann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seager, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koeplinger, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartman, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bilodeau, M. T.</span><span> </span><span class="NLM_article-title">Quinolizidinone carboxylic acids as CNS penetrant, selective m1 allosteric muscarinic receptor modulators</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">263</span><span class="NLM_x">–</span> <span class="NLM_lpage">267</span><span class="refDoi"> DOI: 10.1021/ml100095k</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml100095k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref11/cit11e&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=1%3ACAS%3A528%3ADC%252BC3cXmvFKlsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=263-267&author=S.+D.+Kudukauthor=R.+K.+Changauthor=C.+N.+Di+Marcoauthor=W.+J.+Rayauthor=L.+Maauthor=M.+Wittmannauthor=M.+A.+Seagerauthor=K.+A.+Koeplingerauthor=C.+D.+Thompsonauthor=G.+D.+Hartmanauthor=M.+T.+Bilodeau&title=Quinolizidinone+carboxylic+acids+as+CNS+penetrant%2C+selective+m1+allosteric+muscarinic+receptor+modulators&doi=10.1021%2Fml100095k"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11eR"><div class="casContent"><span class="casTitleNuber">11e</span><div class="casTitle"><span class="NLM_cas:atitle">Quinolizidinone Carboxylic Acids as CNS Penetrant, Selective M1 Allosteric Muscarinic Receptor Modulators</span></div><div class="casAuthors">Kuduk, Scott D.; Chang, Ronald K.; Di Marco, Christina N.; Ray, William J.; Ma, Lei; Wittmann, Marion; Seager, Matthew A.; Koeplinger, Kenneth A.; Thompson, Charles D.; Hartman, George D.; Bilodeau, Mark T.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">263-267</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Pos. allosteric modulation of the M1 muscarinic receptor represents an approach to treat the cognitive decline in patients with Alzheimer's disease.  Replacement of a quinolone ring system in a quinolone carboxylic acid series of M1 modulators with a quinolizidinone bearing a basic amine linkage led to a series of compds. with higher free fraction, enhanced CNS exposure, and improved efficacy in rodent in vivo models of cognition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrSw8FeLsW52bVg90H21EOLACvtfcHk0li367MRrf0t-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXmvFKlsro%253D&md5=d07d556638f4c5380fd2c4578b344b58</span></div><a href="/servlet/linkout?suffix=cit11e&amp;dbid=16384&amp;doi=10.1021%2Fml100095k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml100095k%26sid%3Dliteratum%253Aachs%26aulast%3DKuduk%26aufirst%3DS.%2BD.%26aulast%3DChang%26aufirst%3DR.%2BK.%26aulast%3DDi%2BMarco%26aufirst%3DC.%2BN.%26aulast%3DRay%26aufirst%3DW.%2BJ.%26aulast%3DMa%26aufirst%3DL.%26aulast%3DWittmann%26aufirst%3DM.%26aulast%3DSeager%26aufirst%3DM.%2BA.%26aulast%3DKoeplinger%26aufirst%3DK.%2BA.%26aulast%3DThompson%26aufirst%3DC.%2BD.%26aulast%3DHartman%26aufirst%3DG.%2BD.%26aulast%3DBilodeau%26aufirst%3DM.%2BT.%26atitle%3DQuinolizidinone%2520carboxylic%2520acids%2520as%2520CNS%2520penetrant%252C%2520selective%2520m1%2520allosteric%2520muscarinic%2520receptor%2520modulators%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D1%26spage%3D263%26epage%3D267%26doi%3D10.1021%2Fml100095k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit11f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Kuduk, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Marco, C. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cofre, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pitts, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ray, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wittmann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Veng, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seager, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koeplinger, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartman, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bilodeau, M. T.</span><span> </span><span class="NLM_article-title">N-heterocyclic derived M1 positive allosteric modulators</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">1334</span><span class="NLM_x">–</span> <span class="NLM_lpage">1337</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2010.01.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11f&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=10.1016%2Fj.bmcl.2010.01.013" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=1334-1337&author=S.+D.+Kudukauthor=C.+N.+Di+Marcoauthor=V.+Cofreauthor=D.+R.+Pittsauthor=W.+J.+Rayauthor=L.+Maauthor=M.+Wittmannauthor=L.+Vengauthor=M.+A.+Seagerauthor=K.+Koeplingerauthor=C.+D.+Thompsonauthor=G.+D.+Hartmanauthor=M.+T.+Bilodeau&title=N-heterocyclic+derived+M1+positive+allosteric+modulators&doi=10.1016%2Fj.bmcl.2010.01.013"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11f&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2010.01.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2010.01.013%26sid%3Dliteratum%253Aachs%26aulast%3DKuduk%26aufirst%3DS.%2BD.%26aulast%3DDi%2BMarco%26aufirst%3DC.%2BN.%26aulast%3DCofre%26aufirst%3DV.%26aulast%3DPitts%26aufirst%3DD.%2BR.%26aulast%3DRay%26aufirst%3DW.%2BJ.%26aulast%3DMa%26aufirst%3DL.%26aulast%3DWittmann%26aufirst%3DM.%26aulast%3DVeng%26aufirst%3DL.%26aulast%3DSeager%26aufirst%3DM.%2BA.%26aulast%3DKoeplinger%26aufirst%3DK.%26aulast%3DThompson%26aufirst%3DC.%2BD.%26aulast%3DHartman%26aufirst%3DG.%2BD.%26aulast%3DBilodeau%26aufirst%3DM.%2BT.%26atitle%3DN-heterocyclic%2520derived%2520M1%2520positive%2520allosteric%2520modulators%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D1334%26epage%3D1337%26doi%3D10.1016%2Fj.bmcl.2010.01.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit11g"><span><span class="NLM_label">(g) </span><span class="NLM_contrib-group">Kuduk, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Marco, C. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ray, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wittmann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seager, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koeplinger, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartman, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bilodeau, M. T.</span><span> </span><span class="NLM_article-title">Quinolizidinone carboxylic acid selective M1 allosteric modulators: SAR in the piperidine series</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">1710</span><span class="NLM_x">–</span> <span class="NLM_lpage">1715</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2011.01.094</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11g&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=10.1016%2Fj.bmcl.2011.01.094" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=1710-1715&author=S.+D.+Kudukauthor=R.+K.+Changauthor=C.+N.+Di+Marcoauthor=W.+J.+Rayauthor=L.+Maauthor=M.+Wittmannauthor=M.+A.+Seagerauthor=K.+A.+Koeplingerauthor=C.+D.+Thompsonauthor=G.+D.+Hartmanauthor=M.+T.+Bilodeau&title=Quinolizidinone+carboxylic+acid+selective+M1+allosteric+modulators%3A+SAR+in+the+piperidine+series&doi=10.1016%2Fj.bmcl.2011.01.094"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11g&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2011.01.094&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2011.01.094%26sid%3Dliteratum%253Aachs%26aulast%3DKuduk%26aufirst%3DS.%2BD.%26aulast%3DChang%26aufirst%3DR.%2BK.%26aulast%3DDi%2BMarco%26aufirst%3DC.%2BN.%26aulast%3DRay%26aufirst%3DW.%2BJ.%26aulast%3DMa%26aufirst%3DL.%26aulast%3DWittmann%26aufirst%3DM.%26aulast%3DSeager%26aufirst%3DM.%2BA.%26aulast%3DKoeplinger%26aufirst%3DK.%2BA.%26aulast%3DThompson%26aufirst%3DC.%2BD.%26aulast%3DHartman%26aufirst%3DG.%2BD.%26aulast%3DBilodeau%26aufirst%3DM.%2BT.%26atitle%3DQuinolizidinone%2520carboxylic%2520acid%2520selective%2520M1%2520allosteric%2520modulators%253A%2520SAR%2520in%2520the%2520piperidine%2520series%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D1710%26epage%3D1715%26doi%3D10.1016%2Fj.bmcl.2011.01.094" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit11h"><span><span class="NLM_label">(h) </span><span class="NLM_contrib-group">Kuduk, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Marco, C. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cofre, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ray, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wittmann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seager, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koeplinger, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartman, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bilodeau, M. T.</span><span> </span><span class="NLM_article-title">Fused heterocyclic M1 positive allosteric modulators</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">2769</span><span class="NLM_x">–</span> <span class="NLM_lpage">2772</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2010.10.028</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11h&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=10.1016%2Fj.bmcl.2010.10.028" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=2769-2772&author=S.+D.+Kudukauthor=C.+N.+Di+Marcoauthor=V.+Cofreauthor=W.+J.+Rayauthor=L.+Maauthor=M.+Wittmannauthor=M.+A.+Seagerauthor=K.+A.+Koeplingerauthor=C.+D.+Thompsonauthor=G.+D.+Hartmanauthor=M.+T.+Bilodeau&title=Fused+heterocyclic+M1+positive+allosteric+modulators&doi=10.1016%2Fj.bmcl.2010.10.028"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11h&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2010.10.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2010.10.028%26sid%3Dliteratum%253Aachs%26aulast%3DKuduk%26aufirst%3DS.%2BD.%26aulast%3DDi%2BMarco%26aufirst%3DC.%2BN.%26aulast%3DCofre%26aufirst%3DV.%26aulast%3DRay%26aufirst%3DW.%2BJ.%26aulast%3DMa%26aufirst%3DL.%26aulast%3DWittmann%26aufirst%3DM.%26aulast%3DSeager%26aufirst%3DM.%2BA.%26aulast%3DKoeplinger%26aufirst%3DK.%2BA.%26aulast%3DThompson%26aufirst%3DC.%2BD.%26aulast%3DHartman%26aufirst%3DG.%2BD.%26aulast%3DBilodeau%26aufirst%3DM.%2BT.%26atitle%3DFused%2520heterocyclic%2520M1%2520positive%2520allosteric%2520modulators%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D2769%26epage%3D2772%26doi%3D10.1016%2Fj.bmcl.2010.10.028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Kuduk, S. D.; Dimarco, C. N.; Yang, Z.-Q.</span><span> </span><span class="NLM_article-title">N-linked quinolineamide M1 receptor positive allosteric modulators</span>. WO 2012158474, May 11,<span class="NLM_x"> </span><span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=S.+D.+Kuduk&author=C.+N.+Dimarco&author=Z.-Q.+Yang&title=N-linked+quinolineamide+M1+receptor+positive+allosteric+modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DKuduk%26aufirst%3DS.%2BD.%26atitle%3DN-linked%2520quinolineamide%2520M1%2520receptor%2520positive%2520allosteric%2520modulators%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit12b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Kuduk, S. D.; Di Marco, C. N.; Greshock, T. J.</span><span> </span><span class="NLM_article-title">N-methyl-tetrahydroquinoline M1 receptor positive allosteric modulators</span>. WO 2012158473, May 11,<span class="NLM_x"> </span><span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=S.+D.+Kuduk&author=C.+N.+Di+Marco&author=T.+J.+Greshock&title=N-methyl-tetrahydroquinoline+M1+receptor+positive+allosteric+modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DKuduk%26aufirst%3DS.%2BD.%26atitle%3DN-methyl-tetrahydroquinoline%2520M1%2520receptor%2520positive%2520allosteric%2520modulators%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit12c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Kuduk, S. D.; Chang, R. K.; Greshock, T. J.</span><span> </span><span class="NLM_article-title">Dihydrobenzoquinazolinone M1 receptor positive allosteric modulators</span>. WO 2012047702, September 29,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=S.+D.+Kuduk&author=R.+K.+Chang&author=T.+J.+Greshock&title=Dihydrobenzoquinazolinone+M1+receptor+positive+allosteric+modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DKuduk%26aufirst%3DS.%2BD.%26atitle%3DDihydrobenzoquinazolinone%2520M1%2520receptor%2520positive%2520allosteric%2520modulators%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit12d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Kuduk, S. D.; Beshore, D. C.; Yang, Z.-Q.; Shu, Y.; Pitts, D.</span><span> </span><span class="NLM_article-title">Preparation of benzoisoindolylmethyllactam derivatives and analogs for use as M1 receptor positive allosteric modulators</span>. WO 2012158475, May 11,<span class="NLM_x"> </span><span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=S.+D.+Kuduk&author=D.+C.+Beshore&author=Z.-Q.+Yang&author=Y.+Shu&author=D.+Pitts&title=Preparation+of+benzoisoindolylmethyllactam+derivatives+and+analogs+for+use+as+M1+receptor+positive+allosteric+modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DKuduk%26aufirst%3DS.%2BD.%26atitle%3DPreparation%2520of%2520benzoisoindolylmethyllactam%2520derivatives%2520and%2520analogs%2520for%2520use%2520as%2520M1%2520receptor%2520positive%2520allosteric%2520modulators%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit12e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Kuduk, S. D.; Beshore, D. C.; Yang, Z.; Shu, Y.</span><span> </span><span class="NLM_article-title">Fused isoindolone M1 receptor positive allosteric modulators and their preparation and use for the treatment of M1-mediated diseases</span>. WO 2012003147, June 27,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=S.+D.+Kuduk&author=D.+C.+Beshore&author=Z.+Yang&author=Y.+Shu&title=Fused+isoindolone+M1+receptor+positive+allosteric+modulators+and+their+preparation+and+use+for+the+treatment+of+M1-mediated+diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12e&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DKuduk%26aufirst%3DS.%2BD.%26atitle%3DFused%2520isoindolone%2520M1%2520receptor%2520positive%2520allosteric%2520modulators%2520and%2520their%2520preparation%2520and%2520use%2520for%2520the%2520treatment%2520of%2520M1-mediated%2520diseases%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit12f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Kuduk, S. D.; Skudlarek, J. W.</span><span> </span><span class="NLM_article-title">Preparation of heterocyclic fused phenanthrolinones as M1 receptor positive allosteric modulators for the treatment of diseases mediated by the M1 receptor</span>. WO 2011159553, June 10,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=S.+D.+Kuduk&author=J.+W.+Skudlarek&title=Preparation+of+heterocyclic+fused+phenanthrolinones+as+M1+receptor+positive+allosteric+modulators+for+the+treatment+of+diseases+mediated+by+the+M1+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12f&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DKuduk%26aufirst%3DS.%2BD.%26atitle%3DPreparation%2520of%2520heterocyclic%2520fused%2520phenanthrolinones%2520as%2520M1%2520receptor%2520positive%2520allosteric%2520modulators%2520for%2520the%2520treatment%2520of%2520diseases%2520mediated%2520by%2520the%2520M1%2520receptor%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit12g"><span><span class="NLM_label">(g) </span><span class="NLM_contrib-group">Kuduk, S. D.; Schlegel, K.-A.; Yang, Z.-Q.</span><span> </span><span class="NLM_article-title">Quinoline-amide derivatives as M1 receptor positive allosteric modulators and their preparation, pharmaceutical compositions and use in the treatment of diseases</span>. WO 2011084368, December 13,<span class="NLM_x"> </span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=S.+D.+Kuduk&author=K.-A.+Schlegel&author=Z.-Q.+Yang&title=Quinoline-amide+derivatives+as+M1+receptor+positive+allosteric+modulators+and+their+preparation%2C+pharmaceutical+compositions+and+use+in+the+treatment+of+diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12g&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DKuduk%26aufirst%3DS.%2BD.%26atitle%3DQuinoline-amide%2520derivatives%2520as%2520M1%2520receptor%2520positive%2520allosteric%2520modulators%2520and%2520their%2520preparation%252C%2520pharmaceutical%2520compositions%2520and%2520use%2520in%2520the%2520treatment%2520of%2520diseases%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit12h"><span><span class="NLM_label">(h) </span><span class="NLM_contrib-group">Kuduk, S. D.; Gilbert, K. F.</span><span> </span><span class="NLM_article-title">Preparation of tetrahydroquinolinylamide derivatives for use as M1 receptor positive allosteric modulators</span>. WO 2011159554, June 10,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=S.+D.+Kuduk&author=K.+F.+Gilbert&title=Preparation+of+tetrahydroquinolinylamide+derivatives+for+use+as+M1+receptor+positive+allosteric+modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12h&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DKuduk%26aufirst%3DS.%2BD.%26atitle%3DPreparation%2520of%2520tetrahydroquinolinylamide%2520derivatives%2520for%2520use%2520as%2520M1%2520receptor%2520positive%2520allosteric%2520modulators%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit12i"><span><span class="NLM_label">(i) </span><span class="NLM_contrib-group">Kuduk, S. D.; Chang, R. K.; Greshock, T. J.</span><span> </span><span class="NLM_article-title">Benzoquinazolinone derivatives as M1 receptor positive allosteric modulators and their preparation, pharmaceutical compositions and use in the treatment of diseases</span>. WO 2011025851, August 26,<span class="NLM_x"> </span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=S.+D.+Kuduk&author=R.+K.+Chang&author=T.+J.+Greshock&title=Benzoquinazolinone+derivatives+as+M1+receptor+positive+allosteric+modulators+and+their+preparation%2C+pharmaceutical+compositions+and+use+in+the+treatment+of+diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12i&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DKuduk%26aufirst%3DS.%2BD.%26atitle%3DBenzoquinazolinone%2520derivatives%2520as%2520M1%2520receptor%2520positive%2520allosteric%2520modulators%2520and%2520their%2520preparation%252C%2520pharmaceutical%2520compositions%2520and%2520use%2520in%2520the%2520treatment%2520of%2520diseases%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit12j"><span><span class="NLM_label">(j) </span><span class="NLM_contrib-group">Kuduk, S. D.; Chang, R. K.; Greshock, T. J.</span><span> </span><span class="NLM_article-title">Quinolizine-3-carboxamide derivatives as M1 receptor positive allosteric modulators and their preparation and for the treatment of diseases</span>. WO 2011062853, November 15,<span class="NLM_x"> </span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=S.+D.+Kuduk&author=R.+K.+Chang&author=T.+J.+Greshock&title=Quinolizine-3-carboxamide+derivatives+as+M1+receptor+positive+allosteric+modulators+and+their+preparation+and+for+the+treatment+of+diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12j&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DKuduk%26aufirst%3DS.%2BD.%26atitle%3DQuinolizine-3-carboxamide%2520derivatives%2520as%2520M1%2520receptor%2520positive%2520allosteric%2520modulators%2520and%2520their%2520preparation%2520and%2520for%2520the%2520treatment%2520of%2520diseases%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit12k"><span><span class="NLM_label">(k) </span><span class="NLM_contrib-group">Kuduk, S. D.; Chang, R. K.; Greshock, T. J.</span><span> </span><span class="NLM_article-title">Pyridoquinazolinone as M1 receptor positive allosteric modulators and their preparation, pharmaceutical compositions and use in the treatment of diseases</span>. WO 2011075371, December 9,<span class="NLM_x"> </span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=S.+D.+Kuduk&author=R.+K.+Chang&author=T.+J.+Greshock&title=Pyridoquinazolinone+as+M1+receptor+positive+allosteric+modulators+and+their+preparation%2C+pharmaceutical+compositions+and+use+in+the+treatment+of+diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12k&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DKuduk%26aufirst%3DS.%2BD.%26atitle%3DPyridoquinazolinone%2520as%2520M1%2520receptor%2520positive%2520allosteric%2520modulators%2520and%2520their%2520preparation%252C%2520pharmaceutical%2520compositions%2520and%2520use%2520in%2520the%2520treatment%2520of%2520diseases%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit12l"><span><span class="NLM_label">(l) </span><span class="NLM_contrib-group">Kuduk, S. D.; Beshore, D. C.; Dimarco, C. N.; Greshock, T. J.</span><span> </span><span class="NLM_article-title">Aminobenzoquinazolinone M1 receptor positive allosteric modulators</span>. WO 2011084371, December 13,<span class="NLM_x"> </span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=S.+D.+Kuduk&author=D.+C.+Beshore&author=C.+N.+Dimarco&author=T.+J.+Greshock&title=Aminobenzoquinazolinone+M1+receptor+positive+allosteric+modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12l&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DKuduk%26aufirst%3DS.%2BD.%26atitle%3DAminobenzoquinazolinone%2520M1%2520receptor%2520positive%2520allosteric%2520modulators%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit12m"><span><span class="NLM_label">(m) </span><span class="NLM_contrib-group">Beshore, D. C.; Kuduk, S. D.; Dipardo, R. M.</span><span> </span><span class="NLM_article-title">Pyrazoloquinolinone derivatives as M1 receptor positive allosteric modulators and their preparation and use for the treatment of M1 receptor-mediated diseases</span>. WO 2011049731, October 1,<span class="NLM_x"> </span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=D.+C.+Beshore&author=S.+D.+Kuduk&author=R.+M.+Dipardo&title=Pyrazoloquinolinone+derivatives+as+M1+receptor+positive+allosteric+modulators+and+their+preparation+and+use+for+the+treatment+of+M1+receptor-mediated+diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12m&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBeshore%26aufirst%3DD.%2BC.%26atitle%3DPyrazoloquinolinone%2520derivatives%2520as%2520M1%2520receptor%2520positive%2520allosteric%2520modulators%2520and%2520their%2520preparation%2520and%2520use%2520for%2520the%2520treatment%2520of%2520M1%2520receptor-mediated%2520diseases%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit12n"><span><span class="NLM_label">(n) </span><span class="NLM_contrib-group">Beshore, D. C.; Kuduk, S. D.</span><span> </span><span class="NLM_article-title">Heterocyclic-fused pyrazolo[4,3-c]pyridin-3-one M1 receptor positive allosteric modulators</span>. WO 2011041143, September 20,<span class="NLM_x"> </span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=D.+C.+Beshore&author=S.+D.+Kuduk&title=Heterocyclic-fused+pyrazolo%5B4%2C3-c%5Dpyridin-3-one+M1+receptor+positive+allosteric+modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12n&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBeshore%26aufirst%3DD.%2BC.%26atitle%3DHeterocyclic-fused%2520pyrazolo%255B4%252C3-c%255Dpyridin-3-one%2520M1%2520receptor%2520positive%2520allosteric%2520modulators%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit12o"><span><span class="NLM_label">(o) </span><span class="NLM_contrib-group">Beshore, D. C.; Kuduk, S. D.</span><span> </span><span class="NLM_article-title">Heterocyclic quinolizine derived M1 receptor positive allosteric modulators</span>. WO 2011137049, April 25,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=D.+C.+Beshore&author=S.+D.+Kuduk&title=Heterocyclic+quinolizine+derived+M1+receptor+positive+allosteric+modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12o&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBeshore%26aufirst%3DD.%2BC.%26atitle%3DHeterocyclic%2520quinolizine%2520derived%2520M1%2520receptor%2520positive%2520allosteric%2520modulators%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit12p"><span><span class="NLM_label">(p) </span><span class="NLM_contrib-group">Beshore, D. C.; Dimarco, C. N.; Kuduk, S. D.</span><span> </span><span class="NLM_article-title">Naphthalene carboxamide muscarinic M1 receptor positive allosteric modulators</span>. WO 2011149801, May 23,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=D.+C.+Beshore&author=C.+N.+Dimarco&author=S.+D.+Kuduk&title=Naphthalene+carboxamide+muscarinic+M1+receptor+positive+allosteric+modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12p&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBeshore%26aufirst%3DD.%2BC.%26atitle%3DNaphthalene%2520carboxamide%2520muscarinic%2520M1%2520receptor%2520positive%2520allosteric%2520modulators%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit12q"><span><span class="NLM_label">(q) </span><span class="NLM_contrib-group">Kuduk, S. D.; Di Marco, C. N.</span><span> </span><span class="NLM_article-title">Preparation of 1-benzyl-4-oxo-1,4-dihydroquinoline-3-carboxylates as M1 receptor positive allosteric modulators</span>. WO 2009094279, July 31,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=S.+D.+Kuduk&author=C.+N.+Di+Marco&title=Preparation+of+1-benzyl-4-oxo-1%2C4-dihydroquinoline-3-carboxylates+as+M1+receptor+positive+allosteric+modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12q&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DKuduk%26aufirst%3DS.%2BD.%26atitle%3DPreparation%2520of%25201-benzyl-4-oxo-1%252C4-dihydroquinoline-3-carboxylates%2520as%2520M1%2520receptor%2520positive%2520allosteric%2520modulators%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit12r"><span><span class="NLM_label">(r) </span><span class="NLM_contrib-group">Kuduk, S. D.; Di Marco, C. N.</span><span> </span><span class="NLM_article-title">Preparation of quinolizidinone M1 receptor positive allosteric modulators</span>. WO 2010042347, September 29,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=S.+D.+Kuduk&author=C.+N.+Di+Marco&title=Preparation+of+quinolizidinone+M1+receptor+positive+allosteric+modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12r&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DKuduk%26aufirst%3DS.%2BD.%26atitle%3DPreparation%2520of%2520quinolizidinone%2520M1%2520receptor%2520positive%2520allosteric%2520modulators%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit12s"><span><span class="NLM_label">(s) </span><span class="NLM_contrib-group">Kuduk, S. D.; Di Marco, C. N.</span><span> </span><span class="NLM_article-title">Preparation of fused heterocyclic M1 receptor positive allosteric modulators</span>. WO 2010047990, October 13,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=S.+D.+Kuduk&author=C.+N.+Di+Marco&title=Preparation+of+fused+heterocyclic+M1+receptor+positive+allosteric+modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12s&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DKuduk%26aufirst%3DS.%2BD.%26atitle%3DPreparation%2520of%2520fused%2520heterocyclic%2520M1%2520receptor%2520positive%2520allosteric%2520modulators%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit12t"><span><span class="NLM_label">(t) </span><span class="NLM_contrib-group">Beshore, D. C.; Kuduk, S. D.</span><span> </span><span class="NLM_article-title">Pyrazolo[4,3-c]cinnolin-3-one derivatives as M1 receptor positive allosteric modulators and their preparation, pharmaceutical compositions and use in the treatment of diseases</span>. WO 2010096338, February 12,<span class="NLM_x"> </span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=D.+C.+Beshore&author=S.+D.+Kuduk&title=Pyrazolo%5B4%2C3-c%5Dcinnolin-3-one+derivatives+as+M1+receptor+positive+allosteric+modulators+and+their+preparation%2C+pharmaceutical+compositions+and+use+in+the+treatment+of+diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12t&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBeshore%26aufirst%3DD.%2BC.%26atitle%3DPyrazolo%255B4%252C3-c%255Dcinnolin-3-one%2520derivatives%2520as%2520M1%2520receptor%2520positive%2520allosteric%2520modulators%2520and%2520their%2520preparation%252C%2520pharmaceutical%2520compositions%2520and%2520use%2520in%2520the%2520treatment%2520of%2520diseases%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit12u"><span><span class="NLM_label">(u) </span><span class="NLM_contrib-group">Beshore, D. C.; Kuduk, S. D.</span><span> </span><span class="NLM_article-title">Preparation of fused pyrazolopyridazines as muscarinic M1 receptor positive allosteric modulators</span>. WO 2010123716, April 13,<span class="NLM_x"> </span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=D.+C.+Beshore&author=S.+D.+Kuduk&title=Preparation+of+fused+pyrazolopyridazines+as+muscarinic+M1+receptor+positive+allosteric+modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12u&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBeshore%26aufirst%3DD.%2BC.%26atitle%3DPreparation%2520of%2520fused%2520pyrazolopyridazines%2520as%2520muscarinic%2520M1%2520receptor%2520positive%2520allosteric%2520modulators%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit12v"><span><span class="NLM_label">(v) </span><span class="NLM_contrib-group">Kuduk, S. D.; Di Marco, C. N.; Shipe, W. D.</span><span> </span><span class="NLM_article-title">Preparation of oxodihydroquinoline derivatives for use as M1 receptor positive allosteric modulators</span>. WO 2009134668, April 23,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=S.+D.+Kuduk&author=C.+N.+Di+Marco&author=W.+D.+Shipe&title=Preparation+of+oxodihydroquinoline+derivatives+for+use+as+M1+receptor+positive+allosteric+modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12v&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DKuduk%26aufirst%3DS.%2BD.%26atitle%3DPreparation%2520of%2520oxodihydroquinoline%2520derivatives%2520for%2520use%2520as%2520M1%2520receptor%2520positive%2520allosteric%2520modulators%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit12w"><span><span class="NLM_label">(w) </span><span class="NLM_contrib-group">Kuduk, S. D.; Chang, R. K.; Di Marco, C. N.</span><span> </span><span class="NLM_article-title">Quinolizidinone M1 receptor positive allosteric modulators</span>. WO 2009102574, February 3,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=S.+D.+Kuduk&author=R.+K.+Chang&author=C.+N.+Di+Marco&title=Quinolizidinone+M1+receptor+positive+allosteric+modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12w&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DKuduk%26aufirst%3DS.%2BD.%26atitle%3DQuinolizidinone%2520M1%2520receptor%2520positive%2520allosteric%2520modulators%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit12x"><span><span class="NLM_label">(x) </span><span class="NLM_contrib-group">Kuduk, S. D.; Chang, R. K.; Di Marco, C. N.</span><span> </span><span class="NLM_article-title">Preparation of quinolizidinone M1 receptor positive allosteric modulators</span>. WO 2009117283, March 11,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=S.+D.+Kuduk&author=R.+K.+Chang&author=C.+N.+Di+Marco&title=Preparation+of+quinolizidinone+M1+receptor+positive+allosteric+modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12x&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DKuduk%26aufirst%3DS.%2BD.%26atitle%3DPreparation%2520of%2520quinolizidinone%2520M1%2520receptor%2520positive%2520allosteric%2520modulators%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit12y"><span><span class="NLM_label">(y) </span><span class="NLM_contrib-group">Kuduk, S. D.; Chang, R. K.</span><span> </span><span class="NLM_article-title">Synthesis of quinolizidinone M1 receptor positive allosteric modulators</span>. WO 2009051715, October 15,<span class="NLM_x"> </span><span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=S.+D.+Kuduk&author=R.+K.+Chang&title=Synthesis+of+quinolizidinone+M1+receptor+positive+allosteric+modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12y&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DKuduk%26aufirst%3DS.%2BD.%26atitle%3DSynthesis%2520of%2520quinolizidinone%2520M1%2520receptor%2520positive%2520allosteric%2520modulators%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit12z"><span><span class="NLM_label">(z) </span><span class="NLM_contrib-group">Kuduk, S. D.; Chang, R. K.</span><span> </span><span class="NLM_article-title">Preparation of heterocyclylmethyl oxoquinolizinecarboxylates as muscarinic M1 receptor positive allosteric modulators</span>. WO 2009094279, January 15,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=S.+D.+Kuduk&author=R.+K.+Chang&title=Preparation+of+heterocyclylmethyl+oxoquinolizinecarboxylates+as+muscarinic+M1+receptor+positive+allosteric+modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12z&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DKuduk%26aufirst%3DS.%2BD.%26atitle%3DPreparation%2520of%2520heterocyclylmethyl%2520oxoquinolizinecarboxylates%2520as%2520muscarinic%2520M1%2520receptor%2520positive%2520allosteric%2520modulators%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit12aa"><span><span class="NLM_label">(aa) </span><span class="NLM_contrib-group">Beshore, D. C.; Dipardo, R. M.; Kuduk, S. D.</span><span> </span><span class="NLM_article-title">Preparation of fused pyridone M1 receptor positive allosteric modulators</span>. WO 2009102588, February 4,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=D.+C.+Beshore&author=R.+M.+Dipardo&author=S.+D.+Kuduk&title=Preparation+of+fused+pyridone+M1+receptor+positive+allosteric+modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12aa&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBeshore%26aufirst%3DD.%2BC.%26atitle%3DPreparation%2520of%2520fused%2520pyridone%2520M1%2520receptor%2520positive%2520allosteric%2520modulators%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit12ab"><span><span class="NLM_label">(ab) </span><span class="NLM_contrib-group">Lindsley, C.; Shipe, W. D.; Yang, F.; Bunda, J. L.</span><span> </span><span class="NLM_article-title">Preparation of benzyl-substituted quinolone M1 receptor positive allosteric modulators</span>. WO 2008002621, June 27,<span class="NLM_x"> </span><span class="NLM_year">2007</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&author=C.+Lindsley&author=W.+D.+Shipe&author=F.+Yang&author=J.+L.+Bunda&title=Preparation+of+benzyl-substituted+quinolone+M1+receptor+positive+allosteric+modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12ab&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DLindsley%26aufirst%3DC.%26atitle%3DPreparation%2520of%2520benzyl-substituted%2520quinolone%2520M1%2520receptor%2520positive%2520allosteric%2520modulators%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit12ac"><span><span class="NLM_label">(ac) </span><span class="NLM_contrib-group">Shipe, W. D.; Lindsley, C.; Hallett, D.</span><span> </span><span class="NLM_article-title">Quinolone derivatives, processes for preparing them, pharmaceutical compositions containing them, and their use as M1 receptor positive allosteric modulators</span>. WO 2007067489, December 4,<span class="NLM_x"> </span><span class="NLM_year">2006</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&author=W.+D.+Shipe&author=C.+Lindsley&author=D.+Hallett&title=Quinolone+derivatives%2C+processes+for+preparing+them%2C+pharmaceutical+compositions+containing+them%2C+and+their+use+as+M1+receptor+positive+allosteric+modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12ac&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DShipe%26aufirst%3DW.%2BD.%26atitle%3DQuinolone%2520derivatives%252C%2520processes%2520for%2520preparing%2520them%252C%2520pharmaceutical%2520compositions%2520containing%2520them%252C%2520and%2520their%2520use%2520as%2520M1%2520receptor%2520positive%2520allosteric%2520modulators%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit12ad"><span><span class="NLM_label">(ad) </span><span class="NLM_contrib-group">Shipe, W. D.; Lindsley, C.; Hallett, D.</span><span> </span><span class="NLM_article-title">Preparation of quinolone M1 receptor positive allosteric modulators</span>. WO 2007100366, December 4,<span class="NLM_x"> </span><span class="NLM_year">2006</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&author=W.+D.+Shipe&author=C.+Lindsley&author=D.+Hallett&title=Preparation+of+quinolone+M1+receptor+positive+allosteric+modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12ad&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DShipe%26aufirst%3DW.%2BD.%26atitle%3DPreparation%2520of%2520quinolone%2520M1%2520receptor%2520positive%2520allosteric%2520modulators%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit12ae"><span><span class="NLM_label">(ae) </span><span class="NLM_contrib-group">Kuduk, S. D.; Beshore, D. C.; Di Marco, C. N.; Greshock, T. J.</span><span> </span><span class="NLM_article-title">Benzoquinazolinone derivatives as M1 receptor positive allosteric modulators and their preparation, pharmaceutical compositions and use in the treatment of diseases</span>. WO 2010059773, May 27,<span class="NLM_x"> </span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=S.+D.+Kuduk&author=D.+C.+Beshore&author=C.+N.+Di+Marco&author=T.+J.+Greshock&title=Benzoquinazolinone+derivatives+as+M1+receptor+positive+allosteric+modulators+and+their+preparation%2C+pharmaceutical+compositions+and+use+in+the+treatment+of+diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12ae&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DKuduk%26aufirst%3DS.%2BD.%26atitle%3DBenzoquinazolinone%2520derivatives%2520as%2520M1%2520receptor%2520positive%2520allosteric%2520modulators%2520and%2520their%2520preparation%252C%2520pharmaceutical%2520compositions%2520and%2520use%2520in%2520the%2520treatment%2520of%2520diseases%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="note"><p class="first last">During the review process of this manuscript the Merck clinical trial (ClinicalTrials.gov Identifier:NCT01852110) was terminated for reasons not disclosed at this time.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Yamada, M.; Suzuki, S.; Sugimoto, T.; Nakamura, M.; Sakamoto, H.; Kamata, M.</span><span> </span><span class="NLM_article-title">Isoindolin-1-one derivatives as cholinergic muscarinic M1 receptor positive allosteric modulators and their preparation and use for the treatment of diseases</span>. WO 2015163485 April 22,<span class="NLM_x"> </span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=M.+Yamada&author=S.+Suzuki&author=T.+Sugimoto&author=M.+Nakamura&author=H.+Sakamoto&author=M.+Kamata&title=Isoindolin-1-one+derivatives+as+cholinergic+muscarinic+M1+receptor+positive+allosteric+modulators+and+their+preparation+and+use+for+the+treatment+of+diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DYamada%26aufirst%3DM.%26atitle%3DIsoindolin-1-one%2520derivatives%2520as%2520cholinergic%2520muscarinic%2520M1%2520receptor%2520positive%2520allosteric%2520modulators%2520and%2520their%2520preparation%2520and%2520use%2520for%2520the%2520treatment%2520of%2520diseases%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit14b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Payne, A.; Castro Pineiro, J. L.; Birch, L. M.; Khan, A.; Braunton, A. J.; Kitulagoda, J. E.; Soejima, M.</span><span> </span><span class="NLM_article-title">Preparation of 4-azaindole derivatives as muscarinic M1 receptor modulators for treatment of cognitive deficits</span>. US 20150094328, September 30,<span class="NLM_x"> </span><span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=A.+Payne&author=J.+L.+Castro+Pineiro&author=L.+M.+Birch&author=A.+Khan&author=A.+J.+Braunton&author=J.+E.+Kitulagoda&author=M.+Soejima&title=Preparation+of+4-azaindole+derivatives+as+muscarinic+M1+receptor+modulators+for+treatment+of+cognitive+deficits"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DPayne%26aufirst%3DA.%26atitle%3DPreparation%2520of%25204-azaindole%2520derivatives%2520as%2520muscarinic%2520M1%2520receptor%2520modulators%2520for%2520treatment%2520of%2520cognitive%2520deficits%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit14c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Ogino, M.; Kimura, E.; Suzuki, S.; Ashizawa, T.; Imaeda, T.; Fujimori, I.; Arai, R.</span><span> </span><span class="NLM_article-title">Preparation of nitrogen-containing heterocyclic compound as muscarinic M1 receptor positive allosteric modulators for treatment of nervous system disease</span>. WO 2015190564, June 11,<span class="NLM_x"> </span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=M.+Ogino&author=E.+Kimura&author=S.+Suzuki&author=T.+Ashizawa&author=T.+Imaeda&author=I.+Fujimori&author=R.+Arai&title=Preparation+of+nitrogen-containing+heterocyclic+compound+as+muscarinic+M1+receptor+positive+allosteric+modulators+for+treatment+of+nervous+system+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DOgino%26aufirst%3DM.%26atitle%3DPreparation%2520of%2520nitrogen-containing%2520heterocyclic%2520compound%2520as%2520muscarinic%2520M1%2520receptor%2520positive%2520allosteric%2520modulators%2520for%2520treatment%2520of%2520nervous%2520system%2520disease%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit14d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Lindsley, C. W.; Conn, P. J.; Stauffer, S. R.; Panarese, J. D.</span><span> </span><span class="NLM_article-title">Preparation of benzyldihydrobenzooxazinecarboxamide derivatives for use as positive allosteric modulators of muscarinic acetylcholine receptor M1</span>. WO 2015080904, November 18,<span class="NLM_x"> </span><span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=C.+W.+Lindsley&author=P.+J.+Conn&author=S.+R.+Stauffer&author=J.+D.+Panarese&title=Preparation+of+benzyldihydrobenzooxazinecarboxamide+derivatives+for+use+as+positive+allosteric+modulators+of+muscarinic+acetylcholine+receptor+M1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26atitle%3DPreparation%2520of%2520benzyldihydrobenzooxazinecarboxamide%2520derivatives%2520for%2520use%2520as%2520positive%2520allosteric%2520modulators%2520of%2520muscarinic%2520acetylcholine%2520receptor%2520M1%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit14e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Groebke Zbinden, K.; Pinard, E.; Ryckmans, T.</span><span> </span><span class="NLM_article-title">Preparation of fluoro-naphthyl derivatives as muscarinic M1 receptor positive allosteric modulators</span>. WO 2015110370, January 19,<span class="NLM_x"> </span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=K.+Groebke+Zbinden&author=E.+Pinard&author=T.+Ryckmans&title=Preparation+of+fluoro-naphthyl+derivatives+as+muscarinic+M1+receptor+positive+allosteric+modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14e&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DGroebke%2BZbinden%26aufirst%3DK.%26atitle%3DPreparation%2520of%2520fluoro-naphthyl%2520derivatives%2520as%2520muscarinic%2520M1%2520receptor%2520positive%2520allosteric%2520modulators%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit14f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Ballard, T. M.; Groebke Zbinden, K.; Pinard, E.; Ryckmans, T.; Schaffhauser, H.</span><span> </span><span class="NLM_article-title">Preparation of indole and indazole derivatives as muscarinic M1 receptor pos. allosteric modulators</span>. WO 2015044072, September 22,<span class="NLM_x"> </span><span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=T.+M.+Ballard&author=K.+Groebke+Zbinden&author=E.+Pinard&author=T.+Ryckmans&author=H.+Schaffhauser&title=Preparation+of+indole+and+indazole+derivatives+as+muscarinic+M1+receptor+pos.+allosteric+modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14f&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBallard%26aufirst%3DT.%2BM.%26atitle%3DPreparation%2520of%2520indole%2520and%2520indazole%2520derivatives%2520as%2520muscarinic%2520M1%2520receptor%2520pos.%2520allosteric%2520modulators%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit14g"><span><span class="NLM_label">(g) </span><span class="NLM_contrib-group">Ballard, T. M.; Flohr, A.; Groebke Zbinden, K.; Pinard, E.; Ryckmans, T.; Schaffhauser, H.</span><span> </span><span class="NLM_article-title">Preparation of pyrrolopyridine and pyrazolopyridine derivatives as muscarinic M1 receptor modulators</span>. WO 2015028483, August 8,<span class="NLM_x"> </span><span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=T.+M.+Ballard&author=A.+Flohr&author=K.+Groebke+Zbinden&author=E.+Pinard&author=T.+Ryckmans&author=H.+Schaffhauser&title=Preparation+of+pyrrolopyridine+and+pyrazolopyridine+derivatives+as+muscarinic+M1+receptor+modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14g&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBallard%26aufirst%3DT.%2BM.%26atitle%3DPreparation%2520of%2520pyrrolopyridine%2520and%2520pyrazolopyridine%2520derivatives%2520as%2520muscarinic%2520M1%2520receptor%2520modulators%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit14h"><span><span class="NLM_label">(h) </span><span class="NLM_contrib-group">Sugimoto, T.; Nakamura, M.; Sakamoto, H.; Suzuki, S.; Yamada, M.; Kamata, M.; Kojima, T.; Fujimori, I.; Shimokawa, K.</span><span> </span><span class="NLM_article-title">Preparation of nitrogen-containing heterocyclic compounds as muscarinic M1 receptor positive allosteric modulators</span>. WO 2014077401, November 18,<span class="NLM_x"> </span><span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=T.+Sugimoto&author=M.+Nakamura&author=H.+Sakamoto&author=S.+Suzuki&author=M.+Yamada&author=M.+Kamata&author=T.+Kojima&author=I.+Fujimori&author=K.+Shimokawa&title=Preparation+of+nitrogen-containing+heterocyclic+compounds+as+muscarinic+M1+receptor+positive+allosteric+modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14h&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DSugimoto%26aufirst%3DT.%26atitle%3DPreparation%2520of%2520nitrogen-containing%2520heterocyclic%2520compounds%2520as%2520muscarinic%2520M1%2520receptor%2520positive%2520allosteric%2520modulators%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit14i"><span><span class="NLM_label">(i) </span><span class="NLM_contrib-group">Lindsley, C. W.; Conn, P. J.; Stauffer, S. R.; Panarese, J. D.</span><span> </span><span class="NLM_article-title">Substituted 1-benzylquinoxalin-2(1H)-one analogs as positive allosteric modulators of muscarinic acetylcholine receptor M1</span>. WO 2014179226, April 28,<span class="NLM_x"> </span><span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=C.+W.+Lindsley&author=P.+J.+Conn&author=S.+R.+Stauffer&author=J.+D.+Panarese&title=Substituted+1-benzylquinoxalin-2%281H%29-one+analogs+as+positive+allosteric+modulators+of+muscarinic+acetylcholine+receptor+M1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14i&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26atitle%3DSubstituted%25201-benzylquinoxalin-2%25281H%2529-one%2520analogs%2520as%2520positive%2520allosteric%2520modulators%2520of%2520muscarinic%2520acetylcholine%2520receptor%2520M1%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit14j"><span><span class="NLM_label">(j) </span><span class="NLM_contrib-group">Lindsley, C. W.; Conn, P. J.; Stauffer, S. R.; Panarese, J. D.</span><span> </span><span class="NLM_article-title">Quinazolinone and pyridopyrimidinone derivatives as positive allosteric modulators of muscarinic acetylcholine receptor M1 and their preparation and use for the treatment of neurological and psychiatric disorders</span>. WO 2014179237, April 28,<span class="NLM_x"> </span><span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=C.+W.+Lindsley&author=P.+J.+Conn&author=S.+R.+Stauffer&author=J.+D.+Panarese&title=Quinazolinone+and+pyridopyrimidinone+derivatives+as+positive+allosteric+modulators+of+muscarinic+acetylcholine+receptor+M1+and+their+preparation+and+use+for+the+treatment+of+neurological+and+psychiatric+disorders"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14j&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26atitle%3DQuinazolinone%2520and%2520pyridopyrimidinone%2520derivatives%2520as%2520positive%2520allosteric%2520modulators%2520of%2520muscarinic%2520acetylcholine%2520receptor%2520M1%2520and%2520their%2520preparation%2520and%2520use%2520for%2520the%2520treatment%2520of%2520neurological%2520and%2520psychiatric%2520disorders%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit14k"><span><span class="NLM_label">(k) </span><span class="NLM_contrib-group">Davie, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valant, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sexton, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Capuano, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christopoulos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scammells, P. J.</span><span> </span><span class="NLM_article-title">Synthesis and pharmacological evaluation of analogues of Benzyl Quinolone Carboxylic Acid (BQCA) designed to bind irreversibly to an allosteric site of the M1 muscarinic acetylcholine receptor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">5405</span><span class="NLM_x">–</span> <span class="NLM_lpage">5418</span><span class="refDoi"> DOI: 10.1021/jm500556a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm500556a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=5405-5418&author=B.+J.+Davieauthor=C.+Valantauthor=J.+M.+Whiteauthor=P.+M.+Sextonauthor=B.+Capuanoauthor=A.+Christopoulosauthor=P.+J.+Scammells&title=Synthesis+and+pharmacological+evaluation+of+analogues+of+Benzyl+Quinolone+Carboxylic+Acid+%28BQCA%29+designed+to+bind+irreversibly+to+an+allosteric+site+of+the+M1+muscarinic+acetylcholine+receptor&doi=10.1021%2Fjm500556a"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14k&amp;dbid=16384&amp;doi=10.1021%2Fjm500556a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500556a%26sid%3Dliteratum%253Aachs%26aulast%3DDavie%26aufirst%3DB.%2BJ.%26aulast%3DValant%26aufirst%3DC.%26aulast%3DWhite%26aufirst%3DJ.%2BM.%26aulast%3DSexton%26aufirst%3DP.%2BM.%26aulast%3DCapuano%26aufirst%3DB.%26aulast%3DChristopoulos%26aufirst%3DA.%26aulast%3DScammells%26aufirst%3DP.%2BJ.%26atitle%3DSynthesis%2520and%2520pharmacological%2520evaluation%2520of%2520analogues%2520of%2520Benzyl%2520Quinolone%2520Carboxylic%2520Acid%2520%2528BQCA%2529%2520designed%2520to%2520bind%2520irreversibly%2520to%2520an%2520allosteric%2520site%2520of%2520the%2520M1%2520muscarinic%2520acetylcholine%2520receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D5405%26epage%3D5418%26doi%3D10.1021%2Fjm500556a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit14l"><span><span class="NLM_label">(l) </span><span class="NLM_contrib-group">Swinnen, D.; Montagne, C.; Pomel, V.; Quattropani, A.; Molette, J.; Gerber, P.</span><span> </span><span class="NLM_article-title">Tetraaza-cyclopenta[a]indenyl derivatives as M1 receptor positive allosteric modulators useful in the treatment of diseases mediated by the muscarinic M1 mediator and their preparation</span>. WO 2013091773, November 30,<span class="NLM_x"> </span><span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=D.+Swinnen&author=C.+Montagne&author=V.+Pomel&author=A.+Quattropani&author=J.+Molette&author=P.+Gerber&title=Tetraaza-cyclopenta%5Ba%5Dindenyl+derivatives+as+M1+receptor+positive+allosteric+modulators+useful+in+the+treatment+of+diseases+mediated+by+the+muscarinic+M1+mediator+and+their+preparation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14l&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DSwinnen%26aufirst%3DD.%26atitle%3DTetraaza-cyclopenta%255Ba%255Dindenyl%2520derivatives%2520as%2520M1%2520receptor%2520positive%2520allosteric%2520modulators%2520useful%2520in%2520the%2520treatment%2520of%2520diseases%2520mediated%2520by%2520the%2520muscarinic%2520M1%2520mediator%2520and%2520their%2520preparation%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit14m"><span><span class="NLM_label">(m) </span><span class="NLM_contrib-group">Sakamoto, H.; Sugimoto, T.</span><span> </span><span class="NLM_article-title">Preparation of heterocyclic compounds as cholinergic muscarinic M1 receptor positive allosteric modulators</span>. WO 2013129622, February 28,<span class="NLM_x"> </span><span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=H.+Sakamoto&author=T.+Sugimoto&title=Preparation+of+heterocyclic+compounds+as+cholinergic+muscarinic+M1+receptor+positive+allosteric+modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14m&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DSakamoto%26aufirst%3DH.%26atitle%3DPreparation%2520of%2520heterocyclic%2520compounds%2520as%2520cholinergic%2520muscarinic%2520M1%2520receptor%2520positive%2520allosteric%2520modulators%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit14n"><span><span class="NLM_label">(n) </span><span class="NLM_contrib-group">Lindsley, C. W.; Conn, P. J.; Wood, M. R.; Melancon, B. J.; Poslusney, M. S.; Tarr, J. C.</span><span> </span><span class="NLM_article-title">Substituted pyrazol-benzyl analogues as positive allosteric modulators of mAChR M1 receptors</span>. WO 2013106795, January 12,<span class="NLM_x"> </span><span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=C.+W.+Lindsley&author=P.+J.+Conn&author=M.+R.+Wood&author=B.+J.+Melancon&author=M.+S.+Poslusney&author=J.+C.+Tarr&title=Substituted+pyrazol-benzyl+analogues+as+positive+allosteric+modulators+of+mAChR+M1+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14n&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26atitle%3DSubstituted%2520pyrazol-benzyl%2520analogues%2520as%2520positive%2520allosteric%2520modulators%2520of%2520mAChR%2520M1%2520receptors%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit14o"><span><span class="NLM_label">(o) </span><span class="NLM_contrib-group">Lindsley, C. W.; Conn, P. J.; Wood, M. R.; Hopkins, C. R.; Melancon, B. J.; Poslusney, M. S.; Engers, D. W.</span><span> </span><span class="NLM_article-title">Substituted 2-(4-heterocyclylbenzyl)isoindolin-1-one analogs as positive allosteric modulators of the muscarinic acetylcholine receptor M1</span>. WO 2013063549, October 28,<span class="NLM_x"> </span><span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=C.+W.+Lindsley&author=P.+J.+Conn&author=M.+R.+Wood&author=C.+R.+Hopkins&author=B.+J.+Melancon&author=M.+S.+Poslusney&author=D.+W.+Engers&title=Substituted+2-%284-heterocyclylbenzyl%29isoindolin-1-one+analogs+as+positive+allosteric+modulators+of+the+muscarinic+acetylcholine+receptor+M1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14o&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26atitle%3DSubstituted%25202-%25284-heterocyclylbenzyl%2529isoindolin-1-one%2520analogs%2520as%2520positive%2520allosteric%2520modulators%2520of%2520the%2520muscarinic%2520acetylcholine%2520receptor%2520M1%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit14p"><span><span class="NLM_label">(p) </span><span class="NLM_contrib-group">Lindsley, C. W.; Conn, P. J.; Wood, M. R.; Hopkins, C. R.; Melancon, B. J.; Poslusney, M. S.</span><span> </span><span class="NLM_article-title">Preparation of substituted benzylspiroindolin-2-one derivatives as positive allosteric modulators of mAChR M1 receptor</span>. WO 2013071201, November 10,<span class="NLM_x"> </span><span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=C.+W.+Lindsley&author=P.+J.+Conn&author=M.+R.+Wood&author=C.+R.+Hopkins&author=B.+J.+Melancon&author=M.+S.+Poslusney&title=Preparation+of+substituted+benzylspiroindolin-2-one+derivatives+as+positive+allosteric+modulators+of+mAChR+M1+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14p&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26atitle%3DPreparation%2520of%2520substituted%2520benzylspiroindolin-2-one%2520derivatives%2520as%2520positive%2520allosteric%2520modulators%2520of%2520mAChR%2520M1%2520receptor%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit14q"><span><span class="NLM_label">(q) </span><span class="NLM_contrib-group">Lindsley, C. W.; Conn, P. J.; Wood, M. R.; Tarr, J. C.; Bridges, T. M.</span><span> </span><span class="NLM_article-title">Indole compounds as positive allosteric modulators of the muscarinic receptor</span>. WO 2011163280, June 21,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=C.+W.+Lindsley&author=P.+J.+Conn&author=M.+R.+Wood&author=J.+C.+Tarr&author=T.+M.+Bridges&title=Indole+compounds+as+positive+allosteric+modulators+of+the+muscarinic+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14q&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26atitle%3DIndole%2520compounds%2520as%2520positive%2520allosteric%2520modulators%2520of%2520the%2520muscarinic%2520receptor%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit14r"><span><span class="NLM_label">(r) </span><span class="NLM_contrib-group">Reid, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bridges, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheffler, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cho, H. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Days, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daniels, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niswender, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weaver, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conn, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindsley, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, M. R.</span><span> </span><span class="NLM_article-title">Discovery and optimization of a novel, selective and brain penetrant M1 positive allosteric modulator (PAM): The development of ML169, an MLPCN probe</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">2697</span><span class="NLM_x">–</span> <span class="NLM_lpage">2701</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2010.12.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14r&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=10.1016%2Fj.bmcl.2010.12.015" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=2697-2701&author=P.+R.+Reidauthor=T.+M.+Bridgesauthor=D.+J.+Shefflerauthor=H.+P.+Choauthor=L.+M.+Lewisauthor=E.+Daysauthor=J.+S.+Danielsauthor=C.+K.+Jonesauthor=C.+M.+Niswenderauthor=C.+D.+Weaverauthor=P.+J.+Connauthor=C.+W.+Lindsleyauthor=M.+R.+Wood&title=Discovery+and+optimization+of+a+novel%2C+selective+and+brain+penetrant+M1+positive+allosteric+modulator+%28PAM%29%3A+The+development+of+ML169%2C+an+MLPCN+probe&doi=10.1016%2Fj.bmcl.2010.12.015"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14r&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2010.12.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2010.12.015%26sid%3Dliteratum%253Aachs%26aulast%3DReid%26aufirst%3DP.%2BR.%26aulast%3DBridges%26aufirst%3DT.%2BM.%26aulast%3DSheffler%26aufirst%3DD.%2BJ.%26aulast%3DCho%26aufirst%3DH.%2BP.%26aulast%3DLewis%26aufirst%3DL.%2BM.%26aulast%3DDays%26aufirst%3DE.%26aulast%3DDaniels%26aufirst%3DJ.%2BS.%26aulast%3DJones%26aufirst%3DC.%2BK.%26aulast%3DNiswender%26aufirst%3DC.%2BM.%26aulast%3DWeaver%26aufirst%3DC.%2BD.%26aulast%3DConn%26aufirst%3DP.%2BJ.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26aulast%3DWood%26aufirst%3DM.%2BR.%26atitle%3DDiscovery%2520and%2520optimization%2520of%2520a%2520novel%252C%2520selective%2520and%2520brain%2520penetrant%2520M1%2520positive%2520allosteric%2520modulator%2520%2528PAM%2529%253A%2520The%2520development%2520of%2520ML169%252C%2520an%2520MLPCN%2520probe%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D2697%26epage%3D2701%26doi%3D10.1016%2Fj.bmcl.2010.12.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit14s"><span><span class="NLM_label">(s) </span><span class="NLM_contrib-group">Tarr, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turlington, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reid, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Utley, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheffler, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cho, H. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pancani, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klein, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bridges, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morrison, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blobaum, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daniels, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niswender, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conn, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindsley, C. W.</span><span> </span><span class="NLM_article-title">Targeting selective activation of M(1) for the treatment of Alzheimer’s disease: further chemical optimization and pharmacological characterization of the M(1) positive allosteric modulator ML169</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">884</span><span class="NLM_x">–</span> <span class="NLM_lpage">895</span><span class="refDoi"> DOI: 10.1021/cn300068s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cn300068s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14s&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVGhs7jI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=884-895&author=J.+C.+Tarrauthor=M.+L.+Turlingtonauthor=P.+R.+Reidauthor=T.+J.+Utleyauthor=D.+J.+Shefflerauthor=H.+P.+Choauthor=R.+Klarauthor=T.+Pancaniauthor=M.+T.+Kleinauthor=T.+M.+Bridgesauthor=R.+D.+Morrisonauthor=A.+L.+Blobaumauthor=Z.+Xiangauthor=J.+S.+Danielsauthor=C.+M.+Niswenderauthor=P.+J.+Connauthor=M.+R.+Woodauthor=C.+W.+Lindsley&title=Targeting+selective+activation+of+M%281%29+for+the+treatment+of+Alzheimer%E2%80%99s+disease%3A+further+chemical+optimization+and+pharmacological+characterization+of+the+M%281%29+positive+allosteric+modulator+ML169&doi=10.1021%2Fcn300068s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14sR"><div class="casContent"><span class="casTitleNuber">14s</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting Selective Activation of M1 for the Treatment of Alzheimer's Disease: Further Chemical Optimization and Pharmacological Characterization of the M1 Positive Allosteric Modulator ML169</span></div><div class="casAuthors">Tarr, James C.; Turlington, Mark L.; Reid, Paul R.; Utley, Thomas J.; Sheffler, Douglas J.; Cho, Hyekyung P.; Klar, Rebecca; Pancani, Tristano; Klein, Michael T.; Bridges, Thomas M.; Morrison, Ryan D.; Blobaum, Anna L.; Xiang, Zixui; Daniels, J. Scott; Niswender, Colleen M.; Conn, P. Jeffrey; Wood, Michael R.; Lindsley, Craig W.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">884-895</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The M1 muscarinic acetylcholine receptor is thought to play an important role in memory and cognition, making it a potential target for the treatment of Alzheimer's disease (AD) and schizophrenia.  Moreover, M1 interacts with BACE1 and regulates its proteasomal degrdn., suggesting selective M1 activation could afford both palliative cognitive benefit as well as disease modification in AD.  A key challenge in targeting the muscarinic acetylcholine receptors is achieving mAChR subtype selectivity.  Our lab has previously reported the M1 selective pos. allosteric modulator ML169.  Herein we describe our efforts to further optimize this lead compd. by prepg. analog libraries and probing novel scaffolds.  We were able to identify several analogs that possessed submicromolar potency, with our best example displaying an EC50 of 310 nM.  The new compds. maintained complete selectivity for the M1 receptor over the other subtypes (M2-M5), displayed improved DMPK profiles, and potentiated the carbachol (CCh)-induced excitation in striatal MSNs.  Selected analogs were able to potentiate CCh-mediated non-amyloidogenic APPα release, further strengthening the concept that M1 PAMs may afford a disease-modifying role in the treatment of AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1gJudWdQ8i7Vg90H21EOLACvtfcHk0lgqtr58Hz_hnw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVGhs7jI&md5=dd85b45664febaaa063a2c53d5379c50</span></div><a href="/servlet/linkout?suffix=cit14s&amp;dbid=16384&amp;doi=10.1021%2Fcn300068s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn300068s%26sid%3Dliteratum%253Aachs%26aulast%3DTarr%26aufirst%3DJ.%2BC.%26aulast%3DTurlington%26aufirst%3DM.%2BL.%26aulast%3DReid%26aufirst%3DP.%2BR.%26aulast%3DUtley%26aufirst%3DT.%2BJ.%26aulast%3DSheffler%26aufirst%3DD.%2BJ.%26aulast%3DCho%26aufirst%3DH.%2BP.%26aulast%3DKlar%26aufirst%3DR.%26aulast%3DPancani%26aufirst%3DT.%26aulast%3DKlein%26aufirst%3DM.%2BT.%26aulast%3DBridges%26aufirst%3DT.%2BM.%26aulast%3DMorrison%26aufirst%3DR.%2BD.%26aulast%3DBlobaum%26aufirst%3DA.%2BL.%26aulast%3DXiang%26aufirst%3DZ.%26aulast%3DDaniels%26aufirst%3DJ.%2BS.%26aulast%3DNiswender%26aufirst%3DC.%2BM.%26aulast%3DConn%26aufirst%3DP.%2BJ.%26aulast%3DWood%26aufirst%3DM.%2BR.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26atitle%3DTargeting%2520selective%2520activation%2520of%2520M%25281%2529%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520further%2520chemical%2520optimization%2520and%2520pharmacological%2520characterization%2520of%2520the%2520M%25281%2529%2520positive%2520allosteric%2520modulator%2520ML169%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2012%26volume%3D3%26spage%3D884%26epage%3D895%26doi%3D10.1021%2Fcn300068s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit14t"><span><span class="NLM_label">(t) </span><span class="NLM_contrib-group">Mistry, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valant, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sexton, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Capuano, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christopoulos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scammells, P. J.</span><span> </span><span class="NLM_article-title">Synthesis and pharmacological profiling of analogues of benzyl quinolone carboxylic acid (BQCA) as allosteric modulators of the M1 muscarinic receptor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">5151</span><span class="NLM_x">–</span> <span class="NLM_lpage">5172</span><span class="refDoi"> DOI: 10.1021/jm400540b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400540b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14t&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=1%3ACAS%3A528%3ADC%252BC3sXosVaqtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=5151-5172&author=S.+N.+Mistryauthor=C.+Valantauthor=P.+M.+Sextonauthor=B.+Capuanoauthor=A.+Christopoulosauthor=P.+J.+Scammells&title=Synthesis+and+pharmacological+profiling+of+analogues+of+benzyl+quinolone+carboxylic+acid+%28BQCA%29+as+allosteric+modulators+of+the+M1+muscarinic+receptor&doi=10.1021%2Fjm400540b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14tR"><div class="casContent"><span class="casTitleNuber">14t</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Pharmacological Profiling of Analogues of Benzyl Quinolone Carboxylic Acid (BQCA) as Allosteric Modulators of the M1 Muscarinic Receptor</span></div><div class="casAuthors">Mistry, Shailesh N.; Valant, Celine; Sexton, Patrick M.; Capuano, Ben; Christopoulos, Arthur; Scammells, Peter J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">5151-5172</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Established therapy in Alzheimer's disease involves potentiation of the endogenous orthosteric ligand, acetylcholine, at the M1 muscarinic receptors found in higher concns. in the cortex and hippocampus.  Adverse effects, due to indiscriminate activation of other muscarinic receptor subtypes, are common.  M1 muscarinic pos. allosteric modulators/allosteric agonists such as BQCA [1-(4-methoxybenzyl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid, I] offer an attractive soln., being exquisitely M1-selective over other muscarinic subtypes.  A common difficulty with allosteric ligands is interpreting SAR, based on composite potency values derived in the presence of fixed concn. of agonist.  In reality these values encompass multiple pharmacol. parameters, each potentially and differentially sensitive to structural modification of the ligand.  We report novel BQCA analogs which appear to augment ligand affinity for the receptor (pKB), intrinsic efficacy (τB), and both binding (α) and functional (β) cooperativity with acetylcholine.  Ultimately, development of such enriched SAR surrounding allosteric modulators will provide insight into their mode of action.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoigST7OJR7vbVg90H21EOLACvtfcHk0lgqtr58Hz_hnw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXosVaqtbs%253D&md5=ab134e0b5400aa825916695eaf1203b1</span></div><a href="/servlet/linkout?suffix=cit14t&amp;dbid=16384&amp;doi=10.1021%2Fjm400540b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400540b%26sid%3Dliteratum%253Aachs%26aulast%3DMistry%26aufirst%3DS.%2BN.%26aulast%3DValant%26aufirst%3DC.%26aulast%3DSexton%26aufirst%3DP.%2BM.%26aulast%3DCapuano%26aufirst%3DB.%26aulast%3DChristopoulos%26aufirst%3DA.%26aulast%3DScammells%26aufirst%3DP.%2BJ.%26atitle%3DSynthesis%2520and%2520pharmacological%2520profiling%2520of%2520analogues%2520of%2520benzyl%2520quinolone%2520carboxylic%2520acid%2520%2528BQCA%2529%2520as%2520allosteric%2520modulators%2520of%2520the%2520M1%2520muscarinic%2520receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D5151%26epage%3D5172%26doi%3D10.1021%2Fjm400540b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit14u"><span><span class="NLM_label">(u) </span><span class="NLM_contrib-group">Davie, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sexton, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Capuano, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christopoulos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scammells, P. J.</span><span> </span><span class="NLM_article-title">Development of a photoactivatable allosteric ligand for the M1 muscarinic acetylcholine receptor</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">902</span><span class="NLM_x">–</span> <span class="NLM_lpage">907</span><span class="refDoi"> DOI: 10.1021/cn500173x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cn500173x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14u&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsVyjt7vO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=902-907&author=B.+J.+Davieauthor=P.+M.+Sextonauthor=B.+Capuanoauthor=A.+Christopoulosauthor=P.+J.+Scammells&title=Development+of+a+photoactivatable+allosteric+ligand+for+the+M1+muscarinic+acetylcholine+receptor&doi=10.1021%2Fcn500173x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14uR"><div class="casContent"><span class="casTitleNuber">14u</span><div class="casTitle"><span class="NLM_cas:atitle">Development of a Photoactivatable Allosteric Ligand for the M1 Muscarinic Acetylcholine Receptor</span></div><div class="casAuthors">Davie, Briana J.; Sexton, Patrick M.; Capuano, Ben; Christopoulos, Arthur; Scammells, Peter J.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">902-907</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The field of G protein-coupled receptor drug discovery has benefited greatly from the structural and functional insights afforded by photoactivatable ligands.  One G protein-coupled receptor subfamily for which photoactivatable ligands have been developed is the muscarinic acetylcholine receptor family, though, to date, all such ligands have been designed to target the orthosteric (endogenous ligand) binding site of these receptors.  Herein the authors report the synthesis and pharmacol. investigation of a novel photoaffinity label, MIPS1455 I, designed to bind irreversibly to an allosteric site of the M1 muscarinic acetylcholine receptor; a target of therapeutic interest for the treatment of cognitive deficits.  MIPS1455 may be a valuable mol. tool for further investigating allosteric interactions at this receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUjdEGSeJezLVg90H21EOLACvtfcHk0lgC3Heoce4ckw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsVyjt7vO&md5=451636b661b7ec22e289573725961fad</span></div><a href="/servlet/linkout?suffix=cit14u&amp;dbid=16384&amp;doi=10.1021%2Fcn500173x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn500173x%26sid%3Dliteratum%253Aachs%26aulast%3DDavie%26aufirst%3DB.%2BJ.%26aulast%3DSexton%26aufirst%3DP.%2BM.%26aulast%3DCapuano%26aufirst%3DB.%26aulast%3DChristopoulos%26aufirst%3DA.%26aulast%3DScammells%26aufirst%3DP.%2BJ.%26atitle%3DDevelopment%2520of%2520a%2520photoactivatable%2520allosteric%2520ligand%2520for%2520the%2520M1%2520muscarinic%2520acetylcholine%2520receptor%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2014%26volume%3D5%26spage%3D902%26epage%3D907%26doi%3D10.1021%2Fcn500173x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit14v"><span><span class="NLM_label">(v) </span><span class="NLM_contrib-group">Quattropani, A.; Kulkarni, S. S.; Murugesan, K.; Banerjee, J.</span><span> </span><span class="NLM_article-title">Preparation of tetraaza-cyclopenta[a]indenyl derivatives as muscarinic M1 mediators</span>. WO 2014198808 Dec 18,<span class="NLM_x"> </span><span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=A.+Quattropani&author=S.+S.+Kulkarni&author=K.+Murugesan&author=J.+Banerjee&title=Preparation+of+tetraaza-cyclopenta%5Ba%5Dindenyl+derivatives+as+muscarinic+M1+mediators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14v&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DQuattropani%26aufirst%3DA.%26atitle%3DPreparation%2520of%2520tetraaza-cyclopenta%255Ba%255Dindenyl%2520derivatives%2520as%2520muscarinic%2520M1%2520mediators%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit14w"><span><span class="NLM_label">(w) </span><span class="NLM_contrib-group">Sugimoto, T.; Shimokawa, K.; Kojima, T.; Sakamoto, H.; Fujimori, I.; Nakamura, M.; Yamada, M.; Murakami, M.; Kamata, M.; Suzuki, S.</span><span> </span><span class="NLM_article-title">Nitrogen-containing heterocyclic compounds and their use for pharmaceuticals and cholinergic muscarinic M1 receptor positive allosteric modulation</span>. WO 2015174534 Nov 19,<span class="NLM_x"> </span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=T.+Sugimoto&author=K.+Shimokawa&author=T.+Kojima&author=H.+Sakamoto&author=I.+Fujimori&author=M.+Nakamura&author=M.+Yamada&author=M.+Murakami&author=M.+Kamata&author=S.+Suzuki&title=Nitrogen-containing+heterocyclic+compounds+and+their+use+for+pharmaceuticals+and+cholinergic+muscarinic+M1+receptor+positive+allosteric+modulation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14w&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DSugimoto%26aufirst%3DT.%26atitle%3DNitrogen-containing%2520heterocyclic%2520compounds%2520and%2520their%2520use%2520for%2520pharmaceuticals%2520and%2520cholinergic%2520muscarinic%2520M1%2520receptor%2520positive%2520allosteric%2520modulation%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit14x"><span><span class="NLM_label">(x) </span><span class="NLM_contrib-group">Davoren, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Neil, S. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brodney, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chenard, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dlugolenski, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edgerton, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garnsey, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grimwood, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kauffman, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaChapelle, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lazzaro, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, C.-W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lotarski, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nason, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Obach, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reinhart, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salomon-Ferrer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steyn, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webb, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span> </span><span class="NLM_article-title">Design and optimization of selective azaindole amide M1 positive allosteric modulators</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">650</span><span class="NLM_x">–</span> <span class="NLM_lpage">655</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2015.11.053</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14x&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=10.1016%2Fj.bmcl.2015.11.053" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14x&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=26631313" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14x&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvFant73L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=650-655&author=J.+E.+Davorenauthor=S.+V.+O%E2%80%99Neilauthor=D.+P.+Andersonauthor=M.+A.+Brodneyauthor=L.+Chenardauthor=K.+Dlugolenskiauthor=J.+R.+Edgertonauthor=M.+Greenauthor=M.+Garnseyauthor=S.+Grimwoodauthor=A.+R.+Harrisauthor=G.+W.+Kauffmanauthor=E.+LaChapelleauthor=J.+T.+Lazzaroauthor=C.-W.+Leeauthor=S.+M.+Lotarskiauthor=D.+M.+Nasonauthor=R.+S.+Obachauthor=V.+Reinhartauthor=R.+Salomon-Ferrerauthor=S.+J.+Steynauthor=D.+Webbauthor=J.+Yanauthor=L.+Zhang&title=Design+and+optimization+of+selective+azaindole+amide+M1+positive+allosteric+modulators&doi=10.1016%2Fj.bmcl.2015.11.053"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14xR"><div class="casContent"><span class="casTitleNuber">14x</span><div class="casTitle"><span class="NLM_cas:atitle">Design and optimization of selective azaindole amide M1 positive allosteric modulators</span></div><div class="casAuthors">Davoren, Jennifer E.; O'Neil, Steven V.; Anderson, Dennis P.; Brodney, Michael A.; Chenard, Lois; Dlugolenski, Keith; Edgerton, Jeremy R.; Green, Michael; Garnsey, Michelle; Grimwood, Sarah; Harris, Anthony R.; Kauffman, Gregory W.; LaChapelle, Erik; Lazzaro, John T.; Lee, Che-Wah; Lotarski, Susan M.; Nason, Deane M.; Obach, R. Scott; Reinhart, Veronica; Salomon-Ferrer, Romelia; Steyn, Stefanus J.; Webb, Damien; Yan, Jiangli; Zhang, Lei</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">650-655</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Selective activation of the M1 receptor via a pos. allosteric modulator (PAM) is a new approach for the treatment of the cognitive impairments assocd. with schizophrenia and Alzheimer's disease.  A novel series of azaindole amides and their key pharmacophore elements are described.  The nitrogen of the azaindole core is a key design element as it forms an intramol. hydrogen bond with the amide N-H thus reinforcing the bioactive conformation predicted by published SAR and the authors' homol. model.  Representative compd. 25 is a potent and selective M1 PAM that has well aligned physicochem. properties, adequate brain penetration and pharmacokinetic (PK) properties, and is active in vivo.  These favorable properties indicate that this series possesses suitable qualities for further development and studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpOEhH8MxkKIrVg90H21EOLACvtfcHk0lgC3Heoce4ckw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvFant73L&md5=5c227d1371fe4f0cc3348af8314dd370</span></div><a href="/servlet/linkout?suffix=cit14x&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2015.11.053&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2015.11.053%26sid%3Dliteratum%253Aachs%26aulast%3DDavoren%26aufirst%3DJ.%2BE.%26aulast%3DO%25E2%2580%2599Neil%26aufirst%3DS.%2BV.%26aulast%3DAnderson%26aufirst%3DD.%2BP.%26aulast%3DBrodney%26aufirst%3DM.%2BA.%26aulast%3DChenard%26aufirst%3DL.%26aulast%3DDlugolenski%26aufirst%3DK.%26aulast%3DEdgerton%26aufirst%3DJ.%2BR.%26aulast%3DGreen%26aufirst%3DM.%26aulast%3DGarnsey%26aufirst%3DM.%26aulast%3DGrimwood%26aufirst%3DS.%26aulast%3DHarris%26aufirst%3DA.%2BR.%26aulast%3DKauffman%26aufirst%3DG.%2BW.%26aulast%3DLaChapelle%26aufirst%3DE.%26aulast%3DLazzaro%26aufirst%3DJ.%2BT.%26aulast%3DLee%26aufirst%3DC.-W.%26aulast%3DLotarski%26aufirst%3DS.%2BM.%26aulast%3DNason%26aufirst%3DD.%2BM.%26aulast%3DObach%26aufirst%3DR.%2BS.%26aulast%3DReinhart%26aufirst%3DV.%26aulast%3DSalomon-Ferrer%26aufirst%3DR.%26aulast%3DSteyn%26aufirst%3DS.%2BJ.%26aulast%3DWebb%26aufirst%3DD.%26aulast%3DYan%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DL.%26atitle%3DDesign%2520and%2520optimization%2520of%2520selective%2520azaindole%2520amide%2520M1%2520positive%2520allosteric%2520modulators%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D26%26spage%3D650%26epage%3D655%26doi%3D10.1016%2Fj.bmcl.2015.11.053" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit14y"><span><span class="NLM_label">(y) </span><span class="NLM_contrib-group">Mistry, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jorg, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lim, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vinh, N. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sexton, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Capuano, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christopoulos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lane, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scammells, P. J.</span><span> </span><span class="NLM_article-title">4-Phenylpyridin-2-one derivatives: A novel class of positive allosteric modulator of the M1 muscarinic acetylcholine receptor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">388</span><span class="NLM_x">–</span> <span class="NLM_lpage">409</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01562</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01562" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14y&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvFegu7zP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=388-409&author=S.+N.+Mistryauthor=M.+Jorgauthor=H.+Limauthor=N.+B.+Vinhauthor=P.+M.+Sextonauthor=B.+Capuanoauthor=A.+Christopoulosauthor=J.+R.+Laneauthor=P.+J.+Scammells&title=4-Phenylpyridin-2-one+derivatives%3A+A+novel+class+of+positive+allosteric+modulator+of+the+M1+muscarinic+acetylcholine+receptor&doi=10.1021%2Facs.jmedchem.5b01562"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14yR"><div class="casContent"><span class="casTitleNuber">14y</span><div class="casTitle"><span class="NLM_cas:atitle">4-Phenylpyridin-2-one Derivatives: A Novel Class of Positive Allosteric Modulator of the M1 Muscarinic Acetylcholine Receptor</span></div><div class="casAuthors">Mistry, Shailesh N.; Jorg, Manuela; Lim, Herman; Vinh, Natalie B.; Sexton, Patrick M.; Capuano, Ben; Christopoulos, Arthur; Lane, J. Robert; Scammells, Peter J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">388-409</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Pos. allosteric modulators (PAMs) of the M1 muscarinic acetylcholine receptor (M1 mAChR) are a promising strategy for the treatment of the cognitive deficits assocd. with diseases including Alzheimer's and schizophrenia.  Herein, we report the design, synthesis, and characterization of a novel family of M1 mAChR PAMs.  The most active compds. of the 4-phenylpyridin-2-one series exhibited comparable binding affinity to the ref. compd., 1-(4-methoxybenzyl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid (BQCA), but markedly improved pos. cooperativity with acetylcholine, and retained exquisite selectivity for the M1 mAChR.  Furthermore, the pharmacol. characterization revealed ligands with a diverse range of activities, including modulators that displayed both high intrinsic efficacy and PAM activity, those that showed no detectable agonism but robust PAM activity and ligands that displayed robust allosteric agonism but little modulatory activity.  Compd. I was found to have the best pharmacol. profile.  Thus, the 4-phenylpyridin-2-one scaffold offers an attractive starting point for further lead optimization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMlFmtgndXrbVg90H21EOLACvtfcHk0lgC3Heoce4ckw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvFegu7zP&md5=315362c43e2b6c204f038f30c6ade642</span></div><a href="/servlet/linkout?suffix=cit14y&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01562&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01562%26sid%3Dliteratum%253Aachs%26aulast%3DMistry%26aufirst%3DS.%2BN.%26aulast%3DJorg%26aufirst%3DM.%26aulast%3DLim%26aufirst%3DH.%26aulast%3DVinh%26aufirst%3DN.%2BB.%26aulast%3DSexton%26aufirst%3DP.%2BM.%26aulast%3DCapuano%26aufirst%3DB.%26aulast%3DChristopoulos%26aufirst%3DA.%26aulast%3DLane%26aufirst%3DJ.%2BR.%26aulast%3DScammells%26aufirst%3DP.%2BJ.%26atitle%3D4-Phenylpyridin-2-one%2520derivatives%253A%2520A%2520novel%2520class%2520of%2520positive%2520allosteric%2520modulator%2520of%2520the%2520M1%2520muscarinic%2520acetylcholine%2520receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D388%26epage%3D409%26doi%3D10.1021%2Facs.jmedchem.5b01562" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit14z"><span><span class="NLM_label">(z) </span><span class="NLM_contrib-group">Davoren, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Neil, S. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brodney, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chenard, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dlugolenski, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edgerton, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garnsey, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grimwood, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kauffman, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaChapelle, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lazzaro, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lotarski, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nason, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Obach, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reinhart, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salomon-Ferrer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steyn, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webb, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span> </span><span class="NLM_article-title">Design and optimization of selective azaindole amide M1 positive allosteric modulators</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">650</span><span class="NLM_x">–</span> <span class="NLM_lpage">655</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2015.11.053</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14z&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=10.1016%2Fj.bmcl.2015.11.053" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14z&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=26631313" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14z&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvFant73L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=650-655&author=J.+E.+Davorenauthor=S.+V.+O%E2%80%99Neilauthor=D.+P.+Andersonauthor=M.+A.+Brodneyauthor=L.+Chenardauthor=K.+Dlugolenskiauthor=J.+R.+Edgertonauthor=M.+Greenauthor=M.+Garnseyauthor=S.+Grimwoodauthor=A.+R.+Harrisauthor=G.+W.+Kauffmanauthor=E.+LaChapelleauthor=J.+T.+Lazzaroauthor=C.+W.+Leeauthor=S.+M.+Lotarskiauthor=D.+M.+Nasonauthor=R.+S.+Obachauthor=V.+Reinhartauthor=R.+Salomon-Ferrerauthor=S.+J.+Steynauthor=D.+Webbauthor=J.+Yanauthor=L.+Zhang&title=Design+and+optimization+of+selective+azaindole+amide+M1+positive+allosteric+modulators&doi=10.1016%2Fj.bmcl.2015.11.053"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14zR"><div class="casContent"><span class="casTitleNuber">14z</span><div class="casTitle"><span class="NLM_cas:atitle">Design and optimization of selective azaindole amide M1 positive allosteric modulators</span></div><div class="casAuthors">Davoren, Jennifer E.; O'Neil, Steven V.; Anderson, Dennis P.; Brodney, Michael A.; Chenard, Lois; Dlugolenski, Keith; Edgerton, Jeremy R.; Green, Michael; Garnsey, Michelle; Grimwood, Sarah; Harris, Anthony R.; Kauffman, Gregory W.; LaChapelle, Erik; Lazzaro, John T.; Lee, Che-Wah; Lotarski, Susan M.; Nason, Deane M.; Obach, R. Scott; Reinhart, Veronica; Salomon-Ferrer, Romelia; Steyn, Stefanus J.; Webb, Damien; Yan, Jiangli; Zhang, Lei</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">650-655</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Selective activation of the M1 receptor via a pos. allosteric modulator (PAM) is a new approach for the treatment of the cognitive impairments assocd. with schizophrenia and Alzheimer's disease.  A novel series of azaindole amides and their key pharmacophore elements are described.  The nitrogen of the azaindole core is a key design element as it forms an intramol. hydrogen bond with the amide N-H thus reinforcing the bioactive conformation predicted by published SAR and the authors' homol. model.  Representative compd. 25 is a potent and selective M1 PAM that has well aligned physicochem. properties, adequate brain penetration and pharmacokinetic (PK) properties, and is active in vivo.  These favorable properties indicate that this series possesses suitable qualities for further development and studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpOEhH8MxkKIrVg90H21EOLACvtfcHk0lgWeV0icA1qKg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvFant73L&md5=5c227d1371fe4f0cc3348af8314dd370</span></div><a href="/servlet/linkout?suffix=cit14z&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2015.11.053&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2015.11.053%26sid%3Dliteratum%253Aachs%26aulast%3DDavoren%26aufirst%3DJ.%2BE.%26aulast%3DO%25E2%2580%2599Neil%26aufirst%3DS.%2BV.%26aulast%3DAnderson%26aufirst%3DD.%2BP.%26aulast%3DBrodney%26aufirst%3DM.%2BA.%26aulast%3DChenard%26aufirst%3DL.%26aulast%3DDlugolenski%26aufirst%3DK.%26aulast%3DEdgerton%26aufirst%3DJ.%2BR.%26aulast%3DGreen%26aufirst%3DM.%26aulast%3DGarnsey%26aufirst%3DM.%26aulast%3DGrimwood%26aufirst%3DS.%26aulast%3DHarris%26aufirst%3DA.%2BR.%26aulast%3DKauffman%26aufirst%3DG.%2BW.%26aulast%3DLaChapelle%26aufirst%3DE.%26aulast%3DLazzaro%26aufirst%3DJ.%2BT.%26aulast%3DLee%26aufirst%3DC.%2BW.%26aulast%3DLotarski%26aufirst%3DS.%2BM.%26aulast%3DNason%26aufirst%3DD.%2BM.%26aulast%3DObach%26aufirst%3DR.%2BS.%26aulast%3DReinhart%26aufirst%3DV.%26aulast%3DSalomon-Ferrer%26aufirst%3DR.%26aulast%3DSteyn%26aufirst%3DS.%2BJ.%26aulast%3DWebb%26aufirst%3DD.%26aulast%3DYan%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DL.%26atitle%3DDesign%2520and%2520optimization%2520of%2520selective%2520azaindole%2520amide%2520M1%2520positive%2520allosteric%2520modulators%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D26%26spage%3D650%26epage%3D655%26doi%3D10.1016%2Fj.bmcl.2015.11.053" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit14aa"><span><span class="NLM_label">(aa) </span><span class="NLM_contrib-group">Mistry, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lim, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jorg, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Capuano, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christopoulos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lane, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scammells, P. J.</span><span> </span><span class="NLM_article-title">Novel Fused Arylpyrimidinone Based Allosteric Modulators of the M Muscarinic Acetylcholine Receptor</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">647</span><span class="NLM_x">–</span> <span class="NLM_lpage">661</span><span class="refDoi"> DOI: 10.1021/acschemneuro.6b00018</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschemneuro.6b00018" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14aa&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=1%3ACAS%3A528%3ADC%252BC28XislaitL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=647-661&author=S.+N.+Mistryauthor=H.+Limauthor=M.+Jorgauthor=B.+Capuanoauthor=A.+Christopoulosauthor=J.+R.+Laneauthor=P.+J.+Scammells&title=Novel+Fused+Arylpyrimidinone+Based+Allosteric+Modulators+of+the+M+Muscarinic+Acetylcholine+Receptor&doi=10.1021%2Facschemneuro.6b00018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14aaR"><div class="casContent"><span class="casTitleNuber">14aa</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Fused Arylpyrimidinone Based Allosteric Modulators of the M1 Muscarinic Acetylcholine Receptor</span></div><div class="casAuthors">Mistry, Shailesh N.; Lim, Herman; Jorg, Manuela; Capuano, Ben; Christopoulos, Arthur; Lane, J. Robert; Scammells, Peter J.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">647-661</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Benzoquinazolinone 1 is a pos. allosteric modulator (PAM) of the M1 muscarinic acetylcholine receptor (mAChR), which is significantly more potent than the prototypical PAM, 1-(4-methoxybenzyl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid (BQCA).  In this study, we explored the structural determinants that underlie the activity of 1 as a PAM of the M1 mAChR.  We paid particular attention to the importance of the tricyclic scaffold of compd. 1, for the activity of the mol.  Complete deletion of the peripheral fused benzene ring caused a significant decrease in affinity and binding cooperativity with acetylcholine (ACh).  This loss of affinity was rescued with the addn. of either one or two Me groups in the 7- and/or 8-position of the quinazolin-4(3H)-one core.  These results demonstrate that the tricyclic benzo[h]quinazolin-4(3H)-one core could be replaced with a quinazolin-4(3H)-one core and maintain functional affinity.  As such, the quinazolin-4(3H)-one core represents a novel scaffold to further explore M1 mAChR PAMs with improved physicochem. properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpah7jlrVCf2rVg90H21EOLACvtfcHk0lgWeV0icA1qKg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XislaitL4%253D&md5=6e2271cd08c284eac5cdb0a553dd7839</span></div><a href="/servlet/linkout?suffix=cit14aa&amp;dbid=16384&amp;doi=10.1021%2Facschemneuro.6b00018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschemneuro.6b00018%26sid%3Dliteratum%253Aachs%26aulast%3DMistry%26aufirst%3DS.%2BN.%26aulast%3DLim%26aufirst%3DH.%26aulast%3DJorg%26aufirst%3DM.%26aulast%3DCapuano%26aufirst%3DB.%26aulast%3DChristopoulos%26aufirst%3DA.%26aulast%3DLane%26aufirst%3DJ.%2BR.%26aulast%3DScammells%26aufirst%3DP.%2BJ.%26atitle%3DNovel%2520Fused%2520Arylpyrimidinone%2520Based%2520Allosteric%2520Modulators%2520of%2520the%2520M%2520Muscarinic%2520Acetylcholine%2520Receptor%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2016%26volume%3D7%26spage%3D647%26epage%3D661%26doi%3D10.1021%2Facschemneuro.6b00018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Brodney, M. A.; Davoren, J. E.; Garnsey, M. R.; Zhang, L.; O’Neil, S. V.</span><span> </span><span class="NLM_article-title">Pyridine derivatives as muscarinic m1 receptor positive allosteric modulators</span>. WO 2016009297, July 2,<span class="NLM_x"> </span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=M.+A.+Brodney&author=J.+E.+Davoren&author=M.+R.+Garnsey&author=L.+Zhang&author=S.+V.+O%E2%80%99Neil&title=Pyridine+derivatives+as+muscarinic+m1+receptor+positive+allosteric+modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBrodney%26aufirst%3DM.%2BA.%26atitle%3DPyridine%2520derivatives%2520as%2520muscarinic%2520m1%2520receptor%2520positive%2520allosteric%2520modulators%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Wager, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hou, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verhoest, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villalobos, A.</span><span> </span><span class="NLM_article-title">Moving beyond rules: the development of a central nervous system multiparameter optimization (CNS MPO) approach to enable alignment of druglike properties</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">435</span><span class="NLM_x">–</span> <span class="NLM_lpage">449</span><span class="refDoi"> DOI: 10.1021/cn100008c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cn100008c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjvVejtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=435-449&author=T.+T.+Wagerauthor=X.+Houauthor=P.+R.+Verhoestauthor=A.+Villalobos&title=Moving+beyond+rules%3A+the+development+of+a+central+nervous+system+multiparameter+optimization+%28CNS+MPO%29+approach+to+enable+alignment+of+druglike+properties&doi=10.1021%2Fcn100008c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Moving beyond Rules: The Development of a Central Nervous System Multiparameter Optimization (CNS MPO) Approach To Enable Alignment of Druglike Properties</span></div><div class="casAuthors">Wager, Travis T.; Hou, Xinjun; Verhoest, Patrick R.; Villalobos, Anabella</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">435-449</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The interplay among commonly used physicochem. properties in drug design was examd. and utilized to create a prospective design tool focused on the alignment of key druglike attributes.  Using a set of six physicochem. parameters ((a) lipophilicity, calcd. partition coeff. (ClogP); (b) calcd. distribution coeff. at pH = 7.4 (ClogD); (c) mol. wt. (MW); (d) topol. polar surface area (TPSA); (e) no. of hydrogen bond donors (HBD); (f) most basic center (pKa)), a druglikeness central nervous system multiparameter optimization (CNS MPO) algorithm was built and applied to a set of marketed CNS drugs (N = 119) and Pfizer CNS candidates (N = 108), as well as to a large diversity set of Pfizer proprietary compds. (N = 11 303).  The novel CNS MPO algorithm showed that 74% of marketed CNS drugs displayed a high CNS MPO score (MPO desirability score ≥ 4, using a scale of 0-6), in comparison to 60% of the Pfizer CNS candidates.  This anal. suggests that this algorithm could potentially be used to identify compds. with a higher probability of successfully testing hypotheses in the clinic.  In addn., a relationship between an increasing CNS MPO score and alignment of key in vitro attributes of drug discovery (favorable permeability, P-glycoprotein (P-gp) efflux, metabolic stability, and safety) was seen in the marketed CNS drug set, the Pfizer candidate set, and the Pfizer proprietary diversity set.  The CNS MPO scoring function offers advantages over hard cutoffs or utilization of single parameters to optimize structure-activity relationships (SAR) by expanding medicinal chem. design space through a holistic assessment approach.  Based on six physicochem. properties commonly used by medicinal chemists, the CNS MPO function may be used prospectively at the design stage to accelerate the identification of compds. with increased probability of success.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqB3Mvkgm_X5bVg90H21EOLACvtfcHk0ljLdhqkBDeA6A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjvVejtr8%253D&md5=e94998f65a420be6ee4dec4a987cb983</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fcn100008c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn100008c%26sid%3Dliteratum%253Aachs%26aulast%3DWager%26aufirst%3DT.%2BT.%26aulast%3DHou%26aufirst%3DX.%26aulast%3DVerhoest%26aufirst%3DP.%2BR.%26aulast%3DVillalobos%26aufirst%3DA.%26atitle%3DMoving%2520beyond%2520rules%253A%2520the%2520development%2520of%2520a%2520central%2520nervous%2520system%2520multiparameter%2520optimization%2520%2528CNS%2520MPO%2529%2520approach%2520to%2520enable%2520alignment%2520of%2520druglike%2520properties%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2010%26volume%3D1%26spage%3D435%26epage%3D449%26doi%3D10.1021%2Fcn100008c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grillo, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burke, M. D.</span><span> </span><span class="NLM_article-title">From synthesis to function via iterative assembly of N-methyliminodiacetic acid boronate building blocks</span> <span class="citation_source-journal">Acc. Chem. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">2297</span><span class="NLM_x">–</span> <span class="NLM_lpage">2307</span><span class="refDoi"> DOI: 10.1021/acs.accounts.5b00128</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.accounts.5b00128" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht1SrsLrE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2015&pages=2297-2307&author=J.+Liauthor=A.+S.+Grilloauthor=M.+D.+Burke&title=From+synthesis+to+function+via+iterative+assembly+of+N-methyliminodiacetic+acid+boronate+building+blocks&doi=10.1021%2Facs.accounts.5b00128"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17aR"><div class="casContent"><span class="casTitleNuber">17a</span><div class="casTitle"><span class="NLM_cas:atitle">From Synthesis to Function via Iterative Assembly of N-Methyliminodiacetic Acid Boronate Building Blocks</span></div><div class="casAuthors">Li, Junqi; Grillo, Anthony S.; Burke, Martin D.</div><div class="citationInfo"><span class="NLM_cas:title">Accounts of Chemical Research</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2297-2307</span>CODEN:
                <span class="NLM_cas:coden">ACHRE4</span>;
        ISSN:<span class="NLM_cas:issn">0001-4842</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The study and optimization of small mol. function is often impeded by the time-intensive and specialist-dependent process that is typically used to make such compds.  In contrast, general and automated platforms have been developed for making peptides, oligonucleotides, and increasingly oligosaccharides, where synthesis is simplified to iterative applications of the same reactions.  Inspired by the way natural products are biosynthesized via the iterative assembly of a defined set of building blocks, we developed a platform for small mol. synthesis involving the iterative coupling of haloboronic acids protected as the corresponding N-methyliminodiacetic acid (MIDA) boronates.  Here we summarize our efforts thus far to develop this platform into a generalized and automated approach for small mol. synthesis.  We and others have employed this approach to access many polyene-based compds., including the polyene motifs found in >75% of all polyene natural products.  This platform further allowed us to derivatize amphotericin B, the powerful and resistance-evasive but also highly toxic last line of defense in treating systemic fungal infections, and thereby understand its mechanism of action.  This synthesis-enabled mechanistic understanding has led us to develop less toxic derivs. currently under evaluation as improved antifungal agents.  To access more Csp3-contg. small mols., we gained a stereocontrolled entry into chiral, non-racemic α-boryl aldehydes through the discovery of a chiral deriv. of MIDA.  These α-boryl aldehydes are versatile intermediates for the synthesis of many Csp3 boronate building blocks that are otherwise difficult to access.  In addn., we demonstrated the utility of these types of building blocks in accessing pharmaceutically relevant targets via an iterative Csp3 cross-coupling cycle.  We have further expanded the scope of the platform to include stereochem. complex macrocyclic and polycyclic mols. using a linear-to-cyclized strategy, in which Csp3 boronate building blocks are iteratively assembled into linear precursors that are then cyclized into the cyclic frameworks found in many natural products and natural product-like structures.  Enabled by the serendipitous discovery of a catch-and-release protocol for generally purifying MIDA boronate intermediates, the platform has been automated.  The synthesis of 14 distinct classes of small mols., including pharmaceuticals, materials components, and polycyclic natural products, has been achieved using this new synthesis machine.  It is anticipated that the scope of small mols. accessible by this platform will continue to expand via further developments in building block synthesis, Csp3 cross-coupling methodologies, and cyclization strategies.  Achieving these goals will enable the more generalized synthesis of small mols. and thereby help shift the rate-limiting step in small mol. science from synthesis to function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8wb3eT2AJ_rVg90H21EOLACvtfcHk0ljLdhqkBDeA6A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht1SrsLrE&md5=60e27155883bd0128616013ade63cd2b</span></div><a href="/servlet/linkout?suffix=cit17a&amp;dbid=16384&amp;doi=10.1021%2Facs.accounts.5b00128&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.accounts.5b00128%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DGrillo%26aufirst%3DA.%2BS.%26aulast%3DBurke%26aufirst%3DM.%2BD.%26atitle%3DFrom%2520synthesis%2520to%2520function%2520via%2520iterative%2520assembly%2520of%2520N-methyliminodiacetic%2520acid%2520boronate%2520building%2520blocks%26jtitle%3DAcc.%2520Chem.%2520Res.%26date%3D2015%26volume%3D48%26spage%3D2297%26epage%3D2307%26doi%3D10.1021%2Facs.accounts.5b00128" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit17b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Gillis, E. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burke, M. D.</span><span> </span><span class="NLM_article-title">Iterative Cross-Couplng with MIDA Boronates: Towards a General Platform for Small Molecule Synthesis</span> <span class="citation_source-journal">Aldrichim. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">17</span><span class="NLM_x">–</span> <span class="NLM_lpage">27</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=22523433" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=1%3ACAS%3A528%3ADC%252BD1MXpslOkurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2009&pages=17-27&author=E.+P.+Gillisauthor=M.+D.+Burke&title=Iterative+Cross-Couplng+with+MIDA+Boronates%3A+Towards+a+General+Platform+for+Small+Molecule+Synthesis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17bR"><div class="casContent"><span class="casTitleNuber">17b</span><div class="casTitle"><span class="NLM_cas:atitle">Iterative cross-coupling with MIDA boronates: towards a general-strategy for small-molecule synthesis</span></div><div class="casAuthors">Gillis, Eric P.; Burke, Martin D.</div><div class="citationInfo"><span class="NLM_cas:title">Aldrichimica Acta</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">17-27</span>CODEN:
                <span class="NLM_cas:coden">ALACBI</span>;
        ISSN:<span class="NLM_cas:issn">0002-5100</span>.
    
            (<span class="NLM_cas:orgname">Aldrich Chemical Co.</span>)
        </div><div class="casAbstract">A review outlines the targeted development of building blocks representing substructures that appear frequently in natural products and the chem. that will enable their precise union via metal-mediated cross-coupling reactions.  N-methyliminodiacetic acid (MIDI) boronates represent a highly promising platform for this iterative cross coupling approach wherein all the required functional groups preinstalled in the correct oxidn. state and with the desired stereochem. relationships are iteratively united using only stereospecific cross-coupling reactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-q8DWdrHxmrVg90H21EOLACvtfcHk0ljLdhqkBDeA6A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXpslOkurc%253D&md5=a20a93b406ff44ee15d7fc52d97aa50a</span></div><a href="/servlet/linkout?suffix=cit17b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGillis%26aufirst%3DE.%2BP.%26aulast%3DBurke%26aufirst%3DM.%2BD.%26atitle%3DIterative%2520Cross-Couplng%2520with%2520MIDA%2520Boronates%253A%2520Towards%2520a%2520General%2520Platform%2520for%2520Small%2520Molecule%2520Synthesis%26jtitle%3DAldrichim.%2520Acta%26date%3D2009%26volume%3D42%26spage%3D17%26epage%3D27" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="note"><p class="first last">Water network was modeled by a 20 ns molecular dynamics simulation using Desmond in Maestro 2015-3 with an OPLS3 force field.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span>The exemplified THP ring has been highlighted in multiple Merck patents. For a recent relevant example see the following: <span class="NLM_contrib-group">Kuduk, S. D.; Gilbert, K. F.</span><span> </span><span class="NLM_article-title">Tetrahydroquinoline amide m1 receptor positive allosteric modulators</span>. WO 2011159554,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=S.+D.+Kuduk&author=K.+F.+Gilbert&title=Tetrahydroquinoline+amide+m1+receptor+positive+allosteric+modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DKuduk%26aufirst%3DS.%2BD.%26atitle%3DTetrahydroquinoline%2520amide%2520m1%2520receptor%2520positive%2520allosteric%2520modulators%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="note"><p class="first last">Though the homology model does not explain the steep SAR observed on the amide bond, it is worth noting that in certain molecular dynamics simulations we did observe a through water hydrogen bond between the THP-OH group and Ser412.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Ryckmans, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horne, V. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Correia, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Owen, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tutt, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, T.</span><span> </span><span class="NLM_article-title">Rapid assessment of a novel series of selective CB(2) agonists using parallel synthesis protocols: A Lipophilic Efficiency (LipE) analysis</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">4406</span><span class="NLM_x">–</span> <span class="NLM_lpage">4409</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2009.05.062</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=10.1016%2Fj.bmcl.2009.05.062" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=19500981" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=1%3ACAS%3A528%3ADC%252BD1MXosVGlsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=4406-4409&author=T.+Ryckmansauthor=M.+P.+Edwardsauthor=V.+A.+Horneauthor=A.+M.+Correiaauthor=D.+R.+Owenauthor=L.+R.+Thompsonauthor=I.+Tranauthor=M.+F.+Tuttauthor=T.+Young&title=Rapid+assessment+of+a+novel+series+of+selective+CB%282%29+agonists+using+parallel+synthesis+protocols%3A+A+Lipophilic+Efficiency+%28LipE%29+analysis&doi=10.1016%2Fj.bmcl.2009.05.062"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Rapid assessment of a novel series of selective CB2 agonists using parallel synthesis protocols: A Lipophilic Efficiency (LipE) analysis</span></div><div class="casAuthors">Ryckmans, Thomas; Edwards, Martin P.; Horne, Val A.; Correia, Ana Monica; Owen, Dafydd R.; Thompson, Lisa R.; Tran, Isabelle; Tutt, Michelle F.; Young, Tim</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">4406-4409</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A series of libraries were designed using the 1-(cyclopropylmethyl)-2-alkyl-4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridin-5-ium templates 2a-b, and Sulfonamide derivs. 11a-n proved to be potent agonists of the CB2 receptor.  Anal. of the Lipophilic Efficiency (LipE) of potent compds. provided new insight for the design of potent, metabolically stable CB2 agonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1cihq9YHuO7Vg90H21EOLACvtfcHk0lgs8wKiRwEHiw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXosVGlsrg%253D&md5=b62d97e5f52a594cfdd510f32d2e566f</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.05.062&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.05.062%26sid%3Dliteratum%253Aachs%26aulast%3DRyckmans%26aufirst%3DT.%26aulast%3DEdwards%26aufirst%3DM.%2BP.%26aulast%3DHorne%26aufirst%3DV.%2BA.%26aulast%3DCorreia%26aufirst%3DA.%2BM.%26aulast%3DOwen%26aufirst%3DD.%2BR.%26aulast%3DThompson%26aufirst%3DL.%2BR.%26aulast%3DTran%26aufirst%3DI.%26aulast%3DTutt%26aufirst%3DM.%2BF.%26aulast%3DYoung%26aufirst%3DT.%26atitle%3DRapid%2520assessment%2520of%2520a%2520novel%2520series%2520of%2520selective%2520CB%25282%2529%2520agonists%2520using%2520parallel%2520synthesis%2520protocols%253A%2520A%2520Lipophilic%2520Efficiency%2520%2528LipE%2529%2520analysis%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D4406%26epage%3D4409%26doi%3D10.1016%2Fj.bmcl.2009.05.062" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Feng, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mills, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davidson, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mireles, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janiszewski, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Troutman, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Morais, S. M.</span><span> </span><span class="NLM_article-title">In vitro P-glycoprotein assays to predict the in vivo interactions of P-glycoprotein with drugs in the central nervous system</span> <span class="citation_source-journal">Drug. Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">268</span><span class="NLM_x">–</span> <span class="NLM_lpage">275</span><span class="refDoi"> DOI: 10.1124/dmd.107.017434</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=10.1124%2Fdmd.107.017434" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=17962372" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1yktbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2008&pages=268-275&author=B.+Fengauthor=J.+B.+Millsauthor=R.+E.+Davidsonauthor=R.+J.+Mirelesauthor=J.+S.+Janiszewskiauthor=M.+D.+Troutmanauthor=S.+M.+de+Morais&title=In+vitro+P-glycoprotein+assays+to+predict+the+in+vivo+interactions+of+P-glycoprotein+with+drugs+in+the+central+nervous+system&doi=10.1124%2Fdmd.107.017434"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro P-glycoprotein assays to predict the in vivo interactions of P-glycoprotein with drugs in the central nervous system</span></div><div class="casAuthors">Feng, Bo; Mills, Jessica B.; Davidson, Ralph E.; Mireles, Rouchelle J.; Janiszewski, John S.; Troutman, Matthew D.; de Morais, Sonia M.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">268-275</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Thirty-one structurally diverse marketed central nervous system (CNS)-active drugs, one active metabolite, and seven non-CNS-active compds. were tested in three P-glycoprotein (P-gp) in vitro assays: transwell assays using MDCK, human MDR1-MDCK, and mouse Mdr1a-MDCK cells, ATPase, and calcein AM inhibition.  Addnl., the permeability for these compds. was measured in two in vitro models: parallel artificial membrane permeation assay and apical-to-basolateral apparent permeability in MDCK.  The exposure of the same set of compds. in brain and plasma was measured in P-gp knockout (KO) and wild-type (WT) mice after s.c. administration.  One drug and its metabolite, risperidone and 9-hydroxyrisperidone, of the 32 CNS compds., and 6 of the 7 non-CNS drugs were detd. to have pos. efflux using ratio of ratios in MDR1-MDCK vs. MDCK transwell assays.  Data from transwell studies correlated well with the brain-to-plasma area under the curve ratios between P-gp KO and WT mice for the 32 CNS compds.  In addn., 3300 Pfizer compds. were tested in MDR1-MDCK and Mdr1a-MDCK transwell assays, with a good correlation (R2 = 0.92) between the efflux ratios in human MDR1-MDCK and mouse Mdr1a-MDCK cells.  Permeability data showed that the majority of the 32 CNS compds. have moderate to high passive permeability.  This work has demonstrated that in vitro transporter assays help in understanding the role of P-gp-mediated efflux activity in detg. the disposition of CNS drugs in vivo, and the transwell assay is a valuable in vitro assay to evaluate human P-gp interaction with compds. for assessing brain penetration of new chem. entities to treat CNS disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsQyRSOySyGLVg90H21EOLACvtfcHk0lgs8wKiRwEHiw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1yktbc%253D&md5=bbf8b6969bd6d6b3d741b6ef9e7853f3</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1124%2Fdmd.107.017434&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.107.017434%26sid%3Dliteratum%253Aachs%26aulast%3DFeng%26aufirst%3DB.%26aulast%3DMills%26aufirst%3DJ.%2BB.%26aulast%3DDavidson%26aufirst%3DR.%2BE.%26aulast%3DMireles%26aufirst%3DR.%2BJ.%26aulast%3DJaniszewski%26aufirst%3DJ.%2BS.%26aulast%3DTroutman%26aufirst%3DM.%2BD.%26aulast%3Dde%2BMorais%26aufirst%3DS.%2BM.%26atitle%3DIn%2520vitro%2520P-glycoprotein%2520assays%2520to%2520predict%2520the%2520in%2520vivo%2520interactions%2520of%2520P-glycoprotein%2520with%2520drugs%2520in%2520the%2520central%2520nervous%2520system%26jtitle%3DDrug.%2520Metab.%2520Dispos.%26date%3D2008%26volume%3D36%26spage%3D268%26epage%3D275%26doi%3D10.1124%2Fdmd.107.017434" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Reichel, A.</span><span> </span><span class="NLM_article-title">The role of blood-brain barrier studies in the pharmaceutical industry</span> <span class="citation_source-journal">Curr. Drug Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">183</span><span class="NLM_x">–</span> <span class="NLM_lpage">203</span><span class="refDoi"> DOI: 10.2174/138920006775541525</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=10.2174%2F138920006775541525" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=16472107" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1Oms7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2006&pages=183-203&author=A.+Reichel&title=The+role+of+blood-brain+barrier+studies+in+the+pharmaceutical+industry&doi=10.2174%2F138920006775541525"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">The role of blood-brain barrier studies in the pharmaceutical industry</span></div><div class="casAuthors">Reichel, Andreas</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Metabolism</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">183-203</span>CODEN:
                <span class="NLM_cas:coden">CDMUBU</span>;
        ISSN:<span class="NLM_cas:issn">1389-2002</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The blood-brain barrier (BBB) remains one of the greatest challenges for the discovery and development of treatments for CNS disorders, which to this day remains one of the most risky disease areas in terms of clin. success rates.  Although the BBB is currently seen predominantly as a permeability obstacle for CNS drug delivery, it is becoming increasingly clear that the BBB has many more implications for the pharmaceutical industry impacting on CNS pharmacol. and pathol., CNS pharmacokinetics and pharmacodynamics, and adverse CNS effects, to name but a few areas.  The present review does not intend to summarize the activities in the field of BBB research per se, which was accomplished by a no. of excellent recent reviews, but instead to provide an overview of the role of BBB studies from a pharmaceutical industry perspective.  This review will elaborate on the specific needs in terms of BBB-related issues across the different drug discovery and development phases, i.e. target identification and validation, lead generation and optimization, candidate selection and profiling, preclin. development and clin. studies.  The specific approaches taken will be discussed in terms of specific requirements, questions to be asked, feasibility, interpretability, and impact.  It becomes clear that few of the existing BBB models fully meet the requirements of the industrialized drug discovery process, highlighting the need for an array of new or modified tools and approaches that are more effective in helping make decisions which are more specifically tailored to the various stages of the lengthy process from target to the clinic.  In looking at the numerous ongoing activities in the area of BBB research from the drug discovery and development point of view, an attempt was made to place a stronger emphasis on the applicability of particular techniques and approaches, to identify gaps and areas for future activities.  In order to materialize the considerable knowledge gained in recent years, the review is intended to foster an increased awareness of the need to better integrate basic academic research with the specific requirements of the pharmaceutical industry for the search of effective and safe new CNS medicines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWYQEy2IuSnrVg90H21EOLACvtfcHk0lgs8wKiRwEHiw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1Oms7o%253D&md5=aa9c03f9ea46b2dd74d7b517865dbdea</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.2174%2F138920006775541525&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138920006775541525%26sid%3Dliteratum%253Aachs%26aulast%3DReichel%26aufirst%3DA.%26atitle%3DThe%2520role%2520of%2520blood-brain%2520barrier%2520studies%2520in%2520the%2520pharmaceutical%2520industry%26jtitle%3DCurr.%2520Drug%2520Metab.%26date%3D2006%26volume%3D7%26spage%3D183%26epage%3D203%26doi%3D10.2174%2F138920006775541525" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Lombardo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shalaeva, M. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tupper, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, F.</span><span> </span><span class="NLM_article-title">ElogD(oct): a tool for lipophilicity determination in drug discovery. 2. Basic and neutral compounds</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">2490</span><span class="NLM_x">–</span> <span class="NLM_lpage">2497</span><span class="refDoi"> DOI: 10.1021/jm0100990</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0100990" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=1%3ACAS%3A528%3ADC%252BD3MXksFOmtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2001&pages=2490-2497&author=F.+Lombardoauthor=M.+Y.+Shalaevaauthor=K.+A.+Tupperauthor=F.+Gao&title=ElogD%28oct%29%3A+a+tool+for+lipophilicity+determination+in+drug+discovery.+2.+Basic+and+neutral+compounds&doi=10.1021%2Fjm0100990"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">ElogDoct: A Tool for Lipophilicity Determination in Drug Discovery. 2. Basic and Neutral Compounds</span></div><div class="casAuthors">Lombardo, Franco; Shalaeva, Marina Y.; Tupper, Karl A.; Gao, Feng</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">2490-2497</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We present an RP-HPLC method for the detn. of the octanol-water distribution coeffs. at pH 7.4, as log Doct7.4 values, for neutral and basic drugs, which combines ease of operation with high accuracy.  The method is shown to work for a training set of 90 mols. comprised largely of drugs, and it was also applied to a test set of 10 proprietary compds.  This work expands the applicability of the method presented in our earlier report, for the detn. of logPoct for neutral compds. (J. Med. Chem. 2000, 43, 2922-2928), and it offers the same general features but widens the scope.  Generally, the method (i) is compd. sparing (≤1 mL of a 50-100 μg/mL soln. needed), (ii) is insensitive to concn. and phase ratio effects obsd. in some shake-flask detns., (iii) is amenable to rapid detns. (≤20 min on av.), (iv) is insensitive to impurities, (v) possesses a wide lipophilicity range (>7 log Doct7.4 units), and (vi) offers a good accuracy, (vii) an excellent reproducibility, (viii) and an excellent potential for automation.  To the best of our knowledge, a similar performance, on a set of noncongeneric drugs, has not been previously reported.  We refer to the value generated via this method as ElogDoct.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrynjvQ2-0sibVg90H21EOLACvtfcHk0lgs8wKiRwEHiw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXksFOmtbc%253D&md5=e390cfeacbb1cab5660909eccfeb7eb2</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fjm0100990&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0100990%26sid%3Dliteratum%253Aachs%26aulast%3DLombardo%26aufirst%3DF.%26aulast%3DShalaeva%26aufirst%3DM.%2BY.%26aulast%3DTupper%26aufirst%3DK.%2BA.%26aulast%3DGao%26aufirst%3DF.%26atitle%3DElogD%2528oct%2529%253A%2520a%2520tool%2520for%2520lipophilicity%2520determination%2520in%2520drug%2520discovery.%25202.%2520Basic%2520and%2520neutral%2520compounds%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2001%26volume%3D44%26spage%3D2490%26epage%3D2497%26doi%3D10.1021%2Fjm0100990" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Di, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whitney-Pickett, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Umland, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gebhard, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Federico, J. J.,  3rd</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davidson, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reyner, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rotter, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varma, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kempshall, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fenner, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">El-Kattan, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liston, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Troutman, M. D.</span><span> </span><span class="NLM_article-title">Development of a new permeability assay using low-efflux MDCKII cells</span> <span class="citation_source-journal">J. Pharm. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">100</span><span class="NLM_x">, </span> <span class="NLM_fpage">4974</span><span class="NLM_x">–</span> <span class="NLM_lpage">4985</span><span class="refDoi"> DOI: 10.1002/jps.22674</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=10.1002%2Fjps.22674" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=21766308" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=1%3ACAS%3A528%3ADC%252BC3MXovFGltb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2011&pages=4974-4985&author=L.+Diauthor=C.+Whitney-Pickettauthor=J.+P.+Umlandauthor=H.+Zhangauthor=X.+Zhangauthor=D.+F.+Gebhardauthor=Y.+Laiauthor=J.+J.+Federicoauthor=R.+E.+Davidsonauthor=R.+Smithauthor=E.+L.+Reynerauthor=C.+Leeauthor=B.+Fengauthor=C.+Rotterauthor=M.+V.+Varmaauthor=S.+Kempshallauthor=K.+Fennerauthor=A.+F.+El-Kattanauthor=T.+E.+Listonauthor=M.+D.+Troutman&title=Development+of+a+new+permeability+assay+using+low-efflux+MDCKII+cells&doi=10.1002%2Fjps.22674"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Development of a new permeability assay using low-efflux MDCKII cells</span></div><div class="casAuthors">Di, Li; Whitney-Pickett, Carrie; Umland, John P.; Zhang, Hui; Zhang, Xun; Gebhard, David F.; Lai, Yurong; Federico, James J.; Davidson, Ralph E.; Smith, Russ; Reyner, Eric L.; Lee, Caroline; Feng, Bo; Rotter, Charles; Varma, Manthena V.; Kempshall, Sarah; Fenner, Katherine; El-kattan, Ayman F.; Liston, Theodore E.; Troutman, Matthew D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">100</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4974-4985</span>CODEN:
                <span class="NLM_cas:coden">JPMSAE</span>;
        ISSN:<span class="NLM_cas:issn">0022-3549</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Permeability is an important property of drug candidates.  The Madin-Darby canine kidney cell line (MDCK) permeability assay is widely used and the primary concern of using MDCK cells is the presence of endogenous transporters of nonhuman origin.  The canine P-glycoprotein (Pgp) can interfere with permeability and transporter studies, leading to less reliable data.  A new cell line, MDCKII-LE (low efflux), has been developed by selecting a subpopulation of low-efflux cells from MDCKII-WT using an iterative fluorescence-activated cell sorting technique with calcein-AM as a Pgp and efflux substrate.  MDCKII-LE cells are a subpopulation of MDCKII cells with over 200-fold lower canine Pgp mRNA level and fivefold lower protein level than MDCKII-WT.  MDCKII-LE cells showed less functional efflux activity than MDCKII-WT based on efflux ratios.  Notably, MDCKII-MDR1 showed about 1.5-fold decreased expression of endogenous canine Pgp, suggesting that using the net flux ratio might not completely cancel out the background endogenous transporter activities.  MDCKII-LE cells offer clear advantages over the MDCKII-WT by providing less efflux transporter background signals and minimizing interference from canine Pgp.  The MDCKII-LE apparent permeability values well differentiates compds. from high to medium/low human intestinal absorption and can be used for Biopharmaceutical Classification System.  The MDCKII-LE permeability assay (4-in-1 cassette dosing) is high throughput with good precision, reproducibility, robustness, and cost-effective. © 2011 Wiley-Liss, Inc. and the American Pharmacists Assocn. J Pharm Sci.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTVtRmYnbF17Vg90H21EOLACvtfcHk0ljVv127QlSp3A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXovFGltb8%253D&md5=97f647fc215ea6d04882351ffc912a1e</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1002%2Fjps.22674&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjps.22674%26sid%3Dliteratum%253Aachs%26aulast%3DDi%26aufirst%3DL.%26aulast%3DWhitney-Pickett%26aufirst%3DC.%26aulast%3DUmland%26aufirst%3DJ.%2BP.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DGebhard%26aufirst%3DD.%2BF.%26aulast%3DLai%26aufirst%3DY.%26aulast%3DFederico%26aufirst%3DJ.%2BJ.%26aulast%3DDavidson%26aufirst%3DR.%2BE.%26aulast%3DSmith%26aufirst%3DR.%26aulast%3DReyner%26aufirst%3DE.%2BL.%26aulast%3DLee%26aufirst%3DC.%26aulast%3DFeng%26aufirst%3DB.%26aulast%3DRotter%26aufirst%3DC.%26aulast%3DVarma%26aufirst%3DM.%2BV.%26aulast%3DKempshall%26aufirst%3DS.%26aulast%3DFenner%26aufirst%3DK.%26aulast%3DEl-Kattan%26aufirst%3DA.%2BF.%26aulast%3DListon%26aufirst%3DT.%2BE.%26aulast%3DTroutman%26aufirst%3DM.%2BD.%26atitle%3DDevelopment%2520of%2520a%2520new%2520permeability%2520assay%2520using%2520low-efflux%2520MDCKII%2520cells%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D2011%26volume%3D100%26spage%3D4974%26epage%3D4985%26doi%3D10.1002%2Fjps.22674" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Johnson, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dress, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, M.</span><span> </span><span class="NLM_article-title">Using the Golden Triangle to optimize clearance and oral absorption</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">5560</span><span class="NLM_x">–</span> <span class="NLM_lpage">5564</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2009.08.045</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=10.1016%2Fj.bmcl.2009.08.045" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=19720530" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFaktbfE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=5560-5564&author=T.+W.+Johnsonauthor=K.+R.+Dressauthor=M.+Edwards&title=Using+the+Golden+Triangle+to+optimize+clearance+and+oral+absorption&doi=10.1016%2Fj.bmcl.2009.08.045"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Using the Golden Triangle to optimize clearance and oral absorption</span></div><div class="casAuthors">Johnson, Ted W.; Dress, Klaus R.; Edwards, Martin</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">5560-5564</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The Golden Triangle is a visualization tool developed from in vitro permeability, in vitro clearance and computational data designed to aid medicinal chemists in achieving metabolically stable, permeable and potent drug candidates.  Classifying compds. as permeable and stable and plotting mol. wt. (MW) vs. octanol:buffer (pH 7.4) distribution coeffs. (log D) or estd. octanol:buffer (pH 7.4) distribution coeffs. (elog D) reveals useful trends.  Anal. of at least 2 orthogonal trends, such as permeability and clearance, can be extremely effective in balancing and optimizing multiple properties.  In addn., mol. wt. and log D impact potency-efficiency calcns., allowing potency, clearance and permeability to be optimized simultaneously.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqjGjEaOp0237Vg90H21EOLACvtfcHk0ljVv127QlSp3A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFaktbfE&md5=3cfed1288ec451eb4419f1db753ae4b4</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.08.045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.08.045%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DT.%2BW.%26aulast%3DDress%26aufirst%3DK.%2BR.%26aulast%3DEdwards%26aufirst%3DM.%26atitle%3DUsing%2520the%2520Golden%2520Triangle%2520to%2520optimize%2520clearance%2520and%2520oral%2520absorption%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D5560%26epage%3D5564%26doi%3D10.1016%2Fj.bmcl.2009.08.045" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span>Independent to our own research efforts Takeda published a patent on a set of compounds containing a similarly substituted pyridine ring. See the following: <span class="NLM_contrib-group">Ogino, M.; Kimura, E.; Suzuki, S.; Ashizawa, T.; Imaeda, T.; Fujimori, I.; Arai, R.</span><span> </span><span class="NLM_article-title">Nitrogen-containing heterocyclic compound</span>. WO2015190564,<span class="NLM_x"> </span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=M.+Ogino&author=E.+Kimura&author=S.+Suzuki&author=T.+Ashizawa&author=T.+Imaeda&author=I.+Fujimori&author=R.+Arai&title=Nitrogen-containing+heterocyclic+compound"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DOgino%26aufirst%3DM.%26atitle%3DNitrogen-containing%2520heterocyclic%2520compound%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Johnson, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richardson, P. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bailey, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brooun, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burke, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collins, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cui, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deal, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deng, Y. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dinh, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Engstrom, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffman, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kania, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kath, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lam, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lam, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lingardo, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McTigue, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palmer, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sach, N. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smeal, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stewart, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Timofeevski, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zou, H. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, M. P.</span><span> </span><span class="NLM_article-title">Discovery of (10R)-7-amino-12-fluoro-2,10,16-trimethyl-15-oxo-10,15,16,17-tetrahydro-2H-8,4-(metheno)pyrazolo[4,3-h][2,5,11]-benzoxadiazacyclotetradecine-3-carbonitrile (PF-06463922), a macrocyclic inhibitor of anaplastic lymphoma kinase (ALK) and c-ros oncogene 1 (ROS1) with preclinical brain exposure and broad-spectrum potency against ALK-resistant mutations</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">4720</span><span class="NLM_x">–</span> <span class="NLM_lpage">4744</span><span class="refDoi"> DOI: 10.1021/jm500261q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm500261q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=1%3ACAS%3A528%3ADC%252BC2cXnvVSgtL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=4720-4744&author=T.+W.+Johnsonauthor=P.+F.+Richardsonauthor=S.+Baileyauthor=A.+Broounauthor=B.+J.+Burkeauthor=M.+R.+Collinsauthor=J.+J.+Cuiauthor=J.+G.+Dealauthor=Y.+L.+Dengauthor=D.+Dinhauthor=L.+D.+Engstromauthor=M.+Heauthor=J.+Hoffmanauthor=R.+L.+Hoffmanauthor=Q.+Huangauthor=R.+S.+Kaniaauthor=J.+C.+Kathauthor=H.+Lamauthor=J.+L.+Lamauthor=P.+T.+Leauthor=L.+Lingardoauthor=W.+Liuauthor=M.+McTigueauthor=C.+L.+Palmerauthor=N.+W.+Sachauthor=T.+Smealauthor=G.+L.+Smithauthor=A.+E.+Stewartauthor=S.+Timofeevskiauthor=H.+Zhuauthor=J.+Zhuauthor=H.+Y.+Zouauthor=M.+P.+Edwards&title=Discovery+of+%2810R%29-7-amino-12-fluoro-2%2C10%2C16-trimethyl-15-oxo-10%2C15%2C16%2C17-tetrahydro-2H-8%2C4-%28metheno%29pyrazolo%5B4%2C3-h%5D%5B2%2C5%2C11%5D-benzoxadiazacyclotetradecine-3-carbonitrile+%28PF-06463922%29%2C+a+macrocyclic+inhibitor+of+anaplastic+lymphoma+kinase+%28ALK%29+and+c-ros+oncogene+1+%28ROS1%29+with+preclinical+brain+exposure+and+broad-spectrum+potency+against+ALK-resistant+mutations&doi=10.1021%2Fjm500261q"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of (10R)-7-Amino-12-fluoro-2,10,16-trimethyl-15-oxo-10,15,16,17-tetrahydro-2H-8,4-(metheno)pyrazolo[4,3-h][2,5,11]-benzoxadiazacyclotetradecine-3-carbonitrile (PF-06463922), a Macrocyclic Inhibitor of Anaplastic Lymphoma Kinase (ALK) and c-ros Oncogene 1 (ROS1) with Preclinical Brain Exposure and Broad-Spectrum Potency against ALK-Resistant Mutations</span></div><div class="casAuthors">Johnson, Ted W.; Richardson, Paul F.; Bailey, Simon; Brooun, Alexei; Burke, Benjamin J.; Collins, Michael R.; Cui, J. Jean; Deal, Judith G.; Deng, Ya-Li; Dinh, Dac; Engstrom, Lars D.; He, Mingying; Hoffman, Jacqui; Hoffman, Robert L.; Huang, Qinhua; Kania, Robert S.; Kath, John C.; Lam, Hieu; Lam, Justine L.; Le, Phuong T.; Lingardo, Laura; Liu, Wei; McTigue, Michele; Palmer, Cynthia L.; Sach, Neal W.; Smeal, Tod; Smith, Graham L.; Stewart, Albert E.; Timofeevski, Sergei; Zhu, Huichun; Zhu, Jinjiang; Zou, Helen Y.; Edwards, Martin P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4720-4744</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Although crizotinib demonstrates robust efficacy in anaplastic lymphoma kinase (ALK)-pos. non-small-cell lung carcinoma patients, progression during treatment eventually develops.  Resistant patient samples revealed a variety of point mutations in the kinase domain of ALK, including the L1196M gatekeeper mutation.  In addn., some patients progress due to cancer metastasis in the brain.  Using structure-based drug design, lipophilic efficiency, and phys.-property-based optimization, highly potent macrocyclic ALK inhibitors were prepd. with good absorption, distribution, metab., and excretion (ADME), low propensity for p-glycoprotein 1-mediated efflux, and good passive permeability.  These structurally unusual macrocyclic inhibitors were potent against wild-type ALK and clin. reported ALK kinase domain mutations.  Significant synthetic challenges were overcome, utilizing novel transformations to enable the use of these macrocycles in drug discovery paradigms.  This work led to the discovery of 8k (PF-06463922), combining broad-spectrum potency, central nervous system ADME, and a high degree of kinase selectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqXkb49ad31bVg90H21EOLACvtfcHk0liQWkp7iLOlDw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXnvVSgtL4%253D&md5=db21844f8e9a2f9ca5953bca56ad7b1c</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fjm500261q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500261q%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DT.%2BW.%26aulast%3DRichardson%26aufirst%3DP.%2BF.%26aulast%3DBailey%26aufirst%3DS.%26aulast%3DBrooun%26aufirst%3DA.%26aulast%3DBurke%26aufirst%3DB.%2BJ.%26aulast%3DCollins%26aufirst%3DM.%2BR.%26aulast%3DCui%26aufirst%3DJ.%2BJ.%26aulast%3DDeal%26aufirst%3DJ.%2BG.%26aulast%3DDeng%26aufirst%3DY.%2BL.%26aulast%3DDinh%26aufirst%3DD.%26aulast%3DEngstrom%26aufirst%3DL.%2BD.%26aulast%3DHe%26aufirst%3DM.%26aulast%3DHoffman%26aufirst%3DJ.%26aulast%3DHoffman%26aufirst%3DR.%2BL.%26aulast%3DHuang%26aufirst%3DQ.%26aulast%3DKania%26aufirst%3DR.%2BS.%26aulast%3DKath%26aufirst%3DJ.%2BC.%26aulast%3DLam%26aufirst%3DH.%26aulast%3DLam%26aufirst%3DJ.%2BL.%26aulast%3DLe%26aufirst%3DP.%2BT.%26aulast%3DLingardo%26aufirst%3DL.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DMcTigue%26aufirst%3DM.%26aulast%3DPalmer%26aufirst%3DC.%2BL.%26aulast%3DSach%26aufirst%3DN.%2BW.%26aulast%3DSmeal%26aufirst%3DT.%26aulast%3DSmith%26aufirst%3DG.%2BL.%26aulast%3DStewart%26aufirst%3DA.%2BE.%26aulast%3DTimofeevski%26aufirst%3DS.%26aulast%3DZhu%26aufirst%3DH.%26aulast%3DZhu%26aufirst%3DJ.%26aulast%3DZou%26aufirst%3DH.%2BY.%26aulast%3DEdwards%26aufirst%3DM.%2BP.%26atitle%3DDiscovery%2520of%2520%252810R%2529-7-amino-12-fluoro-2%252C10%252C16-trimethyl-15-oxo-10%252C15%252C16%252C17-tetrahydro-2H-8%252C4-%2528metheno%2529pyrazolo%255B4%252C3-h%255D%255B2%252C5%252C11%255D-benzoxadiazacyclotetradecine-3-carbonitrile%2520%2528PF-06463922%2529%252C%2520a%2520macrocyclic%2520inhibitor%2520of%2520anaplastic%2520lymphoma%2520kinase%2520%2528ALK%2529%2520and%2520c-ros%2520oncogene%25201%2520%2528ROS1%2529%2520with%2520preclinical%2520brain%2520exposure%2520and%2520broad-spectrum%2520potency%2520against%2520ALK-resistant%2520mutations%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D4720%26epage%3D4744%26doi%3D10.1021%2Fjm500261q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><div class="note"><p class="first last">For additional SAR see the followingpatent application:</p></div><span class="NLM_contrib-group">Brodney, M. A.; Davoren, J. E.; Garnsey, M. R.; Zhang, L.; O’Neil, S. V.</span><span> </span><span class="NLM_article-title">Pyridine derivatives as muscarinic m1 receptor positive allosteric modulators</span>. WO 2016009297,<span class="NLM_x"> </span><span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=M.+A.+Brodney&author=J.+E.+Davoren&author=M.+R.+Garnsey&author=L.+Zhang&author=S.+V.+O%E2%80%99Neil&title=Pyridine+derivatives+as+muscarinic+m1+receptor+positive+allosteric+modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBrodney%26aufirst%3DM.%2BA.%26atitle%3DPyridine%2520derivatives%2520as%2520muscarinic%2520m1%2520receptor%2520positive%2520allosteric%2520modulators%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Kenakin, T. P.</span> <span class="citation_source-book">A Pharmacology Primer: Techniques for More Effective and Strategic Drug Discovery</span>, <span class="NLM_edition">4</span>th ed.; <span class="NLM_publisher-name">Academic Press</span>: <span class="NLM_publisher-loc">San Diego, CA</span>,<span class="NLM_x"> </span><span class="NLM_year">2014</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">469</span><span class="NLM_x">–</span> <span class="NLM_lpage">470</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&pages=469-470&author=T.+P.+Kenakin&title=A+Pharmacology+Primer%3A+Techniques+for+More+Effective+and+Strategic+Drug+Discovery"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DKenakin%26aufirst%3DT.%2BP.%26btitle%3DA%2520Pharmacology%2520Primer%253A%2520Techniques%2520for%2520More%2520Effective%2520and%2520Strategic%2520Drug%2520Discovery%26pub%3DAcademic%2520Press%26date%3D2014%26spage%3D469%26epage%3D470" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="note"><p class="first last">FLIPR, IP1, and β-arrestin assays were run using three different cell lines with differing M1 expression levels (<i>B</i><sub>max</sub>), determined using [<sup>3</sup>H]NMS binding: FLIPR, 0.542 pmol/mg; IP1, 20.7 pmol/mg; β-arrestin, 33.2 pmol/mg.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Dasari, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gulledge, A. T.</span><span> </span><span class="NLM_article-title">M1 and M4 receptors modulate hippocampal pyramidal neurons</span> <span class="citation_source-journal">J. Neurophysiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">105</span><span class="NLM_x">, </span> <span class="NLM_fpage">779</span><span class="NLM_x">–</span> <span class="NLM_lpage">792</span><span class="refDoi"> DOI: 10.1152/jn.00686.2010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=10.1152%2Fjn.00686.2010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=21160001" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=1%3ACAS%3A280%3ADC%252BC3M7ns1GhsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2011&pages=779-792&author=S.+Dasariauthor=A.+T.+Gulledge&title=M1+and+M4+receptors+modulate+hippocampal+pyramidal+neurons&doi=10.1152%2Fjn.00686.2010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32aR"><div class="casContent"><span class="casTitleNuber">32a</span><div class="casTitle"><span class="NLM_cas:atitle">M1 and M4 receptors modulate hippocampal pyramidal neurons</span></div><div class="casAuthors">Dasari Sameera; Gulledge Allan T</div><div class="citationInfo"><span class="NLM_cas:title">Journal of neurophysiology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">105</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">779-92</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Acetylcholine (ACh), acting at muscarinic ACh receptors (mAChRs), modulates the excitability and synaptic connectivity of hippocampal pyramidal neurons.  CA1 pyramidal neurons respond to transient ("phasic") mAChR activation with biphasic responses in which inhibition is followed by excitation, whereas prolonged ("tonic") mAChR activation increases CA1 neuron excitability.  Both phasic and tonic mAChR activation excites pyramidal neurons in the CA3 region, yet ACh suppresses glutamate release at the CA3-to-CA1 synapse (the Schaffer-collateral pathway).  Using mice genetically lacking specific mAChRs (mAChR knockout mice), we identified the mAChR subtypes responsible for cholinergic modulation of hippocampal pyramidal neuron excitability and synaptic transmission.  Knockout of M1 receptors significantly reduced, or eliminated, most phasic and tonic cholinergic responses in CA1 and CA3 pyramidal neurons.  On the other hand, in the absence of other G(q)-linked mAChRs (M3 and M5), M1 receptors proved sufficient for all postsynaptic cholinergic effects on CA1 and CA3 pyramidal neuron excitability.  M3 receptors were able to participate in tonic depolarization of CA1 neurons, but otherwise contributed little to cholinergic responses.  At the Schaffer-collateral synapse, bath application of the cholinergic agonist carbachol suppressed stratum radiatum-evoked excitatory postsynaptic potentials (EPSPs) in wild-type CA1 neurons and in CA1 neurons from mice lacking M1 or M2 receptors.  However, Schaffer-collateral EPSPs were not significantly suppressed by carbachol in neurons lacking M4 receptors.  We therefore conclude that M1 and M4 receptors are the major mAChR subtypes responsible for direct cholinergic modulation of the excitatory hippocampal circuit.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTVYbKOx7U120mhnSqMnvzDfW6udTcc2eYsjE_ZZ3rbVLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3M7ns1GhsA%253D%253D&md5=2ec39251cc89ce5ed15cbf36aa9261f4</span></div><a href="/servlet/linkout?suffix=cit32a&amp;dbid=16384&amp;doi=10.1152%2Fjn.00686.2010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fjn.00686.2010%26sid%3Dliteratum%253Aachs%26aulast%3DDasari%26aufirst%3DS.%26aulast%3DGulledge%26aufirst%3DA.%2BT.%26atitle%3DM1%2520and%2520M4%2520receptors%2520modulate%2520hippocampal%2520pyramidal%2520neurons%26jtitle%3DJ.%2520Neurophysiol.%26date%3D2011%26volume%3D105%26spage%3D779%26epage%3D792%26doi%3D10.1152%2Fjn.00686.2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit32b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Langmead, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Austin, N. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Branch, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchanan, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forbes, I. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fry, V. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hagan, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herdon, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeggo, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kew, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mazzali, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melarange, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pardoe, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Randall, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roopun, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Starr, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teriakidis, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whittington, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, J.</span><span> </span><span class="NLM_article-title">Characterization of a CNS penetrant, selective M1 muscarinic receptor agonist, 77-LH-28-1</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">154</span><span class="NLM_x">, </span> <span class="NLM_fpage">1104</span><span class="NLM_x">–</span> <span class="NLM_lpage">1115</span><span class="refDoi"> DOI: 10.1038/bjp.2008.152</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=10.1038%2Fbjp.2008.152" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=18454168" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=1%3ACAS%3A528%3ADC%252BD1cXnvVGrurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=154&publication_year=2008&pages=1104-1115&author=C.+J.+Langmeadauthor=N.+E.+Austinauthor=C.+L.+Branchauthor=J.+T.+Brownauthor=K.+A.+Buchananauthor=C.+H.+Daviesauthor=I.+T.+Forbesauthor=V.+A.+Fryauthor=J.+J.+Haganauthor=H.+J.+Herdonauthor=G.+A.+Jonesauthor=R.+Jeggoauthor=J.+N.+Kewauthor=A.+Mazzaliauthor=R.+Melarangeauthor=N.+Patelauthor=J.+Pardoeauthor=A.+D.+Randallauthor=C.+Robertsauthor=A.+Roopunauthor=K.+R.+Starrauthor=A.+Teriakidisauthor=M.+D.+Woodauthor=M.+Whittingtonauthor=Z.+Wuauthor=J.+Watson&title=Characterization+of+a+CNS+penetrant%2C+selective+M1+muscarinic+receptor+agonist%2C+77-LH-28-1&doi=10.1038%2Fbjp.2008.152"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32bR"><div class="casContent"><span class="casTitleNuber">32b</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of a CNS penetrant, selective M1 muscarinic receptor agonist, 77-LH-28-1</span></div><div class="casAuthors">Langmead, C. J.; Austin, N. E.; Branch, C. L.; Brown, J. T.; Buchanan, K. A.; Davies, C. H.; Forbes, I. T.; Fry, V. A. H.; Hagan, J. J.; Herdon, H. J.; Jones, G. A.; Jeggo, R.; Kew, J. N. C.; Mazzali, A.; Melarange, R.; Patel, N.; Pardoe, J.; Randall, A. D.; Roberts, C.; Roopun, A.; Starr, K. R.; Teriakidis, A.; Wood, M. D.; Whittington, M.; Wu, Z.; Watson, J.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">154</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1104-1115</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Background and purpose: M1 muscarinic ACh receptors (mAChRs) represent an attractive drug target for the treatment of cognitive deficits assocd. with diseases such as Alzheimer's disease and schizophrenia.  However, the discovery of subtype-selective mAChR agonists has been hampered by the high degree of conservation of the orthosteric ACh-binding site among mAChR subtypes.  The advent of functional screening assays has enabled the identification of agonists such as AC-42 (4-n-butyl-1-[4-(2-methylphenyl)-4-oxo-1-butyl]-piperidine), which bind to an allosteric site and selectively activate the M1 mAChR subtype.  However, studies with this compd. have been limited to recombinantly expressed mAChRs.  Exptl. approach: In this study, we have compared the pharmacol. profile of AC-42 and a close structural analog, 77-LH-28-1 (1-[3-(4-butyl-1-piperidinyl)propyl]-3,4-dihydro-2(1H)-quinolinone) at human recombinant, and rat native, mAChRs by calcium mobilization, inositol phosphate accumulation and both in vitro and in vivo electrophysiol.  Key results: Calcium mobilization and inositol phosphate accumulation assays revealed that both AC-42 and 77-LH-28-1 display high selectivity to activate the M1 mAChR over other mAChR subtypes.  Furthermore, 77-LH-28-1(I), but not AC-42, acted as an agonist at rat hippocampal M1 receptors, as demonstrated by its ability to increase cell firing and initiate gamma frequency network oscillations.  Finally, 77-LH-28-1 stimulated cell firing in the rat hippocampus in vivo following s.c. administration.  Conclusions and implications: These data suggest that 77-LH-28-1 is a potent, selective, bioavailable and brain-penetrant agonist at the M1 mAChR and therefore that it represents a better tool than AC-42, with which to study the pharmacol. of the M1 mAChR.  British Journal of Pharmacol. (2008) 154, 1104-1115; doi:10.1038/bjp.2008.152; published online 5 May 2008.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5pNVy427ynLVg90H21EOLACvtfcHk0lhxRNH4VwYDkQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXnvVGrurc%253D&md5=8eeb8522c09910e1a13f9832f775f846</span></div><a href="/servlet/linkout?suffix=cit32b&amp;dbid=16384&amp;doi=10.1038%2Fbjp.2008.152&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fbjp.2008.152%26sid%3Dliteratum%253Aachs%26aulast%3DLangmead%26aufirst%3DC.%2BJ.%26aulast%3DAustin%26aufirst%3DN.%2BE.%26aulast%3DBranch%26aufirst%3DC.%2BL.%26aulast%3DBrown%26aufirst%3DJ.%2BT.%26aulast%3DBuchanan%26aufirst%3DK.%2BA.%26aulast%3DDavies%26aufirst%3DC.%2BH.%26aulast%3DForbes%26aufirst%3DI.%2BT.%26aulast%3DFry%26aufirst%3DV.%2BA.%26aulast%3DHagan%26aufirst%3DJ.%2BJ.%26aulast%3DHerdon%26aufirst%3DH.%2BJ.%26aulast%3DJones%26aufirst%3DG.%2BA.%26aulast%3DJeggo%26aufirst%3DR.%26aulast%3DKew%26aufirst%3DJ.%2BN.%26aulast%3DMazzali%26aufirst%3DA.%26aulast%3DMelarange%26aufirst%3DR.%26aulast%3DPatel%26aufirst%3DN.%26aulast%3DPardoe%26aufirst%3DJ.%26aulast%3DRandall%26aufirst%3DA.%2BD.%26aulast%3DRoberts%26aufirst%3DC.%26aulast%3DRoopun%26aufirst%3DA.%26aulast%3DStarr%26aufirst%3DK.%2BR.%26aulast%3DTeriakidis%26aufirst%3DA.%26aulast%3DWood%26aufirst%3DM.%2BD.%26aulast%3DWhittington%26aufirst%3DM.%26aulast%3DWu%26aufirst%3DZ.%26aulast%3DWatson%26aufirst%3DJ.%26atitle%3DCharacterization%2520of%2520a%2520CNS%2520penetrant%252C%2520selective%2520M1%2520muscarinic%2520receptor%2520agonist%252C%252077-LH-28-1%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2008%26volume%3D154%26spage%3D1104%26epage%3D1115%26doi%3D10.1038%2Fbjp.2008.152" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Ehlert, F. J.</span><span> </span><span class="NLM_article-title">Analysis of allosterism in functional assays. J</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">315</span><span class="NLM_x">, </span> <span class="NLM_fpage">740</span><span class="NLM_x">–</span> <span class="NLM_lpage">754</span><span class="refDoi"> DOI: 10.1124/jpet.105.090886</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=10.1124%2Fjpet.105.090886" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=16046613" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFyhtr%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=315&publication_year=2005&pages=740-754&author=F.+J.+Ehlert&title=Analysis+of+allosterism+in+functional+assays.+J&doi=10.1124%2Fjpet.105.090886"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33aR"><div class="casContent"><span class="casTitleNuber">33a</span><div class="casTitle"><span class="NLM_cas:atitle">Analysis of allosterism in functional assays</span></div><div class="casAuthors">Ehlert, Frederick J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">315</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">740-754</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The theor. basis for analyzing the effects of an allosteric modulator on the response to an agonist is described.  The effects of an allosteric modulator on the concn.-response curve to an agonist can be attributed to changes in the obsd. dissocn. const. and intrinsic efficacy of the agonist-receptor complex.  Each of these two changes can be represented by a coeff. or factor.  It is possible to est. the ratio of the coeff. of change in agonist efficacy divided by that for the agonist dissocn. const.  This ratio is designated as the relative activity (RA) of the agonist in the presence of the allosteric modulator.  The RA value can be estd. for each concn. of allosteric modulator by nonlinear regression anal., regardless of the shape of the concn.-response curve.  Regression anal. of the RA values against the concn. of allosteric modulator yields ests. of the dissocn. const. (KA) of the allosteric modulator and the maximal RA value.  If the concn.-response curve to the agonist obeys a logistic function and the allosteric modulator influences the maximal response, it is possible to distinguish between the maximal change in affinity from that of efficacy.  If the agonist concn.-response curve obeys a logistic equation with a Hill slope of 1, the RA values can be estd. easily from the agonist EC50 and Emax values.  This anal. illustrates the utility of the RA value in quantifying allosteric effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKvK9-uIW607Vg90H21EOLACvtfcHk0lhxRNH4VwYDkQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFyhtr%252FO&md5=0cb5a02f65f93990511d12fb06f5da12</span></div><a href="/servlet/linkout?suffix=cit33a&amp;dbid=16384&amp;doi=10.1124%2Fjpet.105.090886&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.105.090886%26sid%3Dliteratum%253Aachs%26aulast%3DEhlert%26aufirst%3DF.%2BJ.%26atitle%3DAnalysis%2520of%2520allosterism%2520in%2520functional%2520assays.%2520J%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2005%26volume%3D315%26spage%3D740%26epage%3D754%26doi%3D10.1124%2Fjpet.105.090886" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit33b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Kenakin, T.</span><span> </span><span class="NLM_article-title">New concepts in drug discovery: collateral efficacy and permissive antagonism</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">919</span><span class="NLM_x">–</span> <span class="NLM_lpage">927</span><span class="refDoi"> DOI: 10.1038/nrd1875</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=10.1038%2Fnrd1875" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=16264435" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFKlsLfO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2005&pages=919-927&author=T.+Kenakin&title=New+concepts+in+drug+discovery%3A+collateral+efficacy+and+permissive+antagonism&doi=10.1038%2Fnrd1875"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33bR"><div class="casContent"><span class="casTitleNuber">33b</span><div class="casTitle"><span class="NLM_cas:atitle">New Concepts in Drug Discovery: Collateral Efficacy and Permissive Antagonism</span></div><div class="casAuthors">Kenakin, Terry</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">919-927</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  New perspectives on the complexity of G-protein-coupled receptor (GPCR) signaling and the increased resoln. of existing tools for studying GPCR behavior has led to the conception of new hypotheses that affect the discovery of drugs acting at GPCRs.  Taking into consideration the novel concepts of collateral efficacy and permissive antagonism in the search for synthetic agonists and antagonists, resp., will be essential in the search for drugs with unique therapeutic profiles.  Here, the design of drugs against HIV is used as an example of how these concepts might be taken into consideration for GPCR-targeted drugs in general.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp26TMWCy0fUrVg90H21EOLACvtfcHk0lhxRNH4VwYDkQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFKlsLfO&md5=b7e09bcb4f73d52b4ab80f521ab78a64</span></div><a href="/servlet/linkout?suffix=cit33b&amp;dbid=16384&amp;doi=10.1038%2Fnrd1875&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd1875%26sid%3Dliteratum%253Aachs%26aulast%3DKenakin%26aufirst%3DT.%26atitle%3DNew%2520concepts%2520in%2520drug%2520discovery%253A%2520collateral%2520efficacy%2520and%2520permissive%2520antagonism%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2005%26volume%3D4%26spage%3D919%26epage%3D927%26doi%3D10.1038%2Fnrd1875" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit33c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Price, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baillie, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevenson, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Easson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goodwin, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McLean, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McIntosh, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goodwin, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westwood, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marrs, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomson, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cowley, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christopoulos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pertwee, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ross, R. A.</span><span> </span><span class="NLM_article-title">Allosteric modulation of the cannabinoid CB1 receptor</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">1484</span><span class="NLM_x">–</span> <span class="NLM_lpage">1495</span><span class="refDoi"> DOI: 10.1124/mol.105.016162</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=10.1124%2Fmol.105.016162" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=16113085" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtF2it7nM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2005&pages=1484-1495&author=M.+R.+Priceauthor=G.+L.+Baillieauthor=A.+Thomasauthor=L.+A.+Stevensonauthor=M.+Eassonauthor=R.+Goodwinauthor=A.+McLeanauthor=L.+McIntoshauthor=G.+Goodwinauthor=G.+Walkerauthor=P.+Westwoodauthor=J.+Marrsauthor=F.+Thomsonauthor=P.+Cowleyauthor=A.+Christopoulosauthor=R.+G.+Pertweeauthor=R.+A.+Ross&title=Allosteric+modulation+of+the+cannabinoid+CB1+receptor&doi=10.1124%2Fmol.105.016162"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33cR"><div class="casContent"><span class="casTitleNuber">33c</span><div class="casTitle"><span class="NLM_cas:atitle">Allosteric modulation of the cannabinoid CB1 receptor</span></div><div class="casAuthors">Price, Martin R.; Baillie, Gemma L.; Thomas, Adele; Stevenson, Lesley A.; Easson, Morag; Goodwin, Richard; McLean, Adele; McIntosh, Lorraine; Goodwin, Gillian; Walker, Glenn; Westwood, Paul; Marrs, Julia; Thomson, Fiona; Cowley, Phillip; Christopoulos, Arthur; Pertwee, Roger G.; Ross, Ruth A.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1484-1495</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">0026-895X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The authors investigated the pharmacol. of three novel compds., Org 27569, Org 27759 and Org 29647 at the cannabinoid CB1 receptor.  In equil. binding assays, the Org compds. significantly increased the binding of the CB1 receptor agonist [3H]CP 55,940 [(1R,3R,4R)-3-[2-hydroxy-4-(1,1-dimethylheptyl)phenyl]-4-(3-hydroxypropyl) cyclohexan-1-ol], indicative of a pos. cooperative allosteric effect.  The same compds. caused a significant, but incomplete, decrease in the specific binding of the CB1 receptor inverse agonist [3H]SR 141716A [N-(piperidin-1-yl)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H -pyrazole-3-carboximide hydrochloride], indicative of a limited neg. binding cooperativity.  Anal. of the data according to an allosteric ternary complex model revealed that the estd. affinity of each Org compd. was not significantly different when the radioligand was [3H]CP 55,940 or [3H]SR 141716A.  However, the estd. cooperatively factor for the interaction between modulator and radioligand was greater than 1 when detd. against [3H]CP 55,940 and less than 1 when detd. against [3H]SR 141716A.  [3H]CP 55,940 dissocn. kinetic studies also validated the allosteric nature of the Org compds., because they all significantly decreased radioligand dissocn.  These data suggest that the Org compds. bind allosterically to the CB1 receptor and elicit a conformational change that increases agonist affinity for the orthosteric binding site.  In contrast to the binding assays, however, the Org compds. behaved as insurmountable antagonists of receptor function; in the reporter gene assay, the guanosine 5'-O-(3-[35S]thio)triphosphate binding assay and the mouse vas deferens assay they elicited a significant redn. in the Emax value for CB1 receptor agonists.  The data presented clearly demonstrate, for the first time, that the cannabinoid CB1 receptor contains an allosteric binding site that can be recognized by synthetic small mol. ligands.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq98nUa2ffQ7bVg90H21EOLACvtfcHk0lhxRNH4VwYDkQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtF2it7nM&md5=a342d304a8157b1e7b962755a775154d</span></div><a href="/servlet/linkout?suffix=cit33c&amp;dbid=16384&amp;doi=10.1124%2Fmol.105.016162&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.105.016162%26sid%3Dliteratum%253Aachs%26aulast%3DPrice%26aufirst%3DM.%2BR.%26aulast%3DBaillie%26aufirst%3DG.%2BL.%26aulast%3DThomas%26aufirst%3DA.%26aulast%3DStevenson%26aufirst%3DL.%2BA.%26aulast%3DEasson%26aufirst%3DM.%26aulast%3DGoodwin%26aufirst%3DR.%26aulast%3DMcLean%26aufirst%3DA.%26aulast%3DMcIntosh%26aufirst%3DL.%26aulast%3DGoodwin%26aufirst%3DG.%26aulast%3DWalker%26aufirst%3DG.%26aulast%3DWestwood%26aufirst%3DP.%26aulast%3DMarrs%26aufirst%3DJ.%26aulast%3DThomson%26aufirst%3DF.%26aulast%3DCowley%26aufirst%3DP.%26aulast%3DChristopoulos%26aufirst%3DA.%26aulast%3DPertwee%26aufirst%3DR.%2BG.%26aulast%3DRoss%26aufirst%3DR.%2BA.%26atitle%3DAllosteric%2520modulation%2520of%2520the%2520cannabinoid%2520CB1%2520receptor%26jtitle%3DMol.%2520Pharmacol.%26date%3D2005%26volume%3D68%26spage%3D1484%26epage%3D1495%26doi%3D10.1124%2Fmol.105.016162" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Kenakin, T.</span><span> </span><span class="NLM_article-title">Gaddum Memorial Lecture 2014: receptors as an evolving concept: from switches to biased microprocessors</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">172</span><span class="NLM_x">, </span> <span class="NLM_fpage">4238</span><span class="NLM_x">–</span> <span class="NLM_lpage">4253</span><span class="refDoi"> DOI: 10.1111/bph.13217</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=10.1111%2Fbph.13217" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=26075971" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtF2hs7zJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=172&publication_year=2015&pages=4238-4253&author=T.+Kenakin&title=Gaddum+Memorial+Lecture+2014%3A+receptors+as+an+evolving+concept%3A+from+switches+to+biased+microprocessors&doi=10.1111%2Fbph.13217"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Gaddum Memorial Lecture 2014: receptors as an evolving concept: from switches to biased microprocessors</span></div><div class="casAuthors">Kenakin, Terry</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">172</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">4238-4253</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Pharmacol. models used to describe drug agonism and antagonism have evolved over the past 20 years from a parsimonious model describing single active and inactive receptor states to models of multiconformational receptor systems modified by ligand conformational selection.  These latter models describe the obsd., presently underexploited, pharmacol. mechanism of ligand-directed biased signalling.  Biased signals can be quantified with transduction coeffs. (ΔΔLog(τ/KA) values), a scale grounded in the Black/Leff operational model; this enables the optimization of biased profiles through medicinal chem.  The past decades have also brought the availability of new technologies to measure multiple functional effects mediated by seven transmembrane receptors.  These have confirmed that drugs can have many efficacies, which may be collaterally linked, that is there is no linear sequence of activities required.  In addn., new functional screening assays have introduced increasing nos. of allosteric ligands into drug discovery.  These mols. are permissive (they do not necessarily preclude endogenous signalling in vivo); therefore, they may allow better fine tuning of pathol. physiol.  The permissive quality of allosteric ligands can also change the quality of endogenous signalling efficacy ('induced bias') as well as the quantity of signal; in this regard, indexes related to ΔΔLog(τ/KA) values (namely ΔLog(αβ) values) can be used to quantify these effects for optimization in the drug discovery process.  All of these added scales of drug activity will, hopefully, allow better targeting of candidate mols. towards therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrK9AlxGN4g27Vg90H21EOLACvtfcHk0lhSVKdeDMiF7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtF2hs7zJ&md5=f360ac4ff8a9301d598215881b007680</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1111%2Fbph.13217&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbph.13217%26sid%3Dliteratum%253Aachs%26aulast%3DKenakin%26aufirst%3DT.%26atitle%3DGaddum%2520Memorial%2520Lecture%25202014%253A%2520receptors%2520as%2520an%2520evolving%2520concept%253A%2520from%2520switches%2520to%2520biased%2520microprocessors%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2015%26volume%3D172%26spage%3D4238%26epage%3D4253%26doi%3D10.1111%2Fbph.13217" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="note"><p class="first last">Agonist EC<sub>50</sub> in the M1 FLIPR assay was highly variable. See <a href="/doi/suppl/10.1021/acs.jmedchem.6b00544/suppl_file/jm6b00544_si_002.pdf" class="ext-link">Supporting Information</a> for more detail.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Ehlert, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, E. A.</span><span> </span><span class="NLM_article-title">Functional role of M2 muscarinic receptors in the guinea pig ileum</span> <span class="citation_source-journal">Life Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">965</span><span class="NLM_x">–</span> <span class="NLM_lpage">971</span><span class="refDoi"> DOI: 10.1016/0024-3205(94)00035-Q</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=10.1016%2F0024-3205%2894%2900035-Q" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=1995&pages=965-971&author=F.+J.+Ehlertauthor=E.+A.+Thomas&title=Functional+role+of+M2+muscarinic+receptors+in+the+guinea+pig+ileum&doi=10.1016%2F0024-3205%2894%2900035-Q"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36a&amp;dbid=16384&amp;doi=10.1016%2F0024-3205%2894%2900035-Q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0024-3205%252894%252900035-Q%26sid%3Dliteratum%253Aachs%26aulast%3DEhlert%26aufirst%3DF.%2BJ.%26aulast%3DThomas%26aufirst%3DE.%2BA.%26atitle%3DFunctional%2520role%2520of%2520M2%2520muscarinic%2520receptors%2520in%2520the%2520guinea%2520pig%2520ileum%26jtitle%3DLife%2520Sci.%26date%3D1995%26volume%3D56%26spage%3D965%26epage%3D971%26doi%3D10.1016%2F0024-3205%2894%2900035-Q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit36b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Ehlert, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffin, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawyer, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bailon, R.</span><span> </span><span class="NLM_article-title">A simple method for estimation of agonist activity at receptor subtypes: comparison of native and cloned M3 muscarinic receptors in guinea pig ileum and transfected cells</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">289</span><span class="NLM_x">, </span> <span class="NLM_fpage">981</span><span class="NLM_x">–</span> <span class="NLM_lpage">992</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=10215678" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=1%3ACAS%3A528%3ADyaK1MXislGis7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=289&publication_year=1999&pages=981-992&author=F.+J.+Ehlertauthor=M.+T.+Griffinauthor=G.+W.+Sawyerauthor=R.+Bailon&title=A+simple+method+for+estimation+of+agonist+activity+at+receptor+subtypes%3A+comparison+of+native+and+cloned+M3+muscarinic+receptors+in+guinea+pig+ileum+and+transfected+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36bR"><div class="casContent"><span class="casTitleNuber">36b</span><div class="casTitle"><span class="NLM_cas:atitle">A simple method for estimation of agonist activity at receptor subtypes: comparison of native and cloned M3 muscarinic receptors in guinea pig ileum and transfected cells</span></div><div class="casAuthors">Ehlert, Frederick J.; Griffin, Michael T.; Sawyer, Gregory W.; Bailon, Regina</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">289</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">981-992</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The authors describe a simple method for calcg. the pharmacol. activity of an agonist (A) relative to a std. agonist (S) using only the concn.-response curves of the two agonists.  In most situations, the authors show that the product of the ratios of maximal responses (Emax - A/Emax - S) and potencies (EC50 - S/EC50 - A) is equiv. to the product of the affinity and intrinsic efficacy of A expressed relative to that of S.  The authors refer to this term as the IRA value of A.  In a cooperative system where the concn.-response curve of the std. agonist is steep and that of the test agonist is flatter with a lower maximal response, the simple calcn. of IRA described above underestimates agonist activity; however, the authors also describe a means of correcting the IRA in this situation.  The authors have validated the authors anal. with modeling techniques and have shown exptl. that the IRA values of muscarinic agonists for stimulating contractions in the guinea pig ileum (M3 response) are in excellent agreement with those measured in the phosphoinositide assay on Chinese hamster ovary cells expressing the M3 muscarinic receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1mB3BMIxjZ7Vg90H21EOLACvtfcHk0lhSVKdeDMiF7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXislGis7Y%253D&md5=9ff89312ae34de8576f030fdf25ad3fb</span></div><a href="/servlet/linkout?suffix=cit36b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEhlert%26aufirst%3DF.%2BJ.%26aulast%3DGriffin%26aufirst%3DM.%2BT.%26aulast%3DSawyer%26aufirst%3DG.%2BW.%26aulast%3DBailon%26aufirst%3DR.%26atitle%3DA%2520simple%2520method%2520for%2520estimation%2520of%2520agonist%2520activity%2520at%2520receptor%2520subtypes%253A%2520comparison%2520of%2520native%2520and%2520cloned%2520M3%2520muscarinic%2520receptors%2520in%2520guinea%2520pig%2520ileum%2520and%2520transfected%2520cells%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1999%26volume%3D289%26spage%3D981%26epage%3D992" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="note"><p class="first last">A caveat to this data is that we did not determine if this is was a true agonist effect or if compound <b>38</b> is modulating an unknown endogenous level of acetylcholine.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="note"><p class="first last">To measure the effects of compound <b>38</b> on GPI in PAM mode, we combined compound <b>38</b> with 200 nM donepezil, an acetylcholinesterase inhibitor, which produced a contraction that was equivalent to an EC<sub>20</sub> of carbachol’s maximal response in this preparation.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Vanover, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Veinbergs, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, R. E.</span><span> </span><span class="NLM_article-title">Antipsychotic-like behavioral effects and cognitive enhancement by a potent and selective muscarinic M-sub-1 receptor agonist, AC-260584</span> <span class="citation_source-journal">Behav. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">122</span><span class="NLM_x">, </span> <span class="NLM_fpage">570</span><span class="NLM_x">–</span> <span class="NLM_lpage">575</span><span class="refDoi"> DOI: 10.1037/0735-7044.122.3.570</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=10.1037%2F0735-7044.122.3.570" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=122&publication_year=2008&pages=570-575&author=K.+E.+Vanoverauthor=I.+Veinbergsauthor=R.+E.+Davis&title=Antipsychotic-like+behavioral+effects+and+cognitive+enhancement+by+a+potent+and+selective+muscarinic+M-sub-1+receptor+agonist%2C+AC-260584&doi=10.1037%2F0735-7044.122.3.570"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39a&amp;dbid=16384&amp;doi=10.1037%2F0735-7044.122.3.570&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1037%252F0735-7044.122.3.570%26sid%3Dliteratum%253Aachs%26aulast%3DVanover%26aufirst%3DK.%2BE.%26aulast%3DVeinbergs%26aufirst%3DI.%26aulast%3DDavis%26aufirst%3DR.%2BE.%26atitle%3DAntipsychotic-like%2520behavioral%2520effects%2520and%2520cognitive%2520enhancement%2520by%2520a%2520potent%2520and%2520selective%2520muscarinic%2520M-sub-1%2520receptor%2520agonist%252C%2520AC-260584%26jtitle%3DBehav.%2520Neurosci.%26date%3D2008%26volume%3D122%26spage%3D570%26epage%3D575%26doi%3D10.1037%2F0735-7044.122.3.570" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit39b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Jones, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brady, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bubser, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tantawy, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kane, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bridges, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bradley, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peterson, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ansari, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baldwin, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kessler, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deutch, A. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lah, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levey, A. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindsley, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conn, P. J.</span><span> </span><span class="NLM_article-title">Novel selective allosteric activator of the M1 muscarinic acetylcholine receptor regulates amyloid processing and produces antipsychotic-like activity in rats</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">10422</span><span class="NLM_x">–</span> <span class="NLM_lpage">10433</span><span class="refDoi"> DOI: 10.1523/JNEUROSCI.1850-08.2008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=10.1523%2FJNEUROSCI.1850-08.2008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=18842902" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1GksLfF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2008&pages=10422-10433&author=C.+K.+Jonesauthor=A.+E.+Bradyauthor=A.+A.+Davisauthor=Z.+Xiangauthor=M.+Bubserauthor=M.+N.+Tantawyauthor=A.+S.+Kaneauthor=T.+M.+Bridgesauthor=J.+P.+Kennedyauthor=S.+R.+Bradleyauthor=T.+E.+Petersonauthor=M.+S.+Ansariauthor=R.+M.+Baldwinauthor=R.+M.+Kesslerauthor=A.+Y.+Deutchauthor=J.+J.+Lahauthor=A.+I.+Leveyauthor=C.+W.+Lindsleyauthor=P.+J.+Conn&title=Novel+selective+allosteric+activator+of+the+M1+muscarinic+acetylcholine+receptor+regulates+amyloid+processing+and+produces+antipsychotic-like+activity+in+rats&doi=10.1523%2FJNEUROSCI.1850-08.2008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39bR"><div class="casContent"><span class="casTitleNuber">39b</span><div class="casTitle"><span class="NLM_cas:atitle">Novel selective allosteric activator of the M1 muscarinic acetylcholine receptor regulates amyloid processing and produces antipsychotic-like activity in rats</span></div><div class="casAuthors">Jones, Carrie K.; Brady, Ashley E.; Davis, Albert A.; Xiang, Zixiu; Bubser, Michael; Tantawy, Mohammed Noor; Kane, Alexander S.; Bridges, Thomas M.; Kennedy, J. Phillip; Bradley, Stefania R.; Peterson, Todd E.; Ansari, M. Sib; Baldwin, Ronald M.; Kessler, Robert M.; Deutch, Ariel Y.; Lah, James J.; Levey, Allan I.; Lindsley, Craig W.; Conn, P. Jeffrey</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">41</span>),
    <span class="NLM_cas:pages">10422-10433</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Recent studies suggest that subtype-selective activators of M1/M4 muscarinic acetylcholine receptors (mAChRs) may offer a novel approach for the treatment of psychotic symptoms assocd. with schizophrenia and Alzheimer's disease.  Previously developed muscarinic agonists have provided clin. data in support of this hypothesis, but failed in clin. development because of a lack of true subtype specificity and adverse effects assocd. with activation of other mAChR subtypes.  We now report characterization of a novel highly selective agonist for the M1 receptor with no agonist activity at any of the other mAChR subtypes, termed TBPB [1-((1'-2-methylbenzyl)-1,4'-bipiperidin-4-yl)-1H-benzo[d]imidazol-2(3H)-one].  Mutagenesis and mol. pharmacol. studies revealed that TBPB activates M1 through an allosteric site rather than the orthosteric acetylcholine binding site, which is likely crit. for its unprecedented selectivity.  Whole-cell patch-clamp recordings demonstrated that activation of M1 by TBPB potentiates NMDA receptor currents in hippocampal pyramidal cells but does not alter excitatory or inhibitory synaptic transmission, responses thought to be mediated by M2 and M4.  TBPB was efficacious in models predictive of antipsychotic-like activity in rats at doses that did not produce catalepsy or peripheral adverse effects of other mAChR agonists.  Finally, TBPB had effects on the processing of the amyloid precursor protein toward the non-amyloidogenic pathway and decreased Aβ prodn. in vitro.  Together, these data suggest that selective activation of M1 may provide a novel approach for the treatment of symptoms assocd. with schizophrenia and Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5LP3cEBPDvbVg90H21EOLACvtfcHk0likOCg0KzVDlQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1GksLfF&md5=25b306eb2aa00bdce1c08ad24bd59b35</span></div><a href="/servlet/linkout?suffix=cit39b&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.1850-08.2008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.1850-08.2008%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DC.%2BK.%26aulast%3DBrady%26aufirst%3DA.%2BE.%26aulast%3DDavis%26aufirst%3DA.%2BA.%26aulast%3DXiang%26aufirst%3DZ.%26aulast%3DBubser%26aufirst%3DM.%26aulast%3DTantawy%26aufirst%3DM.%2BN.%26aulast%3DKane%26aufirst%3DA.%2BS.%26aulast%3DBridges%26aufirst%3DT.%2BM.%26aulast%3DKennedy%26aufirst%3DJ.%2BP.%26aulast%3DBradley%26aufirst%3DS.%2BR.%26aulast%3DPeterson%26aufirst%3DT.%2BE.%26aulast%3DAnsari%26aufirst%3DM.%2BS.%26aulast%3DBaldwin%26aufirst%3DR.%2BM.%26aulast%3DKessler%26aufirst%3DR.%2BM.%26aulast%3DDeutch%26aufirst%3DA.%2BY.%26aulast%3DLah%26aufirst%3DJ.%2BJ.%26aulast%3DLevey%26aufirst%3DA.%2BI.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26aulast%3DConn%26aufirst%3DP.%2BJ.%26atitle%3DNovel%2520selective%2520allosteric%2520activator%2520of%2520the%2520M1%2520muscarinic%2520acetylcholine%2520receptor%2520regulates%2520amyloid%2520processing%2520and%2520produces%2520antipsychotic-like%2520activity%2520in%2520rats%26jtitle%3DJ.%2520Neurosci.%26date%3D2008%26volume%3D28%26spage%3D10422%26epage%3D10433%26doi%3D10.1523%2FJNEUROSCI.1850-08.2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Popiolek, M.; Nguyen, D.; Reinhart, V.; Edgerton, J.; Harms, J.; Lotarski, S. M.; Steyn, S. J.; Davoren, J. E.; Grimwood, S.</span>, <span> </span><span class="NLM_article-title">Quantifying CNS M1 muscarinic aetylcholine receptor modulation using an in-vivo IP1 accumulation assay</span>. Unpublished results.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Popiolek%2C+M.%3B+Nguyen%2C+D.%3B+Reinhart%2C+V.%3B+Edgerton%2C+J.%3B+Harms%2C+J.%3B+Lotarski%2C+S.+M.%3B+Steyn%2C+S.+J.%3B+Davoren%2C+J.+E.%3B+Grimwood%2C+S.%2C+Quantifying+CNS+M1+muscarinic+aetylcholine+receptor+modulation+using+an+in-vivo+IP1+accumulation+assay.+Unpublished+results."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DPopiolek%26aufirst%3DM.%26atitle%3DQuantifying%2520CNS%2520M1%2520muscarinic%2520aetylcholine%2520receptor%2520modulation%2520using%2520an%2520in-vivo%2520IP1%2520accumulation%2520assay" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Tracy, J. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monaco, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giovannetti, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abraham, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Josiassen, R. C.</span><span> </span><span class="NLM_article-title">Anticholinergicity and cognitive processing in chronic schizophrenia</span> <span class="citation_source-journal">Biol. Psychol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">22</span><span class="refDoi"> DOI: 10.1016/S0301-0511(00)00083-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=10.1016%2FS0301-0511%2800%2900083-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=11240312" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=1%3ACAS%3A280%3ADC%252BD3MzmvVCgtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2001&pages=1-22&author=J.+I.+Tracyauthor=C.+Monacoauthor=T.+Giovannettiauthor=G.+Abrahamauthor=R.+C.+Josiassen&title=Anticholinergicity+and+cognitive+processing+in+chronic+schizophrenia&doi=10.1016%2FS0301-0511%2800%2900083-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41aR"><div class="casContent"><span class="casTitleNuber">41a</span><div class="casTitle"><span class="NLM_cas:atitle">Anticholinergicity and cognitive processing in chronic schizophrenia</span></div><div class="casAuthors">Tracy J I; Monaco C; Giovannetti T; Abraham G; Josiassen R C</div><div class="citationInfo"><span class="NLM_cas:title">Biological psychology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-22</span>
        ISSN:<span class="NLM_cas:issn">0301-0511</span>.
    </div><div class="casAbstract">Patients with chronic schizophrenia suffer from alterations in cholinergic functioning due to several factors, including the disease diathesis and pharmacologic treatments.  Acetylcholine-cognition relationships are well explored in normals but are unclear in schizophrenia.  Prior work indicated serum anticholinergicity does not cause global cognitive impairment in this group (Tracy et al., 1998a), raising the possibility that anticholinergicity normalizes an abnormal hyperactive cholinergic state.  Serum anticholinergic levels were determined in 38 chronic schizophrenia patients using an established radioreceptor assay method.  Six cognitive functions associated with cholinergic tone in normals were tested.  The potential role of autonomic arousal and cigarette smoking were also assessed as both have been linked to cholinergic functioning.  Regression analyses showed measures of inhibitory executive control and effortful memory accounted for a greater proportion of the variance in the anticholinergicity measure compared to the other variables.  The data demonstrate a relationship between high anticholinergicity and worse performance on two types of attention-resource demanding cognitive processes and do not support the notion that reduced cholinergic tone normalizes a hyperactive cortical acetylcholine substrate.  Relevant neuroanatomic structures and implications for models of cognitive deficits in schizophrenia are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTo4csLrgw5B-2qxNLjzXe8fW6udTcc2eakCgRE2KNipbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3MzmvVCgtQ%253D%253D&md5=ffa863c5e0ef48cf746192cba065389c</span></div><a href="/servlet/linkout?suffix=cit41a&amp;dbid=16384&amp;doi=10.1016%2FS0301-0511%2800%2900083-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0301-0511%252800%252900083-1%26sid%3Dliteratum%253Aachs%26aulast%3DTracy%26aufirst%3DJ.%2BI.%26aulast%3DMonaco%26aufirst%3DC.%26aulast%3DGiovannetti%26aufirst%3DT.%26aulast%3DAbraham%26aufirst%3DG.%26aulast%3DJosiassen%26aufirst%3DR.%2BC.%26atitle%3DAnticholinergicity%2520and%2520cognitive%2520processing%2520in%2520chronic%2520schizophrenia%26jtitle%3DBiol.%2520Psychol.%26date%3D2001%26volume%3D56%26spage%3D1%26epage%3D22%26doi%3D10.1016%2FS0301-0511%2800%2900083-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit41b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Vinogradov, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warm, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holland, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirshner, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pollock, B. G.</span><span> </span><span class="NLM_article-title">The cognitive cost of anticholinergic burden: decreased response to cognitive training in schizophrenia</span> <span class="citation_source-journal">Am. J. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">166</span><span class="NLM_x">, </span> <span class="NLM_fpage">1055</span><span class="NLM_x">–</span> <span class="NLM_lpage">1062</span><span class="refDoi"> DOI: 10.1176/appi.ajp.2009.09010017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=10.1176%2Fappi.ajp.2009.09010017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=19570929" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=1%3ACAS%3A280%3ADC%252BD1MrpsFagsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=166&publication_year=2009&pages=1055-1062&author=S.+Vinogradovauthor=M.+Fisherauthor=H.+Warmauthor=C.+Hollandauthor=M.+A.+Kirshnerauthor=B.+G.+Pollock&title=The+cognitive+cost+of+anticholinergic+burden%3A+decreased+response+to+cognitive+training+in+schizophrenia&doi=10.1176%2Fappi.ajp.2009.09010017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41bR"><div class="casContent"><span class="casTitleNuber">41b</span><div class="casTitle"><span class="NLM_cas:atitle">The cognitive cost of anticholinergic burden: decreased response to cognitive training in schizophrenia</span></div><div class="casAuthors">Vinogradov Sophia; Fisher Melissa; Warm Heather; Holland Christine; Kirshner Margaret A; Pollock Bruce G</div><div class="citationInfo"><span class="NLM_cas:title">The American journal of psychiatry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">166</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1055-62</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">OBJECTIVE:  Schizophrenia is treated with medications that raise serum anticholinergic activity and are known to adversely affect cognition.  The authors examined the relationship between serum anticholinergic activity and baseline cognitive performance and response to computerized cognitive training in outpatients with schizophrenia.  METHOD:  Fifty-five patients were randomly assigned to either computerized cognitive training or a computer games control condition.  A neurocognitive battery based on the Measurement and Treatment Research to Improve Cognition in Schizophrenia (MATRICS) initiative was performed at baseline and after the intervention.  Serum anticholinergic activity, measured at study entry by radioreceptor assay, was available for 49 patients.  RESULTS:  Serum anticholinergic activity showed a significant negative correlation with baseline performance in verbal working memory and verbal learning and memory, accounting for 7% of the variance in these measures, independent of age, IQ, or symptom severity.  Patients in the cognitive training condition (N=25) showed a significant gain in global cognition compared to those in the control condition, but this improvement was negatively correlated with anticholinergic burden.  Serum anticholinergic activity uniquely accounted for 20% of the variance in global cognition change, independent of age, IQ, or symptom severity.  CONCLUSIONS:  Serum anticholinergic activity in schizophrenia patients shows a significant association with impaired performance in MATRICS-based measures of verbal working memory and verbal learning and memory and is significantly associated with a lowered response to an intensive course of computerized cognitive training.  These findings underscore the cognitive cost of medications that carry a high anticholinergic burden.  The findings also have implications for the design and evaluation of cognitive treatments for schizophrenia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSSzVfjWI3hq0kUaC_kzhvyfW6udTcc2eb4NH6bQr2qabntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1MrpsFagsg%253D%253D&md5=79f0d2ccc76d80d4eb6b469d5f733f2c</span></div><a href="/servlet/linkout?suffix=cit41b&amp;dbid=16384&amp;doi=10.1176%2Fappi.ajp.2009.09010017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1176%252Fappi.ajp.2009.09010017%26sid%3Dliteratum%253Aachs%26aulast%3DVinogradov%26aufirst%3DS.%26aulast%3DFisher%26aufirst%3DM.%26aulast%3DWarm%26aufirst%3DH.%26aulast%3DHolland%26aufirst%3DC.%26aulast%3DKirshner%26aufirst%3DM.%2BA.%26aulast%3DPollock%26aufirst%3DB.%2BG.%26atitle%3DThe%2520cognitive%2520cost%2520of%2520anticholinergic%2520burden%253A%2520decreased%2520response%2520to%2520cognitive%2520training%2520in%2520schizophrenia%26jtitle%3DAm.%2520J.%2520Psychiatry%26date%3D2009%26volume%3D166%26spage%3D1055%26epage%3D1062%26doi%3D10.1176%2Fappi.ajp.2009.09010017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit41c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Minzenberg, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poole, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benton, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vinogradov, S.</span><span> </span><span class="NLM_article-title">Association of anticholinergic load with impairment of complex attention and memory in schizophrenia</span> <span class="citation_source-journal">Am. J. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">161</span><span class="NLM_x">, </span> <span class="NLM_fpage">116</span><span class="NLM_x">–</span> <span class="NLM_lpage">124</span><span class="refDoi"> DOI: 10.1176/appi.ajp.161.1.116</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=10.1176%2Fappi.ajp.161.1.116" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=14702259" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=1%3ACAS%3A280%3ADC%252BD2c%252FgsF2mtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=161&publication_year=2004&pages=116-124&author=M.+J.+Minzenbergauthor=J.+H.+Pooleauthor=C.+Bentonauthor=S.+Vinogradov&title=Association+of+anticholinergic+load+with+impairment+of+complex+attention+and+memory+in+schizophrenia&doi=10.1176%2Fappi.ajp.161.1.116"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41cR"><div class="casContent"><span class="casTitleNuber">41c</span><div class="casTitle"><span class="NLM_cas:atitle">Association of anticholinergic load with impairment of complex attention and memory in schizophrenia</span></div><div class="casAuthors">Minzenberg Michael J; Poole John H; Benton Cynthia; Vinogradov Sophia</div><div class="citationInfo"><span class="NLM_cas:title">The American journal of psychiatry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">161</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">116-24</span>
        ISSN:<span class="NLM_cas:issn">0002-953X</span>.
    </div><div class="casAbstract">OBJECTIVE:  The authors' goals were 1) to establish a clinically useful standard index of the relative anticholinergic potency of psychiatric medications; 2) to determine which cognitive functions are most affected by the administration of anticholinergic medications to patients with schizophrenia; and 3) to compare in vitro and clinically derived indexes of anticholinergic load in predicting these cognitive impairments.  METHOD:  One hundred six clinically stable patients with schizophrenia were given a brief neuropsychological battery and evaluated on a standard symptom rating scale.  The anticholinergic load associated with their psychiatric medications was estimated by using 1) a pharmacological index, calculated from a compilation of published studies reporting in vitro brain muscarinic receptor antagonism, and 2) a clinical index, based on clinician ratings of the anticholinergic side effects of medications.  The authors analyzed the correlations of both indexes with the neuropsychological measures and with summary neuropsychological factor scores.  RESULTS:  The clinical and pharmacological anticholinergic indexes were highly correlated with each other and showed virtually identical associations with neuropsychological measures.  Anticholinergic load was associated with lower scores on measures of attention and declarative memory, including several measures of auditory and visual memory and two tests of complex attention, but was unrelated to intelligence, simple attention, working memory, executive functions, conceptual fluency, or motor speed.  CONCLUSIONS:  This pattern of cognitive impairment with central cholinergic antagonism is consistent with emerging models of the functional anatomy of ascending forebrain cholinergic subsystems.  Both pharmacological and clinical indexes show utility in predicting the effects of anticholinergic load on cognition in schizophrenia.  Doses of psychiatric medication within the range of routine pharmacotherapy practice may have clinically significant effects on memory and complex attention in patients with schizophrenia; these effects may contribute as much as one-third to two-thirds of the memory deficit typically seen in patients with schizophrenia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQq9SPY1Vvv46e0F5ixvZgXfW6udTcc2eZYtIo_m-tN2Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2c%252FgsF2mtw%253D%253D&md5=8ff96909be81fbf2bdd00cca20f2971e</span></div><a href="/servlet/linkout?suffix=cit41c&amp;dbid=16384&amp;doi=10.1176%2Fappi.ajp.161.1.116&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1176%252Fappi.ajp.161.1.116%26sid%3Dliteratum%253Aachs%26aulast%3DMinzenberg%26aufirst%3DM.%2BJ.%26aulast%3DPoole%26aufirst%3DJ.%2BH.%26aulast%3DBenton%26aufirst%3DC.%26aulast%3DVinogradov%26aufirst%3DS.%26atitle%3DAssociation%2520of%2520anticholinergic%2520load%2520with%2520impairment%2520of%2520complex%2520attention%2520and%2520memory%2520in%2520schizophrenia%26jtitle%3DAm.%2520J.%2520Psychiatry%26date%3D2004%26volume%3D161%26spage%3D116%26epage%3D124%26doi%3D10.1176%2Fappi.ajp.161.1.116" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Kumari, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soni, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathew, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharma, T.</span><span> </span><span class="NLM_article-title">Prepulse inhibition of the startle response in men with schizophrenia: effects of age of onset of illness, symptoms, and medication</span> <span class="citation_source-journal">Arch. Gen. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">609</span><span class="NLM_x">–</span> <span class="NLM_lpage">614</span><span class="refDoi"> DOI: 10.1001/archpsyc.57.6.609</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=10.1001%2Farchpsyc.57.6.609" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=10839340" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=1%3ACAS%3A280%3ADC%252BD3c3ps1Wmsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2000&pages=609-614&author=V.+Kumariauthor=W.+Soniauthor=V.+M.+Mathewauthor=T.+Sharma&title=Prepulse+inhibition+of+the+startle+response+in+men+with+schizophrenia%3A+effects+of+age+of+onset+of+illness%2C+symptoms%2C+and+medication&doi=10.1001%2Farchpsyc.57.6.609"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Prepulse inhibition of the startle response in men with schizophrenia: effects of age of onset of illness, symptoms, and medication</span></div><div class="casAuthors">Kumari V; Soni W; Mathew V M; Sharma T</div><div class="citationInfo"><span class="NLM_cas:title">Archives of general psychiatry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">609-14</span>
        ISSN:<span class="NLM_cas:issn">0003-990X</span>.
    </div><div class="casAbstract">BACKGROUND:  Prepulse inhibition of the startle reflex response refers to the ability of a weak prestimulus to transiently inhibit the response to a closely following strong sensory stimulus.  This effect represents an operational index of sensorimotor gating and is found to be deficient in schizophrenia.  Prepulse inhibition deficits in schizophrenia seem to be partially normalized by typical antipsychotics and more fully by some atypical antipsychotics.  Early onset of schizophrenia, particularly in men, has been associated with abnormal brain maturation, profound neuropsychological deficits, and less responsiveness to antipsychotic medication.  We evaluated the effects of the age of onset of illness, current positive and negative symptoms, and the type of medication (typical vs atypical) on prepulse inhibition of the startle response in schizophrenia.  METHODS:  Thirty-eight male schizophrenic patients and 20 healthy male controls underwent testing for prepulse inhibition of the acoustic startle response.  RESULTS:  Earlier onset of illness was associated with reduced prepulse inhibition, while adult onset of illness was not.  No significant relationships occurred between current symptoms and prepulse inhibition.  Patients given typical, but not atypical, antipsychotics exhibited less prepulse inhibition compared with healthy controls.  CONCLUSION:  Early onset of illness is associated with profound deficits in prepulse inhibition of the startle response in men with schizophrenia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ0gLxkR5OJveRS7coPn-RtfW6udTcc2eZYtIo_m-tN2Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3c3ps1Wmsg%253D%253D&md5=e7131d6e9bb0f2954521eeb0464bb5d6</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1001%2Farchpsyc.57.6.609&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1001%252Farchpsyc.57.6.609%26sid%3Dliteratum%253Aachs%26aulast%3DKumari%26aufirst%3DV.%26aulast%3DSoni%26aufirst%3DW.%26aulast%3DMathew%26aufirst%3DV.%2BM.%26aulast%3DSharma%26aufirst%3DT.%26atitle%3DPrepulse%2520inhibition%2520of%2520the%2520startle%2520response%2520in%2520men%2520with%2520schizophrenia%253A%2520effects%2520of%2520age%2520of%2520onset%2520of%2520illness%252C%2520symptoms%252C%2520and%2520medication%26jtitle%3DArch.%2520Gen.%2520Psychiatry%26date%3D2000%26volume%3D57%26spage%3D609%26epage%3D614%26doi%3D10.1001%2Farchpsyc.57.6.609" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="note"><p class="first last">Data from the individual decibels is in the <a href="/doi/suppl/10.1021/acs.jmedchem.6b00544/suppl_file/jm6b00544_si_002.pdf" class="ext-link">Supporting Information</a>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="note"><p class="first last">In dog, it was challenging to obtain high plasma exposures due to <b>38</b>’s low thermodynamic solubility (2.7 μg/mL at pH 6.5) that limited absorption. To improve exposure, the formulation was changed to a spray dried dispersion (SDD).</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Alt, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pendri, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertekap, R. L.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benitex, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nophsker, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rockwell, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burford, N. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sum, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herbst, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrante, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hendricson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cvijic, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westphal, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Connell, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banks, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gentles, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jenkins, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loy, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macor, J. E.</span><span> </span><span class="NLM_article-title">Evidence for classical cholinergic toxicity associated with selective activation of M1 muscarinic receptors</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">356</span><span class="NLM_x">, </span> <span class="NLM_fpage">293</span><span class="NLM_x">–</span> <span class="NLM_lpage">304</span><span class="refDoi"> DOI: 10.1124/jpet.115.226910</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=10.1124%2Fjpet.115.226910" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=26582730" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=1%3ACAS%3A528%3ADC%252BC28XpvVelsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=356&publication_year=2016&pages=293-304&author=A.+Altauthor=A.+Pendriauthor=R.+L.+Bertekapauthor=G.+Liauthor=Y.+Benitexauthor=M.+Nophskerauthor=K.+L.+Rockwellauthor=N.+T.+Burfordauthor=C.+S.+Sumauthor=J.+Chenauthor=J.+J.+Herbstauthor=M.+Ferranteauthor=A.+Hendricsonauthor=M.+E.+Cvijicauthor=R.+S.+Westphalauthor=J.+O%E2%80%99Connellauthor=M.+Banksauthor=L.+Zhangauthor=R.+G.+Gentlesauthor=S.+Jenkinsauthor=J.+Loyauthor=J.+E.+Macor&title=Evidence+for+classical+cholinergic+toxicity+associated+with+selective+activation+of+M1+muscarinic+receptors&doi=10.1124%2Fjpet.115.226910"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Evidence for classical cholinergic toxicity associated with selective activation of M1 muscarinic receptors</span></div><div class="casAuthors">Alt, Andrew; Pendri, Annapurna; Bertekap, Robert L., Jr.; Li, Guo; Benitex, Yulia; Nophsker, Michelle; Rockwell, Kristin L.; Burford, Neil T.; Sum, Chi Shing; Chen, Jing; Herbst, John J.; Ferrante, Meredith; Hendricson, Adam; Cvijic, Mary Ellen; Westphal, Ryan S.; O'Connell, Jonathan; Banks, Martyn; Zhang, Litao; Gentles, Robert G.; Jenkins, Susan; Loy, James; Macor, John E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">356</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">293-304</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The muscarinic acetylcholine receptor subtype 1 (M1) receptors play an important role in cognition and memory, and are considered to be attractive targets for the development of novel medications to treat cognitive impairments seen in schizophrenia and Alzheimer's disease.  Indeed, the M1 agonist xanomeline has been shown to produce beneficial cognitive effects in both Alzheimer's disease and schizophrenia patients.  Unfortunately, the therapeutic utility of xanomeline was limited by cholinergic side effects (sweating, salivation, gastrointestinal distress), which are believed to result from nonselective activation of other muscarinic receptor subtypes such as M2 and M3.  Therefore, drug discovery efforts targeting the M1 receptor have focused on the discovery of compds. with improved selectivity profiles.  Recently, allosteric M1 receptor ligands have been described, which exhibit excellent selectivity for M1 over other muscarinic receptor subtypes.  In the current study, the following three compds. with mixed agonist/pos. allosteric modulator activities that are highly functionally selective for the M1 receptor were tested in rats, dogs, and cynomologous monkeys: (3-((1S,2S)-2-hydrocyclohexyl)-6-((6-(1-methyl-1H-pyrazol-4-yl)pyridin-3-yl)methyl)benzo[h]quinazolin-4(3H)-one; 1-((4-cyano-4-(pyridin-2-yl)piperidin-1-yl)methyl)-4-oxo-4H-quinolizine-3-carboxylic acid; and (R)-Et 3-(2-methylbenzamido)-[1,4'-bipiperidine]-1'-carboxylate).  Despite their selectivity for the M1 receptor, all three compds. elicited cholinergic side effects such as salivation, diarrhea, and emesis.  These effects could not be explained by activity at other muscarinic receptor subtypes, or by activity at other receptors tested.  Together, these results suggest that activation of M1 receptors alone is sufficient to produce unwanted cholinergic side effects such as those seen with xanomeline.  This has important implications for the development of M1 receptor-targeted therapeutics since it suggests that dose-limiting cholinergic side effects still reside in M1 receptor selective activators.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4zRN2771-9bVg90H21EOLACvtfcHk0lhxkWhWTsPQOA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XpvVelsLo%253D&md5=6cf55475ab7da402a6e08099bfc0f030</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1124%2Fjpet.115.226910&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.115.226910%26sid%3Dliteratum%253Aachs%26aulast%3DAlt%26aufirst%3DA.%26aulast%3DPendri%26aufirst%3DA.%26aulast%3DBertekap%26aufirst%3DR.%2BL.%26aulast%3DLi%26aufirst%3DG.%26aulast%3DBenitex%26aufirst%3DY.%26aulast%3DNophsker%26aufirst%3DM.%26aulast%3DRockwell%26aufirst%3DK.%2BL.%26aulast%3DBurford%26aufirst%3DN.%2BT.%26aulast%3DSum%26aufirst%3DC.%2BS.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DHerbst%26aufirst%3DJ.%2BJ.%26aulast%3DFerrante%26aufirst%3DM.%26aulast%3DHendricson%26aufirst%3DA.%26aulast%3DCvijic%26aufirst%3DM.%2BE.%26aulast%3DWestphal%26aufirst%3DR.%2BS.%26aulast%3DO%25E2%2580%2599Connell%26aufirst%3DJ.%26aulast%3DBanks%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DGentles%26aufirst%3DR.%2BG.%26aulast%3DJenkins%26aufirst%3DS.%26aulast%3DLoy%26aufirst%3DJ.%26aulast%3DMacor%26aufirst%3DJ.%2BE.%26atitle%3DEvidence%2520for%2520classical%2520cholinergic%2520toxicity%2520associated%2520with%2520selective%2520activation%2520of%2520M1%2520muscarinic%2520receptors%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2016%26volume%3D356%26spage%3D293%26epage%3D304%26doi%3D10.1124%2Fjpet.115.226910" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Cruickshank, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brudzynski, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McLachlan, R. S.</span><span> </span><span class="NLM_article-title">Involvement of M1 muscarinic receptors in the initiation of cholinergically induced epileptic seizures in the rat brain</span> <span class="citation_source-journal">Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">643</span><span class="NLM_x">, </span> <span class="NLM_fpage">125</span><span class="NLM_x">–</span> <span class="NLM_lpage">129</span><span class="refDoi"> DOI: 10.1016/0006-8993(94)90017-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=10.1016%2F0006-8993%2894%2990017-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=8032910" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=1%3ACAS%3A528%3ADyaK2cXivFGrtrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=643&publication_year=1994&pages=125-129&author=J.+W.+Cruickshankauthor=S.+M.+Brudzynskiauthor=R.+S.+McLachlan&title=Involvement+of+M1+muscarinic+receptors+in+the+initiation+of+cholinergically+induced+epileptic+seizures+in+the+rat+brain&doi=10.1016%2F0006-8993%2894%2990017-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46aR"><div class="casContent"><span class="casTitleNuber">46a</span><div class="casTitle"><span class="NLM_cas:atitle">Involvement of M1 muscarinic receptors in the initiation of cholinergically induced epileptic seizures in the rat brain</span></div><div class="casAuthors">Cruickshank, James W.; Brudzynski, Stefan M.; McLachlan, Richard S.</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">643</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">125-9</span>CODEN:
                <span class="NLM_cas:coden">BRREAP</span>;
        ISSN:<span class="NLM_cas:issn">0006-8993</span>.
    </div><div class="casAbstract">The present study was designed to det. the types of acetylcholine receptors involved in the initiation of epileptic seizures from the zona incerta and surrounding structures by cholinergic stimulation in rats.  Unilateral intracerebral microinjection of the mixed muscarinic and nicotinic agonist carbachol (3 μg) produced generalized seizures in 12 of 20 rats studied.  Local pretreatment with equimolar doses of acetylcholine receptor antagonists was used as a method of detg. the receptor type involved in the initiation of cholinergically induced seizures in the rat diencephalon.  Pretreatment with the M1 muscarinic receptor antagonist, pirenzepine (7 μg), abolished carbachol-induced seizures in 91% of the animals tested.  The M2 muscarinic receptor antagonist, methoctramine (12 μg) and the nicotinic receptor antagonist, mecamylamine (3 μg), were relatively ineffective in antagonizing seizures in 9% and 27%, resp.  The results suggest that M1 muscarinic receptors are preferentially involved in the initiation of generalized epileptic seizures in the basal diencephalon of the rat.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1KFGgI9np_rVg90H21EOLACvtfcHk0lhxkWhWTsPQOA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXivFGrtrg%253D&md5=b60f88c71cacb00217841df372c67408</span></div><a href="/servlet/linkout?suffix=cit46a&amp;dbid=16384&amp;doi=10.1016%2F0006-8993%2894%2990017-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-8993%252894%252990017-5%26sid%3Dliteratum%253Aachs%26aulast%3DCruickshank%26aufirst%3DJ.%2BW.%26aulast%3DBrudzynski%26aufirst%3DS.%2BM.%26aulast%3DMcLachlan%26aufirst%3DR.%2BS.%26atitle%3DInvolvement%2520of%2520M1%2520muscarinic%2520receptors%2520in%2520the%2520initiation%2520of%2520cholinergically%2520induced%2520epileptic%2520seizures%2520in%2520the%2520rat%2520brain%26jtitle%3DBrain%2520Res.%26date%3D1994%26volume%3D643%26spage%3D125%26epage%3D129%26doi%3D10.1016%2F0006-8993%2894%2990017-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit46b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Hamilton, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loose, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levey, A. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hille, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKnight, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Idzerda, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nathanson, N. M.</span><span> </span><span class="NLM_article-title">Disruption of the m1 receptor gene ablates muscarinic receptor-dependent M current regulation and seizure activity in mice</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">94</span><span class="NLM_x">, </span> <span class="NLM_fpage">13311</span><span class="NLM_x">–</span> <span class="NLM_lpage">13316</span><span class="refDoi"> DOI: 10.1073/pnas.94.24.13311</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=10.1073%2Fpnas.94.24.13311" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=1997&pages=13311-13316&author=S.+E.+Hamiltonauthor=M.+D.+Looseauthor=M.+Qiauthor=A.+I.+Leveyauthor=B.+Hilleauthor=G.+S.+McKnightauthor=R.+L.+Idzerdaauthor=N.+M.+Nathanson&title=Disruption+of+the+m1+receptor+gene+ablates+muscarinic+receptor-dependent+M+current+regulation+and+seizure+activity+in+mice&doi=10.1073%2Fpnas.94.24.13311"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46b&amp;dbid=16384&amp;doi=10.1073%2Fpnas.94.24.13311&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.94.24.13311%26sid%3Dliteratum%253Aachs%26aulast%3DHamilton%26aufirst%3DS.%2BE.%26aulast%3DLoose%26aufirst%3DM.%2BD.%26aulast%3DQi%26aufirst%3DM.%26aulast%3DLevey%26aufirst%3DA.%2BI.%26aulast%3DHille%26aufirst%3DB.%26aulast%3DMcKnight%26aufirst%3DG.%2BS.%26aulast%3DIdzerda%26aufirst%3DR.%2BL.%26aulast%3DNathanson%26aufirst%3DN.%2BM.%26atitle%3DDisruption%2520of%2520the%2520m1%2520receptor%2520gene%2520ablates%2520muscarinic%2520receptor-dependent%2520M%2520current%2520regulation%2520and%2520seizure%2520activity%2520in%2520mice%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1997%26volume%3D94%26spage%3D13311%26epage%3D13316%26doi%3D10.1073%2Fpnas.94.24.13311" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><a href="http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292340.pdf" class="extLink">http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292340.pdf</a> (accessed February 11,<span class="NLM_x"> </span><span class="NLM_year">2016</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=http%3A%2F%2Fwww.fda.gov%2Fdownloads%2Fdrugs%2Fguidancecomplianceregulatoryinformation%2Fguidances%2Fucm292340.pdf+%28accessed+February+11%2C+2016%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group">Friesen, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shanker, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crew, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smithey, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curatolo, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nightingale, J. A.</span><span> </span><span class="NLM_article-title">Hydroxypropyl methylcellulose acetate succinate-based spray-dried dispersions: an overview</span> <span class="citation_source-journal">Mol. Pharmaceutics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">1003</span><span class="NLM_x">–</span> <span class="NLM_lpage">1019</span><span class="refDoi"> DOI: 10.1021/mp8000793</span> </span><div class="citationLinks">[<a href="/doi/10.1021/mp8000793" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVSntb3F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2008&pages=1003-1019&author=D.+T.+Friesenauthor=R.+Shankerauthor=M.+Crewauthor=D.+T.+Smitheyauthor=W.+J.+Curatoloauthor=J.+A.+Nightingale&title=Hydroxypropyl+methylcellulose+acetate+succinate-based+spray-dried+dispersions%3A+an+overview&doi=10.1021%2Fmp8000793"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Hydroxypropyl Methylcellulose Acetate Succinate-Based Spray-Dried Dispersions: An Overview</span></div><div class="casAuthors">Friesen, Dwayne T.; Shanker, Ravi; Crew, Marshall; Smithey, Daniel T.; Curatolo, W. J.; Nightingale, J. A. S.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmaceutics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1003-1019</span>CODEN:
                <span class="NLM_cas:coden">MPOHBP</span>;
        ISSN:<span class="NLM_cas:issn">1543-8384</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Spray-dried dispersions (SDDs) of low-soly. drugs have been prepd. using the polymer hydroxypropyl methylcellulose acetate succinate (HPMCAS).  For a variety of drug structures, these SDDs provide supersatn. in in vitro dissoln. detns. and large bioavailability increases in vivo.  In bile-salt/lecithin in vitro solns., these SDDs provide amorphous drug/polymer colloids and an increased concn. of free drug and drug in micelles relative to cryst. or amorphous drug.  As dry powders, the SDDs are a single amorphous phase in which the drug remains amorphous and dispersed and does not crystallize over storage times relevant for practical drug products.  A melting temp. (Tm)/glass-transition temp. (Tg) (K/K) vs. log P map for 139 compds. formulated as SDDs provides a perspective on an appropriate formulation strategy for low-soly. drugs with various phys. properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqf-Shnc2vArbVg90H21EOLACvtfcHk0lhxkWhWTsPQOA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVSntb3F&md5=fde03d051c36ecaeb377c4591e6d51fe</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1021%2Fmp8000793&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fmp8000793%26sid%3Dliteratum%253Aachs%26aulast%3DFriesen%26aufirst%3DD.%2BT.%26aulast%3DShanker%26aufirst%3DR.%26aulast%3DCrew%26aufirst%3DM.%26aulast%3DSmithey%26aufirst%3DD.%2BT.%26aulast%3DCuratolo%26aufirst%3DW.%2BJ.%26aulast%3DNightingale%26aufirst%3DJ.%2BA.%26atitle%3DHydroxypropyl%2520methylcellulose%2520acetate%2520succinate-based%2520spray-dried%2520dispersions%253A%2520an%2520overview%26jtitle%3DMol.%2520Pharmaceutics%26date%3D2008%26volume%3D5%26spage%3D1003%26epage%3D1019%26doi%3D10.1021%2Fmp8000793" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4MQT" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4MQT','PDB','4MQT'); return false;">PDB: 4MQT</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i24"><a href="/doi/suppl/10.1021/acs.jmedchem.6b00544">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_14577"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.6b00544">10.1021/acs.jmedchem.6b00544</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.6b00544/suppl_file/jm6b00544_si_001.csv">CSV</a>)</p></li><li><p class="inline">Full synthetic procedures and characterization for all analogues whose procedures are not included in the main manuscript; experimental details and additional material including statistics and data analyses for our biology assays (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.6b00544/suppl_file/jm6b00544_si_002.pdf">PDF</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b00544/suppl_file/jm6b00544_si_001.csv">jm6b00544_si_001.csv (0.93 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b00544/suppl_file/jm6b00544_si_002.pdf">jm6b00544_si_002.pdf (2.79 MB)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.6b00544&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.6b00544%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2016.59.issue-13%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.6b00544" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                4MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799a253bdad3ca6","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
